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SUMMARY 
The FRAME KB cytotoxicity assay is an ill vitro test for basal cytotoxicity 
which measures the sub-lethal inhibition of cell growth by toxic substances. 
Exponentially growing 3T3-Ll mouse fibroblasts are exposed to a range of 
concentrations of a test substance for 72 hours, then relative cell number is 
estimated by the protein/kenacid blue dye-binding method. 
The assay was evaluated for its ability to predict parameters of in vivo acute 
lethal potency. In vivo/in vitro comparisons were performed for a set of 
miscellaneous chemicals and for a set of metal compounds. The degree of 
correlation was closer for the metal compounds than for the unrelated set, in 
the in vitro/mouse i.p. LDso comparison. The cytotoxicity assay was more 
useful than metal "softness" (a physico-chemical parameter) for predicting 
metal compound toxicity ill vivo. 
An investigation of the ill vitro toxicities of a group of commercial chemicals 
and formulations revealed very poor ill vivo/in vitro correlations. Some were 
toxic to the 3T3-Ll cells, yet of very low toxicity to rats. This was partly due 
to the poor solubility of some of the substances, which probably caused their 
virtual non-toxicity to rats by oral dosage. Chemical volatility is another 
methodological problem for ill vitro assays. A simple modification of the 
FRAME KB cytotoxicity assay was successfully developed in order to prevent 
the underestimation of the cytotoxicities of volatile liquids. 
The assay also demonstrated potential use for providing data for the safety 
assessment of surfactants and toiletry formulations. It is emphasised that the 
FRAME KB cytotoxicity assay should never be used in isolation, but as part 
of a battery of tests chosen for a particular type of toxicity and/or type of 
chemical or formulation. 
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The F9 embryonal carCInoma cell line was evaluated for its potential 
usefulness in in vitro toxicity testing. F9 cells were induced to differentiate 
morphologically and biochemically, and it was found that cells in different 
stages of differentiation did not respond in the same way to toxic chemicals. 
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1.1 ETHICAL, SCIENTIFIC AND ECONOMIC ISSUES 
In recent years, ill vitro toxicology has rapidly developed into a challenging new 
scientific discipline, through the support and use of ethical, scientific and 
economic arguments (Gad, 1989; Goldberg and Frazier, 1989). 
The growth of ill vitro toxicology can be measured by the success during the 
1980s of international conferences, such as the Practical III Vitro Toxicology 
meetings and the International Workshops on In Vitro Toxicology, and 
international journals, such as In Vitro Toxicology, Toxicology III Vitro and 
Alternatives to Laboratory Animals (Rack and Spira, 1989). Furthermore, the 
establishment of a database of ill vitro toxicity test protocols, INVITTOX 
(Warren et al., 1990) has attracted world-wide interest, demonstrating the 
expansion of research into in vitro toxicology from Europe and America to 
Asia and Australia. 
Ethical arguments against the use of animals in biomedical science have been 
made for well over a century (Rowan and Andrutis, 1990). Toxicologists 
began to use laboratory animals in large numbers in the 1960s, and public 
objection to the massive scale of ill vivo toxicity testing has grown into the 
widely-publicised campaigns of today (Rack and Spira, 1989). The targets for 
such campaigns have principally been the Draize eye and skin irritancy tests 
and the "classical" LDso test (Rowan and Goldberg, 1985; Goldberg and 
Frazier, 1989), as these are seen as causing the most unnecessary suffering and 
death. Thus, in vitro toxicity tests have gained the support of many animal 
welfare organisations, and are seen as one of the most promising means 
whereby the reduction and replacement of animal usage can be achieved 
(Rack and Spira, 1989; Zbinden, 1989; Balls, 1991a). Toxicologists themselves 
have been calling for a more humane approach to the use of animals in 
toxicity testing (e.g. Zbinden, 1985; Fielder et aI., 1987; van den Heuvel, 1990). 
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However, the majority of the population would agree that the safety of the 
human consumer is paramount, and hence in vitro toxicology should be judged 
not on whether it is simply an alternative to an in vivo test, but whether it is 
a scientifically valid, relevant and reliable alternative (Balls et al., 1987; Flint, 
1988). 
The scientific merit of ill vitro toxicology is not in doubt (Goldberg, 1985; Balls 
and Southee, 1990; Flint, 1990). The use of ill vitro techniques in all areas of 
biomedical science is increasing, because they allow detailed studies of well-
defined biological events (Grisham and Smith, 1984; Zbinden, 1990). Their 
application in toxicology has also been widening, as new methods of tissue and 
cell culture are developed (Goldberg, 1984), which present new and better 
ways of investigating mechanisms of toxicity (Purchase, 1986). The practical 
uses of in vitro toxicology are numerous, but in the field of toxicity testing, 
" 
regulatory guidelines and the lack of "adequately validated" alternative tests 
(Mehlman et ai., 1989; Anon, 1990) have hindered the adoption of ill vitro 
tests. However, scientists now see ill vitro methods as the way forward to a 
more flexible and scientific approach to safety assessment (Goldberg and 
Frazier, 1989; Zbinden, 1989; Parish, 1990). 
Usually, in comparison to the high cost of laboratory animal experimentation, 
in vitro toxicity tests are inexpensive, and hence the economic argument in 
their favour is compelling (Hertzfeld and Myers, 1987). However, in the 
politically-sensitive area of human safety, cost factors are not, and should not, 
be of prime importance (Roberfroid and Goethals, 1990). Regulatory bodies 
tend to follow the opinion leaders in industry in the acceptance of new 
technologies (Hertzfeld and Myers, 1987), but it may not be financially 
attractive to some sectors of the toxicity testing industry to adopt cheaper non-
animal alternatives, however valid they may be. Nevertheless, the majority of 
companies who perform in-house testing now appreciate the economic benefits 
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of finding alternatives to animals. The benefits include not only cost savings, 
but also the favourable publicity in our society, where "cruelty-free" product 
labelling is increasingly seen as important (Balls, 1991 b). 
1.2 COMPARISON OF IN VWO AND IN VITRO TOXICOLOGY 
It has been stated that toxicology should be a single discipline, using ill vitro 
and in vivo models in an integrated manner, rather like modern physiology 
(Brown, 1991). It would certainly be of benefit if the barriers between in vitro 
and in vivo toxicology could be brought down, but there appears to be little 
possibility of this happening in the near future. This is partly due to the 
entrenched attitudes of toxicologists in industry, academia and regulatory 
bodies (Anon, 1990), and the fact that ill vivo toxicity tests are governed by 
strict guidelines which, in general, currently do not permit or encourage the 
use of an integrated approach. This is despite legislation which requires 
experimenters to consider whether their use of animals is scientifically justified 
(Balls, 1989). Fairly or not, in vitro toxicology has tended to be held up 
against the in vivo science, for direct comparison rather than using it as part 
of an integrated or complementary approach. This is for two main reasons. 
Firstly, during drug development, or retrospective studies on drug toxicity, in 
vitro findings are frequently confirmed by, or compared with, in vivo 
experimentation. Secondly, it is necessary that ill vitro toxicity tests be 
validated for use (Balls et al., 1990a). Because in vivo tests are regarded (by 
the regulators) as the current "gold standard" in toxicity testing, it has become 
common to compare the results of ill vitro tests with existing in vivo data, in 
order to establish whether equivalent information has been provided. It seems 
that in vitro toxicology must somehow mirror ill vivo toxicology, for the former 
to be accepted. Certain ill vivo toxicity tests are highly inflexible and are 
performed simply to comply with the regulatory requirements of different 
countries, with no questioning of their relevance or scientific merit (Zbinden, 
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1981). The use of the classical LDso has been severely criticised in this 
respect (Zbinden, 1989; Tamborini et al., 1990), as have the Draize irritancy 
tests (Zbinden, 1987; Gad, 1989). In vitro toxicologists have the opportunity 
to set new standards in toxicity testing, and provide credible data for safety 
assessment by the use of experimental protocols which have a strong scientific 
and mechanistic rationale. However, this will not occur if the in vitro tests are 
required to be validated against the results of ill vivo tests, which were 
themselves never validated against human experience (Sharpe, 1985; Hellberg 
et al., 1990). 
Although advances in cell and tissue culture reflect great potential for the 
future of in vitro toxicology, widespread use of ill vitro toxicological techniques 
has not yet occurred. The three main uses of in vitro toxicology today reflect 
the Three Rs of Russell and Burch, namely the reduction, refinement and 
replacement of animal use in experiments (Purchase, 1990a). These uses can 
be termed, for discussion purposes, screening tests, adjunct studies and 
replacement tests (Frazier, 1990), although the distinction between them is not 
always great. Opinions vary as to the value of each of these categories, and 
their future prospects. 
1.3 SCREENING TESTS 
A screening test is normally a first-order toxicity test which is relatively simple 
and rapid to perform. It is therefore useful for testing large numbers of 
substances, to permit the selection of a small number for further development 
(Balls et a/., 1990a; Frazier, 1990). The use of screening tests (or pre-screens) 
early in product development is thus mainly elective, because there are few 
mandatory requirements for them to be performed (Purchase, 1990a). 
Because of the elective aspect, there is little standardisation between 
laboratories who use them. Screening tests provide information for three main 
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purposes (Purchase, 1990a):-
(a) to identify substances which lack the particular toxic property which is 
to be screened out. Any lack of toxicity in vitro is normally confirmed 
later in vivo; 
(b) to rank the substances which possess the desired biological activities in 
order of priority for further evaluation, by identifying which are most 
toxic; 
( c) to identify particular toxic properties of a substance, so that in vivo 
testing can be avoided, or the suffering of animals can be reduced. 
Examples of in vitro screening tests are those for dust fibrogenicity (Purchase, 
1990a), the Salmonella mutagenicity tests such as the Ames test (Ames et al., 
1975), and tests for skin corrosivity using human, rat or rabbit skin slices 
(Oliver et al., 1986). The latter test is an example of a test which can help 
reduce animal suffering. If the test detects corrosive properties in a neat 
substance, then it will be diluted for application in the in vivo experiments. 
The micromass teratogenicity test (Flint, 1987) has been used to distinguish 
chemicals that should progress to further development. For example, a series 
of fungicidal chemicals had been developed, and the micromass assay was used 
to select out those which demonstrated the greatest potential teratogenicity 
(Flint, 1986). 
Other, more specialised screening procedures include rat brain re-aggregate 
cultures, which are used as models for central nervous system neurotoxicity 
(Atterwill, 1990), and primary cultures of porcine thyrocytes which provide an 
in vitro system for testing chemicals for potential thyrotoxicity (Atterwill and 
Fowler, 1990). 
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There is considerable scope for ill vitro tests to be employed in many areas of 
toxicity testing in early product development (Flint, 1988; Rhodes et al., 1989; 
Frazier, 1990). The adoption of in vitro screening tests in industry is a good 
example of the successful application of ill vitro techniques in toxicology. 
Eventually, screening tests may be found to be good enough to be accepted 
as replacement tests. 
1.4 ADJUNCT TESTS 
Adjunct in vitro toxicology studies are run in conjunction with ill VIVO 
experiments, in order to improve the specificity and sensitivity of the in vivo 
work (Parish, 1990; Purchase, 1990a). Specificity, e.g. differences in species 
susceptibilities, cannot be easily investigated ill vivo, because the whole body 
approach is not conducive to the elucidation of mechanisms and sites of action 
of the toxic substance. Substances whose primary site of action is a particular 
organ (such as the brain, kidney or liver) are tested in cell or tissue cultures 
of that organ, from the different animals of interest. Areas of target organ 
toxicity which have benefited from adjunct III vitro studies include 
nephrotoxicity (Gandolfi and Brendel, 1990; Gonzalez et al., 1990), 
cardiotoxicity (Toraason et al., 1990) and lung toxicity (Ryrfeldt et al., 1990). 
The study of liver toxicity using cultures of hepatocytes from different species 
is one of the most advanced areas of ill vitro toxicology (Frazier, 1990). 
Hepatocytes have been used successfully to determine mechanisms of toxicity 
of a variety of xenobiotics (Blaauboer et al., 1990; Guillouzo et al., 1990), for 
example di(2-ethylhexyl phthalate) and nafenopin (Bieri et al., 1990). 
Improving the sensitivity of in vivo studies can be achieved through ill vitro 
models which are able to contribute information about the pharmacokinetics 
or toxicokinetics of a substance (Dean and Chenery, 1990; Purchase, 1990a). 
The competing routes of metabolic activation or inactivation of a substance 
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can be measured ill vitro (Garle and Fry, 1988), but the development of 
reliable techniques for the detection of metabolism-mediated cytotoxicity are 
still in their early stages (Glatt et al., 1989; Fry et al., 1990a). The rate of 
penetration of a chemical through human cadaver skin samples ill vitro can 
provide toxicokinetic information which is useful for risk assessment purposes 
(Rhodes et al., 1989). 
Phototoxicity is one area of toxicology where animal methods have not been 
standardised and there are no regulatory guidelines. Although many ill vivo 
procedures exist, they are often performed alongside ill vitro and human tests, 
because of the acknowledged limitations of the animal methods (Maurer, 
1987). Webster et al. (1982) combined human and ill vitro investigations in an 
attempt to elucidate the mechanism of phototoxicity of benoxaprofen. 
Adjunct studies can therefore provide high quality toxicological data, which 
otherwise may not have been obtainable ill vivo. Like screening tests, adjunct 
studies are generally elective, because each individual substance requires a 
different approach to elucidate its mechanism of action. The future of ill vitro 
systems for this application appears to be very promising. 
1.5 REPLACEMENT TESTS 
Replacement of animal tests, the third R in Russell and Burch's Three Rs, is 
highly controversial in toxicology. Whilst it is becoming acknowledged that ill 
vitro techniques have much to offer as adjuncts, or can be useful as pre-
screens, the true replacement of any regulation-defined ill vivo test has not 
occurred. Some believe that whole animal studies will never be replaced 
(Brown, 1991), particularly in systemic toxicity tests. This belief is based on 
the fact that the latter depend on the interplay of uptake, distribution, 
metabolism and excretion of a substance in eliciting the toxic response 
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(Rowan, 1983; Zbinden, 1989). Although current ill vitro methods cannot 
currently model the whole of this pharmacokinetic process, it is not 
unreasonable to believe that this is achievable in the future (Frazier, 1990; 
Balls, 1991c). The replacement of in vivo tests ultimately depends on the 
decision-makers at regulatory authority and government level, and, although 
attitudes are shifting (Balls et al., 1990b), progress is inevitably slow. For 
example, the Fixed Dose Procedure (FDP) is an ill vivo acute systemic toxicity 
test which has recently been validated (but still not universally accepted) as an 
alternative to the classical LDso test (van den Heuvel et al., 1990). Despite the 
overwhelming scientific evidence in favour of the FDP, and the discrediting of 
the LDso test, the FDP is still only deemed an altenlative to the LDso, not a 
replacement (van den Heuvel, 1990). Regulatory toxicologists naturally have 
human safety as their prime concern, and therefore appear unwilling to change 
a system which they perceive as being satisfactory for the purpose of safety 
assessment. 
The diversity and complexity of toxic mechanisms and sites of action of all 
chemicals within one type of toxicity cannot, and probably will not, 
satisfactorily be modelled with one ill vitro test system. Therefore, an ill vivo 
test which call evaluate many mechanisms within one type of toxicity is unlikely 
to be replaced with one ill vitro test (Frazier, 1990). In several areas of in vitro 
toxicology, a battery of test systems has been proposed (Shopsis el al., 1985; 
Balls et al., 1991a). Each battery would consist of a number of alternative 
tests which together would provide a span of the toxic mechanisms or target 
processes of interest (Shopsis et al., 1987; Ekwall et al., 1991). "Alternative 
tests" includes not only ill vitro procedures, but also computer molecular and 
mathematical modelling techniques (Parke et al., 1990). Any test battery 
based on mechanistic relevance in this way, and found to be highly predictive 
in validation studies, could offer a feasible and more acceptable means of 
replacing an in vivo test completely (Frazier, 1990). 
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1.6 VALIDATION 
For an in vitro toxicity test to be accepted as a replacement to an ill vivo test, 
the former must be rigorously and adequately validated (van den Heuvel and 
Fielder, 1990). Until recently, the validation process has not been strictly 
defined, and several expensive validation studies have been performed which 
have achieved very little (Balls and Clothier, 1989). Although international 
validation workshops have made recommendations as to how studies should 
be organised (Balls et al., 1990a, Balls et al., 1990b), it is not clear who should 
have the final decision on whether a test has been adequately validated or not. 
Validation may be defined as "the process by which the reliability and 
relevance of a procedure are established for a specific purpose" (Balls et al., 
1990a). Toxicity tests are designed to predict adverse effects in humans, and 
it is therefore logical that a test should be validated using data from human 
experience (Hellberg et al., 1990). Human systemic poisoning data is available 
for some common drugs and poisons (Ekwall, 1980), but is insufficient or 
unavailable for other types of toxic effect and other classes of substances (Balls 
and Clothier, 1989). It would therefore be difficult to interpret the in 
vitrolhuman comparison when the human data was unreliable or anecdotal. 
The Scandinavian multi-centre evaluation of in vitro cytotoxicity (MEIC) 
involves chemicals selected for inclusion by the virtue of having human 
poisoning data of sufficient quality to permit a meaningful estimate of human 
lethal blood concentrations (Ekwall et al., 1989). Values have been calculated 
for 50 human poisons, using information supplied by the Swedish Poisons 
Information Centre and from the literature. 
Toxicity data from animals, however, constitute a much larger and more 
available information set with which to compare ill vitro results. However, if 
animal data are to be used, their drawbacks must be acknowledged, so that 
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any comparisons do not regard the ill vivo results as inviolable, absolute values. 
These drawbacks include: the reliability of the data source itself (for example, 
the Registry of Toxic Effects of Chemical Substances (RTECS; Lewis and 
Tatken, 1982) is known to contain a significant proportion of errors); the 
underlying requirement to accept the extrapolation of the animal model to 
man; variability in test protocols; and ambiguous classification of results (Balls 
et ai., 1990a). In order to overcome some of these drawbacks, the 
establishment of an international reference chemical data bank has been 
proposed (Purchase, 1990b). The purpose of the data bank would be to 
provide appropriate selections of chemicals, backed by a reliable source of 
toxicological data and expert advice for validation studies. The international 
databank of in vitro toxicity test protocols, INVITTOX (Warren et ai., 1990), 
also has a role in validation. By disseminating protocols to laboratories in 
many countries, more scientists will try out the methods and therefore 
contribute to the range of chemicals tested, as well as providing further 
information on the interlaboratory reproducibility and usefulness of the 
methods. 
Numerous ill vitro alternatives to ill vivo eye irritancy tests have been proposed 
(Wilcox and Bruner, 1990). Several of these have been the subject of 
validation studies designed to measure the degree of correlation between the 
in vitro results and in vivo irritancy data. The methods which have received the 
most attention are the Neutral Red Uptake cytotoxicity test (Borenfreund and 
Puerner, 1985), the chicken egg chorio-allantoic membrane assay (van Erp and 
Weterings, 1990), EYTEXTM (Gordon and Bergman, 1987), and the bovine 
isolated eye assay (van Erp and Weterings, 1990). Interlaboratory trials have 
been taking place in Europe and America (e.g. Kalweit et ai., 1990), but the 
outcomes are not yet fully known. Nevertheless, certain industrial in-house 
testing laboratories, such as Avon Products Inc., have felt confident enough in 
some of the alternative methods that Draize ocular testing of their products 
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is no longer conducted. The complete replacement of Draize eye testing 
protocols at regulatory level may seem a long way off to some observers (Gad, 
1989; Wilcox and Bruner, 1990), but the belief now exists in many circles that 
it is an achievable objective. 
In contrast, there has been slow progress towards validating suitable 
alternatives in the field of acute systemic toxicity. Several in vitro tests have 
been developed as alternatives in this field, mainly based on the measurement 
of basal cytotoxicity in cell cultures (Ekwall, 1983a). A substance which is 
basally cytotoxic is one which interferes with the basic cellular functions or 
structures which are present in all cells (Bernson et al., 1986; Fry et al., 1990b). 
Examples are anti-metabolites, microtubule inhibitors and surfactants. Hence, 
basal, or "general", cytotoxicity tests tend to use relatively undifferentiated cell 
lines, which may be continuous or finite-lived, and have no specialised 
functional characteristics (Ekwall and Ekwall, 1988). 
The endpoint most commonly employed to measure toxic interference with 
these basic attributes is the sublethal inhibition of cell growth (Flint, 1988). 
Stark et ale (1986) described this endpoint (quantified by various assays such 
as vital dye uptake, total cell protein, cell counting or colony formation) as 
being ideal, because it is relevant to virtually any mode of insult. However, it 
is not relevant if the test substance requires metabolic activation to produce 
a cytotoxic effect and the cells in culture do not possess the metabolic capacity 
to activate the test substance. In this situation, it must be acknowledged that 
the cytotoxicity test will measure the effects of the parent compound, and not 
the metabolites which are responsible for toxicity in vivo. It is also not relevant 
if one wishes to examine substances which cause organ-specific or tissue-
specific effects, i.e. they interfere with cell or tissue functions or structures 
which are specific to a particular tissue or organ. For this, one requires a cell-
line or culture which possesses the specialised attributes of that tissue or 
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organ. In order to establish whether or not the cytotoxicity measured in the 
specialised cell culture is basal, one must also test the substance in parallel in 
an undifferentiated cell line (Ekwall and Ekwall, 1988). 
In addition to ill vitro alternatives, there have been several attempts to model 
acute systemic toxicity by quantitative structure-activity relationships (QSAR) 
(Enslein, 1988; Phillips et aZ., 1990). Most have attempted to predict LD50 
values, but Phillips et aZ. (1990) concluded that the LD50 as a toxic endpoint 
cannot be predicted by QSAR, because of the diversity of toxic mechanisms 
involved, unless a set of compounds with a common mechanism of action were 
chosen. Knowledge of such mechanisms must be developed further before 
QSAR can exert a significant influence in predictive toxicology (Purchase et 
aZ., 1990). 
The results of some ill vitro cytotoxicity tests have been compared to animal 
acute lethal potency parameters, such as LDso values (e.g. Walum and 
Peterson, 1983; Shops is and Eng, 1985; Borenfreund and Babich, 1987a; 
Simmons et aZ., 1987; Clothier et al., 1989; Fry et al., 1990b) and to human 
toxicity parameters (Ekwall et al., 1989; Knobeloch et aZ., 1990). In some 
cases, too few chemicals were compared for definite conclusions to be drawn, 
although, in general, the indications were that ill vitro and ill vivo parameters 
correlated reasonably well (Ekwall and Ekwall, 1988). The MEIC study found 
that for 10 unrelated drugs and poisons, there was a good correlation between 
ill vitro cytotoxicity assays and rodent oral LDso or human acute lethal toxicity 
values (Ekwall et al., 1989). The multivariate cytotoxicity model was able to 
predict the human values as accurately as the mouse oral LDso. Clothier et al. 
(1989) found that the cytotoxicities of 59 miscellaneous pure chemicals 
correlated well with rat oral and mouse i.p. LDso values. Rat oral LDso data 
were considered appropriate because they are widely used as a parameter by 
which to classify chemicals for hazard labelling, and as a basis for selecting 
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dosage in other in vivo tests. Mouse i.p. values are also reasonably abundant 
in the literature, and have been proposed as a more logical parameter with 
which to compare ill vitro data (Fry et ai., 1988a). Clothier et ai. (1989) and 
Fry et ai. (1990b) both concluded that the mouse i.p. LDso values correlate 
better than rat oral LDso values with ill vitro cytotoxicity test results. 
The choice of chemicals for an ill vitro/ill vivo comparison can influence the 
significance of the correlation found. For some validation studies, it is 
considered appropriate to select chemicals with a wide variety of toxic potency 
and mode of action (Purchase et ai., 1987). This serves to demonstrate 
whether the test under validation can detect the same spread of toxic potency 
as the "gold standard" test. The selection of chemicals with many modes of 
action can serve to evaluate whether the test under validation can detect 
toxicity by all these modes of action. However, while many ill vitro cytotoxicity 
tests will be able to demonstrate a correlation with ill vivo data for a group of 
unrelated chemicals, it is difficult to interpret how useful the in vitro test would 
be at predicting the ill vivo toxicity of further, unrelated chemicals. 
It is therefore becoming recognised that the ill vitro testing of chemicals which 
are related will permit better interpretation of the results (Balls et ai., 1990a; 
Phillips et ai., 1990). Several approaches can be taken. Pairs, or small groups 
of chemical analogues can be tested in order to establish whether one or more 
has the particular toxic property of interest (Purchase et ai., 1987). This is 
used particularly during the validation of ill vitro tests for teratogenicity and 
genotoxicity. A different approach is to select a larger number of chemicals 
related by their chemical structure and/or mode of toxicity. If a strong in 
vitro/in vivo correlation is noted for this group, then this will allow greater 
confidence to be placed in the ill vitro prediction of the in vivo toxicities of 
further chemicals which are known to have the same structure or toxic 
mechanism. This in turn may lead to the acceptance of the test as valid for 
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that type of substance, but not for other types of substance (Flint, 1990). 
Another method is to test substances related by their commercial use, such as 
shampoos, fungicides or solvents. This may permit the manufacturer to select 
the least harmful substance from a group which were equally active for their 
desired purpose. Alternatively, it can provide a database of a range of ill vitro 
toxicities for substances in a particular product group (whose safety profiles 
are known), which may be referred to when testing (ill vitro) further products 
from that group. According to whether a new product in the group gives an 
in vitro toxicity result inside or outside the known range, the information can 
be used in the safety assessment process. 
1.7 IN VITRO TOXICOLOGY IN INDUSTRY 
The question of the use of an ill vitro toxicity test in industry is very relevant. 
There is little point in developing an in vitro test which cannot be adapted for 
use within industry, as it is their responsibility for testing novel substances for 
safety assessment purposes. Toxicity studies are carried out by industrial 
companies on chemicals and formulations for many reasons. Some studies are 
for research and evaluation purposes, when elective screening tests are 
performed and decisions about priority among candidate compounds are made 
(Purchase, 1990a); each company may perform a different set of tests at this 
stage. In the final development of a novel substance (pure chemical or 
formulation), definitive data must be obtained according to official protocols, 
in order to satisfy regulatory requirements so that it can be legally marketed. 
These sets of mandatory toxicity tests differ according to the proposed use of 
the substance (van den Heuvel and Fielder, 1990). The regulatory agencies 
have a duty to ensure that the new substances are not likely to endanger the 
health of the industrial worker in the manufacturing company (by applying 
adequate hazard warning labels) or the final user (by ascertaining that they are 
not harmful in normal use). At present, the vast majority of these mandatory 
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tests are performed in animals. Only fully validated alternative tests will be 
considered as possible replacements for the in vivo tests. In vitro genotoxicity 
tests have been accepted by the U.K. Department of Health as a valid part of 
genetic toxicity testing. A certain amount of scientific freedom is allowed in 
the choice of these genotoxicity tests, but in vivo tests still cannot be avoided 
altogether (Richold, 1990). The UK Environmental Mutagen Society has 
provided a useful forum for industrialists and academics, and this has assisted 
in the standardisation of test protocols (Venitt and Parry, 1984). 
An industry/academia collaboration of this sort would potentially speed up the 
adoption of other types of in vitro toxicity tests. In the early 1980s, the Fund 
for the Replacement of Animals in Medical Experiments (FRAME) initiated 
a research project on in vitro cytotoxicology, the aim of which was to 
investigate the extent to which "cell cultures could profitably and reliably be 
used to replace live animal methods used in routine tests on the acute toxicity 
of chemicals" (Balls and Bridges, 1984). A basal cytotoxicity test was 
developed through the collaboration of four UK research laboratories and the 
financial support of several large companies involved in the toxicity testing of 
chemicals (Balls and Horner, 1985; Knox et al., 1986; Balls et al., 1987). The 
basis of this test is that a cytotoxic chemical, regardless of the site or 
mechanism of its action, will interfere with the proliferation of cells which 
normally grow in culture. The sublethal inhibition of the growth, related to 
the concentration of the test chemical applied, will provide an indication of 
cytotoxic potency. The cytotoxicity test underwent inter-laboratory evaluation 
and was found to be reliable and reproducible (Balls and Horner, 1985; Knox 
et ai., 1986). The test became known as the FRAME Kenacid Blue (KB) 
method or assay. The KB stain binds to protein, and is used to measure the 
relative amounts of cellular protein in culture wells, following the exposure of 
exponentially growing cultures of cells to test materials. The interlaboratory 
evaluation involved the testing of chemicals whose modes of action and known 
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toxic potencies were chosen to be as wide-ranging as possible. However. they 
tended to include a large proportion of chemicals likely to cause toxicity 
following systemic, rather than topical, exposure. In addition, some chemicals 
were deliberately included because of the difficulties they would be likely to 
cause in in vitro tests, such as aqueous insoluble or volatile substances, or those 
which require metabolic activation to exert their toxicity (Knox et al., 1986). 
It is known that the majority of cell lines possess very little enzymic capacity 
for the activation of such chemicals (Fry et al., 1988b). 
When the human fibroblast-like BCL-Dl cell line used in the initial evaluation, 
suddenly and unexpectedly ceased to be available, the test was re-evaluated 
with the murine fibroblast-like 3T3-Ll cell line (Riddell et al., 1986a,b). An 
extended set of test substances was then chosen to include all the chemicals 
from the first evaluation (Knox et al., 1986), but attention was also paid to the 
selection of some sets of related chemicals, such as metal compounds, 
surfactants and straight chain alcohols (Clothier et al., 1988; Hulme et al., 
1989). Hunt et al. (1987) evaluated the FRAME KB cytotoxicity assay for 
testing water toxicity, but the application of the assay in the context of the 
safety assessment of chemicals and formulations for industrial and regulatory 
purposes has yet to be ascertained. 
In this thesis, the FRAME KB cytotoxicity assay is evaluated by its application 
to several sets of related substances, to examine whether the ill vivo 
predictivity of the assay is improved by selecting related groups. Metal 
compounds, surfactants, toiletries, industrial biocides and formulations were 
tested, and the results obtained were considered for their relevance to the type 
of ill vivo toxicity data required for these substances. In response to the stated 
lack of confidence in results for volatile liquids (Knox et al. 1986; Clothier et 
ai., 1988), an investigation was made into whether the basic cytotoxicity assay 
could be adapted to permit volatile liquids to be tested with greater 
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confidence. A series of preliminary experiments were also undertaken, in 
order to evaluate the potential usefulness of a differentiating embryonal 
carcinoma cell line in the development of an in vitro test for teratogenicity. 
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2.1 METHODS 
2.1.1 FRAME Kenacid Blue (KB) Cytotoxicity Assay 
The KB assay method was used for testing the 150 chemicals (Chapter 3), the 
metal compounds (Chapter 4) and the pure surfactants (Chapter 6). The 
Rhone-Poulenc Ltd. products (Chapter 5) and the cosmetic and toiletry 
formulations (Chapter 6) were also tested by this method, but in 96-well 
culture plates only. 
2.1.1.1 Cell culture 
3T3-L1 embryonic mouse fibroblasts were kindly supplied by Professor John 
Mayer, Department of Biochemistry, University of Nottingham. The cells were 
routinely cultured in 75cm2 tissue culture flasks in 3T3-L1 culture medium at 
37°C in a 5% CO2/95% air atmosphere. They were dissociated for subculture 
twice weekly with 0.05% (w/v) trypsin/0.02% (w/v) EDT A. Cell stocks were 
maintained under liquid nitrogen (-196°C) or at -70°C in 3T3-L1 cell freezing 
medium. Fresh cultures were regenerated from frozen stocks once the existing 
line had undergone 50 subcultures. 
2.1.1.2 Cytotoxicity testing 
The method used was based on that of Knox et al. (1986). 3T3-L1 cells were 
seeded at a density of 1 x 104/cm2 in 23 wells of a 24-well plate (2 x 104 cells 
in 1ml of medium), or 95 wells of a 96-well plate (1.6 x 104 cells in 0.2ml of 
medium). The remaining well received medium only. Control studies showed 
that different sized culture surfaces produced the same cytotoxicity test results. 
After overnight incubation, the medium was aspirated and replaced by 
medium containing a dissolved test substance. The substances were dissolved 
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directly into culture medium where possible. Substances which were 
insufficiently soluble in aqueous medium were dissolved initially in methanol, 
ethanol or dimethyl sulphoxide. The final concentration of these solvents was 
always 1% (v/v) , at which level the rate of control cell growth was not 
adversely affected. Test substance solutions, and control medium or 1 % (v/v) 
solvent controls were all included in triplicate. 
After 72 hours of test substance exposure, the medium was removed and cell 
mono layers were washed twice with warm PBS. Cells were then fixed ill situ 
with KB fixative for 20-30 minutes. The fixative was replaced with KB stain 
and the plates were agitated for a further 20 minutes. The stain was washed 
away with several changes of KB wash solution. Each well then received an 
exact volume of KB desorb solution (24-well plate - 1ml; 96-well plate - 0.2ml). 
Plates were agitated until the desorbed stain solutions were homogenous. The 
absorbances of 24-well plate wells were measured at 570nm in a Dynatech 
Minireader. 96-well plates were read in a Kontron SLT-210 plate reader at 
577nm, against a 404nm reference filter. In both cases the absorbance of the 
well without cells was used as the blank. 
2.1.1.3 Calculation of results 
Each substance was tested on at least three separate occasions. The mean 
absorbance of the triplicate wells for each test substance concentration on 
each occasion was expressed as a percentage of the mean absorbance of the 
control wells. KB absorbance has been shown to have a linear relationship 
with total cell number and total cell protein (Knox et aI., 1986). Hence, the 
concentrations of substances which reduced the final total cellular protein 
content of wells by 20%, 50% and 80% (the ID2o, ID50 and IDso values 
respectively) could be calculated from the dose-response (concentration - % 
of control well absorbance) curves. The mean ID2o, ID50 and IDgO values from 
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the three (or more) experiments were then calculated. 
2.1.2 Modification of the FRAME KB Cytotoxicity Assay for tests on volatile 
chemicals 
This assay method for volatile materials was used for testing the chemicals 
discussed in Chapter 7. 3T3-L1 cells were cultured as described in section 
2.1.1.1, except that the ingredients for the 3T3-L1 culture medium were 
supplied by Northumbria Biologicals Ltd. 
2.1.2.1 Cell culture and cytotoxicity tests 
3T3-L1 cells were seeded at a density of 0.5 x 104/cm2 in 95 wells of a 96-well 
plate (0.15 x 104 cells in 0.15ml of medium). The remaining well received 
medium only. After overnight incubation, the medium was aspirated and 
replaced by medium containing a dissolved test substance (solid or liquid). 
The test substances were made into solutions as described in section 2.1.1.2, 
except that organic solvents were used at 0.1 % (v/v). 
Unsealed (US) culture plates were returned to the incubator as usual. Every 
well in the oil-sealed (OS) culture plates received O.lml of light paraffin oil 
which, due to its low density, floated on top of the medium. The film-sealed 
(FS) culture plates had the adhesive film firmly attached directly onto the top 
of the wells. The lids were replaced and all plates were returned to the 
incubator. 
After 72 hours of test substance exposure, the cultures were examined by 
phase-contrast microscopy. The medium was then removed and the cell 
monolayers were washed twice with warm PBS. Cells were then fixed ill situ 
with KB fixative for up to 4 hours. The fixative was then replaced with KB 
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stain. In the absence of a plate agitator or shaker, the stain was left in contact 
with the cells for 2 hours. The stain was washed away with several changes of 
KB wash solution. Each well then received 0.15ml of KB desorb solution. 
The KB stain was desorbed by trituration. The absorbances of each well were 
measured at 595nm in a Flow Titertek Multiscan plate reader. The 
absorbance values were read directly into a computer program, Titersoft, 
which calculated the mean percentage absorbances of test substance treated 
wells compared with the untreated control wells. The absorbance of the well 
without cells was used as the blank. 
2.1.2.2 Calculation of results 
Each substance was tested on at least three separate occasions. The mean 
absorbance of the triplicate wells for each substance concentration on each 
occasion was expressed as a percentage of the mean absorbance of the control 
wells. Hence the concentrations of each test substance which reduced the final 
total cellular protein content of wells by 20%, 50% and 80% (The ID20, 1D5o 
and 1Dso values, respectively) could be calculated from the dose-response 
(concentration - % of control well absorbance) curves. The mean IDzo, 1D5o 
and 1Dso values from the three (or more) experiments were then calculated. 
2.1.3 Experiments with F9 embryonal carcinoma cells 
These methods were used in the experiments described in Chapter 8. 
2.1.3.1 Cell culture 
F9 murine embryonal carcinoma cells (a gift from Dr A K Daly, Department 
of Pharmacological Sciences, University of Newcastle-upon-Tyne) were 
cultured in 75cm2 tissue culture tlasks in F9 culture medium at 37°C in a 5% 
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CO2/95% air atmosphere. F9 cells require culture surfaces to be coated with 
gelatin to aid adherence. Hence, prior to use, the surfaces of flasks and plates 
were rinsed with a 0.1 % (w/v) porcine gelatin solution. Excess solution was 
aspirated and the vessels were left to dry overnight. Cells were subcultured 
every 2-3 days following treatment with the trypsinisation reagent. Cell stocks 
were maintained under liquid nitrogen (-196°C) or at -70°C in F9 freezing 
medium. Fresh cultures were regenerated from frozen stocks every 8 to 10 
weeks (i.e. every 25 to 30 passages). 
2.1.3.2 Cytotoxicity testing 
On undifferentiated cells 
The method used was based on that of Knox et al. (1986), using 24-well plates, 
but with the test chemical exposure time reduced from 72 to 48 hours. 
Undifferentiated F9 cells were seeded at 2.5 x 104/cm2 (5 x 104 cells in 1ml of 
medium) in 23 wells of a 24-well plate. The remaining well received medium 
only. After overnight incubation, the medium was aspirated and replaced by 
1ml of medium containing a dissolved test chemical. Chemicals which did not 
dissolve directly into medium at the concentrations required were dissolved 
initially in either ethanol or DMSO. The final concentration of the ethanol or 
the DMSO was 1% (v/v) in the medium. Medium only, and 1% solvent 
control wells were also included in triplicate. This allowed six or seven 
chemical concentrations to be tested in triplicate per plate, with the highest 
dose being in duplicate only (to allow for the well without cells). 
After 48 hours exposure, the total well protein was determined by the 
FRAME KB cytotoxicity assay (as described in section 2.1.1.2). Absorbances 
were measured at 570nm in a Dynatech Mini-reader. The well without cells 
was used as the blank. 
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On differentiating cells 
Undifferentiated F9 cells were seeded at 2.5 x 104jcm2 (5 x 104 cells in 1ml of 
medium) in culture medium containing O.lJ.LM retinoic acid (RA) in 23 wells 
of a 24-well plate. They were then treated with test chemicals as for 
undifferentiated cells, but the test chemical and control solutions also 
contained O.lJ,LM RA. At the end of the 48 hour exposure period, the cells 
were washed with PBS to remove serum proteins. The protein in each well 
was solubilised with 1ml of 1M sodium hydroxide for 2 hours with shaking. 
Protein extracts were assayed for total protein using the Bradford method 
(Bradford, 1976). The dye reagent was filtered twice before use, and was 
stable for two weeks. 100J,LI of the cell protein extract solution was mixed with 
1ml of dye solution in a disposable plastic test tube. The absorbance of the 
solution (placed in a 1ml disposable plastic cuvette) was then read at 595nm 
in a Cecil spectrophotometer, using 1M sodium hydroxide in the dye solution 
as the blank. A standard curve was prepared from a range of dilutions (0 to 
600J,Lg/ml) of a Sigma protein standard solution diluted in 1M sodium 
hydroxide. Control well total protein levels (i.e. 100% cell growth) were 
usually between 90 and 130J.Lg per well. 
On differentiated cells 
Differentiated F9 cells were obtained by seeding and growing previously 
undifferentiated cells for 5 or 6 days in the presence of O.lJ,LM RA in 75cm2 
flasks. Because of continued growth during this period, the cells were 
subcultured on day 3 into a fresh solution of O.lJ.LM RA in medium. Cells 
were seeded for tests at 5 x 104jcm2 (10 x 104 cells in 1ml of medium) in 
culture medium containing O.lJ,LM RA in 23 wells of a 24-well plate. Chemical 
treatments and the Bradford protein assay were conducted as for the 
differentiating cells. 
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2.1.3.3 Calculation of results 
Each chemical was tested on at least three separate occasions. 
Undifferentiated F9 cells: The mean absorbance of the triplicate wells for each 
chemical concentration on each occasion was expressed as a percentage of the 
mean absorbance of the control wells. 
Differentiating and differentiated F9 cells: The mean quantity of protein in the 
triplicate wells for each chemical concentration on each occasion was 
expressed as a percentage of the mean quantity of protein in the control wells. 
The concentrations of the test chemicals which reduced the final total cellular 
protein content of wells by 20%,50% and 80% (the ID2o, 1Dso and 1D8o values 
respectively) could be calculated from the dose-response (concentration - % 
of control well absorbance or protein) curves. The mean ID2o, 1Dso and 1D8o 
values from the three (or more) experiments were then calculated. 
2.1.3.4 Enzyme-Linked Immunosorbent Assay (ELISA) for Laminin 
Outline of the assay 
The ELISA method was based on that of Williams et al. (1987), which had 
been developed to measure retinoid-induced F9 cell differentiation into 
parietal endoderm-like cells. Briefly, cell culture medium samples were co-
incubated with a rabbit IgG anti-mouse laminin antibody. The mixture was 
then transferred to microtitre wells coated with laminin. Any unbound anti-
laminin in the mixture became immobilised on the solid phase. This was then 
detected using an alkaline phosphatase/goat anti-rabbit IgG antibody 
conjugate, with p-nitrophenol phosphate as the substrat.e to generate colour. 
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Laminin assay procedure 
Samples of medium were collected after the 48 hour exposure period from 
every culture well in the cytotoxicity tests (including both differentiating and 
differentiated F9 cells) and stored at -20°C until required for the assay. 
Samples were thawed then centrifuged at 2500g to remove dead cells. Each 
sample was diluted to 40% (v/v) with PBST. 501-'1 of the diluted medium was 
then mixed with an equal volume of a 1 in 12000 dilution of rabbit IgG anti-
mouse laminin antibody in PBST, in the wells of a 96-well flexible polyvinyl 
ELISA plate. The medium and anti-Iaminin antibody mixture was incubated 
at 22-24°C overnight, during which time any laminin in the medium became 
bound to the anti-Iaminin antibody. At the same time, a laminin-coated 96-
well polyvinyl ELISA plate was prepared by incubating 501-'1 of 11-'g/ml mouse 
laminin in a pH 9.6 coating buffer in each well, overnight at 4°C. 
The laminin-coated plate was allowed to come to room temperature and was 
washed with PBST to remove any unbound laminin. The washing technique 
consisted of filling each well with PBST and immediately shaking it out. This 
was repeated twice more. After the final wash, all liquid was removed from 
wells onto paper towels by flicking the plate. 501-'1 aliquots of the 
medium/anti-laminin incubations were transferred to the laminin-coated plate, 
and incubated for 30 minutes at room temperature. During this time, any 
excess unbound anti-laminin antibody became immobilised on the laminin-
coated solid phase. The plate was washed three times with PBST, as above. 
The presence of immobilised rabbit anti-laminin was detected by the addition 
to every well of 501-'1 of a 1 in 1000 dilution of alkaline phosphatase/goat anti-
rabbit IgG antibody conjugate in PBST. After incubation at room temperature 
for 60 minutes, any unbound conjugate was washed out twice with PBST, then 
twice with pH 9.8 substrate buffer, to bring the plate to the correct pH. 1001-'1 
of freshly-prepared p h o s p h a t a ~ e e substrate (lmg/ml p-nitrophenol phosphate 
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in pH 9.8 substrate buffer) was added to each well. The production of a 
yellow colour, due to the conversion by alkaline phosphatase of p-nitrophenol 
phosphate to p-nitrophenol, was measured at 404nm in a Kontron SLT-210 96-
well plate reader. The colour was allowed to develop for between 100 and 
200 minutes, until the absorbance had reached approximately 1.0 in the 
control (no laminin) wells. A standard curve was prepared using a range of 
dilutions from 5 to 200ng/ml of the purified mouse laminin in 40% culture 
medium/60% PBST (v/v). The standard dilutions were assayed on four 
separate occasions and a standard curve was constructed from the mean of the 
results (Figure 2.1). The full range of standard dilutions was not included in 
every assay run. Instead, 40ng/ml and 200ng/ml dilutions were assayed in each 
run to confirm that the assay was performing correctly. 
Absorbance results were expressed as a percentage of the maxImum 
absorbance (i.e. the me"an absorbance of the 0 ng/mllaminin wells) generated 
in each assay run. The limits of detection of the ELISA were taken as 5 to 
100ng/ml, i.e. between 80% and 30% maximum absorbance. In order to 
detect greater than 100ng/ml, medium samples were diluted below 40% in 
PBST in the initial dilution. The final dilution factor of medium in the 
medium/anti-Iaminin coincubation was 1 in 5, hence laminin concentrations 
read from the standard curve were multiplied by five. 
2.1.4 Statistical tests 
Linear regression analysis was performed using the Techni-Curve graph-
plotting software programme. The two-sample median test was performed 
using the Unistat statistics software programme. 
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Figure 2.1. Laminin ELISA standard curve 
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2.2 REAGENT RECIPES 
2.2.1 3T3-L1 cell culture reagents 
3T3-Ll culture medium 
Dulbecco's modified Eagle's mInImum essential medium (DMEM) 
supplemented with: 
10% (v/v) new-born calf serum (heat-inactivated) 
2mM L-glutamine 
100 IVlml sodium benzylpenicillin 
100JLg/ml streptomycin sulphate 
2JLg/ml Fungizone 
3T3-Ll trypsinisation reagent 
0.05% (w/v) trypsin 
0.02% (w/v) EDTA 
in Puck's Saline (Gibco) 
or PBS (Northumbria Biologicals) 
3T3-Ll freezing medium 
90% (v/v) 3T3-L1 culture medium 
10% (v/v) dimethyl sulphoxide 
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2.2.2 FRAME Kenacid Blue (KB) cytotoxicity assay reagents 
KB Fixative 
1 % (v/v) glacial acetic acid 
49% (v/v) distilled water 
50% (v/v) absolute ethanol 
KB stain 
0.04% (w/v) Kenacid Blue R 
25% (v/v) absolute ethanol 
63% (v/v) distilled water 
Immediately before use, the stain was filtered and 12% (v/v) glacial acetic acid 
was added. 
KB wash 
10% (v/v) absolute ethanol 
5% (v/v) glacial acetic acid 
85% (v/v) distilled water 
KB desorhing solution 
9.82% (w/v) potassium acetate 
70% (v/v) absolute ethanol 
30% (v/v) distilled water 
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2.2.3 F9 cell culture, Bradford assay and laminin ELISA reagents 
F9 culture medium 
Dulbecco's modified Eagle's mInImum essential medium (DMEM) 
supplemented with: 
10% fetal calf serum 
2mM L-glutamine 
100 IO/ml sodium benzylpenicillin 
100p-glml streptomycin sulphate 
F9 trypsinisation reagent 
0.05% (w/v) trypsin 
0.02% (w/v) EDT A in Puck's saline 
F9 freezing medium 
DMEM, supplemented with: 
25 % fetal calf serum 
10% glycerol 
0.1 % porcine gelatin solution 
0.1 % (w/v) porcine gelatin 
Double distilled water 
Autoc1aved 
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Bradford protein assay dye reagent 
0.01 % (w/v) Coomassie Brilliant Blue G-250 
4.7% (v/v) absolute ethanol 
8.5% (v/v) phosphoric acid 
PBST 
Phosphate buffered saline 
0.05% (v/v) Tween 20 
0.02% (w/v) sodium azide 
Coating buffer, pH 9.6 
35mM sodium hydrogen carbonate 
0.02% (w/v) sodium azide 
Substrate buffer, pH 9.8 
9.7% (v/v) diethanolamine 
0.02% (w/v) sodium azide 
0.098mM magnesium chloride hexahydrate 
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2.3 SUPPLIERS 
Gibco Ltd. 
Dulbecco's Modification of Eagle's Minimal Essential Medium (supplied as 
lOX, without sodium bicarbonate) 
Fetal calf serum 
New-born calf serum (heat-inactivated) 
200mM L-glutamine 
0.05% (w/v) trypsin, 0.02% (w/v) EDT A in Puck's Saline 
7.5% (w/v) sodium bicarbonate 
24 well tissue culture plates (Nunc) 
75cm2 tissue culture flasks (Nunc) 
Purified laminin (produced from Engelbreth-Holm-Swarm sarcoma in mice) 
Rabbit anti-mouse laminin antibody 
Northumbria Biologicals Ltd. 
Dulbecco's Modification of Eagle's Minimal Essential Medium (supplied as 
IX, with sodium bicarbonate) 
New-born calf serum (heat-inactivated) 
0.05% (w/v) Trypsin, 0.02% (w/v) EDTA in PBS 
Phosphate-buffered saline without Ca2+ and Mg2+ 
200mM L-glutamine 
250lJ,glmi Fungizone 
10000 IU/ml sodium benzylpenicillin, 100001J,g/ml streptomycin sulphate in PBS 
75cm2 tissue culture flask (Costar) 
96-well tissue culture plates (Costar) 
Adhesive microwell plate sealing film (Costar C3095) 
Aldrich Chemical Co. Ltd. 
Cadmium chloride 
5-Fluorouracil 
6-Aminonicotinamide 
Diethylstilboestrol 
Acetylsalicylic acid 
Phenytoin 
Pentachlorophenol 
Isoniazid 
Saccharin 
Trichloroacetic acid 
Sodium chloride 
Vanadium (V) oxide 
Silver (1) nitrate 
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Mercury (II) chloride 
Copper (1) chloride 
Thallium (1) sulphate 
Thallium (1) acetate 
Zinc (II) chloride 
Tellurium (IV) chloride 
Cobalt (II) chloride 
Selenium (IV) oxide 
Rhodium (III) chloride trihydrate 
Sodium (I) tetrathionate dihydrate 
Tin (II) chloride 
Nickel (II) chloride hexahydrate 
Lead (II) nitrate 
Palladium (II) chloride 
Yttrium (III) nitrate hydrate 
Gadolinium (III) chloride 
hexahydrate 
Lanthanum (III) chloride 
heptahydrate 
Sodium (I) fluoride 
Potassium (I) fluoride 
Lithium (I) fluoride 
Aluminium (III) nitrate 
nonahydrate 
Lithium (I) chloride 
Strontium (II) chloride hexahydrate 
Lithium (I) sulphate 
Magnesium (II) chloride 
hexahydrate 
Lithium (I) iodide 
Lithium (I) bromide 
Potassium (I) iodide 
Potassium (I) sulphate 
Sodium (I) sulphate 
Potassium (I) bromide 
Sodium (I) iodide 
Sodium (I) bromide 
Ammonium chloride 
Sigma Chemical Co. Ltd. 
Sodium dodecyl sulphate 
Methanol 
Ethanol 
Propan-Iol 
Butan-I-ol 
Pentanol 
Hexanol 
Heptanol 
Octanol 
Acetaldehyde 
Acetonitrile 
Acetone 
Pyrrole 
Allyl alcohol 
Ethyl acetate 
2-Methoxyethanol 
Glycerol 
1,2,4-Trichlorobenzene 
1,2-Dibromomethane 
Aniline 
Tri-n-butytinchloride 
Brij 35 
Alkaline phosphatase/goat anti-rabbit IgG antibody conjugate 
p-Nitrophenol phosphate 
Protein standard solution (BOmg/ml) 
Diethanolamine 
Porcine skin gelatin, type A, approx 175 Bloom 
Dibutyryl cyclic adenosine monophosphate 
Coomassie Brilliant Blue G-250 
Light paraffin oil (M3516) 
(all-trans) Retinoic acid 
Caffeine 
Cyclophosphamide 
Tween 20 
Sodium azide 
Sodium hydrogen carbonate 
Colchicine 
Dexamethasone 
2,4-Dinitrophenol 
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Chloramphenicol 
Lead (IV) tetra-acetate 
Chromium (III) chloride hexahydrate 
Dimethyl formamide 
Cetyl pyridinium bromide 
Cetyl dimethyl ethyl ammonium bromide 
Hexadecyl trimethyl ammonium bromide 
Benzalkonium chloride 
Dodecyl trimethyl ammonium bromide 
Triton X-I 00 
Benzethonium chloride 
Nonidet P40 
N-Lauroyl sarcosine, sodium salt 
Dodecyl benzene sulphonic acid, sodium salt 
Deoxycholic acid, sodium salt 
Tween 40 
Tween 60 
Tween 80 
Tween 85 
1-Decanesulphonic acid, sodium salt 
Caprylic acid, sodium salt 
Cholic acid 
1-Heptanesulphonic acid, sodium salt 
CHAPS 
CHAPSO 
Taurocholic acid, sodium salt 
Zinc pyrithione 
BDH Ltd. 
Phosphoric acid 
Dimethyl sulphoxide 
Sodium hydroxide 
Potassium (I) chloride 
Calcium (II) chloride dihydrate 
Barium (II) acetate 
Aluminium (III) chloride 
hexahydrate 
Tin (IV) chloride pentahydrate 
Copper (II) chloride 
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Zinc (II) acetate 
Manganese (II) sulphate 
tetrahydrate 
Nickel (II) sulphate heptahydrate 
Iron (II) sulphate heptahydrate 
Iron (III) sulphate 
Benyllium sulphate tetrahydrate 
Kenacid Blue R 
Glacial acetic acid 
Sulphuric acid 
Hydrochloric acid 
Rhone-Poulenc Ltd. 
Thalidomide (TO X 16) 
Coded chemicals TOX 01 to TOX 46, as described in Chapter 5. 
Oxoid 
Dulbecco's 'A' Phosphate Buffered Saline tablets (1 tablet dissolved in 
lOamI of double distilled water) 
Avon 
6-Methylcoumarin 
Nonoxynol-11 
Teals 
Miranol 
Applied Biosystems 
Trifluoroacetic acid 
James Burroughs 
Methanol 
Ethanol (absolute) 
Boots the Chemists Ltd. 
Anti-dandruff shampoo 
Silk protein dandruff shampoo 
Revlon Inc. 
Flex conditioner 
Flex shampoo 
Hennara 
Henna shampoo 
Beechams 
Vidal Sassoon Wash 'n' Go conditioning shampoo for frequent use 
41 
E. R. Squibb Ltd. 
Fungizone 
Evans Medical Ltd. 
Streptomycin sulphate 
Glaxo Laboratories Ltd. 
Sodium benzylpenicillin 
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3.1 INTRODUCTION 
During the development of an in vitro toxicity test, such as the FRAME KB 
cytotoxicity assay, it is desirable that a wide variety of chemical types are 
tested and that the range of toxic concentrations detectable by the test is 
established. Within the wide variety of chemical types, if possible, there 
should be a reasonable number of representatives from each chemical type. 
This permits the recognition of those types of chemicals for which the assay 
is appropriate or inappropriate. 
Hence, 150 chemicals were selected to be tested in the FRAME KB 
cytotoxicity assay, so that many modes of toxic action were covered and a wide 
range of toxic potencies would be spanned. Some chemical were chosen to be 
part of related subgroups, such as metal compounds, alcohols and surfactants. 
A number of chemicals were included because of their industrial use, and the 
fact that industrial sponsors of the FRAME Research Programme on 
Cytotoxicology were interested in their in vitro toxicity. Certain types of 
chemicals were known to cause difficulties in in vitro toxicity tests, and 
therefore representatives of these types (for example, volatile or unstable 
substances, those with poor aqueous solubility and those which exert toxicity 
in vivo through their metabolites) were tested in order to determine whether 
the FRAME KB cytotoxicity assay could be applied to them. 
Results from a group of miscellaneous chemicals in an in vitro toxicity test can 
be compared to in vivo toxicity parameters, or, smaller groups of related 
substances can be used for comparisons. The results for the 150 chemicals in 
the FRAME KB cytotoxicity assay are therefore presented, not only as a 
miscellaneous set for comparison to in vivo toxicity parameters, but also as a 
basis for the studies of related substances (metal compounds, Chapter 4; 
industrial chemicals and mixtures, Chapter 5; surfactants and toiletry products, 
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Chapter 6; volatile liquids, Chapter 7; and chemicals recommended for 
inclusion in in vitro teratogenicity test validation, Chapter 8). 
Because the FRAME KB cytotoxicity assay involves the continuous exposure 
of cells for 72 hours, and also because a large proportion of the 150 chemicals 
are likely to cause toxicity following systemic exposure, the in vivo toxicity 
parameters for which the assay would most likely be predictive are measures 
of acute lethal potency. Although it is desirable to use indices of toxicity in 
humans wherever possible (Hellberg et ai., 1990), the data are difficult to 
obtain and are inherently of variable quality (Balls et ai., 1990a; Flint, 1991). 
Currently-accepted indices of acute lethal potency include rodent LDso values, 
which are therefore available in relative abundance in the literature. Rat oral 
LDso values are commonly used to assign chemicals to hazard categories for 
labelling purposes. However, it has been suggested that in vitro cytotoxicity 
data might correlate better with LDso values obtained from parenteral (i.p. or 
i.v.) dosage (Fry et ai., 1988a). Hence, rat oral and mouse i.p. LDso values 
were compared with the in vitro toxicities of the 150 miscellaneous chemicals. 
3.2 RESULTS 
3.2.1 In vitro toxicities of 150 chemicals 
The 150 chemicals gave a very wide range of cytotoxicities to the 3T3-Ll cells. 
The results are presented in rank order of IDso (,."g/ml) (Table 3.1), with 
values covering seven orders of magnitude, from < 0.01 to 134,000,."g/ml. 
There is a fairly even spread of results across this concentration range. 
The IDso value is used as the parameter by which to rank the chemicals (and 
thereby to judge their relative cytotoxicities), because it is taken from the 
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Table 3.1 In vitro toxicities of 150 test chemicals listed in order of 1D50 (J..Lg/ml) 
No. Test Chemical Solvent ID20 1D50 1Dso 
(J..Lg/ml (J..Lg/ml (J..Lg/ml 
+ s.e.m.) + s.e.m.) + s.e.m.) 
001 5-Fluorouracil D <0.01 <0.01 <0.01 
002 6-Mercaptopurine monohydrate D <0.01 <0.01 <0.01 
003 Acrolein E <0.01 <0.01 <0.01 
004 Rotenone D <0.1 <0.1 <0.1 
005 Vincristine sulphate W 0.01 + 0 <0.1 >100 
006 Cycloheximide M <0.1 <0.1 0.3 + 0.1 
007 Cadmium (II) chloride W 0.1 + 0 0.1 + 0 0.2 + 0.1 
008 Tributyltin chloride E 0.1 + 0.01 0.3 + 0.01 0.4 + 0 
009 Silver (I) nitrate W 1 + 0 2 + 0 2 + 0 
010 Vanadium (V) oxide W 0.2 + 0.1 2 + 0 3 + 1 
011 p-Chloromercuribenzoic acid D <0.1 3 + 1 8 + 1 
012 Copper (I) chloride W 2+0 3 + 0 5 + 1 
013 Copper (II) chloride W 2 + 1 3 + 1 4 + 1 
014 Mercury (II) chloride E 2 + 1 4 + 1 6+0 
015 Chloropromazine hydrochloride W 3 + 0 5 + 1 7 + 1 
016 Benzalkonium chloride W 4 + 1 7 + 0 9 + 2 
017 Chloroquine sulphate W 4 + 0 7 + 0 >10 
018 Colchicine E 2 + 1 8 + 1 >10 
019 Hexachlorophene E 3 + 1 9 + 2 14 + 2 
020 Zinc (II) chloride W 6 + 1 9 + 0 12 + 1 
Table 3.1. (contd) 
No. Test Chemical Solvent IDzo ID50 ID80 
(JLg/ml (JLg/ml (JLg/ml 
+ s.e.m.) + s.e.m.) + s.e.m.) 
021 p-Aminophenol D 4 + 2 10 + 1 33 + 12 
022 Selenium (IV) oxide W 5 + 1 10 + 2 15 + 2 
023 Cobalt (II) chloride W 3 + 1 11 + 1 24 + 6 
024 Propanolol hydrochloride M 8 + 1 12 + 0 14 + 0 
025 Diethylstilboestrol E 4 + 1 14 + 3 60 + 17 
026 Triton X-100 W 2 + 2 14 + 3 50 + 12 
027 Thallium (I) sulphate W 7 + 3 15 + 3 25 + 5 
028 Manganese (II) sulphate W 11 + 2 15 + 1 25 + 3 
tetrahydrate 
029 Zinc acetate W 12 + 1 15 + 1 18 + 1 
030 Diethyl maleate E 12 + 0 17 + 2 27 + 3 
031 Thallium (I) acetate W 9 + 1 17 + 2 30 + 2 
032 6-Aminonicotinamide D 11 + 1 20 + 6 27 + 2 
033 Iron (II) sulphate heptahydrate W I 20 + 9 I 
034 Tellurium (IV) chloride D 8 + 1 22 + 2 31 + 2 
035 Bendiocarb D 7 + 2 30 + 5 147 + 3 
036 Pentachlorophenol E 22 + 1 31 + 1 38 + 1 
037 Nickel (II) sulphate heptahydrate W 20 + 3 33 + 3 53 + 3 
038 Phenylbutazone D 29 + 1 45 + 1 65 + 3 
039 Versalide E 30 + 1 45 + 1 >50 
040 Butylated hydroxyanisole E 30 + 1 45 + 1 >50 
Table 3.1. (contd) 
No. Test Chemical Solvent ID20 IDso ID80 
(J.Lglml (J.Lglml (J.Lglml 
+ s.e.m.) + s.e.m.) + s.e.m.) 
041 loxynil D 32 + 4 47 + 1 57 + 1 
042 Fungizone W 8 + 2 48 + 3 85 
043 Retinoic acid D 40 + 10 49 + 10 57 + 9 
044 Dieldrin D 26 + 2 50 + 3 123 + 25 
045 Tin (II) chloride W 21 + 6 53 + 10 124 + 31 
046 Sodium (I) fluoride W 35 + 6 53 + 4 73 + 4 
047 Rhodium (III) chloride trihydrate W 26 + 3 55 + 2 100 + 1 
048 Tin (IV) chloride pentahydrate W 34 64 + 3 98 
049 2,4-Dinitrophenol D 34 + 10 72 + 9 87 + 10 
050 Sodium tetrathionate dihydrate W 33 + 4 74 + 5 128 + 22 
051 Nickel (II) chloride hexahydrate W 43 + 3 77 + 13 98 + 18 
052 Lithium (I) fluoride W 51 + 12 77 + 25 142 + 24 
053 Paracetamol M 44 + 4 90 + 10 136 + 18 
054 Sodium dodecyl sulphate W 66 + 11 94 + 12 162 + 17 
055 Phenacetin D 84 + 1 95 + 1 >100 
056 Palladium (II) chloride W 62 + 14 103 + 2 115 
057 Methylparaben E 64 + 4 106 + 16 >300 
058 Lead (II) nitrate W 53 + 21 119 + 45 345 + 19 
059 Lead (IV) tetra-acetate D 82 + 22 119 + 5 286 + 34 
060 1,2,4-Trichlorobenzene E 89 + 11 122 + 14 >200 
Table 3.1. (contd) 
No. Test Chemical Solvent ID20 IDso IDso 
(JLglml (JLglml (JLglml 
+ s.e.m.) + s.e.m.) + s.e.m.) 
061 Acrylamide W >100 123 + 8 182 + 8 
062 Iron (III) sulphate W 37 + 7 123 + 24 309 + 69 
063 Naphthalene D 44 + 13 123 + 1 189 + 9 
064 Dodecylbenzene suI phonic acid, W 120 + 6 137 + 1 150 + 2 
sodium salt 
065 Potassium (I) fluoride W 70 + 16 150 + 6 260 + 25 
066 Beryllium (II) sulphate W 66 + 9 157 + 17 387 + 48 
tetrahydra te 
067 Tween 40 E 53 + 5 159 + 49 295 + 50 
068 2,4-Dichlorophenoxyacetic acid M 70 + 15 162 + 19 >500 
069 6-Methy1coumarin E 130 + 7 169 + 16 403 + 140 
070 Diethyl phthalate E 93 + 22 198 + 8 281 + 8 
071 Chloram phenicol M 96 + 28 226 + 41 397 + 42 
072 2-Chloroquinoline E 145 + 25 233 + 17 331 + 42 
073 Tween 60 E 146 + 31 244 + 27 345 + 9 
074 Dexamethasone D 74 252 + 43 >400 
075 Tween 20 W 123 + 5 262 + 43 396 + 42 
076 Yttrium (III) nitrate hexahydrate W 227 + 20 262 + 7 286 + 3 
077 Phenytoin D 57 + 3 265 + 44 >1000 
078 Acrylonitrile E 147 + 28 266 + 40 290 + 16 
079 Thioacetamide E 167 + 11 274 + 8 >500 
Table 3.1. (contd) 
No. Test Chemical Solvent ID20 IDso IDgO 
(J.Lg/ml (J.Lg/ml (J.Lg/ml 
± s.e.m.) + s.e.m.) + s.e.m.) 
080 Warfarin D 187 + 39 285 + 26 398 + 25 
081 1-0ctanol E 236 + 6 298 + 4 360 + 2 
082 Indium (III) nitrate hydrate W 26 + 3 303 + 57 546 + 97 
083 3-Chloroaniline E 97 + 11 308 + 68 460 + 138 
084 L-Ascorbic acid W 295 + 60 323 + 58 351 + 55 
085 Ammonium chloride D 168 + 47 337 + 63 >500 
086 Allyl alcohol W 191 + 23 355 + 52 521 + 34 
087 Phorone E 188 + 16 378 + 27 600 + 68 
088 Bromobenzene E 284 + 23 389 + 29 486 + 38 
089 Gadolinium (III) chloride W 360 + 3 389 + 6 419 + 12 
hexahydrate 
090 Iproniazid phosphate W 117 + 20 393 + 37 420 + 76 
091 Lanthanum (III) chloride W 373 441 + 34 567 + 19 
heptahydrate 
092 Acetylsalicylic acid E 153 + 28 465 + 86 821 + 52 
093 Tween 85 E 253 + 149 507 + 50 821 + 7 
094 Trichloroacetic acid W 311 + 69 524 + 109 658 + 126 
095 2,4,6-Trinitrobenzene sulphonic W 269 + 42 536 + 46 772 + 11 
acid 
096 Phenobarbital M <500 543 + 15 9]7 + 34 
097 Lithium (I) chloride W 343 + 67 554 + 95 810 + 73 
Table 3.1. (contd) 
No. Test Chemical Solvent ID20 IDso IDgO 
(J.£g/ml (J.£g/ml (J.£g/ml 
+ s.e.m.) + s.e.m.) + s.e.m.) 
098 Carbon tetrachloride E 506 + 32 600 + 28 665 + 32 
099 Tween 80 E 135 + 25 619 + 69 836 + 9 
100 Isoxepac D 292 + 90 644 + 38 >1000 
101 1,2-Dibromoethane D 589 645 + 240 924 + 250 
102 Imidazole D 371 + 44 688 + 12 >750 
103 Frusemide D 628 + 70 756 + 52 873 + 45 
104 Aluminium (III) chloride W 738 + 120 830 + 60 1050 + 82 
hexahydrate 
105 Acetonylacetone W 798 + 34 937 + 23 >1000 
106 Barium (II) acetate W 566 + 280 982 + 62 2470 
107 1-Heptanol E 887 + 26 1010 + 86 1150 + 74 
108 Caffeine W 330 + 30 1110 + 57 3240 + 310 
109 Aluminium (III) nitrate W 953 + 75 1190 + 37 1280 
nonahydrate 
110 L-Cysteine hydrochloride W 498 + 120 1190 + 160 1650 
monohydrate 
111 Aniline E 1320 + 170 1480 + 330 2540 + 190 
112 Chromium (III) chloride W 857 + 160 1500 + 24 2170 + 84 
hexahydrate 
113 Thiophene E 1240 + 31 1680 + 130 >2000 
114 Cyclophosphamide W 1320 + 150 1800 + 490 2470 + 100 
Table 3.1. (contd) 
No. Test Chemical Solvent ID20 1Dso IDgO 
(",glml (",glml (",glmi 
+ s.e.m.) + s.e.m.) + s.e.m.) 
115 Isoniazid W 1320 + 78 2170 + 330 3970 + 730 
116 Lithium (I) sulphate W 953 + 210 2460 + 600 6460 + 2000 
117 Lithium (I) bromide W 1790 + 390 3290 + 130 7050 + 630 
118 1-Pentanol W 2880 + 490 3540 + 550 4160 + 610 
119 1-Hexanol W 2580 + 530 3600 + 540 4320 + 960 
120 Calcium (II) chloride dihydrate W 2230 3860 8900 
121 Sodium benzylpenicillin W 1730 3970 + 78 6280 + 48 
122 Strontium (II) chloride W 1940 + 290 4060 + 220 10900 + 940 
hexahydrate 
123 Streptomycin sulphate W 1450 4160 + 430 6990 + 240 
124 Potassium (I) chloride W 3060 + 300 4360 + 200 5560 + 75 
125 Lithium (I) iodide W 2470 + 810 4690 + 460 7710 + 1100 
126 I-Butanol W 3320 + 970 4780 + 490 6320 + 570 
127 Magnesium (II) chloride W 3260 + 420 5600 + 750 7910 + 960 
hexahydrate 
128 Sodium chloride W 1790 + 700 6230 + 720 8390 + 660 
129 Pyrrole W 5740 + 230 6570 + 310 7430 + 380 
130 Potassium iodide W 3280 + 860 7260 + 440 8790 + 440 
131 Potassium (I) bromide W 5900 + 140 7780 + 390 9540 + 360 
132 Potassium (I) sulphate W 6270 + 990 7860 + 690 9230 + 330 
133 Sodium (I) sulphate W 6090 + 890 8930 + 560 10000 + 390 
Table 3.1. (contd) 
No. Test Chemical Solvent ID20 1Dso 1D8o 
(JLg/ml (JLg/ml (JLg/ml 
+ s.e.m.) + s.e.m.) + s.e.m.) 
134 Sodium (I) bromide W 7250 + 450 9840 + 910 11300 + 1000 
135 Kanamycin sulphate W 2960 + 970 11000 + 1200 19200 
136 I-Propanol W 7580 + 480 11200 + 480 17000 
137 Sodium (I) iodide W 8730 + 1700 11800 + 1500 16400 + 1300 
138 1,2-Dichloroethane W 8020 + 1600 13600 + 2800 15900 + 4000 
139 2-Propanol W 7750 + 1000 14200 + 1400 25200 
140 Dimethyl sulphoxide W 11800 + 2100 22400 + 1700 38300 + 5000 
141 Acetonitrile W 14300 + 710 23100 + 2200 31400 + 4000 
142 1,2-Propanediol W 19100 + 1900 26000 + 2600 46200 + 8900 
143 Acetone W 26900 + 7400 35900 + 8500 43700 + 6700 
144 Ethanol W 23200 + 1700 36100 + 870 38700 + 1300 
145 D-Fructose W 15500 + 2100 39200 + 1200 55900 + 340 
146 Ethyl acetate W 24600 + 4900 43300 + 5800 60000 + 7100 
147 Methanol W 36500 + 9800 46100 + 10000 47500 + 5300 
148 D-Glucose W 36400 + 7600 48500 + 3900 57900 + 5200 
149 PEG 1900 W 21000 + 6300 77100 + 5500 115000 + 2200 
150 PEG 5000 W 22500 + 5100 134000 + 6400 > 160000 
I = indeterminate; the points around the ID20 and 1D8o points of the dose-response curve were too variable for values to be 
recorded with confidence. Solvent code: D = dimethyl sulphoxide; E = ethanol; M = methanol; W = water. 
middle of the dose-response curve and is therefore subject to less variation 
(Knox et a/1986). The ID20 and 1D8o values are, however, useful for providing 
information about the slope and shape of the dose-response curve (Knox et al., 
1986; Riddell et aI., 1986a). For example, bendiocarb (position 35) and 
pentachlorophenol (position 36) have very similar 1Dso (J,.Lg!ml) values, but the 
dose-response curve for pentachlorophenol was much steeper (Table 3.1). 
The dose-response curve shapes were generally of the S-shape type and 
symmetrical about the 1Dso. Some were exponential, i.e. the toxicity increased 
slowly between the ID20 and 1Dso but rapidly from the 1Dso to the 1D8o (or 
vice versa). For example, acrylonitrile, iproniazid phosphate and methanol 
(positions 78, 90 and 147, Table 3.1) gave exponential dose-response curves, 
while diethylstilboestrol (position 25, Table 3.1) demonstrated an inverse 
exponential curve. 
The s.e.m.s for most of the results represented approximately 10% of the 
mean ID values, although in some cases they were larger than this. However, 
only in the case of iron (II) sulphate heptahydrate (position 33, Table 3.1) was 
the variation in individual ID20 and 1D8o results so great that the mean values 
had to be recorded as indeterminate. The variation in its 1Dso values were 
also large (20 + 9J,.Lg!ml). 
3.2.2 Expression of results 
In vivo LDso toxicity values are normally expressed in units of weight per kg 
of body weight, and the expression of in vitro toxicities in terms of J,.Lg!ml 
follows from this. However, it would seem logical that toxicities are due to the 
number of toxic molecules rather than the total weight of molecules 
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Table 3.2. In vitro toxicities of the 150 chemicals listed in order of IDso (mM) 
Rank No. Test Chemical MW* IDso IDso 
(J.Lglml) (mM) 
2.5 001 5-Fluorouracil 130 <0.01 <0.0001 
2.5 002 6-Mercaptopurine monohydrate 170 <0.01 <0.0001 
2.5 004 Rotenone 394 <0.1 <0.0001 
2.5 005 Vincristine sulphate 923 <0.1 <0.0001 
5 003 Acrolein 56 <0.01 <0.0002 
6 006 Cycloheximide 281 <0.1 <0.0004 
7.5 007 Cadmium (II) chloride 183 0.1 0.001 
7.5 008 Tributyltin chloride 326 0.3 0.001 
10.5 011 p-Chloromercuribenzoic acid 357 3 0.01 
10.5 010 Vanadium (IV) oxide 182 2 0.01 
10.5 009 Silver (I) nitrate 170 2 0.01 
10.5 015 Chlorpromazine hydrochloride 355 5 0.01 
16 014 Mercury (II) chloride 272 4 0.02 
16 017 Chloroquine sulphate 418 7 0.02 
16 018 Colchicine 399 8 0.02 
16 016 Benzalkonium chloride 353ave 7 0.02 
16 013 Copper (II) chloride 134 3 0.02 
16 019 Hexachlorophene 407 9 0.02 
16 026 Triton X-100 647ave 14 0.02 
20.5 012 Copper (I) chloride 99 3 0.03 
20.5 027 Thallium (I) sulphate 505 15 0.03 
22 024 Propranolol hydrochloride 296 12 0.04 
Table 3.2. (contd.) 
Rank No. Test Chemical MW* 1Dso 1Dso 
(J.Lg/ml) (mM) 
23.5 025 Diethylstilboestrol 268 14 0.05 
23.5 042 Fungizone 924 48 0.05 
26.5 031 Thallium (I) acetate 263 17 0.07 
26.5 020 Zinc (II) chloride 136 9 0.07 
26.5 028 Manganese (II) sulphate tetrahydrate 223 15 0.07 
26.5 033 Iron (II) sulphate heptahydrate 278 20 0.07 
29.5 029 Zinc (II) acetate 184 15 0.08 
29.5 034 Tellurium (IV) chloride 269 22 0.08 
32 023 Cobalt (II) chloride 130 11 0.09 
32 022 Selenium (IV) oxide 111 10 0.09 
32 021 p-Aminophenol 109 10 0.09 
34 030 Diethyl maleate 172 17 0.10 
36 036 Pentachlorophenol 266 31 0.12 
36 037 Nickel (II) sulphate heptahydrate 281 33 0.12 
36 067 Tween 40 1284 159 0.12 
39 041 Ioxynil 371 47 0.13 
39 044 Dieldrin 381 50 0.13 
39 035 Bendiocarb 223 30 0.13 
42 032 6-Aminonicotinamide 137 20 0.15 
42 038 Phenylbutazone 308 45 0.15 
42 043 Retinoic acid 300 49 0.16 
44 039 Versalide 258 45 0.17 
Table 3.2. (contd.) 
Rank No. Test Chemical MW* IDso IDso 
(J.Lg/ml) (mM) 
45 048 Tin (IV) chloride pentahydrate 351 64 0.18 
46 073 Tween 60 =1300 244 0.19 
47.5 047 Rhodium (III) chloride trihydrate 263 55 0.21 
47.5 075 Tween 20 1228 262 0.21 
49 050 Sodium tetrathionate dihydrate 306 74 0.24 
50 040 Butylated hydroxyanisole 180 45 0.25 
51 059 Lead (IV) tetra acetate 443 119 0.27 
52 045 Tin (II) chloride 190 53 0.28 
53 062 Iron (III) sulphate 400 123 0.31 
54 051 Nickel (II) chloride hexahydrate 238 77 0.32 
55 054 Sodium dodecyl sulphate 288 94 0.33 
56 058 Lead (II) nitrate 331 119 0.36 
58 093 Tween 85 =1300 507 0.39 
58 049 2,4-Dinitrophenol 184 72 0.39 
58 064 Dodecylbenzene sulphonic acid, sodium salt 349 137 0.39 
60 099 Tween 80 1310 619 0.47 
61 055 Phenacetin 179 95 0.53 
62 056 Palladium (II) chloride 177 103 0.58 
63 053 Paracetamol 151 90 0.60 
64 074 Dexamethasone 393 252 0.64 
65 060 1,2,4-Trichlorobenzene 182 122 0.67 
66 076 Yttrium (III) nitrate hexahydrate 383 262 0.68 
Table 3.2. (contd.) 
Rank No. Test Chemical MW* IDso IDso 
(JLg/ml) (mM) 
67 057 Methylparaben 152 105 0.69 
68 071 Chloramphenicol 323 226 0.70 
69 068 2,4-Dichlorophenoxyacetic acid 221 162 0.73 
70.5 066 Beryllium (II) sulphate tetrahydrate 177 157 0.89 
70.5 070 Diethyl phthalate 222 198 0.89 
72 080 Warfarin 308 285 0.92 
73 063 Naphthalene 128 123 0.96 
74.5 082 Indium (III) nitrate hydrate 301 303 1.0 
74.5 089 Gadolinium (III) chloride hexahydrate 372 389 1.0 
76.5 077 Phenytoin 252 265 1.1 
76.5 069 6-Methylcoumarin 160 169 1.1 
78 091 Lanthanum (III) chloride heptahydrate 371 441 1.2 
79 046 Sodium (I) fluoride 42 53 1.3 
80.5 090 Iproniazid phosphate 277 393 1.4 
80.5 072 2-Chloroquinoline 164 233 1.4 
82 061 Acrylamide 71 123 1.7 
83.5 095 2,4,6-Trinitrobenzenesulphonic acid 293 536 1.8 
83.5 084 L-Ascorbic acid 176 323 1.8 
86 103 Frusemide 331 756 2.3 
86 081 1-0ctanol 130 298 2.3 
86 096 Phenobarbital 232 543 2.3 
88.5 100 Isoxepac 268 644 2.4 
Table 3.2. (contd.) 
Rank No. Test Chemical MW* 1Dso 1Dso 
(J.Lglml) (mM) 
88.5 083 3-Chloroaniline 128 308 2.4 
90 088 Bromobenzene 157 389 2.5 
91.5 092 Acetylsalicylic acid 180 465 2.6 
91.5 065 Potassium (I) fluoride 58 150 2.6 
93 087 Phorone 138 378 2.7 
94 123 Streptomycin sulphate 1458 4160 2.9 
95 052 Lithium (I) fluoride 26 77 3.0 
96.5 109 Aluminium (III) nitrate nonahydrate 375 1190 3.2 
96.5 094 Trichloroacetic acid 163 524 3.2 
98.5 101 1,2-Dibromoethane 188 645 3.4 
98.5 104 Aluminium (III) chloride hexahydrate 242 830 3.4 
100 079 Thioacetamide 75 274 3.6 
101 106 Barium (II) acetate 255 982 3.8 
102 098 Carbon tetrachloride 154 600 3.9 
103 078 Acrylonitrile 53 266 5.0 
104 112 Chromium (III) chloride hexahydrate 266 1500 5.6 
105 108 Caffeine 194 1110 5.7 
106 086 Allyl alcohol 58 355 6.1 
107 085 Ammonium chloride 54 337 6.3 
108 114 Cyclophosphamide 279 1800 6.5 
109 110 L-Cysteine hydrochloride monohydrate 176 1190 6.8 
110 105 Acetonyl acetone 114 937 8.2 
Table 3.2. (contd.) 
Rank No. Test Chemical MW* IDso IDso 
(tLglml) (mM) 
111 107 1-Heptanol 116 1010 8.7 
112 102 Imidazole 68 688 10 
113 121 Sodium benzylpenicillin 356 3970 11 
114 097 Lithium (I) chloride 42 554 13 
115 122 Strontium (II) chloride hexahydrate 267 4060 15 
116.5 115 Isoiazid 137 2170 16 
116.5 111 Aniline 93 1480 16 
118 135 Kanamycin sulphate 581 11000 19 
119 113 Thiophene 84 1680 20 
121 120 Calcium (II) chloride dihydrate 147 3860 26 
122 150 PEG 5000 =5000 134000 27 
123 127 Magnesium (II) chloride hexahydrate 203 5600 28 
124.5 125 Lithium (I) iodide 134 4690 35 
124.5 119 1-Hexanol 102 3600 35 
126 117 Lithium (I) bromide 87 3290 38 
127 118 1-Pentanol 88 3540 40 
128 149 PEG 1900 =1900 77100 41 
129 130 Potassium (I) iodide 166 7260 44 
130 132 Potassium (I) sulphate 174 7860 45 
131 124 Potassium (I) chloride 75 4360 58 
132 133 Sodium (I) sulphate 142 8930 63 
133 126 I-Butanol 74 4780 64 
Table 3.2. (contd.) 
Rank No. Test Chemical MW* IDso IDso 
(lLg/ml) (mM) 
134 131 Potassium (I) bromide 119 7780 65 
135 137 Sodium (I) iodide 150 11800 79 
136 134 Sodium (I) bromide 103 9840 96 
137 129 Pyrrole 67 6570 98 
138 128 Sodium (I) chloride 58 6230 107 
139 138 1,2-Dichloroethane 99 13600 138 
140 36 I-Propanol 60 11200 186 
141 145 D-Fructose 180 39200 218 
142 139 2-Propanol 60 14200 236 
143 148 D-Glucose 180 48500 269 
144 140 Dimethyl sulphoxide 78 22400 287 
145 142 1,2-Propanediol 76 26000 342 
146 146 Ethyl acetate 88 43300 491 
147 141 Acetonitrile 41 23100 562 
148 143 Acetone 58 35900 617 
149 144 Ethanol 46 36100 783 
150 147 Methanol 32 46100 1441 
* MW = molecular weight 
administered (Stark et al., 1986; Clothier et al., 1988). Hence the IDso values 
were converted to millimolar concentrations and ranked in terms of ID 50 
(mM) (Table 3.2). This altered the ranking of a few chemicals which have low 
or high molecular weights. The position of sodium fluoride was changed from 
position 46 (Table 3.1) to 79 (Table 3.2), i.e. ranking by mM values makes this 
appear less toxic among the 150 tested. Similarly, PEG 5000 was made to 
look more toxic in the mM rank. Its position changed from 150 to 122 (Table 
3.2). 
3.2.3 "Difficult" chemicals 
Chemicals with poor aqueous solubility were usually dissolved initially in an 
organic solvent (see section 2.1.1.2) before dilution into the culture medium. 
If, at the range-finding stage, it was not possible to reach an IDso 
concentration for a chemical before its maximum solubility in aqueous 
medium, then it was discarded and the results are not presented in this 
chapter. One chemical reacted exothermically with the aqueous medium, so 
it, too, could not be fully tested. 
Some substances are unstable, and degrade chemically with exposure to light, 
heat or moisture. The results for a moisture-unstable substance, iron (II) 
sulphate heptahydrate, were very variable (Table 3.1). Other substances 
known to be chemically unstable in aqueous solution (e.g. L-ascorbic acid and 
retinoic acid) did not give a level of variation in the results any different from 
those for the majority of the 150 chemicals. 
When high doses of volatile liquids, such as acetonitrile, thiophene and 
methanol, were tested, it was sometimes noticeable that control cell growth 
was decreased. Some volatile chemicals, for example, methanol, gave larger 
s.e.m.s than other volatile chemicals. 
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3.2.4 Comparison of in vivo and in vitro toxicity data for 59 chemicals 
Rat oral and mouse i.p. LDso data was gathered from the ICI toxicology 
profiles (Purchase et al., 1986; Clothier et al., 1989), or, if not available from 
ICI, values were taken from RTECS (Lewis and Tatken, 1982). Although rat 
oral LDso values were found for 94 of the 150 chemicals tested in the FRAME 
KB cytotoxicity assay, and mouse i.p. values for 86 of them, both rat and 
mouse data were available for only 59 chemicals. In order to be comparable 
with the IDso (mM) values, the LDso values were converted to mmol/kg. The 
1Dso and LDso data for the 59 chemicals are shown in Table 3.3. 
Linear regression analysis was used to compare the in vitro (log IDso) and in 
vivo rat or mouse (log LDso) toxicities for the 59 chemicals. The correlation 
coefficients were very similar: 
KB IDsoirat oral LDso 
KB IDsoimouse i.p. LDso 
r = 0.76 
r = 0.80 
On both linear regressIon plots (Figures 3.1 and 3.2), there is a wider 
scattering of points towards the lefthand (more toxic) ends of the graphs. The 
points which are most distant from the regression line are those where the in 
vitro toxicities would predict the in vivo toxicities to be greater than they are. 
3.2.5 Conclusions 
The FRAME KB cytotoxicity assay is able to detect toxicity to 3T3-Ll cells of 
a wide range of chemical types with different modes of toxicity, and which are 
toxic at a very wide range of concentrations. The assay gives reproducible 
results for the vast majority of chemicals tested. It was found that a small 
number of chemicals caused problems methodologically and/or in the 
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Table 3.3. In vitro and in vivo toxicities of 59 miscellaneous chemicals 
Test Chemical IDso Rat oral Mouse i.p. 
(mM) LDso LDso 
(mmol/kg) (mmol/kg) 
6-Mercaptopurine monohydrate 0.0001 2.5 1.7 
Rotenone 0.0001 0.34 0.01 
Acrolein 0.0002 0.64 0.13 
Cycloheximide 0.0004 0.01 0.49 
Cadmium (II) chloride 0.001 0.48 0.05 
Chloropromazine hydrochloride 0.01 0.93 0.32 
Mercury (II) chloride 0.02 0.004 0.02 
Chloroquine sulphate 0.02 2.6 0.23 
Benzalkonium chloride 0.02 1.1 0.03 
Copper (II) chloride 0.02 1.0 0.06 
Zinc (II) chloride 0.07 2.6 0.23 
Iron (II) sulphate heptahydrate 0.07 2.1 0.42 
Zinc (II) acetate 0.08 14 0.31 
Cobalt (II) chloride 0.09 0.62 0.38 
Phenylbutazone 0.15 2.4 0.84 
Retinoic acid 0.16 6.7 1.2 
Tin (II) chloride 0.28 3.7 0.35 
Nickel (II) chloride hexahydrate 0.32 0.81 0.20 
Sodium dodecyl sulphate 0.33 6.5 0.87 
2,4-Dinitrophenol 0.39 0.20 0.14 
Phenacetin 0.53 14 5.8 
Palladium (II) chloride 0.58 1.1 0.59 
Paracetamol 0.60 16 2.4 
Chloramphenicol 0.70 7.7 3.9 
2,4-Dichlorophenoxyacetic acid 0.73 6.7 1.2 
Naphthalene 0.96 14 1.2 
Phenytoin 1.1 8.5 0.87 
Lanthanum (II) chloride 1.2 17 0.49 
heptahydrate 
Sodium (I) fluoride 1.3 4.3 1.2 
Iproniazid 1.4 1.7 3.3 
Acrylamide 1.7 2.8 2.4 
Phenobarbital 2.3 1.5 1.0 
Bromobenzene 2.5 16 6.4 
Acetylsalicylic acid 2.6 9.9 1.9 
1,2-Dibromoethane 3.4 0.57 1.2 
Carbon tetrachloride 3.9 18 30 
Acrylonitrile 5.0 2.1 0.74 
; 
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Table 3.3. (contd.) 
Test Chemical IDso Rat oral Mouse i.p. 
(mM) LDso LDso 
(mmol/kg) (mmol/kg) 
Chromium (II) chloride 5.6 6.7 2.0 
hexahydrate 
Caffeine 5.7 1.8 1.4 
Allyl alcohol 6.1 1.1 0.72 
Ammonium chloride 6.6 31 9.0 
Cyclophosphamide 6.5 0.79 1.7 
Acetonyl acetone 8.2 19 14 
Lithium (I) chloride 13 18 14 
Strontium (II) chloride 15 14 5.7 
hexahydrate 
Isoniazid 16 17 1.0 
Aniline 16 5.2 5.3 
Calcium (II) chloride dihydrate 26 9.0 2.5 
Magnesium (II) chloride 28 40 1.0 
hexahydrate 
Sodium (1) iodide 79 29 5.8 
Sodium (I) chloride 107 74 53 
2-Propanol 236 97 16 
Dimethyl sulphoxide 287 217 168 
1,2-Propanediol 342 263 150 
Ethyl acetate 491 125 8.1 
Acetonitrile 562 91 8.2 
Acetone 617 168 22 
Ethanol 783 287 130 
Methanol 1441 313 263 
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interpretation of r e s ~ l l t s . . Methodological problems include difficulties in 
dissolving a substance in aqueous medium, and with volatile liquids, interfering 
with control cell growth. 
For certain types of "difficult" chemicals, the FRAME KB cytotoxicity assay 
will have to be adapted in order to provide more-meaningful results. This may 
mean providing alternative methods of solubilising the insoluble chemicals or 
reducing the evaporation of volatile chemicals. 
Most of the alterations in toxicity ranking when converting IDso results from 
J.Lg/ml to mM were minor. Even where chemicals of low or high molecular 
weight had their positions altered more considerably, this would not affect the 
overall assessment of their in vitro toxic potency. 
The FRAME KB cytotoxicity assay data correlated reasonably well with both 
the rat oral and mouse i.p. LDso values. Across the toxicity range, the 
FRAME KB cytotoxicity assay was least accurate in predicting the in vivo 
toxicities of very toxic compounds. 
3.3 DISCUSSION 
An important aspect of in vitro toxicity test development is how the data 
should be interpreted, how they should be presented, and what they should be 
compared with. The results for a single test substance in the FRAME KB 
cytotoxicity assay (lD20, IDso and ID80 figures) have no value on their own. 
However, when compared to the results for all the other chemicals, a rank 
order of toxicity can be established. This rank order may be compared to the 
rank order obtained with the same set of chemicals in a different toxicity test. 
A standard set of ten chemicals has been suggested for this purpose (Clothier 
et at., 1988). This set was chosen deliberately to span a wide range of toxic 
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potencies and modes of action, and is also useful during interlaboratory 
comparisons of absolute values obtained with the standard FRAME KB 
cytotoxicity assay protocol. Rank ordering has the disadvantage that it implies 
that the differences from one substance to the next in the ranking are 
equivalent. This is not the case with the ISO chemicals, because the spread of 
results across the 7 orders of magnitude is not completely even; there are few 
chemicals with very low or very high ID50 values. 
The ID50 results for the ISO chemicals could be used to place chemicals in 
categories of toxic potency, for example, ID50 < O.OSmM = very toxic, ID50 
0.06 to 1.0mM = toxic, and so on. However, if chemicals are simply 
categorised as "toxic" or "non toxic", it would not be possible to indicate 
whether one "toxic" chemical was, in fact, far more toxic than another. ID50 
values, at one end of a category would tend to be closer to values at the 
beginning of the next category, than to values at the beginning of the former 
category. Hence, categorisation is not a very useful way of presenting in vitro 
toxicity results. 
Although the mM rank order (Table 3.2) was not very different from the 
J.Lg/ml rank (Table 3.1), it is still useful to look at both sets of figures. The 
J.Lg/ml values are often easier to understand, because the experimenter will 
weigh out a chemical and prepare test solutions in terms of J.Lg/ml or mg/ml. 
At the very toxic end of the scale, the FRAME KB cytotoxicity assay protocol 
does not recommend that values below O.OIJ.Lg/ml are recorded as definitive, 
because of the greater risk of inaccuracy in making test chemical dilutions at 
this level. With very low toxicities (around 100mg/ml), the possibility of the 
amount of dissolved test compound affecting the volume of the solution must 
be taken into account. Hence, using J.Lg/ml values makes one more aware of 
these factors. The mM values offer a more physiological approach, whereby 
the number, not weight, of test chemical molecules is considered. This has a 
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scientific basis, and should therefore be the preferred units of expression. 
Chemicals such as bromobenzene, cyclophosphamide and paracetamol are 
metabolised to toxic products in vivo. 3T3-L1 cells have little or no enzymes 
for the metabolic activation of such chemicals, and therefore the FRAME KB 
cytotoxicity assay has measured the toxicities of the parent compounds, not of 
the metabolites which are responsible for their toxic effects in vivo. 
Conversely, some chemicals are rapidly detoxified by metabolic processes in 
vivo. These are issues which can lead to difficulties of interpretation, if the in 
vitro results are to be compared to the situation in vivo. Horner (1986) and 
Reader (1988) have examined the problems of metabolism-mediated 
cytotoxicity. This thesis is therefore complementary to these earlier theses, as 
it intends to address some of the methodological problems in the FRAME KB 
cytotoxicity assay, such as those connected with low solubility, and high 
volatility. 
The 59 chemicals used in the KB IDsofLDso comparisons were as varied in 
their toxic potencies and modes of action as the set of 150. The correlation 
coefficients were therefore unexpectedly high, if one considers recent 
discussions (Clothier et ai., 1989, Fry et ai., 1990b; Phillips et ai., 1990) which 
suggest that only related groups of chemicals would give good in vitro/in vivo 
correlations. 
There are several possible reasons why the toxicities of some of the most toxic 
chemicals in vivo were among the most poorly predicted by the FRAME KB 
cytotoxicity assay. Firstly, the chemical could be detoxified in vivo (so that its 
toxic effects are diminished), whilst in vitro, detoxification cannot occur at the 
same level as in vivo, and hence the toxic chemical can exert its effects on the 
3T3-L1 cells for longer. Secondly, at the very low concentrations involved, 
there is a greater possibility of experimental error in both the in vivo and in 
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vitro tests. A third reason may be that some of the chemicals may not be well 
absorbed from the G.!. tract during the rat oral LD50, and hence their in vivo 
toxicities may be ·underestimated', leading to the disparity between oral LD50 
values and KB ID50 results. 
The MEIe study has shown close correlations between in vitro cytotoxicity and 
human or rodent lethal blood concentrations for a group of ten unrelated 
human poisons (Ekwall et al., 1990). Structurally and/or mechanistically 
related chemicals may give still closer correlations. Hence, a group of 
structurally and mechanistically related substances (metal compounds) were 
selected to examine whether better in vitro/in vivo correlations could be 
obtained than with the 59 chemicals. 
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4.1 INTRODUCfION 
Metal compounds number among the estimated 50 to 70,000 chemical 
substances in production and use, for which inadequate hazard data or no 
hazard data exist (Peters and Piersma, 1990). The exposure of humans to 
metal compounds is increasing, mainly through industrial exposure and via 
contaminated water or foodstuffs (Friberg and Nordberg, 1986). In addition, 
the whole ecosystem is suffering increasing exposure through the growing 
impact of metal ions in the environment, due to pollution and acid rain 
(Friberg and Nordberg, 1986). The toxicology of metals is important, because 
of the indestructibility of metal ions, and their tendency to accumulate in body 
tissues over many years (Clarkson, 1986). Metals and their compounds may 
act through contact with the skin, pulmonary membranes or the gastro-
intestinal mucosa, or systemically in any tissue, and can act as allergens, 
mutagens, teratogens and carcinogens (Heck and Costa, 1982; Kazantzis, 
1986). Certain metals, such as cobalt, zinc and iron, are required in the body 
as essential trace elements, but they may still exert toxic effects if present in 
excess (Clarkson, 1986; Bryce-Smith, 1989). 
Metal toxicity occurs by many diverse mechanisms, but is explainable, at the 
most basic level, as interference with cellular biochemical systems (Friberg and 
Nordberg, 1986). Metals often interact with important sites on cellular 
enzymes or structural proteins, but may also bind to nucleic acids. The 
immediate effects are breaking of hydrogen bonds, displacement of other 
metals (for example, those present as enzyme cofactors) or alteration in the 
tertiary structure of the target molecule. Binding occurs via co-ordinate-
covalent links between the metal cation and electron-donating ligands. The 
consequences include inhibition of active transport, alteration in the passive 
permeability characteristics of the cell membrane, alteration of transcriptional 
and translational processes, and a decrease or increase in the activities of 
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specific enzymes (Clarkson, 1986). 
Protein binding in the plasma varies from metal to metal and may help or 
hinder the diffusion of the metal through the body (Camner et al., 1986). 
Cadmium and mercury ions bind strongly to plasma protein, whilst germanium 
does not bind significantly. 
Although metal ions react with a broad range of ligands, they often have very 
specific target organs or tissues. These are called the critical organs, and the 
concentration of the metal ion which causes adverse functional changes 
(reversible or irreversible) in the most sensitive cells of those organs is called 
the critical concentration (Friberg and Nordberg, 1986). Knowledge of these 
concentrations is required in order to establish safe overall bodily exposure 
limits. Little is known, however, about the toxicology of many metals, 
particularly at the molecular level. Here, in vitro models may be useful (Cox 
and Harrison, 1983; Clarkson, 1986; Elias et al., 1986; Klug et al., 1988; 
Jenssen and Syversen, 1991). 
Metal compound risk assessment is complicated by the many factors which 
influence the effects of metals on animals, such as the nutritional state, age, 
or route of exposure of the animal, and the chemical or physical state of the 
compound (Nordberg et aI., 1986). The identification and estimation of risk 
requires toxicological, medical and scientific judgements, whilst risk evaluation 
and control must also consider technical and economic factors (Friberg, 1986). 
The risk analysis process relies on the use of animal models, but difficulties in 
extrapolating results to man are always present. In addition, the use of 
animals can be questioned on economic and ethical grounds. Current 
resources could never realistically provide data on the full backlog of 
chemicals, so prioritisation is necessary (Purchase, 1990a). Cheaper, non-
animal alternative methods of assessing the toxicity of a compound may be 
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useful in this context. Two such alternatives are the Quantitative Structure 
Activity Relationship (QSAR) approach, and in vitro cytotoxicity testing, e.g. 
with the FRAME KB cytotoxicity assay. These alternatives could be used at 
the initial phase of toxicity assessment (Balls, 1986) and could be used as 
preliminary screens, or as adjuncts to animal tests, or could possibly replace 
the need for animal tests altogether (Balls and Horner, 1985; Balls et ai., 
1990a, b). 
A QSAR is a mathematical relationship between the quantifiable toxic effects 
of a chemical and its structure, and aims to predict the toxic effects of similar, 
as yet untested chemicals (Veith et al., 1985). QSAR studies have attempted 
to provide predictive models for various different types of toxicity, such as 
carcinogenicity, eye irritation and acute lethal toxicity (Enslein, 1988; Phillips 
et al., 1990). Numerous QSAR parameters can be applied in attempts to 
predict the toxicities of metal compounds in animals (Kaiser, 1985). One 
parameter, metal softness (ap), has received attention from toxicologists 
(Jones and Vaughn, 1978; Williams et al., 1982). In addition, Babich and 
Borenfreund (1987) attempted to demonstrate that in vitro toxicity assay data, 
by correlating well with the softness parameter, can be, by extrapolation, useful 
both in the prediction of in vivo toxicity and in the identification of new and 
useful QSARS. 
The "softness" of a metal ion governs its metal-ligand interactions according 
to the theory of Hard and Soft Acids and Bases (HSAB; Jones and Vaughn, 
1978). ap is defined in terms of the coordinate bond energies (CBE) of the 
metal fluoride (F) and metal iodide (I), thus: 
CBE(F) - CBE(I) 
CBE(F) 
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QSAR parameters are most likely to be applicable when used to predict toxic 
endpoints which are caused by the same mechanism (Phillips et aI., 1990). For 
example, correlations of softness to LDso values for metals should only hold 
where the basis of the lethal toxicity involves metal-ligand binding (Jones and 
Vaughn, 1978). However, it is questionable whether all metals exert their toxic 
effects by binding to target molecules (Cox and Harrison, 1983; Hulme et ai., 
1989). 
The FRAME KB cytotoxicity assay results and the softness parameter were 
therefore assessed for their ability to predict indices of acute toxicity in 
mammals. As rat oral and mouse i.p. LDso values had been used in the 
comparison involving unrelated chemicals (chapter 3), the two alternative 
methods were assessed for their ability to predict these two in vivo parameters. 
Metal compounds already present in the culture medium were:- calcium (II) 
chloride (2mM); iron (III) nitrate (O.OlmM); magnesium (II) sulphate (lmM) 
sodium (I) chloride (160mM); sodium (I) hydrogen carbonate (94mM); sodium 
(I) dihydrogen phosphate.2HzO (0.5mM) and sodium (I) pyruvate (0.5mM). 
4.2 RESULTS 
4.2.1 In vitro toxicities of 52 metal compounds 
4.2.1.1 In vitro toxicities of 52 metal compounds 
The 52 metal compounds tested revealed a wide range of cytotoxicities, with 
ID50 values from O.lj.£g!ml to 11800j.£g!ml (Table 4.1). Heavy metal 
compounds appear toward the top of the toxicity ranking. By contrast, 
compounds of the alkali and alkaline earth metals were toward the lower end, 
giving values considered to be of low toxicity. 
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Table 4.1. In vitro toxicities of 52 metal compounds 
ID20 IDso lOgo 
(I-'g/ml + s.e.m.) (I'glml + s.e.m.) ~ + s . e m ) )
Cadium II chloride 0.1 + 0 0.1 + 0 0.2 + 0.1 
Silver I nitrate 1 + 0 2+0 2+0 
Vanadium V oxide 0.2 + 0.1 2+0 3 + 1 
Copper I chloride 2+0 3+0 5 + 1 
Copper II chloride 2 + 1 3 + 1 4 + 1 
Mercury II chloride 2 + 1 4 + 1 6+0 
Zinc II chloride 6 + 1 9+0 12 + 1 
Selenium IV oxide 5 + 1 10 + 2 15 + 2 
Cobalt II chloride 3 + 1 11 + 1 24 + 6 
Thallium I sulphate 7+3 15 + 3 25 + 5 
Manganese II sulphate.4H20 11 + 2 15 + 1 25 + 3 
Zinc II acetate 12 + 1 15 + 1 18 + 1 
Thallium I acetate 9 + 1 17 + 2 30 + 2 
Iron II sulphate.7H20 I 20 + 9 I 
Tellurium IV chloride 8 + 1 22 + 2 31 + 2 
Nickel II sulphate. ?H2O 20 + 3 33 + 3 53 + 3 
Tin II chloride 21 + 6 53 + 10 124 + 31 
Sodium I fluoride 35 + 6 53 + 4 73 + 4 
Rhodium III chloride.3H20 26 + 3 55 + 2 100 + 1 
Tin IV chloride.5H20 34 64 + 3 98 
Sodium I tetrathionate.2H20 33 + 4 74 + 5 128 + 22 
Nickel II chloride.6H20 43 + 3 77 + 13 98 + 18 
lithium I fluoride 51 + 12 77 + 25 142 + 24 
. ~ > >
Palladium II chloride 62 + 14 103 + 2 115 
Lead II nitrate 53 + 21 119 + 45 345 + 19 
Lead IV tetra -aceta te 82 + 22 119 + 5 286 + 34 
Iron III sulphate 37 + 7 123 + 24 309 + 69 
Potassium I fluoride 70 + 16 150 + 6 260 + 25 
Beryllium II sulphateAHzO 66 + 9 157 + 17 387 + 48 
Yttrium III nitrate.6HzO 227 + 20 262 + 7 286 + 3 
Indium III nitrate.xHzO 26 + 3 303 + 57 546 + 9 
Gadolinium III chloride.6HzO 360 + 3 389 + 6 419 + 12 
Lanthanum III chloride.7HzO 373 441 + 34 567 + 19 
Lithium I chloride 343 + 67 554 + 95 810 + 73 
Aluminium III chloride.6HzO 738 + 120 830 + 60 1050 + 82 
Barium II acetate 566 + 280 982 + 62 2470 
Aluminium III nitrate.9HzO 953 + 75 1190 + 37 1280 
Chromium III chloride.6HzO 857 + 160 1500 + 24 2170 + 84 
Lithium I sulphate 953 + 210 2460 + 600 6460 + 200 
Lithium II bromide 1790 + 390 3290 + 130 7050 + 630 
Calcium II chloride.2HzO 2230 3860 8900 
Strontium II chloride.6HzO 1940 + 290 4060 + 220 10900 + 940 
Potassium I chloride 3060 + 300 4360 + 200 5560 + 75 
Lithium I iodide 2470 + 810 4690 + 460 7710 + 110 
Magnesium II chloride.6HzO 3260 + 420 5600 + 750 7910 + 90 
Sodium I chloride 1790 + 700 6230 + 720 8390 + 660 
Potassium I iodide 3280 + 860 7260 + 440 8790 + 44 
Potassium I bromide 5900 + 140 7780 + 390 9540 + 360 
Sodium I sulphate 6090 + 890 8930 + 560 10000 + 390 
Sodium I bromide 7250 + 450 9840 + 910 I 130) + J(XX) 
Sodium I iodide 8730 + 1700 11800 + 1500 164(X) + 1300 
I = Indeterminate. 
Most metal salts ionise in aqueous solutions, hence the relative number of 
anions and cations in each molecule must be considered. For example, one 
mole of thallium sulphate (T12S0 4) yields twice as many thallium ions per mole 
as thallium acetate (TICH3COO). The toxic effects of thallium would be 
expected to be related to the number of toxic thallium ions in solution, rather 
than the weight of compound dissolved in the solution. Hence, although f..Lglml 
1Dso values are usually taken as the parameters for comparison of test 
substances by rank order (Balls & Horner, 1985; Knox et ai., 1986), in this 
case they were converted to millimolar (mM) concentrations to permit the 
comparison of cytotoxicities in terms of molar concentration (Table 4.2). 
Thallium sulphate and thallium acetate have 1Dso values of 15 and 17 f..Lglml 
respectively, which, when converted, become 0.03 and 0.07mM. This 
demonstrates how thallium sulphate, by yielding two TI+ ions per mole, is 
twice as toxic as thallium acetate. Similarly, the 1Dso (mM) values of the two 
aluminium compounds (aluminium chloride, 3.4mM, and aluminium nitrate, 
3.2mM) are much closer than the 1Dso (f..Lglml) values, 830 and 1190, 
respectively. However, potassium sulphate (K2S04, 1Dso 45mM) is not twice 
as toxic as potassium chloride (KCI), and this indicates that it is not only the 
potassium ion which is causing toxicity. 
By converting 1Dso values from f..Lglml to mM, the compounds whose rankings 
are altered most are those with either a relatively low or a relatively high 
molecular weight (Table 4.2). Nickel (II) chloride hexahydrate and lithium 
fluoride appear to be equally toxic in the f..Lg/ml ranking. However, the mM 
values reveal that lithium fluoride is almost ten times less toxic than the nickel 
compound. 
4.2.1.2 Effects of the anion on metal compound toxicity in vitro 
Since it cannot be assumed that the anions make no contribution to the 
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Table 4.2 Comparison of rank order of IDsoS of 52 metal compounds by millimolar and "glml values. 
IDso Rank order Rank order 
(mM) by IDso (mM) b y I D ~ ~ ~
Cadmium II chloride 0.001 1 1 
Vanadium V oxide 0.01 25 25 
Silver I nitrate 0.01 2.5 2.5 
Mercwy II chloride 0.02 4.5 6 
Copper II chloride 0.02 4.5 4.5 
Copper I chloride 0.03 6.5 4.5 
Thallium I sulphate 0.03 6.5 11 
Thallium I acetate 0.07 9.5 13 
Zinc II chloride 0.07 9.5 7 
Manganese II sulphate.4H2O 0.07 9.5 11 
Iron II sulphate·7H2O 0.07 9.5 14 
Zinc II acetate 0.08 12.5 11 
Tellurium IV chloride 0.08 12.5 15 
Cobalt II chloride 0.09 14.5 9 
Selenium IV oxide 0.09 14.5 8 
Nickel II sulphate·7H2O 0.12 16 16 
Tin IV chloride.5H2O 0.18 17 20 
Rhodium III chloride.3H2O 0.21 18 19 
Sodium I tetrathionate.2H2O 0.24 19 21 
Lead IV tetraacetate 0.27 20 25.5 
Tin II chloride 0.28 21 17.5 
Iron III sulphate 0.31 22 27 
Nickel II chloride.6H2O 0.32 23 22.5 
Lead II nitrate 0.36 24 25.5 
Palladium II chloride 0.58 25 24 
Yttrium III nitrate.6H2O 0.68 26 30 
Beryllium II sulphate.4H2O 0.89 27 29 
Indium III nitrate.xH2O 1.0 28.5 31 
Gadolinium III chloride.6H2O 1.0 28.5 32 
Lanthanum III chloride.7H2O 1.2 30 33 
Sodium I fluoride 1.3 31 17.5 
Potassium I fluoride 2.6 32 28 
Lithium I fluoride 3.0 33 22.5 
Aluminium III nitrate.9H2O 3.2 34 37 
Aluminium III chloride.6H2O 3.4 35 35 
Barium II acetate 3.8 36 36 
Chromium III chloride.6H2O 5.6 37 38 
Lithium I chloride 13 38 34 
Strontium II chloride.6H2O 15 39 42 
Lithium I sulphate 22 40 39 
Calcium II chloride.2H2O 26 41 41 
Magnesium II chloride.6H2O 42 42 45 
Lithium I iodide 35 43 44 
Lithium I bromide 38 44 40 
Potassium I iodide 44 45 47 
Potassium I sulphate 45 46 49 
Potassium I chloride 58 47 43 
Sodium I sulphate 63 48 50 
Potassium I bromide 65 49 48 
Sodium I iodide 79 50 52 
Sodium I bromide 96 51 51 
Sodium I chloride 107 52 46 
toxicity of metal compounds, the toxicities of metal compounds with a common 
anion were considered. Chloride is the most abundant of those anion already 
present in the culture medium. Even with a common anion, however, direct 
comparison between the metal compounds would have to take into account 
the fact that metals of different valencies and different toxicities will contribute 
different amounts of chloride to the test chemical solution. However, the 
culture medium contains over 100mM chloride, so the addition of further 
chloride would be unlikely to greatly alter the chloride concentration. 
Therefore, the cytotoxicities of the 22 chlorides were examined (Table 4.3). 
Only potassium, sodium, calcium and magnesium chlorides produced 1Dso 
(mM) concentrations which could increase the initial medium chloride 
concentration by more than about 20%. Hence, the anion (in this case, 
chloride) is potentially important, particularly when applied as a salt of a 
cation with low cytotoxicity. 
4.2.1.3 Effects of the anion on the in vitro toxicities of salts of alkali metals 
The cytotoxicities of five different salts of lithium, sodium and potassium were 
compared in order to investigate the influence of the anion on metal 
compound cytotoxicity. Compounds of sodium and potassium in general have 
very low cytotoxicity to 3T3-Ll cells, thus reducing the risk that cation toxicity 
would mask any effect caused by the anion. 
The results (Table 4.4) show that, of the halides, fluorides are clearly the most 
toxic ill vitro. Sulphates also appear to be slightly more toxic than the halides. 
The rank order of toxicity for the three metals, for all the salts except fluoride, 
is lithium > potassium > sodium, although the differences are not great 
(Table 4.4). This ranking was found, despite the high concentration of sodium 
and chloride ions already present in the culture medium. 
82 
Table 4.3 In vitro toxicities of the chloride salts of 22 metals 
Metal Valency IDso (mM) 
Cadmium II 0.001 
Mercury II 0.02 
Copper II 0.02 
Copper I 0.03 
Zinc II 0.07 
Tellurium IV 0.08 
Cobalt II 0.09 
Tin IV 0.18 
Rhodium III 0.21 
Tin II 0.28 
Nickel II 0.32 
Palladium II 0.58 
Gadolinium III 1.0 
Lanthanum III 1.2 
Aluminium III 3.4 
Chromium III 5.6 
Lithium I 13 
Strontium II 15 
Calcium II 26 
Magnesium II 28 
Potassium I 58 
Sodium I 107 
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Table 4.4. In vitro toxicities of salts of three alkali metals 
ID50 (mM) 
Lithium Sodium Potassium 
Fluoride 3.0 1.3 2.6 
Chloride 13 107 58 
Bromide 38 96 65 
Iodide 35 79 44 
Sulphate 22 63 45 
4.2.1.4 Conclusions 
The results for the 52 metal compounds tested in the FRAME KB cytotoxicity 
assay spanned six orders of magnitude and hence covered a similar range of 
toxic potencies as the 150 chemicals (Chapter 3). 
The converSIon of the ID50 results from J,Lg!ml to mM removed several 
discrepancies concerning the toxicity of a metal ion (e.g. with thallium and 
aluminium). The expression of metal compound toxicity results in mM is 
therefore necessary, because it takes into account the number of toxic metal 
ions in solution. 
The anion of the metal compound is of little importance in the toxicity of the 
whole compound, unless the anion is intrinsically toxic and/or the metal is of 
low toxicity. The most common anions are of low toxicity and do not affect the 
toxicity ranking of the metals. 
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4.2.2 Comparison of in vitro toxicity data and the metal softness parameter 
with published in vivo toxicity data, by linear regression analysis 
In order to test whether the FRAME KB cytotoxicity assay and/or the softness 
parameter could be useful predictors of mammalian toxicity, both the assay 
results and the ap values were compared with the parameters of acute in vivo 
toxicity. 
Table 4.5 includes the cytotoxicity IDso (mM) values for all 52 metal 
compounds along with rat oral and mouse i.p. LDso data and softness (ap) 
values, where available. Rat oral LDso values were available for 27 of the 
compounds, and mouse i.p. values for 28. Softness (ap) values were available 
for 31 out of 35 different metal ions present in the compounds, and were 
taken from Williams et al. (1982), except for those for Li+, Na+, K+, Cu+, 
Ca2+ Fe2+ Sn2+ Al3+ y3+ and La3+ which were taken from Pearson and 
, , " , 
Mawby (1967). Both rat and mouse in vivo values, as well as softness values, 
were available for 19 of the compounds. 
4.2.2.1 Selection of data sets for analysis 
In order that correlations of the two alternatives (the FRAME KB cytotoxicity 
assay and the softness parameter) with acute in vivo toxicity data would be 
comparable, only the 19 compounds with both rat and mouse LDso values 
were used. Four data sets within this 19 were selected, so that any correlation 
using a particular data set involved the same set of chemicals. 
The first two data sets were used for correlations between the FRAME KB 
cytotoxicity assay results (IDso in mM) and the rat oral or mouse i.p. LDso 
values (in mmol/kg). These were:-
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Table 4.5. In vitro and in vivo toxicities and softness values of 52 metal compounds 
IDso Rat Oral LDso Mouse i.p. LDso Softness 
(mM) (mmol/kg) (mmol/kg) (up) 
Cadmium II chloride 0.001 0.48 0.05 0.081 
Vanadium V oxide 0.01 0.05 
Silver I nitrate 0.01 0.13 0.073 
Mercury II chloride 0.02 0.004 0.02 0.064 
Copper II chloride 0.02 1.0 0.06 0.104 
Copper I chloride 0.03 2.7 0.112 
Thallium I sulphate 0.03 0.215 
Thallium I acetate 0.07 0.14 0.215 
Zinc II chloride 0.07 2.6 0.23 0.115 
Manganese II sulphate.4H2O 0.07 2.4 0.124 
Iron II sulphate·7H20 0.07 2.1 0.42 0.129 
Zinc II acetate 0.08 14 0.31 0.115 
Tellurium IV chloride 0.08 
Cobalt II chloride 0.09 0.62 0.38 0.130 
Selenium IV oxide 0.09 
Nickel II sulphate.7H20 0.12 0.14 0.126 
Tin IV chloride.5H20 0.18 0.18 0.075 
Rhodium III chloride.3H20 0.21 0.055 
Sodium I tetrathionate.2H20 0.24 0.211 
Lead IV tetraacetate 0.27 
Tin II chloride 0.28 3.7 0.35 0.148 
Iron III sulphate 0.31 0.097 
Nickel II chloride.6H20 0.32 0.81 0.20 0.126 
Lead II nitrate 0.36 0.131 
Palladium II chloride 0.58 1.1 0.59 0.069 
Yttrium III nitrate.6H2O 0.68 6.2 0.147 
Beryllium II sulphate.4H2O 0.89 0.78 0.172 
Indium III nitrate.xH2O 1.0 0.100 
Gadolinium III chloride.6H2O 1.0 1.4 0.157 
Lanthanum III chloride.7H2O 1.2 17 0.49 0.171 
Sodium I fluoride 1.3 4.3 1.2 0.211 
Potassium I fluoride 2.6 4.2 0.232 
Lithium I fluoride 3.0 0.247 
Aluminium III nitrate.9H2O 3.2 0.7 0.136 
Aluminium III chloride.6H2O 3.4 28 0.136 
Barium II acetate 3.8 3.6 0.184 
Chromium III chloride.6H2O 5.6 6.7 2.0 0.107 
Lithium I chloride 13 18 14 0.247 
Strontium II chloride.6H2O 15 14 5.7 0.172 
Lithium I sulphate 22 0.247 
Calcium II chloride.2H2O 26 9.0 2.5 0.181 
Magnesium II chloride.6H2O 28 40 1.0 0.167 
Lithium I iodide 35 0.247 
Lithium I bromide 38 0.247 
Potassium I iodide 44 6.7 0.232 
Potassium I sulphate 45 0.232 
Potassium I chloride 58 7.4 0.232 
Sodium I sulphate 63 0.2] ] 
Potassium I bromide 65 0.232 
Sodium I iodide 79 29 5.8 0.211 
Sodium I bromide 96 34 0.211 
Sodium I chloride 107 74 53 0.211 
Set 1: any compound (n = 19), and 
Set 2: chlorides only (n = 15) 
The chlorides were chosen as a data set in order to investigate whether the 
omission of other, potentially toxic, anions from the analysis would affect the 
correlations. 
Softness values can only be used on a comparative scale amongst ions of the 
same valency (Williams et ai., 1982). The compounds therefore had to be 
divided into the metal valency groupings before correlations involving the 
softness parameter could be made. There were inadequate (i.e. less than ten) 
numbers of monovalent, trivalent and tetravalent metals in the available set 
of 19 compounds for valid correlations to be made. The third and fourth data 
sets used in comparisons were: 
Set 3: divalent metal compounds only (n = 13), and 
Set 4: divalent metal chlorides only (n = 11) 
Data sets 3 and 4 were used for comparIsons between the FRAME KB 
cytotoxicity assay results or softness values and the in vivo data, as well as for 
comparisons between the FRAME KB cytotoxicity assay results and softness 
values. 
4.2.2.2 Influence of size of data set on correlation coefficients 
The majority of the correlation coefficients did not alter dramatically when the 
data sets were reduced from 19 to 15 to 13 to 11 compounds (Table 4.6), or 
from 13 to 11 (Table 4.7), indicating that the basic correlations are sound, 
even though a relatively small number of data points were involved. However, 
it is noteworthy that, in the KB IDsoirat oral LDso comparisons (column A, 
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Table 4.6. 
DATA 
SET 
n 
r 
r(Hg) 
Comparison of the FRAME KB cytotoxicity assay 1050 values with rat oral and mouse i.p. LOso values, for four 
groups of metal compounds 
COMPARISON 
1 All compounds with 
both rat and mouse 
data (n* = 19) 
2 All chlorides with 
both rat and mouse 
data (n = 15) 
3 All divalents with 
both rat and mouse 
data (n = 13) 
4 All divalent 
chlorides with both 
rat and mouse 
data (n = 11) 
A 
Log KB 1050 
to Log Rat 
oral L050 
r = 0.74 
r(Hg) = 0.82 
r = 0.77 
r(Hg) = 0.87 
r = 0.63 
r(Hg) = 0.74 
r = 0.70 
r(Hg) = 0.85 
number of metal compounds in data groups 
B 
Log KB 1050 
to Log Mouse 
i.p. L050 
r = 0.89 
r(Hg) = 0.90 
r = 0.90 
r(Hg) = 0.89 
r = 0.86 
r(Hg) = 0.90 
r = 0.88 
r(Hg) = 0.91 
correlation coefficient obtained from linear regression analysis 
correlation coefficient obtained when analysis was carried out omitting mercury (II) chloride 
Table 4.7 
DATA 
SET 
n 
r 
r(Hg) 
Comparison of the softness (ap) values with rat oral and mouse i.p. LDso values and FRAME KB cytotoxicity 
assay IDso values for two groups of metal compounds 
3 All divalents with 
both rat and mouse 
data (n = 13) 
4 All divalent 
chlorides with both 
rat and mouse 
data (n = 11) 
A 
Log ap to 
Log Rat 
oral LDso 
r = 0.77 
r(Hg) = 0.67 
r = 0.81 
r(Hg) = 0.74 
number of metal compounds in data groups 
COMPARISON 
B 
Log ap to 
Log Mouse 
i.p. LDso 
r = 0.80 
r(Hg) = 0.70 
r = 0.76 
r(Hg) = 0.65 
correlation coefficient obtained from linear regression analysis 
C 
Log ap to 
Log 
KB IDso 
r = 0.70 
r(Hg) = 0.70 
r = 0.73 
r(Hg) = 0.72 
correlation coefficient obtained when analysis was carried out omitting mercury (II) chloride 
Table 4.6), there is an increasing difference between the correlation coefficient 
for each complete data set (r) and the correlation coefficient for the same 
data set without mercury (II) chloride (r(Hg)), as the data set size decreases. 
4.2.2.3 Comparison of in vivo and in vitro toxicity data for the metal 
compounds 
For all four data sets, the FRAME KB cytotoxicity assay gave higher 
correlation coefficients when compared to mouse i.p. LDso data (Table 4.6, 
column B) than when compared to rat oral LDso data (Table 4.6, column A). 
The KB IDsoirat oral LDso linear regression lines are skewed toward the 
horizontal by an outlying point (Figures 4.1(a), 4.2(a), 4.3(a) and 4.4(a)). This 
point represents mercury (II) chloride, the most toxic compound in the rat oral 
LDso test among the metal compounds shown in Table 4.5. By omitting the 
mercury (II) chloride point from the KB IDsoirat oral LDso comparisons, the 
regression lines become steeper and the correlation coefficients increase. 
However, the correlation coefficients are still below the values for the 
corresponding KB 1Dsolmouse i.p. LDso comparisons. The slopes of the KB 
IDsoirat oral LDso regression lines without mercury (II) chloride, move closer 
to the slopes of the lines for the KB 1Dsolmouse Lp. LDso comparisons 
(Figures 4.1(b), 4.2(b), 4.3(b) and 4.4(b). 
The KB IDsoirat oral LDso correlation coefficients (Table 4.6, column A) are 
fairly similar for data sets 1, 2 and 4, although for set 3 (the divalents) it is 
somewhat lower (r = 0.63). Among the KB 1Dsolmouse i.p. LDso comparisons 
(Table 4.6, column B), the coefficients are also similar, whichever data are 
used. Mercury (II) chloride is not distant from the regression line on the KB 
ID solmouse L p. LD so plots (Figures 4.1 (b), 4.2(b), 4.3(b) and 4.4(b)), hence, 
when it was omitted from the KB 1Dso mouse i.p. LDso comparisons, the 
coefficients remained virtually unchanged. 
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Figure 4.1(a) Figure 4.1(b) 
Figure 4.1 Linear Regression plots for comparisons of 
(a) FRAME KB cytotoxicity assay 1Dso with rat oral LOso; and (b) FRAME KB cytotoxicity assay 1050 with mouse i.p. LDso, 
for 19 metal compounds. 
r = the correlation coefficient; r(Hg) = the correlation coefficient when 
mercury (II) chloride is omitted from the comparison 
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Figure 4.2( a) Figure 4.2(b) 
Figure 4.2 Linear Regression plots for comparisons of 
(a) FRAME KB cytotoxicity assay IDso with rat oral LDso; and 
(b) FRAME KB cytotoxicity assay IDso with mouse i.p. LDso, 
for 15 metal chlorides. 
r = the correlation coefficient; r(Hg) = the correlation coefficient when 
mercury (II) chloride is omitted from the comparison 
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Figure 4.3 Linear Regression plots for comparison of 
(a) FRAME KB cytotoxicity assay 1Dso with rat oral LDso; 
(b) FRAME KB cytotoxicity assay 1Dso with mouse i.p. LDso; 
(c) Softness parameter (up) with rat oral LDso; 
(d) Softness parameter (up) with mouse i.p. LDso; and 
(e) Softness parameter (up) with FRAME KB cytotoxicity 
assay 1Dso 
for 13 divalent metal compounds. 
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r = the correlation coefficient; r(Hg) = the correlation coefficient when 
mercury (II) chloride is omitted from the comparison 
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Figure 4.4 Linear Regression plots for comparisons of 
(a) FRAME KB cytotoxicity assay 1Dso with rat oral LDso; 
(b) FRAME KB cytotoxicity assay 1Dso with mouse i.p. LDso; 
(c) Softness parameter (up) with rat oral LDso; 
(d) Softness parameter (up) with mouse i.p. LDso; and 
( e) Softness parameter (up) with FRAME KB cytotoxicity 
assay I D s ~ ~
for 11 divalent metal chlorides. 
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r = the correlation coefficient; r(Hg) = the correlation coefficient when 
mercury (II) chloride is omitted from the comparison 
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If data set restrictions are removed, then comparison of the FRAME KB 
cytotoxicity assay with rat oral LDso for all compounds with rat data (n = 27) 
gives an correlation coefficient of 0.73. Similarly, for all compounds with 
mouse data (n = 28), the KB 1Dsolmouse i.p. LDso comparison gives an 
correlation coefficient of 0.86. 
4.2.2.4 Comparison of the in vivo toxicity data with the softness parameter 
The comparisons of softness (ap) with rat oral LDso data (Table 4.7, column 
A) gave higher correlation coefficients (0.77 and 0.81) than for the 
corresponding KB IDsoirat oral LDso comparisons (0.63 and 0.70; Table 4.6, 
column A), for the data sets 3 and 4. However, the comparisons of softness 
to mouse i.p. LDso data (Table 4.7, column B) gave lower correlation 
coefficients (0.80 and 0.76) than the corresponding KB 1Dso mouse i.p. LDso 
comparisons (0.86 and 0.88; Table 4.6, column B). 
The correlation coefficients for the softness/in vivo compansons were not 
altered dramatically by the move from the divalents data set (set 3) to the 
divalent chlorides data set (set 4). 
Omission of mercury (II) chloride from the softness/in vivo comparisons did 
not improve the correlation coefficients (Table 4.7, columns A and B). By 
contrast, omission of mercury (II) chloride from the KB IDsoirat oral LDso 
comparisons did improve them. 
4.2.2.5 Comparison of the in vitro toxicity data with the softness parameter 
The comparisons of the FRAME KB cytotoxicity assay results with softness 
values (Table 4.7, column C) gave among the poorest correlation coefficients 
in Tables 4.6 and 4.7. Figures 4.3 (e) and 4.4 (e) show that there are two 
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chemicals (mercury (II) chloride and palladium (II) chloride) which are distant 
from the regression line on both plots. Omitting these two points from both 
comparisons causes the correlation coefficients to rise from 0.70 to 0.96 (figure 
4.3 (e)) and from 0.73 to 0.97 (figure 4.4 (e)). 
4.2.2.6 Conclusions 
The FRAME KB cytotoxicity assay data gave a better correlation with mouse 
i.p. LDso values than with rat oral values, with all four data sets. However, in 
the FRAME KB cytotoxicity assay data/rat oral LDso comparisons, the 
correlation coefficients were improved by the omission of mercury (II) 
chloride. The best correlation coefficients in Tables 4.6 and 4.7 were for the 
FRAME KB cytotoxicity assay/mouse i.p. LDso comparisons. 
Softness (ap) values predicted both rat oral and mouse i.p. LDso values equally 
well. The softness parameter gave a better correlation with rat oral data than 
did the FRAME KB cytotoxicity assay. Conversely, the FRAME KB 
cytotoxicity assay gave a better correlation with the mouse i.p. data than did 
the softness parameter. Omission of mercury (II) chloride from the softnesslin 
vivo comparisons worsened the correlations, unlike the KB IDsoirat oral LDso 
comparisons where the correlations were improved with the omission of 
mercury (II) chloride. 
Comparison of the softness parameter with the FRAME KB cytotoxicity assay 
data serves to demonstrate that the two alternatives are not providing identical 
information, despite the fact that they both predict the rat and mouse data 
reasonably well. The regression plots of the KB IDsoisoftness comparisons 
show basically good correlations, except for the outlying points of mercury (II) 
chloride and palladium (II) chloride. The softness values of these two 
compounds predict that they would be more toxic than the FRAME KB 
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cytotoxicity assay indicated. Examination of the softness/in vivo plots shows 
that mercury (II) chloride lies close to the regression lines, i.e. softness 
predicted mercury (II) chloride toxicity well. However, palladium (II) chloride 
remains an out-lier in these plots, so softness did not predict its in vivo toxicity 
correctly. The FRAME KB cytotoxicity assay correctly predicted the in vivo 
toxicity of palladium (II) chloride. Williams et ala (1982) expressed doubt of 
the accuracy of the palladium (II) softness value quoted by Ahrland (1968), 
and it may be "inconsistent" with other divalent metal ion softness values. 
Palladium (II) is also an out-lier in the softness/LDso correlations of Williams 
et ala (1982). 
4.3 DISCUSSION 
A wide range of metal compounds was tested USIng the FRAME KB 
cytotoxicity assay, including some which are regarded as having low toxicity 
(for example, sodium chloride), some of low aqueous solubility and some 
compounds of less common metals, such as tellurium, yttrium and gadolinium. 
While other in vitro assay methods have also been used to assess the rank 
order of metal toxicity, they have tended to concentrate on small groups of the 
more toxic metals (Tan et al., 1984; Babich et al., 1986; Borenfreund and 
Puerner, 1986). It is desirable that, during the validation and evaluation of an 
ill vitro toxicity test, applied to a chosen group of chemicals, a wide range of 
toxicities should be spanned. This ensures that, when further chemicals from 
this group are to be evaluated, there is a sufficiently large database with which 
to compare the new result (Clothier et al., 1988; Balls et al., 1990a). The 
results for the group of 52 metal compounds tested in the FRAME KB 
cytotoxicity assay spanned six orders of magnitude and hence provide a 
satisfactory spread, and a sufficient number of chemicals for such a database 
(Balls et al., 1990a). 
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The expression of the 1Dso values of the compounds in mM units raised 
questions concerning which component of the least toxic compounds was 
causing toxicity. The 1Dso of potassium sulphate (K2S04) is not half that of 
potassium chloride (Kel), as would be expected if the K+ ion was alone 
responsible for the toxicities of these potassium compounds. It is apparent 
that the sulphate and chloride ions have different toxic effects. 
The rank order of the cytotoxicities of the metal compounds generally 
retlected the known human toxicities of the compounds. For example, 
cadmium (II) chloride, mercury (II) chloride and thallium (I) sulphate are 
known to be severe poisons, while sodium (I) chloride, potassium (I) chloride 
and calcium (II) chloride are not normally considered poisonous to humans 
(Friberg et al., 1986). 
Although selecting metal chlorides (thereby avoiding "toxic" anions such as 
tluoride) allows direct comparison of the toxicities of the metal ions, this is 
only true for the more toxic metals (i.e. those with an 1Dso of less than 
approximately 20mM). With chlorides of the least toxic metals (such as 
sodium and potassium), the possibility of anion effects contributing to the 
toxicity of a compound must also be considered, because of the high 
concentrations involved. Further examination of anion effects could be 
undertaken by the testing of additional anions (such as nitrate, phosphate or 
carbonate) with the alkali metals, and also a range of anions with divalent and 
trivalent metal ions of relatively low toxicity (such as chromium (III), strontium 
(II), and magnesium (II)). When testing metal compounds in vitro, in order to 
evaluate toxicity of the metal ions and not the whole compounds, the 
predominant anion in the medium (usually chloride) must be considered. 
However, some metal chlorides are insoluble or highly reactive, hence an 
alternative anion of low toxicity must be chosen. 
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The overall conclusion must be that the nature of the anion does not affect 
the toxicities of the majority of the metal compounds tested. The exceptions 
are the compounds involving intrinsically toxic anions, such as fluoride or 
tetrathionate, and when metal compounds of very low toxicity are tested. In 
the latter situation, the anion may contribute to the toxicity of the compounds 
by (along with the cation) being at a high concentration in the medium. This 
high concentration may affect the ionic strength and/or osmolality of the 
medium to such an extent that the tolerance limits of the cells to high ionic 
strength could be exceeded (Freshney, 1987) and result in inhibition of growth. 
The concentration of metal salts already present in the culture medium should 
also be taken into account (e.g. 3T3-L1 medium contains over 100mM sodium 
ions). However, as with in vivo toxicity tests, the FRAME KB cytotoxicity assay 
measures the effects of the added compound, and controls take into account 
the presence of some test compounds within the test system. 
Of the two alternatives assessed, Le. the FRAME KB cytotoxicity assay and 
the softness parameter, the cytotoxicity assay was found to be the more useful 
predictor of rat oral and mouse i.p. LDso values, for the metal compounds 
examined, when linear regression analysis was used and other factors were 
considered. 
The FRAME KB cytotoxicity assay data gave a better correlation with mouse 
Lp. LDso values than with rat oral LDso values. Absorption of metal 
compounds from the gut following oral administration is known to vary widely 
according to the metal and anion concerned, the solubility of the compounds 
and the state of the subject animal (Camner et al., 1986; Nordberg et al., 
1986). Continuous exposure of cells in culture to a compound, as in the 
FRAME KB cytotoxicity assay, possibly mimics parenteral dosage better, 
where there are fewer absorption barriers to tissue exposure (Fry et af., 1988a; 
Clothier et al., 1989; Fry et al., 1990b). Other workers have also found good 
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correlations between metal toxicity in vitro and in vivo. For example, the 
toxicity of sixteen compounds to Chinese hamster ovary cells correlated well 
with both mouse and Drosophila acute toxicity parameters (Tan et ai., 1984), 
and the NR U so values for six compounds tested on bluegill (fish) cells 
compared favourably with the LCso values from whole bluegill sunfish (Babich 
et ai., 1986). 
The alterations in the correlation coefficients which occurred when only one 
compound (mercury (II) chloride) was omitted from KB IDsoirat oral LDso 
and softness/rat or mouse comparisons, could reduce the confidence placed in 
the accuracy and strength of the coefficient values. Further information can 
be gained from the regression plots. It is important to take into account the 
scatter of data points on either side of the regression line and at its 
furthermost lefthand and righthand edges. Outlying points can skew a 
regression line and make a reasonable correlation look worse by reducing the 
correlation coefficient (as demonstrated with mercury (II) chloride and the KB 
IDsoirat oral LDso comparisons). However, single data points within a small 
data set, at the lefthand or right hand edge of a regression line, can 
disproportionately influence the positioning of the regression line. This can 
make a mediocre correlation look reasonable (as demonstrated with softness/in 
vivo comparisons). 
Mercury (II) chloride was an out-lier in the KB IDsoirat oral LDso 
comparisons, because it appeared to be more toxic by rat oral LDso criterion 
than would be predicted by the FRAME KB cytotoxicity assay. A possible 
explanation for this is the fact that mercury (II) chloride is corrosive to the 
gastro-intestinal tract, which results in enhanced uptake of the Hg2+ ions into 
the circulation (Berlin, 1986). This compound is equally toxic by oral (LDso 
0.004 mmol/kg) and intravenous (LDso 0.01 mmol/kg) administration to rats 
(Lewis and Tatken, 1982). 
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Because it refers to the metal ion only, the softness parameter is incapable of 
predicting the toxicities of compounds consisting of "toxic" anions and "non-
toxic" cations, such as sodium tetrathionate and potassium fluoride. In 
addition, softness/in vivo comparisons in this study could only be made among 
divalent metal compounds, which excluded a high proportion of the 
compounds tested. Further limitations of the softness alternative are the 
variability and availability of published softness values for metals in all their 
valency states, and the suggestion that the alkaline earth metals do not fit into 
the softness scale (Williams et al., 1982). However, existing softness values can 
be readily obtained from the literature, and, when put into the correct context, 
may offer additional or supportive information to that supplied by an in vitro 
cytotoxicity assay. Nevertheless, there is no indication that the softness 
parameter is of any real value on its own as an alternative means of predicting 
metal compound toxicity. There are, however, many other physico-chemical 
parameters of metals that may better predict (either alone or in combination) 
in vivo metal toxicity (Kaiser, 1985). Simple, inorganic metal compounds are 
closely related structurally, and the majority exert their toxicity by a common, 
basic mechanism, i.e. binding of the metal cation to electron-donating ligands 
at the target site. Hence, they are a suitable group of compounds for 
developing QSARs. QSARs are not as applicable with less closely-related 
groups, but may be useful tools in the initial phase of elucidating a new 
chemical's toxicological profile (Balls and Horner, 1985; Enslein, 1988). 
The FRAME KB cytotoxicity assay has demonstrated considerable potential 
for the prediction of the rodent acute toxicities of simple metal compounds. 
It is not possible to conclude that the assay could also predict human toxicity, 
because of the lack of suitable human data with which to perform 
comparisons. However, the assay did, in general terms, find the rank order 
toxicity corresponded with the acknowledged toxicity of the compounds to 
humans. 
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Most of the 52 metal compounds tested were readily soluble in aqueous 
medium, and hence were not problematical to test in the FRAME KB 
cytotoxicity assay. Comparisons with in vivo toxicity parameters were also 
relatively straightforward, because of the availability of a reasonable quantity 
of LDso data for the compounds. In an industrial situation, however, the test 
compounds may not be readily soluble, and may come from a set of 
compounds for which little or no toxicity data is available. It is therefore 
appropriate that the FRAME KB cytotoxicity assay should be assessed for its 
usefulness in testing more complex, commercial compounds and formulations. 
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5.1 INTRODUCTION 
As one of the industrial sponsors of the FRAME Research Programme, 
Rhone-Poulenc Ltd. (formerly May and Baker) had provided several pure 
chemicals which were tested in the first interlaboratory trial of the FRAME 
KB cytotoxicity test (Knox et ai., 1986). These chemicals (Butylated 
hydroxyanisole, Chloroquine sulphate and Ioxynil) were also tested on 3T3-L1 
cells and the results were published as part of a set of 150 unrelated industrial 
and laboratory chemicals and human pharmaceuticals (Chapter 3) (Clothier 
et ai., 1988). 
As part of an ongoing project to assess the applicability of the FRAME KB 
cytotoxicity assay in the prediction of acute lethal toxicity of industrial 
chemicals, Rhone-Poulenc Ltd. provided a further twenty-eight pure chemicals 
and twenty liquid formulations for testing. The samples were tested in the 
standard FRAME KB cytotoxicity assay protocol and the results are presented 
in two sections: pure chemicals and formulations. 
5.2 RESULTS 
5.2.1 Pure Chemicals 
5.2.1.1 Description of the chemicals 
The pure chemicals (Table 5.1) encompass fungicides, herbicides, an 
insecticide, anti-microbial agents, human pharmaceuticals, and chemicals in 
development (use unknown). Some are in commercial use, while some in 
development were found unsuitable for commercial use, or are metabolites of 
drugs. The chemicals also encompass a wide range of structural formulae, and 
cannot, therefore, be considered to be related to one another as a complete 
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Table 5.1. In viIro toxicities of twenty eight Rhone-Poulenc Ltd. pure chemicals 
Rank TOX Chemical ID20 IDso 1080 
Order No. #,g1ml ± s.e.m. #,g1ml ± s.e.m. #,g/ml ± s.e.m. 
No. 
1 22 coccidiostat 0.02 ± 0 0.03 ± 0 0.04 ± 0 
2 40 Chlorothalonil (fungicide) <1 2±0 4±0 
3 30 Dichlorophen (biocide) 7±0 13 ± 1 22 ± 1 
4 25· Propranolol (cardiovascular drug) 7 (n=2) 22 ± 2 33 ± 5 
6= 43 Neburon (herbicide) 16 ± 6 35 ± 9 NO 
6= 33 DXH 1421 (chemical series A) 10 ± 2 35 ± 15 99 ± 22 
7 42 MCP A acid (herbicide) 10 ± 2 36 ± 3 81 + 7 
8 29 anti-protozoal 14 ± 2 40 ± 7 71 (n= 1) 
9 31 JJW 2027 (chemical series A) 20 ± 9 43 ± 18 76 ± 25 
10 24 herbicide 22 ± 3 52 ± 9 133 ± 19 
11 32 JJW 2092/1 (chemical series A) 8 ± 1 81 ± 54 49 (n=l) 
12 39 Cyanazine (herbicide) 27 ± 3 95 ± 7 >100 
13 46 Trifluralin (herbicide) 143 ± 19 210 ± 19 383 ± 90 
14 44 Simazine (herbicide) 24 ± 10 232 ± 70 NO 
15 41 Oimethoate (insecticide) 175 ± 48 317 ± 44 628 ± 92 
16 45 Mecoprop (herbicide) 169 ± 56 361 ± 31 623 ± 78 
17 35 RRB 2306 (chemical series B) 266 ± 33 508 ± 77 877 ± 208 
18 38 RRB 2347 A (chemical series B) 355 ± 107 515 ± 83 817 ± 11 
19 26· metabolite of a cardiovascular drug 302 (n=2) 544 ± 9 668 ± 11 
20 20· 8-Chlorotheophylline (lot B, 1% dimer) 234 ± 46 682 ± 67 1495 ± 262 
21 21· 8-Chlorotheophylline (lot A, 0.05% dimer) 209 ± 56 750 ± 76 1656 ± 197 
22 34 
23 27* 
24 23* 
25 16 
27= 36 
27= 37 
28 28 
* 
t 
NO 
RRB 2316 (chemical series B) 540 ± 186 844 + 199 >1000 
metabolite of a cardiovascular drug 557 (n=2) 990 + 31 1171 + 24 
Asulam (herbicide) 1986 (n=2) 3560 + 149 4794 + 60 
Thalidomide >500t 
RRB 2309/1 (chemical series B) >100Dt 
BDH 202/1 (chemical series B) >100Dt 
intermediate of TOX 29 insoluble 
Were dissolved directly into culture medium for FRAME KB cytotoxicity assay. Remainder were dissolved 
initially in DMSO (DMSO at 1 % (v/v) final concentration in test chemical treatment solution). 
Limit of solubility in culture medium 
Not determined 
group. Within the group, there are five sets of related chemicals. These are: 
(a) TOX 20 and TOX 21 - two batches of 8-Chlorotheophylline (a human 
anti-emetic drug) with different levels of a dimer; 
(b) TOX 42 and TOX 45 are [2-(( 4-chloro-o-tolyl)oxy)] groups with an 
acetic and a propionic side chain, respectively (Figure 5.1); 
(c) TOX 39 and TOX 44, which are structurally identical except for a C= N 
(nitrile) side group in TOX 39 (Figure 5.1). 
(d) TOX 31, 32 and 33 are from the same chemical series (named series 
A); and 
(e) TOX 34, 35, 36, 37 and 38 are from the same chemical series (named 
series B). 
5.2.1.2 In vitro toxicities of pure chemicals 
The 28 pure chemicals gave a wide range of cytotoxicities in the FRAME KB 
cytotoxicity assay, with 1Dso values from 0.03 to over 3000 J.,£g/ml (Table 5.1). 
The cytotoxicity results were not converted to millimolar concentrations, 
because of the need to be able to make comparisons with the results for the 
formulations. Molecular weights, for those chemicals for which the data were 
available, were all in the region of 250. Conversion of the results to millimolar 
concentrations would therefore not greatly alter the toxicity ranking (Table 
5.1 ). 
Definitive 1Dso values were not obtained for four of the chemicals. This was 
due to partial or complete insolubility of the substances in culture medium or 
in any of the organic solvents recommended by FRAME (ethanol, methanol, 
acetone, DMSO). Twenty-one chemicals were not readily soluble in aqueous 
medium, and so were dissolved in DMSO at 100mg/ml, and then the DMSO 
was diluted to 1 % (v/v) in the medium. Many of the chemicals from TOX 31 
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TOX 42 MCPA 
(2-( (4-chloro-o-
tolyl)oxy)acetic acid) 
TOX 45 Mecoprop 
(2-( ( 4-chloro-o-
tolyl )oxy )propionic acid) 
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TOX 39 Cyanazine 
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( ethylamino )-s-
triazin-2-ylamina) 
-2-methyl)propionitrile) 
TOX 44 Simazine 
(2-chloro-4, 6-bis 
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triazine 
Figure 5.1 Chemical structures for 4 Rhone-Poulenc Ltd. pure chemicals 
CN 
I 
Cl rN"'jNHC (CH3) 2 
NyN 
NHCH2CH3 
Cl (N"'jNHCH2CH3 
NyN 
NHCH2CH3 
to 46 precipitated out when diluted to 1mg/ml in the medium. This stock 
solution in medium was used to prepare the dose range-finding solutions. No 
attempt was made to prepare solutions from a stock in which the highest 
concentration of test substance was fully soluble, i.e. which showed no 
precipitate. 
5.2.1.3 In vitro toxicities of the related chemical groups 
(a) The two batches of 8-Chlorotheophylline, with different levels of a by-
product dimer, gave virtually identical IDso results in the KB assay 
(Table 5.1). 
(b) The IDso for MCPA acid was ten times lower than that for Mecoprop 
(Table 5.1). 
(c) The IDso for Simazine was twice that for Cyanazine (Table 5.1). 
(d) In chemical series A, TOX 31 to 33 all gave IDso values close to 
50J.l.g/ml (Table 5.1). 
(e) In chemical series B, TOX 34, 35 and 38 gave IDso values between 
approximately 500 and 1000 J.l.g/ml (Table 5.1). No results were 
obtained for TOX 36 and 37, due to lack of detectable toxic effects at 
the highest dose tested (1000 ,",g/ml). 
5.2.1.4 Toxicity rank according to chemical use 
There is no clear separation within the toxicity ranking according to chemical 
use. Herbicides, such as Neburon and Asulam, and human drugs, such as 
Propranolol and Thalidomide, were among the most and the least toxic 
substances in Table 5.1. However, the three most toxic chemicals (TO X 22, 
30 and 40) were those designed to kill or inhibit the growth of bacteria and/or 
fungi. 
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5.2.1.5 Comparison of new data with published data 
One chemical (TOX 22, Propranolol) was included to test whether the 
FRAME KB cytotoxicity assay could reproduce the published value (Clothier 
et ai., 1988). The IDso value obtained (22+ 2 J.Lg/ml) agreed well with the 
published result (12+0 J.Lg/ml) , when one considers that the full range of 
cytotoxic concentrations measured with the FRAME KB cytotoxicity assay is 
0.01 J.Lg/ml to 140,000 J.Lg/ml (Clothier et ai., 1988). 
5.2.1.6 Comparison of in vivo and in vitro toxicity data for the pure chemicals 
The FRAME KB cytotoxicity assay IDso results were compared with rat oral 
LDso data provided by Rhone-Poulenc Ltd. (Table 5.2) and with parenteral 
LDso data, where available. Rat oral LDso values are used for classification 
of pesticides according to European Community requirements (Brian Ingham, 
personal communication). When the in vivo LDso data were given as an 
approximate or "greater than" value in comparisons, these LDso values were 
taken as being equal to the figures given. There is very little obvious similarity 
between the toxicity ranking by the FRAME KB cytotoxicity assay or by the 
rat oral LDso (Table 5.2). Indeed, there are some striking discrepancies. For 
example, chlorothalonil is highly cytotoxic to 3T3-L1 cells, but is non-toxic to 
the rats by oral administration. 
As the FRAME KB cytotoxicity assay results showed a better correlation with 
mouse i.p. LDso data than with rat oral LDso data for the metal compounds 
(Chapter 4), mouse i.p. data was sought from the Registry of Toxic Effects of 
Chemical Substances (RTECS) (Lewis and Tatken, 1982). Values were 
available for only three of the named chemicals, hence rat i.p., rat i.v. and 
mouse i.v. LDso data was also sought (Table 5.2). Chlorothalonil is, in fact, 
highly toxic to mice by i.p. administration. Dichlorophen, Neburon and MCPA 
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Table 5.2. In vitro and ;n \';\'0 toxicities of twenty eight Rhone-Poulenc Ltd. pure chemicals 
TOX Chemical name KB1Dso Rat oral LDso Other LDso 
No. (if known) (I'glml) (mglkg)* (mglkg) 3 
22 0.03 120 
40 Chlorothalonil 2 >10000 2.5 (m00 i.p.) 
30 Dichlorophen 13 1506 17 (rat i.v.) 
25 Propranolol 22 HO 515 42 (mo i.p.); 23 (mo Lv.); 27 (rat i.v.) 
43 Neburon 35 >10000 180 (mo i.v.) 
33 DXH 1421 (chemical series A) 35 218 
42 MCPAacid 36 700 28 (mo i.p.); 7 (rat i.v.) 
29 40 >2000 
31 JJW 2027 (chemical series A) 43 580 
24 52 >2000 
32 JJW 2092/1 (chemical series A) 81 97 
39 Cyanazine 95 182-380 
46 Trifluralin 210 >10000 > 1500 (mo Lp.) 
44 Sirnazine 232 >5000 100 (rno i.v.) 
41 Dirnethoate 317 500-600 45 (mo i.p.); 100 (rat i.p.); 250 (rat Lv.) 
45 Mecoprop 361 930 402 (rat Lp.) 
35 RRB 2306 (chemical series B) 508 413 
38 RRB 2347 A (chemical series B) 515 >2000 
26 544 
20 8-Chlorotheophylline (lot B) 682 -500 149 (mo Lp.); 200 (mo Lv.):&: 
21 8-Chlorotheophylline (lot A) 750 -500 149 (rno i.p.); 200 (rno Lv.):&: 
34 
27 
23 
16 
36 
37 
28 
* 
® 
o 
t 
t 
RRB 2316 (series B) 844 948 
990 
Asulam 3560 >5000 
Thalidomide >500t 113 
RRB 2309/1 (series B) >100Dt >5000 
BDH 202/1 (series B) >100Dt >5000 
insoluble >5000 
Data supplied by Rhone-Poulenc Ltd. 
Values obtained from RTECS (Lewis and Tatken, 1982). 
mouse. 
Limit of solubility in culture medium. 
Data is for the pure chemical. 
acid are also more toxic to rats or mice by Lp. or i.v. administration than 
orally, and these chemicals are also among the most toxic to the 3T3-L1 cells 
(ranked number 2, 3, 6= and 7 respectively) (Table 5.1). Simazine (ranked 
14) was less harmful to 3T3-L1 cells, non-toxic by rat oral LDso (>5000mglkg), 
but was 50 times more toxic by mouse i.v. LDso (100 mglkg). Dimethoate, 
Mecoprop and 8-Chlorotheophylline, which have similar cytotoxicities to 
Simazine and to each other in the FRAME KB cytotoxicity assay, have, unlike 
Simazine, similar in vivo toxicities by either the oral, i.p. or Lv. routes. Linear 
regression analysis of log KB IDso (J..Lg/ml) compared to log rat oral LDso 
(mg/kg) for the chemicals in Table 5.1 excluding TOX 36, 37 and 28 (i.e., 
chemicals for which no in vivo or precise in vitro data was available), gave a 
correlation coefficient of 0.19, i.e. no correlation could be inferred. 
5.2.1.7 Consideration of in vivo and in vitro data for the structurally related 
groups of chemicals 
The in vitro and in VIVO data for the five groups of structurally-related 
chemicals were examined. Both the FRAME KB cytotoxicity assay and the rat 
oral LDso assay found the 8-Chlorotheophylline with different levels of dimer 
(TOX 20 and 21) gave essentially the same toxicities. Both assays found 
MCP A acid to be more toxic than Mecoprop, and Simazine to be less toxic 
than Cyanazine. However, there were no clear patterns with the chemicals in 
series A or B (Table 5.1). Between the two series, the FRAME KB 
cytotoxicity assay ranked the chemicals in series A more toxic than those in 
series B, and this was also true for the rat oral LDso (Table 5.2). There was 
no obvious correspondence between the toxicity ranking by the FRAME KB 
cytotoxicity assay and by rat oral LDso within series A. However, within series 
B, it appears that, with the exception of RRB 2347/A, the lower the rat oral 
LDso, the lower the KB IDso. 
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5.2.1.8 Consideration of chemical solubility 
The aqueous solubilities of the ten named agrochemicals with in vivo data 
(Table 5.2) were compared with their in vitro and in vivo toxicities (Table 5.3). 
When the chemical are ranked in order of increasing solubility, it is apparent 
that the least soluble are also the least toxic to rats orally. The more soluble 
compounds mostly gave definitive LDso results. There is, however, no 
correspondence between the aqueous solubility limits and the FRAME KB 
cytotoxicity assay 1Dso results. 
5.2.1.9 Conclusions 
About half of the pure chemicals had an IDso below 500 J..Lg/ml in the FRAME 
KB cytotoxicity assay, hence, when compared with the spread of cytotoxicities 
of the 150 chemicals (Chapter 3), these would be considered to be moderately 
harmful. One chemical, Asulam, with an IDso of 3560 J..Lg/ml, would be 
considered to be of low toxicity. The three bactericidal/fungicidal chemicals 
were highly toxic, while the herbicides demonstrated a whole range of 
cytotoxicity from 35 J..Lg/ml to 3560 J..Lg/ml. Only two chemicals gave an IDso 
below 10 J..Lg/ml, with the coccidiostat by far the most toxic. Explanation of 
its high cytotoxicity is not possible, because of lack of information on its 
chemical nature. 
It can be concluded that there is no direct correlation between rat oral LDso 
data and the FRAME KB cytotoxicity assay IDso results for the 25 chemicals 
compared. In most cases, the FRAME KB cytotoxicity assay predicted the 
toxicity to be higher than that obtained in the rat by the oral route. 
For the ten agrochemicals listed in Table 5.3, there is a reasonably close rank 
order correlation between their rat oral toxicities and their aqueous solubilities. 
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Table 5.3 In vivo and in vitro toxicities of ten Rhone-Poulenc Ltd. 
agrochemicals and their aqueous solubility data 
Chemical KB IDso Rat oral LDso Solubility limit 
(J,Lglml) (mglkg) in water (J,Lglml)* 
Chlorothalonil 2 >10000 0.6 
Trifluralin 210 >10000 <1 
Neburon 35 > 10000 4.8 
Simazine 232 >5000 5 
Dichlorophen 13 1506 30 
Cyanazine 95 182-380 171 
Mecoprop 361 930 620 
MCPA acid 36 700 825 
Asulam 3560 >5000 5000 
Dimethoate 317 500-600 25000 
*Data obtained from the Pesticide Manual (Martin and Worthing, 1974). 
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The four poorly soluble chemicals (i.e. 5 J.£g/ml solubility limit or less) gave 
undefinably high rat oral LDso values, but a variety of 1Dso values. Some of 
the group TOX 31-46 were toxic in the FRAME KB cytotoxicity assay at 
concentrations above their quoted aqueous solubility limits (Table 5.3). 
However, it cannot be concluded that the chemicals were not in solution at 
these levels. This is because of the presence of 1 % (v/v) DMSO as well as the 
ingredients of the culture medium, which may have enhanced their solubilities. 
The FRAME KB cytotoxicity assay, as with the rat oral LDso, was unable to 
detect the higher level of impurity in lot B of 8-Chlorotheophylline. Among 
the other related groups there is some indication that the FRAME KB 
cytotoxicity assay could predict the toxicity rank of the closely related pairs. 
However, it is not known how closely related the chemicals in series A and B 
were, and for these the FRAME KB cytotoxicity assay was less able to rank 
them correctly. 
5.2.2 Formulations 
5.2.2.1 Description of the formulations 
Thirteen of the formulations were thick, opaque suspensions or emulsions, of 
various colours. The remaining seven were clear and pale brown or yellow in 
colour. 
Seven of the pure chemicals (Table 5.1) were present as active ingredients in 
thirteen of the formulations. These formulations were for fungicidal, 
herbicidal or insecticidal use. Three formulations contained active ingredients 
which were not tested as pure chemicals (eglumine salt of Nitroxynil and 
Dimefuron). Four formulations (TOX 02,03,05 and 15) contained unknown 
active ingredients and one contained none. Information on the concentrations 
of the active ingredients in the majority of the formulations was not supplied, 
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as it is proprietary. However, it is known that some actives may be present at 
up to approximately 50% (w/v). 
5.2.2.2 In vitro toxicities of the formulations 
The results for the 20 formulations in the FRAME KB cytotoxicity assay 
(Table 5.4) spanned a narrower range of ID50 doses than the results for the 
pure chemicals (6 to 609 J-Lglml). 
As with the pure chemicals, solubility problems were encountered with some 
of the formulations. The opaque suspensions gave cloudy solutions upon 
dilution into culture medium. These often resulted in particles (probably of 
the active chemical) settling out at the bottom of culture wells during the 72-
hour exposure period. In all cases, except TOX 13, the deposit of particles 
was present in wells at doses under or close to the ID50 doses. TOX 13 gave 
a higher toxicity than the other suspensions, and showed no particles in the 
well at the toxic dose level. 
TOX 01 to 15 were tested as one project. TOX 17 to 19, and the two Trodax 
samples, underwent separate investigations. 
Formulations TOX 01 - 15 
The ID50 values for most of TOX 01 to 15 lie between about 100 and 
600J-Lglml (Table 5.4). The exception was TOX 13 (ID5o 6 J-Lglml). Because 
of its high toxicity, TOX 13 was investigated further. The active ingredient, 
Chlorothalonil, was at the time untested as a pure chemical, but was known 
to be non-toxic when given to rats orally. Therefore, the preservative in the 
formulation, Dichlorophen, was suspected as having caused the high toxicity 
of TOX 13. Pure Dichlorophen (Table 5.1) was found to be less toxic than 
TOX 13 itself in the FRAME KB cytotoxicity assay. Chlorothalonil was then 
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Table 5.4. In vitro toxicities of twenty Rhone-Poulenc formulations 
TOX Active ingredient ID20 1Dso IDgO 
No. J.Lg/ml J.Lg/ml J.Lg/ml 
+ s.e.m. + s.e.m. + s.e.m. 
13 Chlorothalonil 3 + 1 6 ± 1 6 (n=2) 
18 none 54 + 2 81 + 3 118 + 15 
17 Dimethoate 71 + 5 96 + 7 146 + 14 
14 Trifluralin 79 + 16 111 + 13 163 + 14 
04 Trifluralin 87 + 11 128 + 5 185 (n=2) 
01 Neburon 12 (n=l) 136 + 15 489 + 16 
Nitroxynil, eglumine salt 85 (n=l) 157 + 20 242 + 15 
37% (w/v) (field sample 
of Trodax) 
11 MCPA acid 91 + 21 161 + 10 239 (n=2) 
05 not known 103 + 9 170 + 13 238 (n=2) 
12 MCPA acid 98 (n=2) 173 + 12 393 (n=2) 
Nitroxynil, eglumine salt 124 (n=l) 183 + 37 316 + 49 
37% (w/v) (lab sample 
of Trodax) 
09 Cyanazine 75 + 42 188 + 37 176 (n=2) 
19 Dimethoate 54 (n=2) 223 + 36 1168 (n=2) 
06 Mecoprop 139 + 10 312 + 35 582 + 91 
15 not known 70 (n=l) 325 + 30 552 (n=2) 
08 Mecoprop 192 ± 71 353 ± 46 565 (n=2) 
02 not known 144 (n=2) 400 + 26 678 + 33 
03 Dimefuron (40% (w/v)) <250 570 + 67 1800 (n= 1) 
10 Cyanazine 220 (n=2) 579 + 92 1040 + 178 
07 Mecoprop 299 + 73 609 + 71 636 (n=2) 
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tested and found to be the most likely source of the toxjcity to the 3T3-Ll 
cells (Table 5.1). 
Formulations TOX 17 - 19 
These three liquids were tested in order to investigate the toxjcity of the 
vehicles used to dissolve or suspend the active ingredients. TOX 17 and 18 
gave very similar IDso values, while TOX 19 was slightly less toxic (Table 5.4). 
It was revealed that TOX 18 was the vehicle for the formulation TOX 17, and 
TOX 19 contained the same active ingredient as TOX 17, but in a different 
vehicle. 
Trodax Formulations 
The two Trodax samples were tested because one (the "field" sample) had 
been returned to Rhone-Poulenc Ltd., with complaints about adverse effects 
to sheep (Trodax is an antihelmitic veterinary drug). The laboratory sample 
was from the same batch as the "field" sample. The two samples were equally 
toxic to cells in the FRAME KB cytotoxicity assay (Table 5.4). It is not known 
whether Rhone-Poulenc Ltd. were able to detect any difference between the 
samples. 
5.2.2.3 Comparison of in vivo and in vitro toxicity data for the formulations 
The FRAME KB cytotoxicity assay IDso results for the first 15 formulations 
are shown in Table 5.5 with rat oral LDso, rat dermal LDso and skin and eye 
irritancy data (provided by Rhone-Poulenc Ltd.). There were no i.p. or i.v. 
LDso data available, since the regulatory requirements are for rat oral data. 
There is no obvious relationship between IDso rank order or actual values with 
any of the in vivo data sets shown. The rabbit eye and skin irritancy data 
appear to be completely random when compared to the KB assay results 
(Table 5.5). 
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Table 5.5. In vitro and in vivo toxicities of fifteen Rhone-Poulenc Ltd. 
formulations (TaX 01-15) 
Tax KB IDso Rat oral Rat dermal Skin Eye 
No. (J-tg!ml) LDso LDso irritancy irritancy 
(mg/kg) * (J-tl/kg)* (rabbit)* (rabbit)* 
13 6 >5000 >2000 V.slight Slight 
14 111 2000 >2000 Irritating Moderate 
04 128 > 2500< 5000J.Ll/kg >2000 Slight Severe 
01 136 3033 >2000 None Slight 
11 161 480J-tl/kg >2000 V.slight Moderate 
05 170 697 >2000 Irritant 
12 173 1500J-tl/kg >2000 Slight Moderate 
09 188 1000J-tl/kg >2000 None None 
06 312 552 1430 Slight Severe 
15 325 2135 1871mg/kg Slight Severe 
08 353 1098 1974mg/kg None Severe 
02 400 1000J-tl/kg >2000 
03 570 10000J-tl/kg >2000 None None 
10 579 1250J-tl/kg >2000 None None 
07 609 963 1952mg/kg Slight Severe 
*Data supplied by Rhone-Poulenc Ltd. 
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5.2.2.4 Consideration of active ingredients and their formulations 
A comparison of the in vitro and in vivo toxicities of seven pure chemicals and 
their formulations is shown in Table 5.6. 
(a) Chlorothalonil and TOX 13 are both highly damaging to cells in the 
FRAME KB cytotoxicity assay, but appear non-toxic to rats orally, 
while Chlorothalonil is highly toxic to mice intraperitoneally. 
(b) Pure Dimethoate is moderately damaging in the FRAME KB 
cytotoxicity assay, but both its formulations (TO X 17 and 19) are more 
toxic than the pure chemical. Both in vivo and in vitro values show that 
TOX 17 is more toxic than Dimethoate. 
(c) Similarly, TOX 04 and 14 are more toxic than their maIn active 
ingredient, Trifluralin, in both the in vivo and in vitro assays. 
(d) Neburon is more toxic to cells in vitro than its formulation TOX 01, 
while being less toxic than TOX 01 in vivo. 
(e) MCP A acid is more toxic in vitro than its formulations TOX 11 and 12. 
One formulation was less toxic in vivo than MCPA acid, and the other 
was more toxic. TOX 11 and 12 gave very similar 1D5o values but their 
rat oral LD50 values differed by a factor of three. 
(f) Conversely, the two 1D5o values of the formulations of Cyanazine (TO X 
09 and 10) differ by a factor of three, while the rat oral LD50 values are 
quite similar. Both formulations are less toxic in vitro than Cyanazine 
itself, and this is also true in vivo. 
(g) Mecoprop has the same toxicity to cells in the FRAME KB cytotoxicity 
assay as two of its formulations (TOX 06 and 08), with TOX 07 being 
slightly less toxic. The rat oral LD50 data shows TOX 07 and 08 being 
equally toxic to Mecoprop, with TOX 06 more toxic. 
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Table 5.6. In vitro and in vivo tOXIcItIes of seven Rhone-Poulenc Ltd. 
agrochemicals and twelve Rhone-Poulenc Ltd. formulations 
which contain them 
Pure Chemical Formulation 
Rat oral Rat oral 
Active IDso LDso TOX IDso LDso 
Ingredient (J-Lglml) (mg/kg) * No. (J-Lglml) (mg/kg) * 
Chlorothalonil 2 > 10000 13 6 >5000 
Dimethoate 317 500-600 17 96 200-250 
19 223 Not known 
Trifluralin 210 >10000 04 128 2500-5000 J-Ll/kg 
14 111 2000 
Neburon 35 > 10000 01 136 3033 
MCPA acid 36 700 11 161 480J-LI/kg 
12 173 1550J-LI/kg 
Cyanazine 95 182-380 09 188 1000J-LI/kg 
10 579 1250J-LI/kg 
Mecoprop 361 930 06 312 552 
07 609 963 
08 353 1098 
Unknown 05 170 697 
Unknown 02 400 1000J-LI/kg 
Dimefuron 1000 03 570 > 10000J-LI/kg 
*Data supplied by Rhone-Poulenc Ltd., except for Dimefuron (RTECS (Lewis 
and Tatken, 1982). 
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5.2.2.5 Consideration of vehicle toxicity 
Rhone-Poulenc Ltd. provided some information on components of the vehicles 
of formulations TOX 02 to 14 (Table 5.7). Wetting agents, preservatives, 
emulsifiers and other ingredients were not specified, but were known to be 
present. There were essentially four types of vehicle base:-
(a) TOX OS, 11 and 12 were prepared in similar vehicles, all containing 
N-methyl pyrrolidone and a light aromatic CI0 solvent. These 
formulations gave essentially identical 1Dso values; 
(b) The CI0 solvent with 5% (v/v) water was the vehicle for TOX 04 and 
14, and these too, gave essentially identical 1Dso values; 
(c) The four formulations containing propylene glycol (TOX 03, 09, 10 and 
13) gave widely differing 1Dso values; and 
(d) The three Mecoprop formulations (TOX 06, 07 and 08) were In 
vehicles containing triethylene glycol and potassium hydroxide at 
varying levels. The 1Dso values appear to increase with decreasing 
triethylene glycol and concurrent increasing potassium hydroxide 
concentrations. The concentration of Mecoprop in these formulations 
is not known, however, so the differential toxicities could be due to 
varying amounts of Mecoprop. 
5.2.2.6 Conclusions 
The majority of the formulations would be considered only moderately harmful 
in the FRAME KB cytotoxicity assay, with the one formulation containing 
Chlorothalonil being much more harmful. However, all the formulations would 
be classified as "non-harmful" based on the basis of in vivo rat oral or dermal 
LDso values. It is possible that the deposits left in the culture wells by some 
of the formulations, when tested at cytotoxic concentrations, may have 
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Table 5.7. Some vehicle ingredients of Rhone-Poulenc Ltd. formulations 
TOX 02 to 14, with in vitro toxicities 
TOX Vehicle Ingredients Active ID50 
No. (excluding emulsifiers, Ingredient (/-Lglml) 
wetting agents) 
13 Propylene glycol, 7.5% (w/v); water Chlorothalonil 6 
10 Propylene glycol, 7.5% (w/v); water Cyanazine 579 
09 Propylene glycol, 6% (w/v); water Cyanazine 188 
03 Propylene glycol, 5% (w/v); water Not known 570 
06 Triethylene glycol, 25% (w/v); water; Mecoprop 312 
50% potassium hydroxide solution, 
16.5% (v/v) 
08 Triethylene glycol, 20% (w/v); water; Mecoprop 353 
50% potassium hydroxide solution, 
21% (v/v) 
07 Triethylene glycol, 15% (w/v); water; Mecoprop 609 
50% potassium hydroxide solution, 
23% (v/v) 
02 Triethylene glycol, 25% (w/v); water Not known 400 
11 N-methyl pyrrolidone, 33% (w/v); MCPA acid 161 
light aromatic C10 solvent 
12 N-methyl pyrrolidone, 30% (w/v); MCPA acid 173 
light aromatic C10 solvent 
05 N-methyl pyrrolidone, 25% (w/v); Not known 170 
light aromatic C10 solvent 
14 Water, 5% (w/v); light aromatic Tritluralin 111 
C10 solvent 
04 Water, 5% (w/v); light aromatic Tritluralin 128 
C10 solvent 
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interfered with the growth of cells. However, the IDso values of those 
formulations showing deposits ranged from 113 to 609 IJ.glml, indicating that 
the presence of a deposit did not cause a consistent effect. If phagocytosis of 
particles did occur, it did not cause the 3T3-Ll cells to detach, or decrease 
their division rate, in any predictable fashion. 
The importance of the vehicle toxicity was demonstrated with TOX 17 to 19. 
The addition of the active ingredient (Dimethoate) to the vehicle (TOX 18) 
did not alter its toxicity. Dimethoate in an alternative vehicle was less toxic. 
This proves that it must not be assumed that it is only the active chemical( s) 
in a formulation which is (are) responsible for the toxicity in vitro. The vehicle 
alone may be damaging, or synergistic effects between the active and its 
vehicle may take place. 
The FRAME KB cytotoxicity assay did not reproduce the difference in toxicity 
to sheep reported between the two samples of Trodax. No information was 
provided as to how serious the instance of adverse in vivo effects was, or 
whether Rhone-Poulenc Ltd. were able to reproduce the difference. 
As with the pure chemicals, there was no correlation between the toxicity of 
the formulations in vitro (as a whole) and in vivo by the rat oral route. In 
addition, there was no correlation with rat dermal LDso, or rabbit skin or eye 
irritancy. The rat oral LDso values covered a relatively small range, as did 
most of the 1Dso values. 
When the rat oral LDso values of the pure chemicals were compared with the 
rat oral LDso values of the formulations that contained them, the same 
relationship between the toxicity values (i.e. whether the pure chemical was 
more toxic than its formulation(s) or vice versa) was generally also reflected 
in the ill vitro values. 
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5.3 DISCUSSION 
Both the pure chemicals and the formulations were a considerable challenge 
to the FRAME KB cytotoxicity assay, due to their chemical and physical 
properties. Solubility problems were encountered with the pure chemicals and 
the formulations. This led to some chemicals providing no result, and to some 
formulations having their results questioned, because of the presence of 
deposits settled out in culture wells. It is a commercial advantage for some of 
the agrochemicals (e.g. herbicides) to be of low aqueous solubility, so that they 
are not easily washed off foliage by the first shower of rain or into water 
courses. Aqueous insoluble substances can be readily administered to 
laboratory animals by the oral route, in the form of a suspension. If the 
FRAME KB cytotoxicity assay is to be useful with this type of chemical, then 
it may be necessary to devise new ways of solubilizing them. Otherwise, it 
must be acknowledged that a proportion of these chemicals will provide results 
only up to their maximum solubility in medium. This is a methodological 
problem for in vitro assays, which has yet to be adequately addressed (Bernson 
et ai., 1986; Stark et ai., 1986). The current FRAME KB cytotoxicity assay 
protocol is designed for use with solubilised substances only. 
The chemical nature of the pure compounds and the formulations led to 
problems with interpretation of results. The identity of half of the chemicals 
was unknown. Although some of these were stated as being chemically 
related, it was not known how closely. Hence, the comparisons of in vivo and 
in vitro data amongst all the chemicals or amongst related groups was 
hampered by lack of knowledge about chemical structures. In addition, lack 
of information about the ingredients of the formulations meant that only 
limited conclusions could be drawn from the results. Both the active 
ingredients and their vehicles were responsible for cytotoxic effects in vitro. 
The extent to which each plays a role in the cytotoxicity of a formulation could 
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only be elucidated if all the ingredients could be tested separately and in 
various combinations. The complexity of some of the formulations means that 
many interactions, such as synergistic effects, could occur. 
At first glance, the FRAME KB cytotoxicity assay appears unable to predict 
the rat oral LDso values for the pure chemicals or for the formulations. There 
were several distinct discrepancies, i.e. materials toxic to cells in vitro, but 
virtually non-toxic to rats orally. These discrepants were, in general, very 
poorly soluble and also much more toxic by parenteral administration. It 
appears doubtful, therefore, that the rat oral assay was detecting a true lack 
of intrinsic toxic properties in these particular chemicals. It is more likely that 
their low solubilities prevented adequate absorption from the G I tract. This 
is most striking with Chlorothalonil, Trifluralin, Neburon and Simazine (Table 
5.3). Trifluralin is of low toxicity parenterally, and this is possibly due to low 
intrinsic toxicity, or to its degradation in the body to metabolites of low toxicity 
(Gosselin et al., 1976). Trifluralin is known to be poorly absorbed from the GI 
tract in the rat (Gosselin et al., 1976) and this probably explains its low oral 
toxicity. One soluble chemical, Asulam, also gave low toxicity to rats orally. 
Although no parenteral LDso data were available, it was of low toxicity in vitro 
(Table 5.3) and hence it probably has low intrinsic toxicity. This may explain 
its low oral toxicity, although it, too, may be poorly absorbed from GI tract, 
despite its solubility. This demonstrates how the degree of absorption of a 
chemical, from the G I tract into the systemic circulation, must be considered 
when performing in vitr%ral LDso data comparisons. Although laboratory 
animals can be easily dosed orally with suspensions of insoluble chemicals, the 
amount that actually enters the circulation may bear no relation to the 
administered dose. In these cases, the oral in vivo assay may not detect any 
toxic effects. Cells in the in vitro assay are continuously bathed in the test 
substance. This equates better to a parenteral dose (Fry et al., 1988a), and is 
therefore more likely to detect intrinsic toxic properties of the substance. It 
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IS acknowledged that ill vitro cytotoxicity assays cannot simulate the 
pharmacokinetic processes involved in the uptake and distribution of a 
chemical administered orally (Ekwall, 1983a; Rowan, 1983). 
The relevance of performing rat oral LDso assays with very high doses of 
herbicides of known poor solubility is, therefore, highly questionable. In the 
modern agrochemical industry, herbicides are selected for their activity at low 
treatment levels (250 mg or less per hectare) and for their low aqueous 
solubility. As it appears that poorly soluble substances do not elicit toxic 
effects when given to rats orally, it would be more relevant to perform a 
toxicity assay which would detect intrinsic toxic properties of a chemical. 
However, the rat oral LDso value must be obtained for classification purposes 
and, because this type of regulation is so inflexible, the assay is still conducted, 
whatever the nature of the chemical. 
Closer inspection of individual related sets of chemicals, and individual 
chemicals with their formulations, showed that, in some cases, reasonable 
similarity between toxicity rank did exist between the IDso and the rat oral 
LDso· 
The overall lack of correlation between the FRAME KB cytotoxicity assay and 
the rat oral LDso assay for the Rhone-Poulenc Ltd. substances can, therefore, 
be attributed mainly to their insolubility. There appears to be a stronger 
correlation between IDso results and LDso values from rat or mouse by i.p. or 
i.v. dose, but with the small amount of data available, firm conclusions cannot 
be drawn. 
Agrochemicals, in general, must have low oral and dernal toxicities to be 
acceptable, and yet must still possess highly specific lethal activities on a wide 
diversity of target organisms. It is possible that it is these specific toxic effects 
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which were, in some cases, detected by the FRAME KB cytotoxicity assay. 
For example, Chlorothalonil, the fungicide, was found to be highly toxic in 
vitro, but is virtually non-toxic to rats orally. This compound is accumulated 
rapidly by yeast cells, and exerts its toxicity ultimately by inhibition of thiol-
dependent enzymes (Tillman et ai., 1973). A similar mechanism could have 
caused the potent inhibition of growth of the 3T3-L1 cells seen in the in vitro 
assay. 
Overall, it is difficult to draw any firm conclusions from the FRAME KB 
cytotoxicity assay results for the Rhone-Poulenc Ltd. chemicals and 
formulations. Although the correlation with rat oral LDso does not look too 
promising at this stage, this is not surprising, because of the diverse chemical 
and physical properties of the test materials. Further work with related 
chemicals and their vehicles and formulations may provide additional 
information. At present, pesticides are classified according to their rat oral 
and/or dermal LDso values (Brian Ingham, personal communication). Based 
on these results, the current FRAME KB cytotoxicity assay could not, 
therefore, be used to test chemicals and formulations for classification 
purposes. It may be more useful for predicting i.p. or i.v. acute toxicity, or for 
predicting the rank order of oral toxicity among closely structurally related 
chemicals. 
The problem of aqueous insolubility of test substances is not confined to in 
vitro toxicology. The high rat oral LDso values for the poorly soluble 
agrochemicals have little meaning as measures of toxic potency. It is therefore 
of no merit to attempt to develop an alternative assay method to predict these 
oral LDso results. Once the methodological and interpretative difficulties 
involved with testing poorly-soluble substances in both in vivo and in vitro 
acute toxicity assays are overcome, then further progress toward a new 
approach to assessing acute toxicity for classification purposes may be possible. 
This should have a more logical and scientific basis (Balls, 1991d), and 
hopefully would place much less reliance on formal in vivo studies. 
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6.1 INTRODUCTION 
A dilemma currently exists in the cosmetics and toiletries industry between 
providing adequate safety assurance for their products, whilst not being seen 
to test them on animals (Balls, 1991a). Safety assessments need to be 
conducted, particularly with new ingredients and new types of formulations, in 
order to ensure that the consumer is not harmed. Safety assessments have 
traditionally been based on results of toxicity tests on animals (Balls, 1991e). 
Tests such as the Draize skin and eye irritancy assays have become 
increasingly unpopular with the public in recent years, and many cosmetics and 
toiletries are now labelled as "not tested on animals" in order to attract 
purchasers. Such claims are not easily substantiated, because, although a final 
product may not have been tested in vivo, it is very likely that some or all of 
its ingredients will have been. Some companies rely on human volunteers to 
test their products. This method of safety assessment cannot, however, be 
used for every newly-developed ingredient or every product, because of the 
large number of volunteers required and the potential risk of permanent 
damage to a person from a new compound which may have inadequate 
background safety data. 
A way out of this dilemma is to use scientifically-validated non-animal 
alternative methods which have been accepted by regulatory authorities. As 
yet, no validated alternative method exists which could provide adequate data 
upon which companies could make safety assessments for cosmetics and 
toiletries (van den Heuvel and Fielder, 1990). A wide range of alternative 
methods do exist, however (Balls et a/., 1991a), but progress towards their 
regulatory acceptance is slow. The goal of a testing strategy for toiletry 
products and ingredients is to select non-irritants. This has proved more 
problematical for some methods than has the selection (i.e. screening out) of 
strong irritants (Reinhardt, 1990). Two types of alternative which are 
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undergoing extensive evaluation are:-
(a) physicochemical tests, e.g. the EYTEXTM method, based on the 
breakdown of proteins in solution (Gordon and Bergman, 1987); and 
(b) cytotoxicity tests, e.g. the FRAME KB cytotoxicity assay (Knox et al., 
1986), the Neutral Red Uptake assay (Borenfreund and Puerner, 1985), 
the FRAME Neutral Red Release assay (Reader et al., 1989) and the 
FRAME fluoroscein dye leakage assay (Shaw et al., 1990) 
Initial evaluations have been conducted uSIng a large number of pure 
chemicals. The tests are now being evaluated with both products in 
development and final products of the cosmetic/toiletry type. 
This chapter considers the potential use of the FRAME KB cytotoxicity assay 
in the testing of surfactant-containing toiletries and pure surfactants, and two 
other categories of toiletry product which do not contain surfactants as their 
principal ingredient. 
6.2 RESULTS 
6.2.1 Pure surfactants 
6.2.1.1 Description of the surfactants 
The cytotoxicity of surfactants in vitro has been well studied, (e.g. Ferguson 
and Prottey, 1976; North-Root et al., 1982; Borenfreund and Borrero, 1984; 
Bracher et al., 1989), often in attempts to correlate the in vitro results to 
Draize eye irritancy scores. Some studies show good rank correlations (North-
Root et al., 1982; Borenfreund and Borrero, 1984), while some gave poorer 
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compansons (Scaife, 1982; Flower, 1987). Few, if any, assays have been 
proposed as in vitro acute lethal toxicity tests for surfactants, despite the fact 
that soaps, detergents and cleaners are frequently accidentally swallowed by 
children (Seabaugh, 1977), and are released into the environment in vast 
quantities, causing damage to animal and plant life (Lewis, 1990; Lewis, 1991). 
The pure surfactants were selected for testing as a group, because many are 
active ingredients in a very wide range of cosmetics, toiletries and household 
and industrial cleaning products. A high proportion of the population is 
exposed to them every day. They were also selected because of their known 
physicochemical activity in disrupting cell membranes (Helenius and Simons, 
1975; Womack et ai., 1983). 
The chemicals tested are related by their surface-active properties and not by 
similarity of chemical structure. However, these surface-active properties are 
a result of a hydrophobic portion and a hydrophilic portion of the surfactant 
molecule. There is, therefore, a tenuous chemical-structure link between the 
surfactants. Their common chemical activity does mean that, when tested in 
in vitro toxicity assays, the results are more likely to correlate well with in vivo 
toxicity than would result for a group of completely unrelated chemicals (Fry 
et ai., 1990b). 
Four types of charged surfactants are available: cationic, anionic, amphoteric 
and non-ionic (Young and Coons, 1945). Amphoteric surfactants become 
cationic or anionic, depending on the pH of the solution. Within each charged 
group, at least two types of chemical structure were tested. Two small sets of 
structurally-related surfactants were included - the non-ionic Tweens 
(polyoxyethylene sorbitans) and the cationic alkyl ammonium bromides. Most 
of the surfactants tested were synthetic, although some were naturally 
occurring gastro-intestinal salts, or derivatives of them. All were dissolved 
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directly into culture medium and hence were tested in the absence of organic 
solvents. 
6.2.1.2 In vitro toxicities of twenty-nine pure surfactants 
The cytotoxicities of 29 surfactants, measured in the FRAME KB cytotoxicity 
assay, ranged from 1 to 4120J.,£g/ml (Table 6.1). This is a narrower range than 
that covered by the group of metal compounds described in Chapter 4. The 
ID values have not been converted to millimolar concentrations for two 
reasons. Firstly, several of the surfactants are polymers of indeterminate 
molecular weight, which makes an accurate molarity calculation impossible, 
and secondly, the J.,£g/ml concentrations allow direct comparisons of the 
cytotoxicities of these pure chemicals with the formulations which contain 
them. The formulations and mixtures obviously have no defined molecular 
weights. 
It can be clearly seen that the cationic (positively charged) surfactants are the 
most toxic of the four surfactant groups tested, following the 72-hour exposure 
period (Table 6.1). The three alkyl ammonium bromides (cetyldimethylethyl -
, tetradecyltrimethyl- and hexadecyltrimethyl-ammonium bromide) are equally 
toxic, and appear to be, in J.,£g/ml terms, more toxic than another cationic 
surfactant, benzethonium chloride. 
The ionic charge of the remaining surfactants does not appear to influence 
their relative positions in the toxicity ranking (Table 6.1). The non-ionics fall 
into two groups, with Triton X-lOO, Brij 35 and Nonidet P40 the most toxic, 
giving IDso values close to those for the least toxic cationics. The remaining 
non-ionics comprise the Tween series (polyoxyethylene sorbitans). These gave 
cytotoxicities ranging from 160 J.,£g/ml to 620 J.,£g/ml. The IDso values for Tween 
20, 40 and 60 are similar, with Tween 80 and 85 being less toxic. The five 
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Table 6.1. III viJro toxicities of twenty nine pure surfactants 
Charge Surfactant ID20 IDso ID80 
(#,glml ± s.e.m.) (#,glml ± s.e.m.) (#,glml ± s.e.m.) 
C Cetylpyridinium bromide 0.1 ± 0 1 ± 0 3 ± 1 
C Cetyldimethylethyl ammonium bromide 0.3 ± 0 2 ± 1 6 ± 1 
C Tetradecyltrimethyl ammonium bromide 0.3 ± 0 2±0 4±0 
C Hexadecyltrimethyl ammonium bromide 0.6 ± 0 2±0 4±0 
C Benzalkonium chloride 4 ± 1 7±0 9±2 
C Dodecyltrimethyl ammonium bromide 2 (n=2) 10 ± 1 17 ± 1 
N Triton X-loo 2±2 14 ± 3 50 ± 12 
C Benzethonium chloride 6±2 17 ± 2 24 ± 5 
N Nonoxynolll 15 ± 1 35 ± 5 68 ± 8 
N Brij 35 15 ± 2 52 ± 7 126 ± 19 
N Nonidet P-40 27 (n=2) 55 ± 7 105 ± 12 
A Sodium dodecyl sulphate 66±1l 94 ± 12 162 ± 17 
A N-Lauroyl sarcosine, sodium salt 104 ± 1 124 ± 2 139 ± 1 
A Dodecylbenzenesulphonic acid, sodium salt 120 ± 6 137 ± 1 150 ± 2 
A Deoxycholic acid, sodium salt 101 (n=2) 141 ± 6 199 ± 20 
N Tween 40 53 ± 5 159 ± 49 295 ± 50 
Z Miranol (38%) 100 ± 27 179 ± 29 261 ± 27 
A 1-Decanesulphonic acid, sodium salt 130 ± 7 223 ± 2 275 ± 3 
N Tween 60 146 ± 31 244 ± 27 345 ± 9 
N Tween 20 123 ± 5 262 ± 43 396 ± 42 
A 
N 
A 
N 
A 
A 
Z 
Z 
A 
Teals (40%) 
Tween 85 
Caprylic acid, sodium salt 
Tween 80 
Cholic acid 
1-Heptanesulphonic acid, sodium salt 
CHAPSO 
CHAPS 
Taurocholic acid, sodium salt 
C = Cationic 
N = Non-ionic 
A = Anionic 
Z = Zwitterionic (amphoteric) 
275 + 30 
253 + 149 
261 + 48 
134 + 25 
565 + 34 
625 + 86 
1850 + 90 
2020 + 99 
2690 + 272 
306 + 31 
507 + 50 
560 + 44 
619 + 69 
802 + 28 
1520 + 92 
2150 + 12 
2380 ± 32 
4120 + 72 
344 + 32 
821 + 7 
843 + 44 
836 + 9 
1110 + 27 
2560 + 367 
2360 + 11 
2640 + 90 
4670 + 34 
Tweens are related in structure, having side chains of different lengths, but 
their cytotoxicities showed no direct correspondence with this. 
The anionic (negatively charged) surfactants are distributed from the centre 
to the low toxicity end of the ranking. The three anionic bile salts tested, 
deoxycholic acid, cholic acid and taurocholic acid, had markedly different 
toxicities, ranging from 141 to 4120 J.£g/ml, i.e. they were found spread 
throughout the anionics range. 
Three amphoteric (zwitterionic) surfactants were tested. Again, there was no 
pattern to their positions in the toxicity ranking, although CHAPS and 
CHAPSO (two cholamidopropyl dimethyl ammonio sulphonates) gave similar 
ID50 results, and were placed at the least-toxic end of the ranking. The third 
zwitterionic tested was a 38% solution of Miranol. Correcting the ID50 for this 
dilution factor would give a value of approximately 70 J.£g/ml for the pure 
chemical, i.e. it would be 30 more toxic than CHAPS or CHAPSO. 
Regardless of the toxicity of the surfactants, it is evident that the toxicity 
increases rapidly with increasing concentration. In most cases the ID20 and 
IDso are approximately symmetrical on either side of the ID50 dose. 
6.2.1.3 Conclusions 
The cationic surfactants were consistently more toxic than the other charged 
groups. There was no clear rank order of toxicity among the anionics, non-
ionics and amphoterics. As a group, the surfactants did not cover as wide a 
spread of toxicities as the metal compounds (Chapter 4) or the miscellaneous 
set (Chapter 3). The majority would be placed in the upper (more toxic) half 
of the toxicity ranking in Table 3.1, and therefore would be considered of high 
toxicity in vitro. 
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6.2.2 Toiletry Formulations 
6.2.2.1 Description of the formulations 
The majority of the toiletry products tested were supplied by manufacturing 
companies, who support the FRAME Research Programme and who wished 
to evaluate the usefulness of FRAME in vitro toxicity assays as part of product 
and ingredient safety assessment. Other products were bought from shops in 
order to provide a reference database. Several skin gels from one 
manufacturer were tested blind, in order to evaluate whether products which 
had unexpectedly caused irritancy in consumers could be detected in the in 
vitro assays. 
Shampoos and hair conditioners contain a high proportion of surfactants as 
their active ingredients. A typical shampoo might contain up to 50% anionic 
surfactants, as these provide good foam and are of low cost (Alexander, 1971). 
Auxiliary surfactants may be of any of the four charged types. Non-ionic 
auxiliary surfactants, such as the Tweens, provide cleansing power and help to 
improve the solubility of the anionics. Amphoterics, such as Miranols or 
amino propionates, are the basis of non-irritant shampoos for children. 
Cationic surfactants have hair conditioning properties; for example, 
amidoamine salts or quaternary ammonium salts, which may be present at up 
to 3% in hair conditioners. Hair products are highly complex formulations and 
contain many non-surfactant additives, such as viscosity enhancers, clarifying 
agents, preservatives, dyes, perfumes and medications. Any of these additives 
may contribute toward the in vivo or in vitro toxicity of a shampoo or 
conditioner. Some additives may help to reduce irritant properties of other 
ingredients. 
Hair sprays typically contain a small proportion of the hair-fixing ingredients, 
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high proportions of an alcohol as solvent, and a propellant gas (Beaven, 1988). 
Some modern pump sprays may not contain aerosol gases, but probably 
contain about the same proportion of hair fixatives. All the hair sprays tested 
were provided by one manufacturer ( A), and were not in aerosol cans. All 
were readily miscible with culture medium. 
The ingredients of facial, body and eye gels and skin liquids tested are 
unknown, but it is likely that they have a high water content and low levels of 
"active" ingredients, such as sunscreen chemicals. The five sun-protective and 
aftersun skin gels were provided by one manufacturer (D) in order to assess 
whether the FRAME KB cytotoxicity assay, or other FRAME in vitro toxicity 
assays, could detect those products which had caused unexpected skin and eye 
irritancy in some consumers. The remaining skin products were from a 
manufacturer (B) who professes to provide cosmetics from well-tried existing 
and "natural" ingredients, with alleged very low risk of adverse skin reactions. 
All the products were readily miscible with aqueous medium. One product, 
an aftersun gel with aloe vera, gave a deposit of small particles in culture wells 
at all the toxic dose ranges tested. The avocado and aloe vera factor 8 sun 
protective gel reacted with the plastic of Universal containers after 
approximately ten minutes of contact, causing it to whiten and roughen. 
6.2.2.2 In vitro toxicities of 29 hair cleaning and conditioning products 
Over all, the 29 hair cleaning and conditioning products gave a range of 
cytotoxicity values (Table 6.2) similar to that shown by the pure surfactants 
(Table 6.1), i.e. 1 to 2530 J.l.g/ml compared with 1 to 4120 J.l.g/ml. However, the 
majority of the formulations would be placed in the middle to bottom of the 
toxicity ranking in Table 6.1. 
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Table 6.2. In vitro toxicities of twenty nine hair cleaning and conditioning products 
Manufacturer· Identity ID20 IDso IDgo 
("glml ("glml ("glml 
± s.e.m.) ± s.e.m.) ± s.e.m.) 
Boots S Anti-dandruff 1 ± 0.1 1 ± 0.2 1 ± 0.3 
A C Rinse-out, code D87 10 70 ± 12 170 
A C Jojoba moisturising, factor 3 deep conditioning 27 ± 11 170 ± 40 926 ± 200 
A C For permed, coloured extra dry hair (batch A437) 62 ± 3 173 ± 20 300 ± 33 
Revlon C Flex 19 ± 2 174 ± 43 463 
A C For permed, coloured extra dry hair (batch A435) 80 ± 6 244 ± 31 397 ± 25 
Boots S Silk protein dandruff shampoo 148 ± 15 282 ± 49 381 ± 66 
Beechams S Vidal Sassoon, Wash 'n' Go conditioning frequent use 190 ± 113 337 ± 118 537 ± 154 
A C Nutrient henna, for dark hair 113 ± 20 344 ± 41 677 ± 76 
A S Jojoba, factor 3, deep cleansing 255 ± 31 408 ± 33 516 ± 41 
A C Nutrient evening primrose, frequent use 112 ± 25 449 ± 21 777 ± 62 
A C Nutrient camomile, for blonde hair 167 ± 53 477 ± 20 838 ± 33 
A S Volumising, code F8 331 512 ± 31 672 ± 33 
B S Grapefruit, frequent wash 390 ± 26 531 ± 11 623 ± 20 
A S Jojoba, factor 2, balanced cleansing 255 ± 31 536 ± 33 628 ± 25 
A S Medicated 445 ± 23 553 ± 42 678 ± 16 
A S Mild, code E7 445 ± 44 598 ± 22 709 ± 24 
Hennara S Henna 482 ± 90 632 ± 113 832 ± 89 
A S Nutrient enriched, henna 505 ± 26 
A S Apple, for greasy hair 412 + 99 
A S Balsam, conditioning, all hair types 428 + 19 
Revlon S Flex 290 + 97 
A S Nutrient enriched, evening primrose, frequent use 486 + 141 
A S Balsam, conditioning, for frequently washed hair 481 + 90 
C S Code 4613/6 644 + 30 
Johnson & 
Johnson S Baby 874 + 134 
C S Zwitsal baby 890 ± 31 
A C Leave-in, Code F5e 1350 + 278 
*The identities of manufacturers A, Band C must be concealed due to confidentiality 
C = Conditioner 
S = Shampoo 
668 + 37 776 + 45 
704 + 17 833 + 32 
748 + 21 890 + 35 
763 + 68 924 + 47 
810 + 23 951 + 15 
959 + 130 > 1000 
1120 + 21 1350 + 36 
1300 + 83 1630 + 53 
1420 + 96 1750 + 118 
2530 + 402 3910 + 820 
One shampoo was very damaging to cells in the assay. This was an anti-
dandruff shampoo, which was four hundred times more toxic than the other 
shampoos tested, and as cytotoxic as pure cetylpyridinium chloride. Another 
medicated (not anti-dandruff) shampoo gave an IDso very similar to the 
majority of the other, non-medicated shampoos, as did a second anti-dandruff 
shampoo. The highly toxic anti-dandruff shampoo contained zinc pyrithione as 
its active anti-dandruff ingredient. Zinc pyrithione itself gave an IDso of 
0.06JLglml in the FRAME KB cytotoxicity assay. 
The Johnson and Johnson baby shampoo was the least toxic shampoo tested. 
Several "mild" and "frequent use" shampoos for adults were tested, but were 
overall neither more or less toxic than the other shampoos. Two conditioning 
shampoos were placed at the lower end of the toxicity ranking in Table 2, but 
their IDso values were still close to those for other shampoos for adults. 
In general, the hair conditioners were more toxic to 3T3-L1 cells than the 
shampoos, but the differences in IDso values were not great. The conditioners 
also tended to give relatively shallower toxicity curves than the shampoos. 
One leave-in conditioner (i.e. it is not meant to be rinsed out of the hair as 
normal hair conditioners are) was much less toxic (IDso 2530 JLglml) than a 
rinse-out conditioner from the same manufacturer (IDso 70 JLglml). 
6.2.2.3 In vitro toxicities of 14 hair spray products 
Table 6.3 shows the cytotoxicities of fourteen hair sprays and gel sprays tested 
in the FRAME KB cytotoxicity assay. The range of IDso values covered is 
small (14900 to 40000 JLglml) and the values themselves are considerably 
larger than those for the pure surfactants and surfactant-containing 
formulations. The gel sprays appear in general to be slightly more toxic than 
the hair sprays. 
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Table 6.3. In vitro toxicities of fourteen hair sprays and gel sprays 
Manufacturer* Product range Identity IDzo IDso 1080 
(JJg/ml (JJg/ml (JJg!m) 
+ s.e.m.) + s.e.m.) + s.e.m.) 
A Gel spray Tresemme 4 + 4 7580 + 730 14900 + 1990 28700 + 8490 
A Gel spray Bold Salon formula 7140 + 1900 15500 + 2660 25300 + 2940 
A Gel spray Indola extra strong 7430 + 1440 17000 + 1820 25700 + 4150 
A Gel spray V05 Mega Hold 4530 + 1630 18500 + 1840 27300 + 3520 
A Hair spray Indola lite, no gas 6520 + 572 21200 + 4700 29700 + 3900 
A Gel spray Salon formula ultimate hold 8870 + 2160 22600 + 2440 33200 + 5500 
A Hair spray V05 Extra Hold 10800 + 1810 25200 + 1660 37700 + 4580 
A Hair spray V05 Ultra Hold 11800 + 3900 27100 + 6340 37800 + 6230 
A Hair spray Salon formula strong hold 12000 + 2040 29100 + 6290 35200 + 10700 
A Gel spray Code F9 9570 + 766 29800 + 1390 37200 + 611 
A Hair spray Pure and clear, extra hold 13400 + 2760 32300 + 4990 42800 + 5610 
A Hair spray Pure and clear, ultra hold 17000 + 3540 32300 + 3310 43800 + 4310 
A Hair spray Code E1c 21400 ± 854 38600 + 1840 48400 + 3140 
A Hair spray Code E1d 19900 + 3640 40000 + 1840 48200 + 1690 
*The identity of manufacturer A must be concealed due to 
6.2.2.4 In vitro toxicities of 10 facial, body and eye gels and skin liquids 
A variety of product types, designed for application to the skin at regular 
intervals without being rinsed off, were tested (Table 6.4). These included 
body gels, eye gels, a facial skin tonic and an eye make-up removing liquid. 
A wide range of 1D50 values was obtained (143 to 16400J.Lg/ml). 
Five of the body gels were sun-care products from the same manufacturer (D), 
and three of these appear to be considerably more damaging to the 3T3-L1 
cells than any of the other products in Table 6.4. The factor 2 and factor 8 
sun-protective gels gave 1D50 values similar to those for Tween 40 (Table 6.1), 
or a J ojoba moisturising hair conditioner (Table 6.2). The aftersun skin gel 
gave an 1D50 value similar to that for Tween 80 or a conditioning shampoo. 
The remaining two skin gels by this manufacturer (another aftersun gel and 
a factor 2 sun-protective gel) gave 1D50 values which would place them 
amongst other weakly damaging substances, such as magnesium (II) chloride 
hexahydrate and sodium (I) iodide in the FRAME KB cytotoxicity assay 
toxicity rank order (Table 3.1). 
The remaining five products were from a second manufacturer (B) and all 
gave cytotoxicities which also placed them in the toxicity rank amongst 
substances of low toxicity. Of these, a perfumed and an unperfumed version 
of the same eye gel gave essentially identical cytotoxicities. 
6.2.2.5 Conclusions 
It is apparent that, in general, the hair conditioners contain ingredients which 
cause them to be slightly more damaging to 3T3-L1 cells than the shampoos. 
The two conditioning shampoos were not more toxic than other, regular, 
shampoos. One anti-dandruff shampoo gave unexpectedly high toxicity in vitro. 
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Table 6.4. In vitro toxicities of ten facial, body and eye gels and skin liquids 
Manu- Product range Identity ID20 IDso IDgO 
facturer* (lLg/ml (lLg/ml (lLg/ml 
+ s.e.m.) + s.e.m.) + s.e.m.) 
D Sun protective skin gel Factor 2, honey and wheatgerm 24 + 4 143 ± 25 232 + 28 
D Sun protective skin gel Factor 8, avocado and aloe vera 47 + 18 165 + 32 243 + 25 
D Aftersun skin gel Cucumber and royal jelly 234 ± 65 748 + 149 1270 + 285 
D Aftersun skin gel Cooling with aloe vera 2010 + 367 5510 + 455 > 10000 
B Eye makeup remover Camomile, for eyes 4450 + 757 7070 + 437 8770 + 481 
B Skin gel Cooling foot and leg (GP/088D) 5830 + 82 8650 + 715 13000 + 2080 
B Skin tonic Salad wipes (AF/041) 5710 + 1430 12200 + 1020 20300 
D Sun protective skin gel Factor 2, with carrot extract 7650 + 1970 12900 + 1220 13300 (n= I) 
B Eye gel Elderflower, unperfumed 9150 + 512 13300 + 1170 17200 + 2080 
B Eye gel Elderflower 12600 16400 + 2620 16700 
*The identities of manufacturers Band D must be concealed due to confidentiality. 
The ingredient responsible for this was almost certainly zinc pyrithione. The 
baby shampoos were, as expected, less damaging than those formulated for 
adult use. 
The hairspray products gave in vitro toxicities similar to one another, and to 
those for the lower alcohols (Table 3.1), and were therefore considerably less 
toxic than the shampoos or conditioners. 
The three body gels which were unexpectedly damaging in the FRAME KB 
cytotoxicity assay were those which had generated customer complaints. They 
appear to be unusually cytotoxic for this category of skin toiletry product. 
6.3 DISCUSSION 
The cationic surfactants were consistently more toxic than the other charged 
groups in the FRAME KB cytotoxicity assay, as has been found in other in 
vitro toxicity studies with surfactants (Borenfreund and Borrero, 1984; Kato et 
al., 1988; Gajjar and Benford, 1989). However, whilst some studies have found 
anionics and amphoterics to be more toxic than non-ionics (North-Root et al., 
1982; Shopsis and Eng, 1985), there was no clear distinction between these 
groups in the FRAME KB cytotoxicity assay. This result may reflect the 
differences in the assay method employed in these studies. Benoit et al. (1987) 
found sodium dodecyl sulphate (SDS) (anionic) to be less toxic than Triton X-
100 (non-ionic) in a 72 hour exposure cytotoxicity assay using 10% FCS in the 
culture medium. With 0 or 1 % FCS, however, SDS was more toxic. Bianchi 
and Fortunati (1990) also found the cytotoxicity of an anionic surfactant 
increased when FCS was omitted from the treatment medium. Brij surfactants 
(non-ionic) were more cytotoxic than anionics over 2, 24, 48 or 72 hours 
exposure in an ill vitro study by Cornelis et al. (1991). Anionics are known to 
bind to serum albumin with higher affinity than other detergents (HeJenius and 
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Simons, 1975). Hence, with assays which involve dissolving the test surfactants 
in serum-containing medium (such as the FRAME KB cytotoxicity assay), it 
must be acknowledged that some surfactants may be partially "de-toxified" by 
binding to the serum proteins (Stark et ai., 1986). 
This phenomenon is only of significance where the binding is of such high 
affinity that a chemical's toxicity rank position is radically altered by testing in 
the presence of little or no serum. It would not be straightforward to test 
chemicals in the FRAME KB cytotoxicity assay using low-serum medium. 
Although Benoit et ai (1987) used a 72 hour exposure period, the endpoint 
measured was 100% cell death (i.e. the assay did not require the cells to 
multiply). The FRAME KB cytotoxicity assay measures inhibition of growth, 
and as 3T3-L1 cell growth would normally be markedly reduced in the absence 
of serum, any cell growth that did occur would probably not be inhibited (in 
the presence of test chemical) in the same manner as in the standard assay. 
Serum-free or low-serum media are commercially available for certain 
attached cells, and 3T3-L1 cells might grow satisfactorily in them. However, 
in order that results would be comparable, all chemicals tested to date in the 
FRAME KB cytotoxicity assay would also have to be tested using the serum-
free or low-serum medium. 
The surfactants, which have rapid toxic effects on cells in culture (Riddell et 
al., 1986a; Garle et ai., 1987; Balls et ai., 1991), can produce meaningful results 
in short-term exposure assays such as the SIRC test (North-Root et ai., 1982) 
or the FRAME Neutral Red Release (NRR) assay (Reader et al., 1989). Cell 
growth during the exposure period is not required in these assays, and hence 
the question of serum binding effects may be examined. Some cytotoxicity 
studies on surfactants have specifically omitted serum from the medium due 
to concern about differential binding (Scaife, 1982) or have omitted testing the 
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cationics and anionics completely, in order to avoid potentially misleading 
results (Ernst and Arditti, 1980). 
It is not possible to conclude definitely that it is the surfactants alone in the 
hair shampoos and conditioners which are responsible for inhibiting cell 
growth in the FRAME KB cytotoxicity assay. There may be both potentiation 
and inhibition of toxicity by other non-surfactant or surfactant ingredients. 
Some surfactants are known to increase cell membrane permeability, thereby 
causing the cells to become more susceptible to toxic chemicals (Parekh and 
Chitnis, 1990). However, the majority of the 1Dso values of the shampoos are 
very similar and are at a level which would suggest they contain similar 
amounts of anionics, with little effect being caused by ingredients such as 
conditioners or simple medications. 
Although the conditioners contain cationic surfactants, which are known to be 
toxic in vitro, it is not possible to conclude definitely that it is the cationics 
which are responsible for the higher toxicities of the conditioners. The low-
toxicity, "leave-in" conditioner probably contains a much lower amount of the 
hair-conditioning agent( s) than the "rinse-out" version. This suggests that the 
conditioning agent is the prime cause of the toxicity of the hair conditioners, 
and is probably a cationic surfactant. Unfortunately, the actual identity of the 
hair conditioning agent( s) present in these formulations is not known, owing 
to trade secrets. Although it is likely that the conditioning shampoos 
contained cationic surfactants, they may also have contained less anionics than 
other shampoos, so their toxicity was not increased. Alternatively, their 
cationic ingredients may have been of lower in vitro cytotoxicity than the types 
used in pure conditioners. 
Zinc pyrithione is reportedly an inhibitor of DNA synthesis (North-Root et al., 
1985) and was the active ingredient in the high toxicity shampoo tested. North-
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Root et al. (1985) tested two "dandruff' shampoo formulations in a one-hour 
exposure, colony survival cytotoxicity assay, and found, in contrast to the 
results in this study, that both gave very similar toxicities, despite the fact that 
one formulation did not contain zinc pyrithione, or any other anti-dandruff 
ingredient. In their study, the "dandruff' formulations gave LCso 
concentrations over ten times lower than those for two "regular" shampoos, 
which were in turn more toxic than two baby shampoos. Muir (1983) and 
Flower (1987) also found a decrease in effect from anti-dandruff to adult to 
baby shampoos in in vitro assays. Further anti-dandruff and baby shampoos 
must be tested in the FRAME KB cytotoxicity assay, before it can be 
confirmed that this toxicity ranking also holds true in this assay. 
In the absence of any propellant chemicals, the hairspray products tested were 
probably almost totally made up of one or more of the lower alcohols. This 
explains their low toxicity to 3T3-L1 cells. The slight differences in the 
toxicities of the gel sprays and hair sprays may therefore reflect either 
inclusion of a greater amount of a more toxic alcohol or different toxic effects 
of different hair fixing ingredients. 
The "irritant" suncare skin gels contained well-tested ingredients, but one was 
at a higher concentration than formerly used. The identity of this ingredient 
is not known due to trade secrets. It is not possible to say whether any sun-
screening chemical was involved in the cytotoxic effects of the honey and 
wheatgerm or the avocado and aloe vera sun-protective gels. As with the 
shampoo and conditioner formulations, additional testing of individual 
ingredients and mixtures is required before these results can be put into their 
proper perspective. The results from the body and eye gels from manufacturer 
B suggest that manufacturer D's toxic gels were indeed unusually damaging for 
this type of skin product. 
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The question remains as to how the in vitro data would be used, in the context 
of safety assessment. Can cell growth inhibition tests, such as the FRAME KB 
cytotoxicity assay, provide relevant information on chemicals and products 
where the prime concern is whether they are irritant? 
The results for the pure surfactants could be compared to in vivo acute lethal 
toxicity data in order to assess whether the in vitro assay could predict in vivo 
toxicity for this type of chemical. A direct comparison with in vivo toxicity 
values was not possible, due to a lack of data in the literature. The human 
acute poisoning rank order for surfactants is cationic > anionic/non-ionic 
(Gosselin et a/., 1976) and this is reflected in the rank order in the FRAME 
KB cytotoxicity assay. When considering systemic toxicity, the problem of 
surfactants binding to proteins in the cell culture medium is of less significance, 
because they may also bind to proteins in the gut or in the circulation of the 
subject animal. It can therefore be argued that low or no-serum conditions 
in vitro are unphysiological when compared to those facing cells inside an 
animal's body. If an outer skin layer is exposed to a chemical, no serum is 
present, because epithelial cells are not naturally bathed in a protein solution. 
The 3T3-L1 cells used in the FRAME KB cytotoxicity assay are fibroblastic, 
not epithelial, and therefore it seems logical that they should be exposed to 
test chemicals in the presence of serum. Although the FRAME KB 
cytotoxicity assay by itself has never been proposed as a test to detect irritant 
properties of chemicals, the results for the surfactants partially correlate with 
acknowledged in vivo irritancy rankings, i.e. cationic > anionic/amphoteric > 
non-ionic (Shopsis et a/., 1985). If the surfactants are considered as a group 
of surface-active chemicals among a large database of unrelated chemicals 
(Chapter 3; Clothier et ai., 1988), they may be seen as being relatively highly 
placed in the overall rank. This is primarily as a result of their specific ability 
to disrupt cell membranes (Helenius and Simons, 1975). 
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The FRAME KB cytotoxicity assay results for the surfactants are likely to 
become useful when they can be used as a reference database for product 
formulations which contain them, such as shampoos or household cleaners. 
Non-surfactant ingredients of these formulations may not produce rapid toxic 
effects like the surfactants, and thus the FRAME KB cytotoxicity assay may 
be more appropriate for these longer-acting substances. In this case the 
results for all the ingredients are required in order to assess which are 
primarily responsible for the toxicity of a formulation. It is necessary to 
increase the database of types of pure surfactants which are included in 
shampoos, conditioners and other cleaning products. 
The results for the hairspray, body gel and liquid products are of a preliminary 
nature only, because there is no database of results for their ingredients and 
no ill vivo data available with which to make comparisons. Further work 
would have to be performed in conjunction with the manufacturers in order 
to assess the usefulness of the FRAME KB cytotoxicity assay with these and 
other product types. With the surfactants and shampoos, however, the assay 
has demonstrated potential for providing relevant information for safety 
assessment. It could be of considerable use as a cell growth inhibition assay 
within a battery of in vitro toxicity assays designed to predict in vivo irritancy 
(Bracher et ai., 1989; Balls, 1991a). Such a battery has yet to be completely 
devised, but the increased collaboration between academic and industrial 
laboratories could lead to one (or more) being developed in the near future 
(Balls, 1989). 
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7.1 INTRODUcrION 
The first interlaboratory evaluation of the FRAME KB cytotoxicity assay was 
conducted as a blind study in four laboratories (Knox et al., 1986). Fifty test 
chemicals, which had been selected with the advice of the FRAME Research 
Advisory Committee on Cytotoxicology, were tested on a human embryo-
derived cell line, BCL-Dl. "Difficult" chemicals, i.e. types of chemicals known 
to pose problems for in vitro toxicology, were deliberately included. These 
included volatile, unstable, and insoluble chemicals, and chemicals which 
require metabolic activation to exert an enhanced effect in vivo. As expected, 
the "difficult" chemicals did pose some problems. For example, little 
confidence was expressed in the results for acrylonitrile, due to its high 
volatility. The ID values for this chemical showed both large intralaboratory 
and interlaboratory variation. It was suggested that volatile compounds could 
not be tested in the 24-well plates, unless a system for reducing evaporation 
of test chemicals was devised. Garle et al. (1987) also expressed low 
confidence in results for acrylonitrile in a 4-hour and a 72-hour exposure 
cytotoxicity assay, due to its volatility. 
Clothier et al. (1988) noted that, even when using 96-well plates with the 
FRAME KB cytotoxicity assay, evaporation of test chemicals from the culture 
medium still occurred. The consequence of this evaporation would be that the 
cell growth inhibitory doses (ID values) calculated might not be a true 
reflection of the concentrations of the chemical which interacted with the 
target cells. If the chemical evaporated before it came into contact with the 
cells, then its toxicity would be drastically underestimated. It was also pointed 
out that care must be taken to prevent such vaporised chemicals from re-
dissolving in the untreated control wells, thereby inhibiting control cell growth. 
This latter problem was most prevalent with chemicals of high volatility and 
low toxicity, as the plates had to be treated with high concentrations of the test 
156 
material. 
Stark et a/. (1986) found that "modular incubator chambers" were effective for 
containing volatile agents being tested in the Neutral Red Uptake cytotoxicity 
assay (Borenfreund and Puerner, 1984). Other workers (Tyson et al., 1983; 
Clemedson et al., 1989; Ghantous et al., 1990) have developed sophisticated 
culture apparatus in order to minimise losses of volatile compounds from 
culture media during cytotoxicity tests. These are not suitable, however, for 
adaptation for use in a simple cytotoxicity test such as the FRAME KB 
cytotoxicity assay, due to their complexity, cost and low rate of test substance 
throughput. 
The difficulty with handling volatile chemicals in in vitro toxicology has 
therefore been perceived as principally that of evaporation of the test chemical 
from the culture medium. The subsequent problem is to decide how much 
confidence can be placed in the results, as there are many degrees of volatility 
and toxicity, and hence some chemicals are more problematical than others. 
The question arises as to what extent different degrees of volatility and toxicity 
in a chemical could cause a researcher to express lack of confidence in a 
result. To date, only a small number of liquids have been acknowledged in the 
literature to represent a problem for simple cytotoxicity assays (Knox et a/., 
1986; Garle et al., 1987; Clothier et a/., 1988), but it is likely that others also 
cause difficulties. It is also pertinent to know whether the FRAME KB 
cytotoxicity assay could be adapted to include a sealing system for use with 
volatile chemicals, and whether the results would correlate better with in vivo 
toxicities than the results obtained in the standard FRAME KB cytotoxicity 
assay protocol. 
There is no clear definition of volatility. Liquids which evaporate rapidly at 
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room temperature, such as acetaldehyde or methanol, are generally regarded 
as "volatile". However, liquids such as propan-I-ol or hydrochloric acid are less 
clearly volatile, but still evaporate rapidly. The volatility of a chemical 
depends mainly on its boiling point and latent heat of vapourisation. Trouton's 
rule indicates that the molar heat of vapourisation divided by the boiling point 
(in degrees absolute) is approximately a constant. Hence, volatility can be 
related directly to the boiling point. 
The rate of evaporation of a test chemical from culture medium during a 
cytotoxicity assay is affected by several factors (Table 7.1). Allor some of 
these factors will contribute to the interlaboratory and intralaboratory 
variations in cytotoxicity values obtained when testing volatile liquids in the 
FRAME KB cytotoxicity assay. Standardisation of some of the factors listed 
in Table 7.1 might be effective in reducing these variations. A system whereby 
treated wells are sealed immediately after test chemical application might help 
to reduce the evaporation rates, and hence also reduce variation. Sealing the 
wells also decreases the risk of transfer of volatile chemicals from treated to 
untreated control cultures. In addition, sealing may help to reduce the 
problem of evaporation of the culture medium itself. This can occur in the 
peripheral wells of 96-well plates and therefore renders them unsuitable for 
inclusion in the standard FRAME KB assay protocol (INVITIOX Protocol 36, 
Warren et ai., 1990). 
Two methods for sealing 96-well plates were considered. In order to fit in 
with the overall objectives of the FRAME KB cytotoxicity assay, the methods 
should be inexpensive and easy to manipulate, and the sealing itself should not 
interfere with the performance of the standard assay. The systems investigated 
were: 
1. Light paraffin oil, layered over the medium in each well (Figure 7.1b); 
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Table 7.1. Potential sources of vanatlon in interlaboratory and 
intralaboratory FRAME KB cytotoxicity assay results with 
regard to volatile chemicals 
1. 
2. 
3. 
4. 
5. 
Environment in which 
the pure liquid test 
chemical is dispensed 
Method of preparation 
of chemical dilution 
series in culture 
medium 
Design of multi-well 
culture plate 
Treatment protocol 
Incubator environment 
Example of how evaporation rate of liquid 
test chemical may be variably affected 
Warm, dry environment with flow of air 
may cause evaporation of the chemical 
during transfer from stock bottle, 
resulting in pipetting error. 
(a) Potential evaporation of initial 
small-volume dilutions in volatile 
solvents. 
(b) Potential evaporation of chemical 
from culture medium solutions if left 
for extended periods before treatment 
of plates. 
Well size and shape, and design of lid, 
affect evaporation rates. Small wells 
(e.g. in 96-well plates) generally have 
lower rates of evaporation of both 
chemical and culture medium. 
(a) Volume of culture medium in each 
well affects surface area to medium 
volume ratio. Low surface area to 
volume ratios increase the potential for 
evaporation of both chemical and medium. 
(b) Proximity of treated wells to plate 
edge. Wells near edge suffer more 
evaporation than central wells. 
(a) Low humidity in incubator increases 
evaporation rates. 
(b) Plates close to incubator internal fan 
will potentially suffer greater evaporation 
rates. 
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and 
2. A self-adhesive, carbon dioxide-permeable plastic film, designed for use 
in microplate immunoassays (Figure 7.1c). 
Selling and Ekwall (1985) employed both paraffin oil and a plastic film in their 
96-well plate cytotoxicity assay. The purpose of these sealants was not stated, 
but appears to have been prevention of carbon dioxide exchange between the 
medium and the atmosphere. 
The adhesive film and the paraffin oil were assessed for ease of use and for 
potential interference with the performance of the FRAME KB cytotoxicity 
assay. Eleven non-volatile (i.e. solid) chemicals were tested initially, using both 
sealants. Subsequently, the sealants were evaluated for use with liquids, 
including a series of straight-chain alcohols, which have varying degrees of 
volatility. The liquids were deemed to be of varying volatilities because of the 
range of their boiling points. 
The results are presented as mM values, rather than J.Lglml values, to allow for 
comparison of test chemicals by the number of test chemical molecules, rather 
than their weight, in solution. 
Note: The experiments described in this chapter were all conducted in the 
laboratories of Northumbria Biologicals Ltd., Nelson Industrial Estate, 
Cramlington, NE23 9BL. 
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Figure 7.1(a): Unsealed. 
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Figure 7.1(b): Paraffin oil as sealant. 
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Figure 7.1(c): Adhesive film as sealant. 
Figure 7.1 Diagram of cross section of culture plates with sealants In 
position. 
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7.2 RESULTS 
7.2.1 Initial assessment of the two sealants 
7.2.1.1 Effects of sealants on cell growth 
3T3-L1 cells were plated at 0.5 x 104/cm2 (0.15 x 104 cells in 0.15ml of 
medium) in identical 96-well culture plates and were allowed to adhere 
overnight. The plates were then either left unsealed, or sealed with the 
adhesive film or with 100J.,£1 per well of light paraffin oil. The mean total 
cellular protein in the central 60 wells of the unsealed and sealed plates was 
measured by the FRAME KB cytotoxicity assay at 0, 24, 48 and 72 hours after 
sealing (or not) of the plates. 
The total protein at the 72 hour endpoint was the same in both unsealed (US) 
and oil-sealed (OS) wells (Table 7.2). The adhesive film-sealed (FS) wells, 
however, showed approximately 40% less total protein at 72 hours. 
Examination of the cells in the FS plates using phase-contrast microscopy, 
both before and after assay fixation, indicated that a proportion of the cells 
became detached and were lost during the washing/fixation step. This 
occurred rarely in US and OS plates. Daily observation of the FS cultures 
revealed that the film sealing did affect cell growth, because fewer living cells 
were observed than in US or OS plates at the 48 and 72 hour timepoints. 
This is reflected in the growth curves (Figure 7.2). Cell growth in FS wells 
appeared to be equivalent to US wells at 24 hours after sealing, but was less 
rapid thereafter. 
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(total protein measured by Kenacid blue (KB) staining). 
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Table 7.2. 
Time 
after sealing 
a hr 
24 hr 
48 hr 
72 hr 
Effects of sealants on the growth of 3T3-L1 cells 
Total protein in the sealed wells, as a 
percentage of total protein in unsealed wells + s.e.m. 
Oil-sealed wells Fihn-sealed wells 
100 + a 100 + a 
166 + 14 87 + 10 
113 + 7 68 + 3 
101 + 1 63 + 9 
7.2.1.2 Effects of sealants on culture medium pH 
The ability of the culture medium in the sealed plates to buffer to the correct 
pH (7.2 - 7.4) was examined. The colour due to the pH indicator (phenol red) 
was the same in unsealed and sealed plates throughout the incubation periods. 
DMEM has a high bicarbonate level and loses carbon dioxide rapidly when 
removed from the 5% carbon dioxide atmosphere of the incubator. This 
causes a noticeable colour change in the phenol red, from orange to pink. 
When plates were removed from the incubator, the medium in US plates 
began to become pinker within a few minutes, whilst medium in OS and FS 
plates did not, indicating that the pH remained at between 7.2 and 7.4. This 
suggested that both sealants reduced the rate of loss of carbon dioxide from 
the culture medium. 
7.2.1.3 Effects of sealants on the protein level within the blank (medium only) 
wells 
The blank well in each plate is used as the blank when the KB absorbance 
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values are read. The well is given medium, but no cells, for the duration of 
the assay. Protein from the serum in the medium adheres to the well plastic. 
Since the blank well was always the corner (position AI) well, there was the 
possibility that medium evaporation could cause a deposit of protein at the 
air/medium interface. The effect of the sealants on the KB absorbance values 
of the blank wells was therefore examined. Ten each of the US, OS and FS 
plates used for cytotoxicity assays were randomly selected. The absorbance 
values for the blank wells were meaned and the results are shown in Table 7.3. 
Table 7.3. Mean absorbance of blank wells on unsealed, oil sealed or film 
sealed plates 
Unsealed plates 
Oil sealed plates 
Film sealed plates 
Mean absorbance + s.e.m. 
0.23 + 0.01 
0.20 + 0.01 
0.23 + 0.01 
The OS blank wells had a slightly lower protein content than the US and FS 
wells. 
7.2.1.4 Effects of adhesive film immersed in culture medium 
A small piece of adhesive film (5-10mm2) was immersed upright in culture well 
medium after cells had adhered overnight. Following incubation for a further 
72 hours, cytotoxicity was observed. In fact, no living cells remained in these 
wells. By contrast, the paraffin oil did not appear to inhibit cell growth. 
7.2.1.5 Conclusions 
It was found that both the paraffin oil and the adhesive film were very easy to 
handle, and added only minimal time and cost to performance of the standard 
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FRAME KB cytotoxicity assay protocol. Neither sealant caused KB 
absorbances to exceed normal (unsealed plate) values, or caused inhibition of 
the process of cellular protein staining. 
Although cell growth was inhibited by the adhesive film, this was not a 
sufficient reason for rejecting use of the film at this stage. 
Neither sealant affected the ability of the culture medium buffering system to 
maintain the correct pH, indicating that the sealants did not adversely affect 
gaseous exchange in the 96-well plates. 
Despite the apparent lower KB absorbance in blank wells on as plates, this 
may not have any significance in terms of indicating reduced evaporation of 
medium. It was possibly due to oil adhering to the sides of the culture well 
and thus preventing the protein from binding to the plastic. 
As both sealants showed no major disadvantages during this initial phase, their 
ability to affect the cytotoxicities of chemicals in the FRAME KB cytotoxicity 
assay was examined. 
7.2.2 Effects of sealants on the in vitro toxicities of chemicals of low volatility 
7.2.2.1 Effects of sealants on chemicals of low volatility 
In order to establish whether either the paraffin oil or the adhesive film 
altered the toxicities of test substances of low volatility, eleven solids were 
tested for cytotoxicity by the FRAME KB cytotoxicity assay in US, as and FS 
wells. The eleven chemicals (Table 7.4) included eight of the ten FRAME-
recommended "standard" chemicals (Clothier et al., 1988). They were also 
tested in order to check whether the assays run on US plates (i.e. by the 
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Table 7.4. III vitro toxicities of eleven solid chemicals on unsealed and sealed culture plates 
ID20 ID50 IDso 
mM ± s.e.m. mM ± s.e.m. mM ± s.e.m. 
Colchicine US <0.00003 0.()()()()8 ± 0.()()()()1 0.006 ± 0.002 
OS 0.00003 ± 0 0.()()()()8 ± O.()()()()() 0.0008 Cn = 2) 
FS <0.00003 < O. ()()()()3 0.008 ± 0.001 
Cadmium chloride US 0.0008 ± 0.0002 0.001 ± 0.000 0.002 ± 0.000 
OS 0.0006 ± 0.0001 0.001 ± 0.000 0.001 ± 0.000 
FS 0.0007 ± 0.0001 0.001 ± 0.000 0.002 ± 0.002 
Pentachlorophenol US 0.06 ± 0.00 0.09 ± 0.00 0.11 ± 0.00 
OS 0.04 ± 0.01 0.09 ± 0.00 0.12 ± 0.00 
FS 0.02 ± 0.00 0.05 ± 0.00 0.08 ± 0.01 
2,4-Dinitrophenol US 0.10 ± 0.01 0.21 ± 0.10 0.30 ± 0.01 
OS 0.08 ± 0.02 0.21 ± 0.01 0.32 ± 0.02 
FS 0.03 Cn = 2) 0.09 ± 0.02 0.18 ± 0.03 
Sodium dodecyl sulphate US 0.22 ± 0.01 0.27 ± 0.01 0.32 ± 0.01 
OS 0.25 ± 0.00 0.30 ± 0.00 0.33 ± 0.00 
FS 0.17 ± 0.02 0.23 ± 0.01 0.28 ± 0.01 
I ~ j , : : : . . . 
Sodium fluoride US 0.51 + 0.13 1.4 + 0.1 2.0 + 0.1 
OS 0.61 + 0.13 1.4 + 0.1 2.1 + 0.1 
FS 0.63 + 0.22 1.3 + 0.1 1.9 + 0.0 
Isoniazid US <0.73 4.2 + 0.4 17 + 0 
OS 1.0 (n = 2) 5.5 + 0.8 17(n=l) 
FS <0.73 1.5 + 0.1 5.3 + 0.6 
Ammonium chloride US 2.9 + 0.7 4.9 + 0.6 5.9 + 0.6 
OS 3.0 (n = 1) 3.5 + 0.7 4.8 + 0.5 
FS 1.9 (n = 1) 3.7 + 0.6 5.0 + 0.4 
Trichloroacetic acid US 3.2 + 0.7 6.3 + 0.4 8.9 + 0.7 
OS 2.7 + 0.4 6.0 + 0.8 8.6 + 0.8 
FS 1.4 (n = 2) 2.8 + 0.7 5.1 + 1.0 
Sodium hydroxide US 17 + 4 28 + 3 40 ± 2 
OS 6.2 ± 0.3 10 + 1 13 + 0 
FS 7.8 + 1.8 10 + 2 13 + 3 
D-Glucose US 139 (n = 2) 200 + 13 269 + 15 
OS 138 (n = 2) 215 ± 16 278 + 16 
FS 133 (n = 1) 188 + 8 252 + 9 
US = Unsealed culture plates 
OS = Oil-sealed culture plates 
FS = Film sealed culture plates 
standard FRAME KB cytotoxicity assay protocol) in the laboratories at 
N orthumbria Biologicals Ltd. provided results close to the published values 
(Clothier et ai., 1988). 
2,4-Dinitrophenol and pentachlorophenol were dissolved initially in DMSO and 
ethanol, respectively, prior to dilution into the culture medium to a final 
solvent concentration of 0.1 % (v/v). This is less than the solvent concentration 
normally used in the FRAME KB cytotoxicity assay (1 % (v/v)), and was used 
because of the inhibition of cell growth by 1% (v/v) solvent on the sealed 
plates. 
The dose-response curves of five of the chemicals were not significantly 
different in the sealed or unsealed plates. However, six chemicals (colchicine, 
2,4-dinitrophenol, isoniazid, sodium dodecyl sulphate, sodium hydroxide and 
trichloroacetic acid) were all significantly more toxic on FS plates than on US 
plates (Table 7.5). Of these six, sodium dodecyl sulphate and sodium 
hydroxide also gave significantly increased toxicity on OS plates. 
Where chemicals gave increased toxicity on sealed plates, the ID2o, IDso and 
ID80 were all reduced by a similar factor (Table 7.4), indicating that the 
sealants did not affect the shape of the dose response curves. The ratio of 
standard error values to their ID values was fairly constant on the sealed and 
unsealed plates, indicating that the sealants did not affect the normal 
experiment to experiment variability of the results for these chemicals. 
The toxicities of the eleven solids on US plates were no different from the 
FRAME published values for these substances (Clothier et ai, 1988) (Table 
7.6). Comparison of the logged IDso (mM) values by linear regression gave 
a correlation coefficient of 0.93. 
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Table 7.5. Comparison of ID50 values for eleven solid chemicals on 
unsealed and sealed culture plates 
ID50 (mM) 
Unsealed Oil-sealed Film-sealed 
plate plate plate 
Colchicine 0.00008 0.00008 <0.00003*® 
Cadmium chloride 0.001 0.001 0.001 
Pentachlorophenol 0.09 0.09 0.05 
2,4-Dinitrophenol 0.21 0.21 0.09*® 
Sodium dodecyl sulphate 0.27 0.30* 0.23*® 
Sodium fluoride 1.4 1.4 1.3 
Isoniazid 4.2 5.5 1.5*® 
Ammonium chloride 4.9 3.5 3.7 
Trichloroacetic acid 6.3 6.0 2.8*® 
Sodium hydroxide 28 10* 10* 
D-Glucose 200 215 188 
* - ID50 significantly different from unsealed plate ID50 
®= ID50 significantly different from oil-sealed plate ID50 
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Table 7.6. Comparison of FRAME published IDso values with those 
obtained at Northumbria Biologicals Ltd. (NBL) for eleven solid 
chemicals, tested on unsealed culture plates 
Chemical FRAME IDso NBL IDso 
(mM) (mM) 
Cadmium chloride 0.001 0.001 
Colchicine 0.02 0.00008 
Pentachlorophenol 0.12 0.09 
Sodium dodecyl sulphate 0.33 0.27 
2,4-Dinitrophenol 0.39 0.21 
Sodium fluoride 1.3 1.4 
Trichloroacetic acid 3.2 6.3 
Ammonium chloride 6.3 4.9 
Isoniazid 16 4.2 
Sodium hydroxide 37 28 
D-Glucose 269 200 
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7.2.2.2 Conclusions 
The paraffin oil provided more-acceptable results in the FRAME KB 
cytotoxicity assay than the adhesive film, as it altered the toxicity of only one 
solid, compared to five under the film. The small increase in toxicities of solid 
chemicals on sealed plates was unexpected, and does not have a simple 
explanation. While sodium dodecyl sulphate is statistically significantly more 
toxic on OS and FS plates than on US, the difference in the IDso values 
between US, OS and FS plates is marginal. 
Due to increased toxicities of organic solvents on sealed plates, the solvent 
concentration was reduced to 0.1% (v/v). This would prevent the testing of 
chemicals requiring a solvent, which were toxic at doses above 100J,.Lg/ml 
(assuming a maximum solubility of 100mg/ml of the chemical in the solvent). 
Interlaboratory variation In results for the solids was low, indicating the 
reproducibilty of the FRAME KB cytotoxicity assay method. 
Although the adhesive film revealed a major drawback in its effect on solid 
chemical cytotoxicity, it was decided to evaluate its use with liquid chemicals 
in order to complete the evaluation of whether the two sealants could provide 
different information with the liquid chemicals. Both sealants were therefore 
tested with a set of related volatile chemicals, the straight-chain alcohols. 
7.2.3 Effects of sealants on the ill vitro toxicities of structurally-related 
volatile chemicals 
7.2.3.1 Effects of sealants on structurally-related volatile chemicals 
A set of eight straight-chain alcohols were tested. The increase in carbon 
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chain length from methanol to octanol results in increased viscosity, a higher 
oil/water partition coefficient (Borenfreund and Babich, 1987b) and an 
increased boiling point (and hence reduced volatility). These chemicals were 
also selected because, although they are closely related structurally, they have 
a wide range of cytotoxicities to 3T3-L1 cells (Clothier et ai., 1988). 
The toxicity curves on US plates showed that the toxicities of the alcohols 
increased with increasing chain length from methanol (1 carbon) up to octanol 
(8 carbons) (Table 7.7). The same pattern of increasing toxicity from 
methanol to octanol is also seen on the sealed plates. With the lower alcohols 
(methanol to propan-I-ol), both the sealants caused increased toxicity to a 
significant degree (Table 7.8), as is shown in the dose-response curves (Figure 
7.3). With the higher alcohols, a variety of effects were noted. The toxicities 
of butan-I-ol and pentanol were the same on US and OS plates, but were 
increased significantly by the film sealant (Table 7.8, Figure 7.4). With 
hexanol, the oil sealant decreased toxicity significantly, but the film did not 
affect it (Table 7.8, Figure 7.5). The toxicity of heptanol was significantly 
decreased by both the oil and the film (Table 7.8), but to a greater degree by 
the oil (Figure 7.5). The toxicity of octanol appeared to be similar in sealed 
and unsealed plates (Table 7.5), but the dose-response curves (Figure 7.4) 
show that the shapes of the curves across the dose range are not the same. 
The curve from the OS plates has a distinct "elbow", which is also noticeable 
on the curve for heptanol on OS plates. This "elbow" is not apparent in the 
curves for the other alcohols. N one of the alcohols showed any evidence of 
cross-contamination of control wells, i.e. control cell growth was not affected 
by the presence of an alcohol in wells on the same plate. 
7.2.3.2 Conclusions 
Sealing the plates with adhesive film or paraffin oil increased the toxicities of 
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Table 7.7. In vitro toxicities of eight straight chain alcohols in unsealed and 
sealed culture plates 
ID20 
mM + s.e.m. 
Octanol US 1.0 + 0.3 
OS 1.7 + 0.0 
FS 1.1 + 0.4 
Heptanol US 1.0 (n = 1) 
OS 4.2 + 0.8 
FS 2.7 + 0.4 
Hexanol US 2.7 + 0.6 
OS 6.9 + 1.0 
FS 3.3 + 0.6 
Pentanol US 25 + 2 
OS 22 + 4 
FS 7.4 + 4.3 
Butan-I-ol US 21 + 6 
OS 23 + 7 
FS 12 + 2 
Propan-I-ol US 68 + 14 
OS 49 (n = 2) 
FS 39 (n = 1) 
Ethanol US 287 + 32 
OS 129 (n = 1) 
FS 169 (n = 1) 
Methanol US 942 (n = 1) 
OS 312 (n = 1) 
FS 551 (n = 1) 
US = unsealed culture plates 
OS = oil-sealed culture plates 
FS = film-sealed culture plates 
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1Dso IDgO 
mM + s.e.m. mM + s.e.m. 
1.7 ± 0.2 2.4 + 0.4 
2.1 + 0.1 2.5 + 0.2 
1.8 + 0.1 2.1 + 0.0 
2.3 + 0.3 3.6 + 0.5 
6.3 + 0.5 7.2 + 0.6 
4.6 + 0.3 5.8 + 0.3 
7.3 + 0.5 9.2 + 0.5 
14 + 1 21 + 3 
7.3 + 0.5 10 + 0 
37 + 32 44 + 3 
36 ± 4 47 + 2 
17 + 4 30 + 5 
45 + 4 72 + 6 
42 + 4 59 + 4 
25 + 2 45 + 3 
114 + 10 169 + 19 
79 + 4 103 + 9 
62 + 3 108 + 11 
418 + 27 518 + 10 
224 + 19 320 + 26 
223 + 32 320 + 31 
1099 + 53 1344 + 43 
571 + 67 842 + 79 
705 + 107 937 + 68 
Table 7.8. Comparison of 1Dso values for eight straight chain alcohols on 
unsealed and sealed culture plates 
1Dso (mM) 
Unsealed Oil-sealed Film-sealed 
plate plate plate 
Octanol 1.7 2.1 1.8 
Heptanol 2.3 6.3* 4.6*® 
Hexanol 7.3 14* 7.3® 
Pentanol 37 36 17*® 
Butan-I-ol 45 42 25*® 
Propan-l-ol 114 79* 62* 
Ethanol 418 224* 223* 
Methanol 1099 571* 705* 
* - 1Dso significantly different from unsealed plate 1Dso 
®= 1Dso significantly different from oil-sealed plate 1Dso 
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Figure 7.3 III vi/ro toxicity of (a) methanol, (b) ethanol and (c) propan-l-ol 
in the FRAME KB cytotoxicity assay, on unsealed to), oil-sealed 
(8) and film-sealed ( ~ ) ) culture plates. 
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III vitro toxicity of (a) hexano], (b) heptano] and (c) octano] in 
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(6) and fi]m-sealed (0) culture plates. 
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the more volatile alcohols. The toxicities of the less volatile alcohols were not 
affected or were even reduced by the sealants, but the two sealants produced 
different levels of effects. 
As the adhesive film did not show any different effects to those of the oil with 
regard to the toxicities of the more volatile alcohols, and as it is also inhibitory 
to cell growth and can adversely alter the toxicities of non-volatile chemicals, 
it was decided not to further evaluate its use. 
7.2.4 Effects of the paraffin oil sealant on the in vitro toxicities of unrelated 
liquid chemicals 
7.2.4.1 Effects of the paraffin oil sealant on unrelated liquid chemicals 
A further nineteen unrelated liquid chemicals were tested on US and as 
plates. Most of the liquids were selected from those previously tested by 
FRAME in the FRAME KB cytotoxicity assay (Clothier et al., 1988). 
As with the straight-chain alcohols, sealing the plates with oil altered the 
toxicity of some of the unrelated liquids (Table 7.9). The change in toxicity 
does not appear to be related to the actual IDso concentration on US plates. 
Acetone and glycerol have the same toxicities in US plates (approximately 
725mM), yet oil sealing has no effect on the toxicity of glycerol, but enhances 
the toxicity of acetone. 
More liquids had their toxicity increased in the presence of the oil sealant 
(nine to a statistically significant degree) than had their toxicity significantly 
decreased (three) (Table 7.10). Liquids generally regarded as volatile (such 
as acetaldehyde and acetone) have their toxicities increased in the presence 
of the oil sealant, while those regarded as having low volatility (such as Table 
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7.9. In vitro toxicities of nineteen liquid chemicals on unsealed and oil-
sealed culture plates 
ID20 1Dso 1Dso 
mM + s.e.m. mM + s.e.m. mM + s.e.m. 
Tri-n-butyltin US 0.0006( n = 1 ) 0.0007 + 0.0001 0.009+0.000 
chloride OS 0.001 + 0.001 0.002+0.000 0.003 (n=2) 
Tween 20 US 0.10 + 0.04 0.20 + 0.04 0.29 + 0.04 
OS 0.13 (n=2) 0.15 + 0.04 0.27 + 0.04 
1,2,4-Trichloro- US 0.62 + 0.05 0.72 + 0.08 0.82 + 0.08 
benzene OS 0.63 + 0.06 0.74 + 0.10 0.88 + 0.09 
1,2-Dibromo- US 1.8 + 0.7 3.7 + 0.4 4.0 (n=l) 
methane OS 1.8 + 0.6 4.1 (n=2) >5.3 
Acetaldehyde US 2.9 + 0.7 6.0 + 0.6 13 + 1 
OS 0.72 (n=2) 0.81 + 0.15 1.3 + 0.2 
Allyl alcohol US 5.7 + 1.2 9.4 + 2.4 11 (n=2) 
OS 3.2 + 0.6 4.7 + 0.4 6.9 + 0.4 
Aniline US 5.9 + 1.8 10 + 1 14 +2 
OS 7.0 + 0.5 11 + 1 15 + 1 
Sulphuric acid US 8.7 + 1.9 13 +0 15 (n=l) 
OS 9.3 + 1.6 13 ±O >15 
Trifluoroacetic US 10 +2 18 + 1 29 (n=2) 
acid OS 13 +2 23 + 1 >26 
Acetic acid US 14 (n=2) 20 + 1 25 + 3 
OS 15 (n= 1) 18 +2 24 + 3 
Pyrrole US 37 + 4 56 +3 71 (n= 1) 
OS 18 (n= 1) 26 +3 40 + 1 
Dimethylformamide US 50 +6 108 +9 164 + 12 
OS 69 ±2 120 +9 180 + 13 
Hydrochloric acid US 86 + 10 126 +2 147 + 3 
OS 83 + 13 128 +0 142 (n= 1) 
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Table 7.9. (contd) 
ID20 
mM + s.e.m. 
2-Methoxyethanol US 62 (n=2) 
OS 66 + 17 
Dimethyl- US 148 (n=2) 
sulphoxide OS 186 + 16 
Ethyl acetate US 187 + 61 
OS 107 + 21 
Glycerol US 479 + 183 
OS 438 + 178 
Acetonitrile US 177 (n=l) 
OS 57 (n=2) 
Acetone US 550 + 11 
OS 134 (n=2) 
US = Unsealed culture plates 
OS = Oil-sealed culture plates 
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1Dso IDgO 
mM + s.e.m. mM + s.e.m. 
153 +7 223 + 7 
150 + 5 216 + 8 
229 ± 17 329 + 16 
287 + 14 483 + 11 
323 + 13 359 + 14 
228 + 38 304 (n=2) 
708 + 127 940 + 137 
706 + 126 967 + 138 
739 ± 174 842 (n=2) 
137 + 31 381 + 54 
774 ± 26 934 + 26 
249 + 31 346 + 19 
Table 7.10. 1Dso values of twenty seven liquids on oil-sealed culture plates, 
expressed as percentages of 1Dso values on unsealed culture 
plates 
Acetaldehyde 
Acetonitrile 
Acetone 
Pyrrole 
Allyl alcohol 
Methanol 
Ethanol 
Propan-I-ol 
Ethyl acetate 
Tween 20 
Acetic acid 
Butan-I-ol 
Pentanol 
Methoxyethanol 
Glycerol 
Sulphuric acid 
Hydrochloric acid 
1,2,4-Trichlorobenzene 
Aniline 
1,2-Dibromomethane 
Dimethylformamide 
Octanol 
Dimethyl sulphoxide 
Trifluoroacetic acid 
Hexanol 
Heptanol 
Tri-n-butyltin chloride 
1Dso (oil-sealed) x 100% 
ID so (unsealed) 
14* 
19* 
32* 
46* 
50* 
52* 
54* 
69* 
71* 
75 
90 
93 
97 
98 
100 
100 
102 
103 
110 
111 
111 
124 
125 
128 
192* 
274* 
286* 
increasingly 
toxic on 
oil-sealed 
plates 
as toxic on 
unsealed as 
on oil sealed 
decreasingly 
toxic on 
oil-sealed 
plates 
* - 1Dso of chemical on oil-sealed plates was significantly different from the 
1Dso on unsealed plates 
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glycerol and dimethyl sulphoxide) did not have their toxicities altered 
significantly. 
Some of the liquids tested showed evidence of cross-contamination i.e., 
redissolving in surrounding, untreated culture wells and affecting their growth. 
This occurred most noticeably with acetaldehyde and pyrrole on unsealed 
plates, but was not apparent on oil-sealed plates. This lends support to the 
effectiveness of the use of oil as a sealant. Pyrrole and acetaldehyde are 
among the most volatile liquids tested, as judged by the increase in toxicity on 
OS plates (Table 7.10). 
7.2.4.2 Comparison of in vivo and in vitro toxicity of volatile liquids 
Rat oral and mouse i.p. LDso data were available for 10 of the 27 liquids 
tested on US and OS plates (Table 7.11). When linear regression analysis was 
performed on logged data, the correlation coefficients for the KB IDsoirat oral 
LDso comparisons were 0.91 for the US 1Dso values and 0.95 for the OS 1Dso 
values. For the KB 1Dsolmouse i.p. LDso comparisons were 0.74 and 0.85 for 
the US and OS 1Dso values, respectively. 
7.2.4.3 Comparison of new cytotoxicity data with published data 
Table 7.12 compares 1Dso the results for 22 of the liquids, as published by 
FRAME (Clothier et ai., 1988) and those obtained at Northumbria Biologicals 
Ltd. The 1Dso values are very similar in both laboratories, except for hexanol 
and heptanol, which were rather more toxic at Northumbria Biologicals Ltd. 
7.2.4.4 Conclusions 
As was found with the more volatile alcohols, the oil sealing increased the 
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Table 7.11 Comparison of in vivo and in vitro toxicity data for 10 liquids 
1Dso (mM) 1Dso (mM) Rat oral Mouse i.p. 
US plate OS plate LDso LDso 
(mmol/kg) (mmol/kg) 
1,2-Dibromomethane 3.7 4.1 0.57 1.2 
Allyl alcohol 9.4 4.7 1.1 0.7 
Aniline 10 11 5.2 5.3 
Propan-I-ol 114 79 323 52 
Dimethyl sulphoxide 229 287 217 168 
Ethyl acetate 323 228 125 8 
Ethanol 418 224 289 130 
Acetonitrile 739 137 91 8 
Acetone 774 249 165 22 
Methanol 1099 571 313 263 
Table 7.12. Comparison of FRAME published 1D5o values with those 
obtained at Northumbria Biologicals Ltd. (NBL) for twenty two 
liquid chemicals 
FRAME 1D5o NBL 1D5o 
(mM) (mM) 
Tri-n-butyltin chloride 0.001 0.0007 
Tween 20 0.21 0.20 
1,2,4-Trichlorobenzene 0.67 0.72 
Octanol 2.3 1.7 
1,2-Dibromomethane 3.4 3.7 
Allyl alcohol 6.1 9.4 
Heptanol 8.7 2.3 
Acetaldehyde 11 6.0 
Aniline 16 10 
Acetic acid 21 20 
Hexanol 35 7.3 
Pentanol 40 37 
Butan-I-ol 64 45 
Pyrrole 98 56 
Propan-I-ol 186 114 
Dimethyl sulphoxide 287 229 
Ethyl acetate 491 323 
Acetonitrile 562 739 
Ethanol 783 418 
Glycerol 713 708 
Acetone 617 774 
Methanol 1441 1099 
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cytotoxicities of the most volatile liquids, presumably by reducing their 
evaporation and thus keeping higher concentrations in contact with the cells 
for longer than would have occurred in an unsealed plate. The most volatile 
liquid tested, acetaldehyde, had its IDso decreased under oil by a factor of 
about seven. This will alter its toxicity rank position (in terms of 1Dso (mM) 
value), and hence its relative toxicity compared to other chemicals. Therefore, 
acetaldehyde would change from being regarded as of low toxicity (result in 
US wells), to being of moderate toxicity in vitro (result in as wells). However, 
other liquids did not have their toxicity altered to the same extent by the oil 
sealing, and therefore their rank position would not change as much. 
Criteria need to be set, to allow a distinction to be made between chemicals 
whose toxicity was unchanged by a sealant, and those whose toxicity would be 
regarded as having been altered. Statistical tests can be employed, but may 
be misleading (for example, with sodium dodecyl sulphate). A reduction or 
increase of more than 25% in the mean IDso is a strong indication that the 
toxicity has been altered by the sealing. In addition, if the ranges of individual 
IDso values from the sets of experiments of unsealed and sealed plates do not 
overlap, then the toxicity may be considered altered. If the ranges do overlap 
then the toxicity may be regarded as unchanged. 
Oil sealing, by virtue of slowing down evaporation, appears to be able to 
reduce or even prevent the phenomenon of cross-contamination of untreated 
or low-dose treated wells. 
The in vitro toxicity results correlated well with rat oral and mouse i.p. values 
for the 10 liquids. There was no difference between correlation coefficients for 
comparisons using US and as in vitro data and rat oral LDso values. The 
mouse i.p. LDsofKB 1Dso correlation was slightly closer with as in vitro data 
than with the US. 
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7.3 DISCUSSION 
Sealing of culture plates was suggested by Knox et al. (1986) as a possible 
means of reducing intralaboratory and interlaboratory variations in FRAME 
KB cytotoxicity assay results for volatile liquids, such as acrylonitrile. Less 
variability would then permit greater confidence to be placed in assay results. 
The introduction of 96-well plates, to replace 24-well plates in the assay 
probably helped to reduce intralaboratory variation, and possibly also 
interlaboratory variation. A new problem was introduced, however - that of 
well-to-well cross-contamination by volatile chemicals, as noted by Stark et al. 
(1986) and Clothier et al. (1988). 
The two sealant procedures assessed for their ability to reduce variation in 
results, paraffin oil and adhesive film, were both easily adapted to the 
FRAME KB cytotoxicity assay protocol. They were found to be effective at 
reducing the evaporation of (and thereby increasing the toxicity of) the more 
volatile straight chain alcohols. However, the adhesive film was less suitable 
for general use than the oil, because it caused a slight inhibition of normal cell 
growth and also increased the toxicities of some solid (i.e. non-volatile) 
chemicals. The adhesive film appears to contain some kind of diffusible toxic 
substances, which were able to leach from the film during its incubation 
immersed in the medium at 37°C, and hence cause cell death. However, the 
film in use as a plate sealant does not come into direct contact with the 
culture medium (Figure 7.1). It is possible, therefore, that the humidified 
atmosphere between the culture medium and the film permitted the transfer 
of the leached toxic substances from the film into the medium. The slow-down 
of the cell growth rate in FS wells at 48 hours after sealing may have been due 
to a gradual build up of these toxins after the film was applied, until a 
threshold limit was reached between 24 and 48 hours, as this was where cell 
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division was first affected. It should be possible to develop a non-toxic 
adhesive film, if this was felt desirable (Srivastava et ai., 1990). 
The adhesive film, by slowing the cell growth rate, may be placing the cells 
under stress, thus causing them to be more susceptible than normal to toxic 
insult from a test chemical. Alternatively, diffusible toxic substance( s) in the 
film may somehow potentiate the cytotoxicity of certain chemicals. It is not 
clear why only some of the solid chemicals tested were affected by the film. 
The increased toxicity of sodium hydroxide under both film and oil may be 
connected with the ability of the medium to buffer from alkaline pH back to 
normal pH on sealed plates. This could be examined by testing other alkaline 
chemicals which are likely to be toxic by altering the pH of the medium. 
Neither sealant appeared able to improve experiment to experiment variation 
in ID2o, IDso and IDso results. The paraffin oil was effective in preventing 
cross-contamination of volatile chemicals into control wells, which occurred 
with some of the most volatile chemicals in unsealed plates. The oil also 
increased the toxicities of chemically-unrelated volatile liquids, while not 
altering the IDso values of non-volatiles (such as DMSO). 
The paraffin oil may have reduced the toxicities of hexanol and heptanol by 
adsorbing a proportion of these hydrophobic alcohols, thus reducing the 
concentration of alcohol in the medium. This also may have occurred with 
butan-I-ol and pentanol, but, by a combination of reducing their evaporation 
and partitioning into the oil, the overall toxicities were not affected. Several 
of the unrelated chemicals, whose IDso values were unaltered on OS plates, 
may have undergone the same effect as was postulated for hexanol and 
heptanol, i.e. the oil was responsible for both keeping chemical in the culture 
well (by preventing its evaporation), and removing it (by partitioning). This 
may be more prevalent with hydrophobic liquids such as 1,2,4-
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trichlorobenzene. Overall, the paraffin oil was the better of the two sealants 
for incorporation into a modified FRAME KB cytotoxicity assay. 
The type of liquids whose toxicities would be significantly increased by the oil 
sealant constitutes a small proportion of the general population of test 
chemicals. However, liquid chemicals predominate in the group which are 
tested for irritancy. Some liquids will have their cytotoxicity altered to a 
greater degree than the others. It is important that this group can now be 
handled in the FRAME KB cytotoxicity assay, with greater confidence that 
their toxicities will not be underestimated. 
In terms of the variation of results between laboratories, evaporation may still 
be of importance. Evaporation could occur after culture plate treatment, or 
as a result of methods of dose-range preparation (Table 7.1). This could only 
be resolved by further experiments in a number of laboratories and by the use 
of very specific protocols. It is possible that the use of 96-well plates alone 
could reduce both intralaboratory variation and lack of confidence in results 
obtained with 24-well plates (Knox et al., 1986). 
The sealing of 96-well plates with paraffin oil sealing may not therefore be 
useful in the context of reducing experiment to experiment variation with 
volatile chemicals, because this variation does not appear to be as great a 
problem with 96-well plates than was seen with 24-well plates. The oil may be 
effective in preventing well-to-well cross-contamination by volatiles, but it is 
also possible to achieve this by arranging treated wells to be surrounded by 
untreated wells. 
The small number of liquids in the in vivo/in vitro comparison does not permit 
firm conclusions to be drawn. There was an uneven spread of toxic potency 
amongst the 10 liquids in the comparison (most were of low toxicity), thus 
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decreasing the validity of the comparison. It is therefore not possible to deduce 
whether the enhanced in vitro toxicity of some liquids on OS plates would give 
a more accurate prediction of in vivo lethal potency. A larger number of 
liquids, with a greater range of potencies and with available in vivo data, need 
to be examined in order to answer this question. 
The similarity of results between FRAME and Northumbria Biologicals Ltd. 
is surprising because of several differences in the way the assays were 
performed at the two locations. For example, cell seeding density, medium 
manufacturer, incubator type and assay operator were different. It is therefore 
likely that the one important common factor, namely, the manufacturer and 
size (96-well) of the culture plates, was significant in keeping the 
interlaboratory variation low, particularly with the liquids (Table 7.11). The 
robustness and reproducibility of the FRAME KB cytotoxicity assay is also 
confirmed. 
Finally, it can be concluded that paraffin oil sealing can be effective in 
reducing the evaporation of very volatile liquids from 96-well culture plates, 
so that there is less likelihood that the cytotoxicities of these liquids will be 
underestimated. It would be useful to include the use of the oil sealant in the 
FRAME KB cytotoxicity assay protocol whenever suspected volatile liquids 
require testing. The paraffin oil method could also be readily adapted to 
other cytotoxicity assays which use 96-well plates. 
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8.1 INTRODUCTION 
8.1.1 Current status of teratogenicity testing 
Many in vitro cytotoxicity tests have been developed during the past 15 years. 
A number employ measurement of cell death or inhibition of cell growth as 
their endpoint and have been proposed as alternatives to various in vivo 
toxicity tests, e.g. the Draize rabbit eye irritancy test (Borenfreund and 
Borrero, 1984; Reinhardt, 1990), rodent oral LDso tests (Ekwall, 1983b) and 
in vivo tests for teratogenicity (Pratt and Willis, 1985). The potential uses of 
one such in vitro test, the FRAME KB cytotoxicity assay, have already been 
discussed in chapters 3 to 7. 
Toxicology, however, is not only concerned with extreme, acute effects leading 
to cell or organism death. Many subtle, sublethal effects can be exerted by 
chemicals, causing dysfunction of one or more processes. Two examples of 
such effects are mutagenesis and teratogenesis. Several in vivo and in vitro 
methods exist for the detection of mutagenic changes induced by chemical (or 
other) agents. Regulatory bodies have accepted the validity of some of the in 
vitro mutagenicity tests, such as the Ames test (Ames et ai., 1975). The use of 
such tests has contributed to a reduction in the use of animals in this area of 
toxicology (van den Heuvel and Fielder, 1990). The search for acceptable in 
vitro alternative tests for potential teratogens, however, continues, but progress 
has been hampered for a number of reasons, related both to scientific opinion 
and the interactive nature of teratogenicity. 
Scientific and regulatory opinion has been very slow to accept that in vitro 
techniques have a place in toxicology, least of all in teratology. In addition, it 
seems that in vitro teratologists have been reluctant to tackle the "real" 
problems in human reproductive and developmental failure, and little visible 
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progress has been made by utilising in vitro studies (Brown, 1991). 
Teratogenesis itself is a highly complex phenomenon and is difficult to define 
precisely. Once considered as the induction of gross morphological 
abnormalities in a fetus during pregnancy (Lansdown, 1988), it is now regarded 
as encompassing a wider range of effects (Table 8.1; Timbrell 1982) and has 
been placed under the umbrella term of developmental toxicity. Several 
mechanisms of teratogenesis have been elucidated (Table 8.2), but their causes 
are not necessarily due to the presence of an exogenous agent (chemical, virus, 
physical phenomenon). The lack of certain nutritional substances, such as 
glucose in diabetic mothers, is also known to cause birth defects (Lansdown, 
1988). This diversity of mechanisms is itself a stumbling block toward the 
development of successful in vitro teratogenicity tests, because the test (or 
battery of tests) should be able to detect effects based on all these mechanisms 
(Daston and D'Amato, 1989). 
Current in vivo reproductive and developmental toxicity studies are based on 
tests recommended by the USA Food and Drug Administration 25 years ago 
(FDA, 1966). Few modifications to this system have occurred since then. The 
Segment II phase remains the standard teratogenicity protocol (Schmid, 1987). 
This requires the sacrifice of over 100 pregnant laboratory animals per test 
chemical, the fetuses of which are examined for embryotoxicity and gross 
abnormalities. This system has a number of drawbacks. It is lengthy, labour 
intensive, expensive, and could not realistically be used to test the thousands 
of chemicals in use today, for which no developmental toxicity data are 
available (Daston and D'Amato, 1989). 
In circumstances where teratologists cannot even agree on terminology 
(Neubert et al., 1985; Broecker and Sowinski, 1987), it is not easy to engender 
serious consideration for alternative tests. But the climate of uncertainty, 
coupled with the urgent need to provide data on previously untested 
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Table 8.1 Examples of adverse developmental events in humans 
Intrauterine growth retardation 
Death: 
of embryo (miscarriage) 
stillbirth 
neonatal 
Morphological malformation, e.g.: 
palate anomalies 
skeletal abnormalities 
cardiac defects 
facial dysmorphia 
urogenital defects 
Functional disorder, e.g.: 
mental retardation 
cerebral palsy 
psychoses 
epilepsy 
neurological abnormalities 
immunological dysfunction 
hormonal dysfunction 
metabolic dysfunction 
Adapted from Schardein and Keller (1989) 
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Table 8.2 Mechanisms of teratogenesis 
Mutation 
Chromosomal aberrations 
Mitotic interference 
Alterations of nuclei acid synthesis and function 
Lack of precursors, substrates and coenzymes for biosynthesis 
Alteration of energy sources 
Enzyme inhibition 
Osmolar imbalance 
Alteration of membrane characteristics 
Other 
From Beckman and Brent (1984) 
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chemicals, makes the investigation and validation of more-rapid alternative 
tests all the more important. No in vitro teratogenicity test has been 
adequately validated for regulatory purposes (Fielder, 1991) but a small 
number are used by pharmaceutical companies in-house, to select drugs for 
further development (Duffy et ai., 1991; Zijlstra, 1991), and some in vitro 
techniques are important in mechanistic studies (Peters and Piersma, 1990). 
Recently, progress has been made toward harmonising regulatory requirements 
for in vivo teratogenicity tests, and this will hopefully lead to a reduction in the 
wasteful practice of duplicating experiments for legal purposes (Duffy et ai., 
1991). 
8.1.2 In vitro approaches in teratology 
Our incomplete understanding of the biochemical regulation of normal 
embryonic and fetal development has hampered research into the mechanisms 
of teratogenesis. Hence, the investigation of teratogenicity in vitro is hindered 
by a lack of basic knowledge of how well the in vitro models of development 
mimic the equivalent processes in vivo. Many such models exist, but only 
some of them are suitable for use in toxicological studies. Some consider that 
it is desirable, but not essential, for an in vitro teratogenicity test system to 
model one or more of the processes of embryonic development (Kimmel et ai., 
1982). However, others (e.g. Flint, 1991) argue that mechanistic relevance to 
the in vivo situation is a pre-requisite for all in vitro toxicity tests. 
Many ill vitro teratogenicity tests have been proposed (Table 8.3), based on 
developmental models utilising dissociated cells through to complete embryos. 
Only those with close mechanistic similarities to mammalian embryogenic 
processes have generated serious interest (Brown, 1987; Neubert, 1989; Duffy 
et ai., 1991). These are the rat whole embryo culture technique (Sadler and 
Warner, 1984) and the rat embryo mid-brain and limb-bud cell micro mass 
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Table 8.3 Alternative tests for teratogenicity 
A. Established cell lines 
Mouse ovarian tumour (MOT) cell attachment 
Human embryonic palatal mesenchyme (HEPM) 
Neuroblastoma differentiation 
V79/HEPM intercellular communication 
Pox-virus morphogenesis 
B. Primary embryonic cell cultures 
Drosophila neuroblasts and myoblasts 
Rat embryo micromass - limb bud 
Rat embryo micromass - neural crest 
Chick embryo neural retina 
C. Embryonic organ culture 
Limb bud (mouse or chick) 
Neural tube (chick) 
D. Whole embryo culture 
Mammalian whole embryo culture 
Chick embryo culture (CHEST) 
Frog embryo culture (FET AX) 
Fish embryo culture 
Hydra lembryo' culture 
Drosophila larvae culture 
Plallaria regeneration 
Sea urchin embryo culture 
Shrimp larvae culture 
Adapted from Faustman (1988) and Daston and D'Amato (1989) 
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method (Flint, 1987). These techniques are undergoing interlaboratory 
validation (Parsons et al., 1990; Piersma et al., 1990; Uphill et al., 1990) and 
may gain wider acceptance for use as pre-screens, as well as in studies of 
mechanisms of action of teratogens (Neubert, 1989). 
The rat whole embryo method has an advantage, in that, although the culture 
period is limited, all the basic processes of development are represented 
(Daston and D'Amato, 1989). The embryos in culture develop in a way 
comparable to those in utero, although growth is retarded. However, this is 
a highly specialised technique, still requires the use of many pregnant rats to 
study one compound, and is classed as an animal experiment in Britain. 
The micromass method uses primary cultures of rat embryo mid-brain and 
limb-bud cells as models of embryonic cell growth and differentiation. The 
cells multiply and differentiate into neurons and chrondocytes, respectively. 
The effects of a test chemical on inhibiting these processes are measured, and 
the relationship between the dose affecting growth on the one hand, and 
differentiation on the other, indicates the potential teratogenicity of the 
chemical. This method, also, requires a high degree of technical skill and uses 
pregnant rats. It would therefore be advantageous if a model of cell growth 
and differentiation which used a permanent cell line could be employed. 
Mummery et al. (1984) proposed the use of a neuroblastoma cell line, which 
could be induced to differentiate morphologically by removing bovine serum 
from the culture medium. Both induction and inhibition of differentiation 
were measured, and the assay was moderately successful at distinguishing 
teratogens from non-teratogens. However, a drawback of the method is the 
single, morphological endpoint, which is scored subjectively. This would put 
the test at risk of poor interlaboratory reproducibility. 
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8.1.3 Embryonal carcinoma cells 
Teratocarcinoma, or embryonal carcinoma (EC), cells have been widely used 
as in vitro models of embryogenesis (Martin, 1975; Martin, 1980; Strickland, 
1981). The use of EC cells in in vitro models of differentiation for 
teratogenicity studies has been proposed recently (Piersma et al., 1988). 
Mouse embryo-derived EC cells can be induced to demonstrate certain 
characteristics also found in the early mouse embryo (Sherman, 1986). Hence, 
the effect of test chemicals on the appearance or degree of expression of these 
characteristics can be investigated. EC cells have the advantage of being 
permanent cell lines, removing the need for animal sacrifice. Their method 
of culture is fully defined, cellular characteristics are well documented, and the 
costs are lower than for primary cultures. Disadvantages include: their 
transformed nature; their lack of ability to metabolically activate chemicals 
(such as cyclophosphamide) whose metabolites exert the toxic effects in vivo; 
their murine, rather than human, origin; and the fact that certain EC lines 
need an added chemical if they are to be induced to differentiate. 
One EC line which has been studied in detail as a model of mouse 
embryogenesis, is the F9 mouse testicular teratocarcinoma (Berns tine et al., 
1973; Hogan et al., 1983). F9 cells were considered nullipotent (i.e. unable to 
differentiate) until it was discovered that retinoic acid (RA) induced them to 
differentiate into endoderm-like cells (Sherman and Miller, 1978; Strickland 
and Mahdavi, 1978). There is an extensive literature on F9 cells, and the cell 
line is available through the European Collection of Animal Cell Cultures 
(Porton Down, Wiltshire, UK). Several marked biochemical, as well as 
morphological, changes occur during F9 cell differentiation (Strickland et al., 
1980). As well as parietal and visceral endoderm-like cells, it has also been 
suggested that neuron-like cells may be formed (Kuff and Fewell, 1980; 
Wartiovaara et aI., 1984), although this is less well documented. Recent 
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studies using F9 cells have included an evaluation of gene transcription during 
RA-induced differentiation (Rickles et al., 1989). 
The F9 cell line was therefore evaluated for potential use in in vitro 
teratogenicity or developmental toxicity studies, as part of the work for this 
thesis. The initial phase of the evaluation consisted of determining F9 cell 
growth characteristics, the establishment of a method for reproducible 
differentiation of a high proportion of the cellular population, and the 
establishment of reliable assay methods for measuring cell growth and the 
chosen biochemical marker of the degree of differentiation (production of 
laminin). A small number of chemicals (some with well-known teratogenic 
properties) were then tested for their cytotoxic effects on undifferentiated 
cells. The differential effects of selected chemicals on cell growth and the 
production of laminin by differentiating and differentiated cells were also 
examined. 
8.2 RESULTS 
8.2.1 Initial Experiments 
8.2.1.1 Establishment of the growth characteristics of F9 cells 
In general, the F9 EC cell line does not require any exceptionally specialised 
culture techniques. However, they do require more frequent attention than 
the 3T3-Ll mouse embryo fibroblast line used in the FRAME KB cytotoxicity 
assay (Clothier et al., 1988). For the F9 cells to grow in monolayers, culture 
surfaces had to be pre-coated with 0.1 % (w/v) gelatin solution (Rudnicki and 
McBurney, 1987). The culture medium contains 10% (v/v) fetal calf serum 
(Daly and Redfern, 1987) rather than the 10% (v/v) new-born calf serum 
which is sufficient for 3T3-L1 cells. Anti-fungal chemicals, such as Fungizone, 
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must not be added to the F9 culture medium! as they can retard growth at 
their effective concentrations (Rudnicki and McBurney, 1987). This resulted 
initially in frequent fungal contamination of cultures. The problem was 
overcome by improving basic laboratory management, such as increasing the 
regularity and extent of cleaning of incubators and work-surfaces with 
methanol, and by instigating more-rigorous standards of sterile technique when 
handling the cells. 
F9 cells grew un reliably from seeding densities of less than 1 x 104/cm2, and, 
when seeded at lower densities, required a large surface area (greater than 
10cm2) to provide a growing culture. Once a culture was established, however, 
the cells had a rapid growth rate, with a cell cycle time of approximately 14 
hours, and hence were subcultured more frequently than 3T3-L1 cells, which 
have a cell cycle time of approximately 22 hours. Stock flasks were 
subcultured three times a week, as it was found that cultures were difficult to 
initiate from flasks that had been left confluent for more than one to two days. 
8.2.1.2 Establishment of a protocol for the differentiation of F9 cells 
For an F9 cell assay to be useful as a model of cell differentiation in in vitro 
toxicology testing, a reliable and reproducible protocol for inducing a high 
proportion of the cells to differentiate was required. The proportion should 
ideally be at least 70%, to allow for the detection of variations in the level of 
differentiation. A number of protocols for inducing morphological and 
biochemical differentiation of F9 cells have been published (see Strickland and 
Mahdavi, 1978; Moore et al., 1986; Rudnicki and McBurney, 1987; Williams 
et aI., 1987). All the protocols require RA and some also use dibutyryl cyclic 
adenosine monophosphate (dbcAMP). 
In early experiments, F9 cells were seeded at 1 x 104/cm2 in 24-well plates, in 
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order that growth could be followed for more than three days. The cells were 
treated 24 hours after plating with culture medium containing RA at 0.001, 
0.01, 0.1 or 1J.LM, with or without 1mM dbcAMP. After 5 days of growth, 
during which time the medium was changed with fresh medium plus RA, and 
with added db cAMP as appropriate, O.OOlJ.LM and O.OlJ.LM RA alone were 
found to be ineffective in inducing significant morphological changes in the F9 
cells. However, both O.lJ.LM and 1J.LM RA were equally effective, and caused 
noticeable morphological changes after 48 hours of treatment. The cells 
altered from the normal phenotype of small and round cells (tightly packed at 
confluency) (Figure 8.1) to a spindle shape, some with long processes (Figure 
8.2). Neighbouring cells did not adhere closely, and the long processes 
sometimes overlapped, as previously described (Strickland and Mahdavi, 1978; 
Kuff and Fewell, 1980; Linder et al., 1981; Moore et al., 1986). The 
proportion of cells undergoing these changes was over 50%, but was difficult 
to assess accurately by phase-contrast microscopy. Treatment of cells with 
O.lJ.1.M or 1J.LM RA plus 1mM dbcAMP induced the same type of 
morphological changes as had been induced by O.lJ.LM or 1J.LM RA alone, i.e. 
there was no synergistic effect and no increase in the proportion of cells 
induced to differentiate. 1mM dbcAMP alone caused no alterations in F9 cell 
morphology, but inhibited growth over 6 days, by up to 20% compared to 
untreated cultures. In addition, exposure of cells to O.lJ.LM or 1J.LM RA plus 
1mM dbcAMP for 6 days caused growth inhibition by over 50%. In 
comparison, O.lJ.1.M or 1J.LM RA caused no growth inhibition after 6 days. As 
it did not appear to offer any advantages, and in view of its toxic effect and 
high cost, dbcAMP was not included in the subsequent protocols for F9 cell 
differentiation. 
The minimum concentration of RA required to induce satisfactory 
morphological changes was therefore O.lJ.LM. The lowest possible 
concentration was desirable, to minimise unwanted toxic effects which resulted 
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Figure 8.1 Undifferentiated F9 cells stained with Kenacid Blue R. 
Magnification x27 
Figure 8.2 F9 cells undergoing differentiation in the presence of O.l/-L M 
RA, stained with Kenacid Blue R. Magnification x27 
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in, for example, reduced growth rate (possibly causing differentiation in itself), 
morphological changes not associated with differentiation, or biochemical 
changes due to toxic perturbations. The concentration of RA which caused 
20% inhibition of growth in the cytotoxicity assay was approximately 10J.LM. 
Phenotypic changes were visible after treatment of growing cultures with 
0.1J.LM RA for 48 hours. During this first 48 hours, the F9 cells were 
undergoing the initial steps in the differentiation pathway (Williams et al., 
1987). The time period for the cytotoxicity assays was also 48 hours, due to 
the cell cycle time. Although no detectable laminin was produced by the cells 
during this time, important subcellular events were almost certainly occurring; 
for example, induction of mRNA for laminin subunits (Durkin et al., 1986). 
F9 cells which had been seeded at 2.5 x 104/cm2 in 24-well plates, allowed to 
adhere overnight and then treated with fresh medium containing 0.1J.LM RA, 
were termed differentiating (DG) cultures. 
It was found that by seeding cells in 75cm2 flasks in medium containing 0.1J.LM 
RA, and then subculturing into fresh 0.1J.LM RA-containing medium at day 3, 
almost 100% morphological differentiation of cells could be reproducibly 
achieved by day 6. This method is very similar to the protocol described by 
Rudnicki and McBurney (1987). The treated cells could then be trypsinised 
on day 6 or 7 and seeded at 5 x 104/cm2 in 0.1J.LM RA-containing medium in 
24-well plates. Morphological changes were not lost, and the cells continued 
to multiply over the following 72 hours (Figure 8.3). Cultures set up in this 
way were termed differentiated (DD). 
8.2.1.3 Establishment of cytotoxicity assay protocol 
Having determined the culture conditions required to obtain reproducible, 
growing cultures of undifferentiated (UD), differentiating (DG), and 
differentiated (DD) F9 cells, cytotoxicity assay protocols were developed. 
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These were based on the FRAME KB cytotoxicity assay, which measures 
inhibition of cell growth as the end point. The F9 cells could not be fixed 
consistently in situ on 96-well plates with standard KB assay fixative and, as a 
result, the cytotoxicity assay could not be miniaturised as has been achieved 
in the FRAME KB cytotoxicity assay using 3T3-L1 cells (Clothier et al., 1988). 
Hence, gelatin-coated 24-well plates were used. 24-well plates were 
advantageous when DG and DD cells were tested. They facilitated culture 
inspection by phase-contrast microscopy, and provided a suitable volume of 
culture medium for the subsequent assay of laminin production. 
Both neutral red uptake (Borenfreund and Puerner, 1985) and KB staining 
(Knox et al., 1986) were evaluated for the measurement of final cell number, 
this being the endpoint parameter of the cytotoxicity test. F9 cells took up 
little neutral red stain, possibly due to a low lysosome number. The KB stain 
binds to protein, and therefore measures relative total cellular protein. The 
intensity of KB staining of protein shows a linear relationship with BCL-D1 
cell number and is known to be reproducible (Knox et al., 1986). 
F9 cells were stained efficiently with KB, and there was a constant relationship 
with cell number and with total protein until the cultures were just sub-
confluent (Figure 8.3). Hence KB staining was chosen for the assay of relative 
total cellular protein in UD cultures. 
In DD cell cultures stained with KB, the cells exhibiting altered morphology 
were often a much paler blue than UD cells, as observed by inverted 
microscopy. The KB stain estimates relative total cell number by assuming 
that each cell takes up an equal amount of stain. In homogeneous cultures, 
this holds true (for example, with UD F9 cells, Figure 8.1). However, the F9 
cell cultures undergoing differentiation were often a heterogeneous mixture of 
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UD, DG and DD cells, which showed different morphologies and intensities 
of KB staining (Figure 8.2). Although the paler staining in DD cells may have 
been due to the cells being flatter and thinner than UD cells, there was also 
the possibility that DD cells took up less stain per cell than UD cells. In order 
to eliminate any potential inaccuracies caused by unequal staining, an 
alternative total protein assay was sought. 
The Bradford protein assay method (Bradford, 1976) has been used reliably 
and successfully in cytotoxicity assays; for example, with V79 cells (Garle et al., 
1987) and Balb/c 3T3 cells (Shopsis and Eng, 1985). It was therefore 
evaluated with growing UD, DG and DD F9 cultures. UD F9 cells were 
seeded at low density (0.4 x 104/cm2) intt1 24-well plates, and quadruplicate 
wells were counted for cell number, and assayed for protein by the KB and the 
Bradford methods, daily for 7 days. The cultures were confluent at day 5, but 
continued to divide and pile up after this time. Over the exponential growth 
phase (prior to confluency), the Bradford assay was shown to be equivalent to 
the KB assay (Fig 8.3) and both provided a good estimation of relative cell 
number. At the later time points, the Bradford assay was found to provide a 
more accurate assessment of total cell number than the KB assay, possibly due 
to the inability of the KB dye to penetrate confluent, piled up cells. 
DG and DD cultures were prepared as described in section 8.2.1.2, and 
triplicate wells were counted for cell number and assayed for protein by the 
Bradford method at 24, 48 and 72 hours after plating. The Bradford protein 
assay was a good estimator of relative cell number (Fig 8.4). 
In summary, for cytotoxicity tests with all three cell types, cells were seeded, 
given 24 hours to attach and then treated with test chemicals for 48 hours. 
DG and DD cells were treated with test chemicals dissolved in medium 
containing O.lJ1.M RA. The RA was used to induce differentiation for DG 
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cultures, and to maintain and continue the process of differentiation in DD 
cultures. DD cells were seeded at a higher density than those for UD and DG 
cultures because of their initial slower initial division rate (Figure 8.4). UD 
cultures were assayed for protein by KB staining, while DG and DD cultures 
were assayed using the Bradford protein method (see section 2.1.3.2). 
8.2.1.4 Establishment of protocol for measuring laminin production by F9 
cells 
It was very difficult to judge accurately the proportion of non-differentiated to 
differentiated cells in a culture well, and hence it was important to find a non-
subjective (i.e. quantitative) method of assessing the extent of differentiation 
in a culture. 
At the same time as differentiating morphologically, the F9 cells also alter 
biochemically in several ways (Moore et al., 1986). One of the alterations 
which is relatively simple to assay is the production of laminin. Laminin is 
produced de novo during differentiation (Moore et al., 1986) and is released 
into the culture medium. Using this biochemical indicator has the advantage 
that cells need not be disrupted in order to monitor the quantity produced. 
An enzyme-linked immunosorbent assay (ELISA) protocol was developed to 
measure laminin production by UD, DG and DD cell cultures. The protocol 
for the ELISA was based on that of Williams et al. (1987); see section 2.1.3.4. 
8.2.1.5 Conclusions 
F9 cells can, with attention to certain culture requirements, be grown in a 
reliable way from a constant seeding density. The addition of O.lJ..£M RA to 
the culture medium could be used to reproducibly induce the cells to alter 
morphologically. A high proportion of the cells were seen to change their 
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phenotype when they were seeded and then subcultured in O.lJ.LM RA-
containing medium (as in DD cultures). As these methods closely matched 
published protocols, and as the morphology of altered cells was also very 
similar to descriptions in the literature, it was concluded that the cells had 
been induced to differentiate by the RA. 
8.2.2 Cytotoxicity tests with UD F9 cells 
8.2.2.1 In vitro toxicities of 24 chemicals to F9 cells 
Twenty-four chemicals were tested for cytotoxicity to UD F9 cells over a 48 
hour exposure period, using the KB assay. The chemicals were selected 
because of their in vitro toxicity values to 3T3-L1 cells in the FRAME KB 
cytotoxicity assay (Clothier et ai., 1988), and included chemicals recommended 
for use in validation trials of in vitro tests for teratogenicity (Smith et ai., 1983). 
Six of the chemicals were subsequently tested on DG and DD cultures. 
The ID2o, ID50 and IDgO values for the chemicals are shown in Table 8.4. 
Good reproducibility was obtained, as is indicated by the small standard errors. 
The toxicity curves for some of the chemicals were not linear, making the IDgO 
value difficult to ascertain. With phenytoin and thalidomide, solubility 
problems prevented estimation of the IDgo. A number of the more toxic 
chemicals gave IDgO values in excess of fifty times the ID50 values, most 
notably 5-fluorouracil, dexamethasone, 6-methylcoumarin and acetylsalicylic 
acid. 
A comparison of the cytotoxicity assay ID50 values obtained from F9 cells and 
3T3-Ll cells for the 24 chemicals is shown in Table 8.5. The range of ID50 
concentrations covered (approximately seven orders of magnitude) is similar 
for the two cell lines. In terms of absolute numerical values, the two cell lines 
209 
Table 8.4 In vitro toxicities of 24 chemicals to undifferentiated F9 cells 
Chemical ID20 IDso IDgO 
(t-tg/ml + s.e.m.) (t-tg/ml + s.e.m.) (t-tWml + s.e.m.) 
5-Fluorouracil 0.005 + 0.001 0.007 + 0.002 >0.5 
Colchicine 0.009 + 0.007 0.02 + 0.01 0.03 + 0.02 
6-Amino- 0.03 + 0.01 0.3 + 0.1 11 + 2 
nicotinamide 
Diethylstilboestrol 0.04 + 0.02 0.3 + 0.2 8 + 2 
Dexamethasone 0.2 + 0.1 0.7 + 0.2 >100 
6-Methylcoumarin 0.3 + 0.1 0.7 + 0.1 54 + 10(n=2) 
Cadmium (II) chloride 0.5 + 0 1 + 0 2+0 
Acetylsalicylic acid 1 + 0 3 + 1 203 + 92 
Phenytoin 0.5 + 0.1 7 + 3 >200 
Retinoic acid 3 + 1 9 + 1 15 + 1 
Pentachlorophenol 14 + 1 20 + 3 30 + 3 
Thalidomide 5 + 0.3 33 + 9 >500a 
2,4-Dinitrophenol 28 + 3 57 + 6 86 
Isoniazid 30 + 7 60 + 13 136 + 33 
Caffeine 62 + 29 111 + 46 333 + 42 
Chloramphenicol 57 + 19 272 + 26 614 + 172 
Saccharin 130 + 20 330 + 70 7800(n= 1) 
Trichloroacetic acid 390 + 60 790 + 80 >20000 
Cyclophosphamide 1100 + 150 1750 + 210 2650 + 310 
Sodium 1300 + 260 2600 + 390 5 ~ ~ + ~ n = 2 ) )
Sodium (I) chloride 2400 + 350 3600 + 540 5300 + 610 
Methanol 10000 + 1500 20900 + 1400 70300 + 3400 
Ethanol 12000 + 2000 21000 + 3400 38800 + 5700 
Dimethyl sulphoxide 21100 + 1700 28500 + 1100 39200 + 300 
a maximum solubility in aqueous medium 
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Table 8.5 In vitro toxicities of 24 chemicals to undifferentiated F9 cells and 
3T3-L1 cells 
Chemical F9 3T3-LF 
IDso (mM) IDso (mM) 
Colchicine <0.0001 0.02 
5-Fluorouracil <0.0001 <0.0001 
Diethylstilboestrol 0.001 0.05 
Dexamethasone 0.002 0.64 
6-Aminonicotinamide 0.002 0.15 
6-Methylcoumarin 0.005 1.1 
Cadmium (II) chloride 0.006 0.001 
Pentachlorophenol 0.007 0.12 
Acetylsalicylic acid 0.02 2.6 
Phenytoin 0.03 1.1 
Retinoic acid 0.03 0.16 
Thalidomide 0.13 >1.9 
2,4-Dinitrophenol 0.31 0.39 
Isoniazid 0.44 16 
Caffeine 0.57 5.7 
Chloramphenicol 0.84 0.70 
Saccharin 1.6 25 
Trichloroacetic acid 4.8 3.2 
Cyclophosphamide 6.3 6.5 
Sodium benzylpenicillin 7.3 11 
Sodium chloride 62 107 
Dimethylsulphoxide 365 287 
Ethanol 458 783 
Methanol 652 1141 
aTaken from Clothier et al. (1986) except for saccharin and thalidomide 
(Hulme et al., 1990). 
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gave, In general, very similar figures. There were, however, substantial 
differences between 1050 values from F9 and 3T3-L1 cells for dexamethasone , 
6-aminonicotinamide, 6-methylcoumarin, acetylsalicylic acid, 
pentachlorophenol, phenytoin, isoniazid, caffeine and saccharin. Colchicine 
and thalidomide also show differences, although the 1050 from one of the cell 
lines is not precise for both chemicals (Table 8.5). All these chemicals showed 
greater toxicity to F9 cells than to 3T3-L1 cells. There were no chemicals 
which showed a greater toxicity to 3T3-L1 cells than to F9 cells. 
Linear regression analysis of log 1050 (mM) for F9 versus log 1050 (mM) for 
3T3-L1 gave a correlation coefficient of 0.88. A comparison of the unlogged 
values gave a correlation coefficient of 0.97. Examination of the linear 
regression plot (Figure 8.5) shows that despite the high correlation coefficients, 
there are two out-liers, cadmium (II) chloride and 5-fluorouracil. 
The toxicity curves (represented by the 1020 to lOgO dose range) for the 
majority of the chemicals tested with 3T3-L1 cells were linear, and usually 
covered no more than 1 order of magnitude (Clothier et ai., 1988). Nine of 
the 24 chemicals tested on the F9 cells gave 1020 and lOgO concentrations 
which spanned more than two orders of magnitude, thus giving shallow, angled 
toxicity curves (for example, 6-methylcoumarin and trichloroacetic acid, Figure 
8.6( a); 6-aminonicotinamide and acetyl salicylic acid, Figure 8.6(b)) compared 
with those for 3T3-L1 cells. 
During the cytotoxicity tests on the UO cells, the cultures were examined by 
phase-contrast microscopy for induction of differentiation. No chemicals 
induced morphological changes characteristic of differentiation, at the 
concentrations tested and over the timescale used. Because of this absence 
of morphological alterations in the cells treated with test chemicals, media 
from UO F9 cultures, used in these cytotoxicity tests, were not examined for 
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presence of laminin. 
8.2.2.2 Conclusions 
Despite the fact that UD F9 cells were subjected to a shorter test chemical 
exposure time than the 3T3-Ll cells, the F9 cells showed a greater sensitivity 
to over half of the chemicals tested (Table 8.5). By contrast, Riddell et al. 
(1986a) and Garle et al. (1987) have demonstrated that decreasing the 
exposure period predominantly decreases the cytotoxic effects of chemicals. 
There are some notable discrepancies between the F9 and 3T3-Ll 1050 results, 
and the reason( s) for such differences is (are) not immediately apparent. 
The F9 cells exhibited an unusual shape of toxicity curve with some of the 24 
chemicals tested, wherein a large increase in concentration of chemical was 
required to shift the curve from 50% growth inhibition (1050 dose) to 80% 
growth inhibition (ID80 dose) (Figure 8.6). This phenomenon is not apparent 
with any of the 150 chemicals tested on 3T3-Ll cells in the FRAME KB 
cytotoxicity assay (Chapter 3; Clothier et al., 1988). 
The comparIson of 1D50 values from UD F9 cells and from 3T3-Ll cells 
showed that, despite large differences with some chemicals, the rank order of 
toxicity is essentially the same from the two cell lines. 
Having established that the UD F9 cells could provide reproducible results in 
a cytotoxicity test, DG and DO cultures were also investigated for their 
response to a limited number of chemicals over the same exposure period of 
48 hours. 
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8.2.3 Cytotoxicity tests with DG and DD F9 cells 
8.2.3.1 In vitro toxicities of 6 chemicals to DG and DD F9 cells 
The six chemicals tested on DG and DD F9 cells were 5-fluorouracil, cadmium 
chloride, caffeine, cyclophosphamide, dimethyl sulphoxide and thalidomide. 
These were selected from the list of 24, because of their widely varying 
toxicities, modes of action, and their known teratogenic or non-teratogenic 
effects in vivo. 
The cytotoxicity test results (Table 8.6) indicate that F9 cells in the three 
culture situations (UD, DG and DD) did not give the same responses to each 
chemical. Cadium chloride, cyclophosphamide and dimethyl sulphoxide each 
produced essentially similar toxicity curves with UD, DG and DD cells. 
However, the DG and DD cells were less sensitive to the remaining three 
chemicals. Thalidomide and 5-fluorouracil gave IDso doses over ten times 
greater with DG and DD cells than with UD cells. Caffeine gave IDso doses 
with DG and DD Cells which were two to three times more than the IDso with 
UD cells. With 5-fluorouracil, thalidomide and caffeine, it is apparent that the 
whole toxicity curve has shifted, and not just the IDso, when using DG or DD 
cells. ID values from DG and DD cultures were as reproducible as those 
obtained with UD cells. 
8.2.3.2 Production of laminin by DG and DD F9 cells 
To assess whether any of the six chemicals could induce production of 
detectable amounts of laminin in the DG cultures, medium samples were 
collected at the 48 hour exposure endpoint and assayed for laminin by the 
ELISA. No laminin was detected in any of the samples from the treated DG 
cultures (detection limit of the ELISA was approximately 5nglml). However, 
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Table 8.6 III vitro toxicities of six chemicals to undifferentiated, differentiating and differentiated F9 cells 
Chemical Cell 102/) 1050 10so 
State (mM + s.e.m.) (mM + s.e.m.) (mM + s.e.m.) 
5-Fluorouracil UO 0.00004 + o.()()()() 1 <0.0001 <0.004 
DG 0.0003 + 0.0002 0.001 + 0.001 O.OOI(n= 1) 
00 0.0003 + 0.0000 0.001 + 0.000 0.003 + 0.000 
Cadmium (II) UO 0.003 + 0.000 0.006 + 0.002 0.01 + 0.00 
chloride DG 0.005 + 0.001 0.01 + 0.00 0.02 + 0.00 
00 0.005 + 0.001 0.01 + 0.00 0.02 + 0.00 
Thalidomide UD 0.02 + 0.00 0.13 + 0.03 >1.ga 
OG >1.ga >1.ga >1.ga 
00 >1.ga >1.ga >1.ga 
Caffeine UO 0.32 + 0.15 0.57 + 0.24 1.7 + 0.2 
OG 0.93 + 0.11 1.9 + 0.1 3.5 + 0.4 
00 0.76 (n=2) 1.7 + 0.2 2.7 + 0.3 
Cyclophosphamide UO 3.9 + 0.5 6.3 + 0.8 9.5 + 1.1 
OG 1.2 (n=l) 2.8 + 0.3 6.7 + 0.3 
DO 1.1 (n=2) 4.9 + 1.2 12 + 2 
Dimethyl 
sulphoxide 
UD 
DG 
DD 
271 + 22 
178 + 16 
201 + 19 
UD = undifferentiated cell cultures 
DG = differentiating cell cultures 
DD = differentiated cell cultures 
a - maximum solubility in aqueous medium 
365 + 14 
328 + 87 
322 + 31 
503 + 4 
490 + 27 
467 + 36 
cultures of control DD cells at the cytotoxicity test endpoint had produced 
laminin in detectable amounts. 
In three experiments, on separate occasions, a total of 54 control culture wells 
were used which gave an average of approximately 0.5J..Lg of laminin produced 
in 48 hours by 1 x 106 DD cells (final cell number) or 4J..Lg laminin per mg final 
cell protein. These values are close to the values of (a) 1-2J..Lg laminin per 106 
cells, achieved by A. Daly (personal communication), and (b) 13.1J..Lg laminin 
per mg cellular protein, achieved by Williams et al. (1987). Both these latter 
results were obtained from F9 cells differentiated using RA and dbcAMP, and 
represent the quantities of laminin released over a 24-hour period only. 
Media from test-chemical treated DD cell culture wells were also tested at the 
end of the 48-hour exposure period. The media samples represented cultures 
which had shown a range from minimal to maximal toxicity in the cytotoxicity 
tests. The amounts of laminin produced in these cultures was compared with 
the amounts of cellular protein in the same wells (Table 8.7). There was a 
possibility, however, that the chemicals tested could affect the production of 
laminin at concentrations that were not cytotoxic. Hence, to correct for this, 
the amount of laminin was plotted as a percentage of the final cellular protein, 
to take account of the change in cell number with increasing cytotoxicity 
(Figures 8.7, 8.8 and 8.9). 
For cyclophosphamide and dimethyl sulphoxide, there was a direct relationship 
between increased toxicity and decreased laminin production (Figure 8.7). 
With 5-fluorouracil and caffeine, while the toxicity increased, the amount of 
laminin did not decrease to the same extent (Figure 8.8). In marked contrast, 
with cadmium (II) chloride, no laminin was detectable at the ID20 dose (Figure 
8.9). 
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Table 8.7 Production of laminin by differentiated F9 cells during 
cytotoxicity tests with six chemicals 
Concentration of Cell 
Chemical Growth 
(% of control) 
5-Fluorouracil (mM x 10-3) 
SC 100 
0.077 106 
0.38 80 
0.77 45 
3.8 13 
7.7 12 
Cadmium Chloride (mM x 10-3) 
MC 100 
0.55 104 
2.7 87 
5.5 76 
10.9 49 
27.3 14 
Thalidomide (mM) 
SC 
0.19 
0.39 
0.97 
1.9a 
Caffeine (mM) 
MCt 
0.52 
1.03 
2.06 
3.09 
4.12 
100 
102 
100 
105 
92 
100 
85 
66 
36 
15 
10 
220 
ng lamininl 
f..Lg protein per well 
4.3 
3.4 
4.0 
4.7 
11.8 
7.9 
3.7 
2.6 
1.1 
BDL® 
BDL 
BDL 
3.0 
2.8 
3.1 
3.1 
2.8 
3.0 
3.3 
4.0 
4.4 
10.0 
8.0 
Table 8.7 (contd.) 
Concentration of Cell ng laminin/ 
chemical Growth 
(% of control) 
J,J.g protein per well 
Cyclophosphamide (mM) 
MC 100 2.5 
0.9 83 2.6 
1.79 66 3.5 
3.58 58 2.6 
5.38 44 3.9 
7.17 34 3.7® 
17.9 7 BDL® 
Dimethyl sulphoxide (mM) 
Me 100 3.3 
128 98 3.9 
256 64 3.3 
385 35 BDL® 
513 16 BDL® 
SC = 1% (v/v) DMSO solvent control + O.lJ,J.M RA 
MC = Medium control + O.lJ,J.M RA 
®Laminin was detectable in only one or two out of the three experiments 
performed with this dose. Result quoted uses the laminin result which was 
repeated twice out of the three experiments. 
BDL = Amount of laminin was below detection limit of ELISA. 
amaximum solubility in aqueous medium. 
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Figure 8.7 Effect of (a) cyclophosphamide and (b) dimethyl sulphoxitle on 
protein (0) and laminin ( ~ ) ) levels (as a percentage of control 
untreated wells) in differentiated F9 cells. 
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Figure 8.8 Effect of ( a) 5-fluorouracil and (b) caffeine on protein (D) and laminin (6) levels (as a percentage of control untreated wells) 
in differentiated F9 cells. 
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Thalidomide had no effect on the growth of DD cells, up to its solubility limit 
of 500J,.Lg!ml aqueous medium. Also, there was no effect on the amount of 
laminin produced by those thalidomide-treated cultures (Table 8.7). 
Despite the alteration of laminin production by three of the chemicals tested 
on DD cells (5-fluorouracil, caffeine and cadmium (II) chloride), no overt 
dedifferentiation (as demonstrated by morphological changes in the cells) was 
observed over the time period of the cytotoxicity tests. 
8.2.3.3 Conclusions 
5-Fluorouracil, thalidomide and caffeine appeared to be less cytotoxic to DG 
and DD F9 cell cultures than to UD cultures, over the same exposure period. 
Cadmium (II) chloride, cyclophosphamide and dimethyl sulphoxide were 
approximately equally cytotoxic to DG and DD cultures as to UD cultures. 
It had been expected that in the cytotoxicity tests with DD cells, the amount 
of laminin would remain proportional to the cell number. While 
cyclophosphamide, thalidomide and dimethyl sulphoxide did demonstrate this 
pattern, cadmium (II) chloride, caffeine and 5-fluorouracil did not. Cultures 
treated with caffeine and 5-fluorouracil showed laminin levels higher than 
expected. When these were examined by phase-contrast microscopy, they 
showed evidence of a slow build-up of toxicity, i.e. wells treated with high 
concentrations did not exhibit toxic effects after 24 hours of exposure, but 
effects were very clear at 48 hours. Cadmium (II) chloride, however, caused 
the cultures to give a laminin level below that expected from the level of 
protein. Laminin production appeared to have been affected by 2.7J,.LM 
cadmium (II) chloride, which was only minimally cytotoxic. 
Therefore, cyclophosphamide, thalidomide and dimethyl sulphoxide did not 
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appear to have a direct selective effect on laminin production. 5-Fluorouracil 
and caffeine were cytotoxic, but did not appear to reduce the metabolic 
capacity of the cells so greatly, and laminin production was retained. 
However, cadmium (II) chloride affected the capacity of the cells to produce 
laminin before being cytotoxic. 
8.3 DISCUSSION 
Despite the obvious preliminary nature of the experiments with the F9 cell 
line, some promising results were obtained. Firstly, a reliable method of 
inducing almost complete morphological differentiation of the cells was 
established. Secondly, a biochemical marker of the differentiation process was 
found to be generated at levels which could easily be detected by ELISA. 
Although the many different cell lines used in in vitro cytotoxicity tests will 
often provide very similar rank orders of results (Balls and Horner, 1985; 
Borenfreund and Shopsis, 1985), they may not always exhibit similar 
susceptibilities, and this was found to be the case with the F9 and 3T3-L1 cell 
lines. Certain chemicals may give highly discrepant results in different cell 
lines (Riddell et ai., 1986a), and it is not easy to find explanations for this. It 
may be linked to the fact that F9 cells are a transformed cell line, whereas 
3T3-L1 cells are not. Alternatively, the faster growth rate of F9 cells may be 
a contributory factor. However, V79 cells, which grow more rapidly than 3T3-
L1 cells, showed similar sensitivity to 3T3-L1 cells, when tested with 27 
chemicals (Garle et ai., 1987). Another possible explanation is the difference 
in culture medium serum supplement for 3T3-L1 (new-born calf serum) and 
F9 cells (fetal calf serum). However, V79 cells also require 10% fetal calf 
serum. A combination of these, plus other unknown, factors could probably 
explain the greater sensitivity of the F9 cells. 
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The reasons for the F9 cells giving unusually wide toxicity curves may be 
connected with the protocol for the cytotoxicity assay with UD F9 cells. The 
cells are plated at 5 x 104/well, which by themselves might produce a KB OD 
of 0.1 or 0.2 (Figure 8.3). Twenty-four hours later, the test chemical is added, 
by which time the cells may have multiplied to give a KB absorbance of more 
than 0.2. Thus, for the endpoint absorbance (usually about 1.0) to be reduced 
by over 80% (to less than 0.2 to calculate the IDso), the endpoint cell number 
must be less than the number at the time of test chemical addition, i.e. cells 
need to have become detached. Thus, the assumption is that, although the 
UD F9 cells were sensitive to many chemicals, in terms of inhibition of growth, 
it took far greater amounts of those chemicals to actually kill the cells outright. 
Another, less likely, explanation is that, as the F9 cells were dividing so rapidly, 
although 50% growth inhibition was achieved by relatively low doses of certain 
chemicals, it took far higher doses to inhibit division to only 20% of the 
normal rate. This may have been due to the properties of those particular 
chemicals. For example, 5-fluorouracil and 6-aminonicotinamide are anti-
metabolites, and will inhibit metabolic processes, but would not necessarily kill 
the cells. Trichloroacetic acid, when at a sufficient concentration to turn the 
medium acid, will fix the cells in situ., i.e. killing them, but not allowing them 
to detach from the culture well surface. 
Although none of the chemicals tested induced any differentiation-related 
morphological changes in the UD F9 cells, this was not unexpected. Firstly, 
the chemicals were added to the culture medium at toxic concentrations and 
hence the cells would have had their capacity to differentiate impaired. 
Secondly, the chemicals were only allowed to interact with the cells for 48 
hours. This is the minimum amount of time required for even the known 
differentiation-inducer, RA, to produce its initial phenotypic alterations. It is 
unlikely that any of the other 23 chemicals would be more potent 
differentiation-inducers than RA. Hence, longer timescales of chemical 
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treatment at sub-lethal doses would probably be required, before any 
alterations would become apparent. This could include subculturing and 
seeding the cells in medium containing the test chemical. 
There are several possible reasons why the DG and DD cultures were less 
sensitive than UD cells to certain chemicals. The DD cells are 
morphologically and biochemically different from UD cells, and exhibited a 
slower growth rate. Therefore, they might be expected to respond differently 
to test chemicals. However, the DG cells were only in the initial stages of RA-
induced differentiation during the 48-hour incubation with a test chemical plus 
0.1t.£M RA. The DG cells did not show any clearly detectable morphological 
alterations until the end of the 48-hour exposure to RA. No detectable 
laminin was produced, nor any change in the cell growth rate seen compared 
with UD cells (Hulme et ai., 1990). Altered growth rate alone cannot, 
therefore, be the reason for the decreased sensitivity of DG cells. It appears 
that the non-toxic concentration of RA in the medium somehow induced 
changes in the cells, reducing their susceptibility to certain chemicals. There 
were two main differences between the cytotoxicity test protocol for UD cells 
and that for DG and DD cells. The UD F9 cell cytotoxicity test used the KB 
staining to measure relative cellular protein, while tests with DG and DD cells 
used the Bradford assay to measure actual amounts of protein. However, the 
difference in the methods of protein assay could not account for these 
differences since, with 5-fluorouracil, thalidomide and caffeine microscopic 
examination of cultures, prior to the protein assays, confirmed that both 
methods of protein determination were a true reflection of relative cell 
number. Furthermore, if the method of protein assay affected the results 
obtained with DG and DD cells, then it would be expected that the results for 
all the chemicals would be similarly affected. This was not the case. It had 
also been established that the KB and Bradford methods agreed in their 
determination of cellular protein. However, it is possible that the RA may 
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have interacted chemically with the 5-fluorouracil, thalidomide and caffeine , 
rendering them less cytotoxic. This possible explanation could be investigated 
further by testing chemicals for cytotoxicity in the presence of O.lJ..£M RA, with 
another cell line - one which does not respond to RA (such as 3T3-L1). In 
addition, a series of chemicals (including caffeine, thalidomide and 5-
fluorouracil) could be tested for cytotoxicity to UD or DD F9 cells in the 
presence and absence of O.lJ..£M RA over different exposure periods. This 
might offer suggestions as to the time of onset of the altered sensitivity of DG 
cells, and whether chemicals which had different toxicities in different cell 
types (i.e. UD, DG or DD) were of a particular chemical group or biological 
activity. 
The higher laminin levels in the near-maximal toxicity DD cultures treated 
with 5-fluorouracil and caffeine may have been due to the release of 
intracellular laminin which had been produced before the cells succumbed to 
cytotoxic effects in the latter half of the 48 hour exposure. Alternatively, 5-
fluorouracil, being a specific inhibitor of DNA synthesis, may have prevented 
cell division without affecting the ability of the cells to produce laminin. 
Several DNA synthesis inhibitors have been shown to induce plasminogen 
activator production (another biochemical marker of F9 cell differentiation) 
in previously undifferentiated F9 cells (Nishimune et ai., 1983). It is known 
that for certain cell lines, inhibition of division is necessary before 
differentiated characteristics can be demonstrated. For example, EL-4 cell 
lines, used in the development of an immunocytotoxicity assay (Lasek et ai., 
1989; Steer et ai., 1990), will produce cytokines if cell division is inhibited with 
phorbol myristyl acetate (McCabe, 1990). Whether highly toxic doses of 5-
fluorouracil and caffeine could have actually enhanced laminin production in 
the already-differentiated cells in this study would have to be investigated by 
time-course experiments and measurements of both intracellular and 
extracellular laminin. 
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The dramatic lack of laminin in DD cultures whose growth was only minimally 
affected by cadmium (II) chloride, could be explained by the cadmium ions 
interfering with the process of laminin production, either intracellularly, or at 
surface sites, without affecting cell proliferation. Cadmium is known to bind 
to proteins with high affinity (Camner et ai., 1986), and could have inhibited 
specific enzymes or structural proteins involved in laminin production or 
release. This effect could be investigated further with a wider range of 
sublethal concentrations of cadmium (II) chloride, and of other chemicals 
which reveal a similar pattern. The depression of laminin production in the 
presence of cadmium (II) chloride could have another explanation, namely, 
that the cadmium interfered with the binding of laminin to anti-Iaminin 
antibody in the ELISA (co-incubation of culture medium aliquots with anti-
laminin antibody). This could be tested by the addition of cadmium (II) 
chloride at the appropriate concentration to the standard curve laminin 
dilutions. 
The disruption of other differentiated functions of F9 cells, such as 
plasminogen activator production, loss of expression of stage-specific 
embryonic antigen (SSEA-1), or polyoma virus infectivity (Moore et ai., 1986) 
could also be investigated. It would probably be worthwhile to examine at 
least one other specific function of differentiated F9 cells, when testing any 
chemical on DD cultures. This additional marker could be one whereby 
differentiated cells lost (rather than gained) activity or expression, such as loss 
of SSEA-1 expression, or loss of alkaline phosphatase activity. 
It is apparent that the laminin synthetic pathway could be a specific target for 
certain chemicals at both non-cytotoxic and cytotoxic doses, resulting in raised 
or decreased laminin production. The cytotoxicity test results suggest that F9 
cells in different stages of differentiation do not always respond in the same 
way to toxic chemicals. In addition, laminin production by differentiated cells 
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may be altered In different ways by chemicals with different biological 
activities. 
A test using F9 cells to provide information about chemicals that can disrupt 
cellular differentiation, would need to involve incubation of the cells with the 
test chemical throughout their differentiation. The effect of the chemical upon 
cell division, morphological alterations and production of laminin could then 
be examined. This would make the test comparable to the micro mass assay, 
which measures inhibition of differentiation of the limb bud or neural crest 
cells. It would still be necessary to measure basal cytotoxicity to the F9 cells 
over the same exposure period. As in the micromass assay, the chemical 
concentration which inhibited cell differentiation by 50% would then be 
related to the cell growth IDso• If 50% inhibition of differentiation was caused 
at a chemical concentration less than a certain proportion (e.g. half) of the cell 
growth IDso, then the chemical would be classified as a potential "teratogen" 
or "developmental toxicant". 
Chemicals could also be investigated for their ability to induce morphological 
alterations and laminin production in F9 cells. Some chemicals are known to 
be able to induce morphological changes (Moore et al., 1986), but their effects 
on biochemical parameters were not consistent. This latter proposal has no 
counterpart in the micromass test, because, in the micromass method, all the 
mid-brain or limb-bud cells are committed to differentiate. Hence, only the 
inhibition, and not the induction, of the differentiation process can be 
measured. F9 cells could therefore be considered more versatile than the 
primary embryonic cell cultures. 
One criticism of the F9 system is that RA must be used to induce 
differentiation, and RA is itself a potent teratogen (Johnson and Chun, 1989). 
However, retinoids, such as vitamin A and RA, are highly important for the 
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health and growth of higher animals (Strickland, 1979) and are thus naturally-
occurring essential molecules. In this respect, RA is probably acting as a 
"natural" chemical messenger to signal F9 cell differentiation, because it is 
known to be a natural inducer of differentiation in vivo (Sporn and Roberts. 
1983). Physiological concentrations of RA (3-33nM) have been found to 
stimulate limb-bud chondrogenesis in vitro (Paulsen et al., 1988). 
On paper, therefore, the F9 cell line appears to be a highly suitable candidate 
for a model of cell differentiation for use in in vitro toxicity testing. The 
results presented in this chapter suggest that it is certainly worthy of further 
investigation. Whether the F9 cells could ultimately be used to detect 
developmental toxicants accurately could not be predicted from the results 
obtained to date. 
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CHAPTER 9 FINAL DISCUSSION 
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The potential use of basal cytotoxicity tests in the prediction of adverse effects 
of substances on humans is being evaluated in many countries. The FRAME 
KB cytotoxicity assay is one such test, and has been shown to be reliable, 
reproducible and sensitive to a very wide range of toxic potencies (Knox et al., 
1986; Clothier et ai., 1988). Despite the ultimate aim of predicting human 
toxicity, the paucity of reliable human data and the voluminous amount of 
rodent data has led many validation schemes to aim to predict rodent in vivo 
toxicity from in vitro assays. This thesis has attempted to discover whether the 
FRAME KB cytotoxicity assay is a good predictor of rodent acute lethal 
potency for a group of unrelated pure chemicals, and whether the 
predictiveness improves when a group of structurally and chemically related 
substances are selected. The assay was also evaluated for potential use with 
formulations and mixtures. To endeavour to increase confidence in results for 
volatile liquids tested in the standard FRAME KB cytotoxicity assay protocol, 
two methods of sealing the culture plates were investigated. Preliminary 
studies into the proposed use of embryonal carcinoma cells in an in vitro 
teratogenicity test were also carried out. 
Despite the diversity of the 59 chemicals in the first in vivo/in vitro comparison 
(Chapter 3), and the problems associated with testing some of them, linear 
regression analysis showed good correlations between FRAME KB cytotoxicity 
assay data and published mouse i.p. or rat oral LDso values (Purchase et al., 
1987 Lewis and Tatken, 1982). Although the correlations are good, lending 
support to the arguments of Ekwall (1983b) and Ekwall et al. (1989) that in 
vitro basal cytotoxicity assays are able to predict in vivo toxicity, the regression 
line could not be used with confidence to predict the toxic potencies of all 
chemical types in existence. This is because a limited number of chemical 
types were represented in the set of 59, and, moreover, only pure chemicals, 
which were soluble in aqueous medium, were involved. It follows that before 
an assay can be used as a predictor of in vivo acute lethal potency, the data 
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set used to produce the prediction should contain a number of closely-related 
chemicals, formulations or substances acting via similar modes of toxicity. If 
the in vivo/in vitro correlation is good for a particular set, then greater 
confidence can be placed in the ability of the assay to predict the potency of 
other chemicals of that type. This approach is similar to that taken with 
QSAR. In general, a small group of structurally-related chemicals is used to 
establish the QSAR, and this is used to predict the activity of chemicals from 
the same series (Phillips et al., 1990). 
A problem in selecting related chemicals to test in vitro is defining what is 
meant by "related". Chemicals can be related by structure and/or by chemical, 
biological or pharmacological activity, or by a host of other, less precise, 
factors such as commercial use, target organ for toxicity and physical form. 
The prediction of rat oral LDso was not improved for the metal compounds 
(which are related by simple cation/anion structure and in general by the 
metal-to-ligand-binding mode of toxicity) compared to the 59 miscellaneous 
chemicals. However, the FRAME KB cytotoxicity assay results were more 
closely correlated with mouse i.p. LDso values for the metal compounds than 
for the 59. With the metal compounds, it was noticeable that the in vitro 
results correlated better with mouse i.p. data than with rat oral data, which is 
in agreement with the findings of Fry et al. (1990). The use of the metal 
softness parameter on its own as a predictor of metal compound toxicity 
appears to be rather limited and simplistic. An approach which included more 
than one physicochemical parameter in the QSAR for metal compounds would 
offer greater scope (Kaiser, 1985). 
The choice of rat oral and mouse i.p. LDso values as the parameters of 
mammalian acute lethal potency was made partly out of necessity, because of 
the inavailability of appropriate human toxicity data and the relative 
abundance of the rat and mouse data. The use of LDso values is not intended 
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to imply that the FRAME KB cytotoxicity assay was being evaluated solely as 
a replacement for the LDso test. In vivo acute toxicity data was needed in 
order to make in vivo/in vitro comparisons and LDso values were the most 
applicable under the circumstances. It would not be of scientific merit to 
develop an alternative toxicity test to the classical LDso, which has been the 
subject of much criticism in recent years. An in vitro test which provided data 
with 100% correlation with data from an in vivo toxicity test would be as 
limited in its applicability to man as the animal test. Nevertheless, there is a 
need to validate non-animal techniques which could supply data for the same 
purposes for which the LDso is performed. The aim is to replace animal 
testing, but to achieve this, it has been agreed, there will be a period during 
which the in vitro assays will be used as prescreens. For such prescreens, the 
data generated needs to predict both likely human and animal toxicity. The 
problem remains as to whether the alternative should have to be validated 
against results from an out-dated and partly discredited in vivo test, such as the 
classical LDso test. 
It must be emphasised that it is unlikely that one alternative test would be 
used in isolation as a replacement for an in vivo test. The battery approach 
suggested by several groups (Shopsis et al., 1985; Bracher et al., 1989; Balls et 
aI., 1991a) is a more logical option, because it allows several endpoints and 
mechanisms of action to be assayed. Alternative tests should have reached a 
satisfactory stage of development and validation before being considered for 
inclusion in a battery. The predictive performance of a battery should also 
undergo rigorous evaluation with an appropriate number of reference 
chemicals (Balls and Clothier, 1992, in press). Alternatives, such as in vitro 
tests, QSAR studies or computer modelling, are often less expensive to run 
than in vivo tests and so the use of several in a battery would not be 
prohibitively costly. 
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The FRAME KB cytotoxicity assay showed some promising correlations with 
in vivo toxicity parameters, for groups of pure chemicals, but it must never be 
assumed that a test that works well with pure chemicals is equally useful with 
formulations and mixtures. The evaluation of the FRAME KB cytotoxicity 
assay with certain product formulations, gave results which were found to be 
difficult to interpret. With the pesticide formulations, some contained "active 
chemicals" in suspension (i.e. not fully dissolved), which led to difficult 
questions about whether the active chemical was interacting with the 3T3-Ll 
cells physically, chemically or neither. With all formulations and mixtures, the 
possibility of synergistic effects between ingredients can never be ruled out. 
Hence, the results for formulations should never be viewed in isolation, but in 
the context of the results of the ingredients. Because the FRAME KB 
cytotoxicity assay estimates the effects of a substance after 72 hours exposure, 
it may be more suitable for testing products which are designed for, or may 
accidentally have, prolonged exposure such as those applied to the skin or 
hair. The assay may also be useful for ingredients of any product type which 
may cause toxic effects only after a longer exposure period, rather than 
immediate effects upon exposure, or chemicals which are rapidly removed, e.g. 
volatile perfumes. 
During the final stages of the preparation of this thesis, the results for Phase 
II of the Cosmetics, Toiletries and Fragrances Association (CTFA) evaluation 
scheme (for alternatives to the Draize eye test) became available (S. Gettings, 
personal communication). The FRAME KB cytotoxicity assay was 1 of 11 
(out of an original 30 assays) selected as promising for predicting the eye 
irritancies of a group of oil-water emulsion type cosmetic and toiletry 
formulations. In addition, results from the European Community pilot 
validation study on Draize eye test alternatives became accessible (M. Balls, 
personal communication). The FRAME KB cytotoxicity assay, the FRAME 
Neutral Red Release assay and the FRAME Fluoroscein Leakage assay all 
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performed well. The FRAME KB cytotoxicity assay did not detect acetic acid 
or sodium hydroxide as potential irritants, presumably because of the buffering 
system in the culture medium. 
Some types of substance will always be problematical for toxicity tests, whether 
in vivo or in vitro. To quote Zbinden (1990): "The most interesting compounds 
are often as soluble as concrete or they are in gaseous form or tend to decom 
pose rapidly when added to the culture medium". In vitro toxicologists must 
not ignore "difficult" substances, but should make efforts to develop assay 
protocols to accommodate them. Using sealed culture plates is one solution 
to the problem of the evaporation of liquid chemicals, but a greater 
standardisation of methods of preparation of chemical dilutions is also 
required. 
Once basal cytotoxicity has been evaluated, certain specialised tests will be 
required for the assessment of potential organ- or tissue-specific toxicity. The 
initial assumption that a continuous cell line could easily replace primary rat 
embryo cultures in a micromass type teratogenicity test was naive. Embryonic 
cell differentiation is a highly complex process, and to be able to accurately 
and reliably model it in vitro is a lengthy and complex task - one far beyond 
the resources of this project. Furthermore, cell differentiation is only one of 
a wide range of cellular and tissue developmental processes. A model of cell 
differentiation cannot, therefore, be expected to simulate all of normal or 
abnormal embryonic development. A considerable amount of work would be 
required to develop a useful in vitro toxicity test based on the differentiation 
of F9 cells. F9, and other EC cell lines, are the subject of much research 
world-wide, and could be a useful contribution to research efforts in molecular 
toxicology, in terms of chemical interference with subcellular mechanisms 
during differentiation. There is a general belief that for in vitro alternatives 
to be capable of predicting specific forms of toxicity, such as teratogenicity, 
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these assays must be based on sound mechanistic understanding. For basal 
cytotoxicity, if the assay is predictive, the mechanisms of action do not need 
to be similar. When organ- or tissue-specific toxicity is concerned, because of 
in vivo/in vivo variation, the in vitro assays should attempt to model the 
mechanisms of toxicity known to occur in man. 
The FRAME KB cytotoxicity assay has proved to be a versatile test for basal 
cytotoxicity in vitro, which satisfies the criteria for an acceptable toxicity test 
system (namely: quantifiable objective endpoint which provides data for a 
dose-response relationship; low intralaboratory and interlaboratory variation; 
rapid and inexpensive; techniques which are simple to learn; low rate of "false" 
results (Gad, 1989)). There is more research to be done, however, before the 
assay could be more widely accepted as a useful tool in in vitro toxicology and 
safety assessment studies. 
Firstly, with pure chemicals, more groups of related chemicals should be 
tested. Care needs to be taken over the selection of such groups, particularly 
with regard to how closely the substances are related, and what in vivo data 
are available for them. In QSAR research, there are three basic requirements 
for the selection of chemicals (Phillips et ai., 1990): (i) there should be a well 
defined mode of action for the compound considered; (ii) the compounds 
should form part of a congeneric group; (iii) there should be a common site 
of action for the biological effect. Perhaps these requirements should be 
considered when attempting to validate an in vitro test with a particular type 
of chemical. 
With formulations and mixtures, the situation is more complex. Because of 
the possibility of synergistic effects between ingredients, it will be necessary to 
test some or all of the ingredients individually. This will put the cytotoxicity 
of the complete formulations into a better perspective. With the continued 
239 
collaboration of industrial sponsors, this should be possible. However, the 
collaboration should be strengthened with increased dialogue between industry 
and academia. Without industry providing specific objectives of what sort of 
toxicity data they require (in order to make their safety and risk assessments), 
academia will not be able to offer relevant solutions. Initially, FRAME has 
only been able to give results for formulations tested in the existing FRAME 
in vitro toxicity assays (which were developed for pure chemicals). There is 
now the opportunity to tailor assays to suit the requirements of one industry, 
or one type of formulation. 
Such tailoring of assays need not only be for chemical types, but also for 
physical types. Although some success has been achieved with adapting the 
FRAME KB cytotoxicity assay for volatile liquids, there remain the problems 
of gases and insoluble solids. The importance of these problems depends on 
which kind of chemical product is the object of interest, but it is still necessary 
for these problems to be addressed in in vitro toxicology. 
The battery approach in in vitro toxicology is not new in theory, but there are 
few examples in practice. Research is required into the usefulness of the 
FRAME KB cytotoxicity assay in batteries for various categories of toxic effect 
or product type. Multivariate models, such as those developed by Hellberg et 
al. (1990), offer a way forward, but before the models will be taken up by 
other toxicologists, these toxicologists will need to gain a greater understanding 
of the mathematical principles involved. The FRAME Toxicity Committee has 
recently set new objectives in the search for ways to reduce, refine and replace 
ill vivo toxicity tests (FRAME Toxicity Committee, 1991). An important part 
of these is the development and validation of test batteries, in which scientists 
are not constrained by a rigid list of required tests, but are able to select an 
appropriate combination of tests, to suit the substance under test, and the type 
of adverse effects to be screened for (Balls et al., 1991b). It is possible that 
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the FRAME KB cytotoxicity assay would be useful as a component in test 
batteries for several types of toxicity. 
The FRAME KB cytotoxicity assay will continue to be developed, adapted and 
evaluated, as part of the industry-sponsored FRAME Research Programme. 
Ongoing support of the research by industrial companies will help to promote 
in vitro toxicology and, hopefully, help to validate the role of the FRAME KB 
cytotoxicity assay, and other FRAME assays, for use in test batteries. 
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APPENDIX A ADDITIONAL BACKGROUND INFORMATION 
MECHANISMS OF CELL DEATH 
Throughout the life of an animal, some of its cells will die through either 
physiological or pathological causes. Physiological causes include cell turnover 
and apoptosis. During cell turnover in epithelia such as the skin, cells die and 
slough off as new ones replace them from beneath. Apoptosis is the term for 
a controlled, programmed form of cell death. It is crucial in phenomena such 
as the development of 5 separate digits in vertebrate limbs and the control of 
organ size in adults (Young, 1992). It is also a vital part of the functioning of 
a healthy immune system. The mechanism of apoptosis requires the synthesis 
of nucleases and other destructive enzymes. Following a stimulus, the enzymes 
are released internally and the cell rapidly breaks up. 
Pathological causes of cell death include loss of blood supply, bacterial toxins 
and physical and chemical agents (Woolf, 1977). The majority of mechanisms 
of chemical cytotoxicity begin with binding of the toxic species to cellular 
molecules. As a result the molecules are altered and hence cannot function 
efficiently or participate normally in cellular processes. Four main factors 
determine the form and extent of chemical cytotoxicity (Bridges, 1985):-
(a) the level and persistence of the initiating factor at the molecular target: 
(b) the role of the target( s) in cell/tissue function and the extent and 
irreversibility of their modification; 
( c) the effectiveness of cellular defence mechanisms in removing offending 
agents, and in the repair, replacement, or compensation for, the cellular 
damage; and 
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(d) the nature and amount of toxic products released from the injured 
cell/tissue. 
Chemical cytotoxicity can be mediated through the depletion of intracellular 
glutathione (Orrenius, 1985). Glutathione acts as a cell defence mechnism, by 
conjugating to toxic, reactive chemical species. Glutathione levels drop when 
the rate of conjugation exceeds the rate at which the cell can replace it, and, 
as a consequence, depletion in protein thiols occurs. Certain thiols are critical 
for cell survival, so, without them, the cell necrotises. Membrane-bound 
protein thiols are important in modulating calcium ion (Ca2+) fluxes. When 
these cannot function correctly, a sustained increase in cytosolic Ca2+ occurs, 
and it is postulated that the excess intracellular Ca2+ leads to the activation of 
catabolic processes (e.g. proteolysis) (Orenius and Nicotera, 1987). and hence 
cell death. There are many manifestations of cytotoxicity (Table AI). 
Table AI. Manifestations of cellular toxicity 
Loss of structural integrity - death 
(a) cell lysis 
(b) nuclear/chromosomal fragmentation, micronuclei 
Defective reproduction 
(a) reproductive sterilization - permanent cycle block 
(b) slowed cell cycling - temporary cycle block or permanent slowing 
( c) "unregulated" cell cycling - neoplastic transformation 
Impaired synthetic and metabolic functions 
(a) mutagenesis 
(b) defective synthesis, e.g. of RNA, DNA, proteins 
( c) defective enzyme function 
(d) defective receptor function 
( e) defects in many other functions 
From Grisham and Smith (1984) 
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A dead or dying cell (whether caused by apoptosis or necrosis) will be 
detected by phagocytic cells and engulfed by them. 
CRITERIA FOR VALIDATION OF IN VITRO TOXICITY TESTS 
Part of the validation of an in vitro toxicity test involves the evaluation of the 
test's relevance, by comparing the in vitro results with in vivo (preferably 
human) data. As proposed at the CAATIERGATT Workshop on the 
validation of toxicity test procedures (Balls et al., 1990a), tests should attain a 
certain degree of predictivity, depending on the proposed use of the test. 
Predictivity may be calculated from specificity and sensitivity values, as defined 
below. 
Sensitivity 
Specificity 
a 
a+b 
c 
c+d 
Positive predictive value a 
a+d 
Negative predictive value c 
b+c 
where a = true positives which the test finds positive 
b = false negatives (positives which the test finds negative) 
c = true negatives which the test finds negative 
d = false positives (negatives which the test finds positive) 
The prevalence of true positives in a set of test chemicals in a validation 
scheme will affect the predictivity of the test. The greater the prevalence of 
true positives, the greater the sensitivity of the test, but the lesser the 
specificity. Calculations of specificity and sensitivity are also useful when 
considering the performance of a battery of tests. It may be thought that 
266 
several tests (with the aim of identifying the same toxic property) in a battery 
would be more accurate than one test alone (Purchase, 1990a). However, 
although performing more tests causes sensitivity to increase (i.e. less false 
negatives), specificity drops (i.e. more false positives). 
Tests such as the FRAME KB cytotoxicity assay do not provide the type of 
binary (+ or -) response which is amenable to predictivity calculations (Balls 
et ai., 1990a). The IDso values are continuous, although they could be 
categorised. It may then be possible to compare the prediction of categories 
of toxicity, but, as stated in Chapter 3, categorisation of test results must be 
approached with caution. Balls et ai., (1990a) proposed that screening tests 
should have a predictive value of greater than 0.5 (e.g. better than random 
classification). The in vivo/in vitro comparisons in Chapter 3 demonstrated 
that the FRAME KB cytotoxicity assay was able to achieve a better than 
random correlation, and this would suggest that the assay has met this 
particular criterion of predictivity for a screening test. 
HIERARCHICAL TESTING 
The hierarchical, or tiered, approach to toxicity testing is envisaged by many 
workers. It is already in operation through the British Toxicology Society's 
support of the hierarchical scheme for dermal and ocular irritancy testing 
(Fielder et ai., 1987). The approach involves following a step-wise decision 
tree, and a general definition has been given by Balls (1986). Five stages are 
proposed: 1. Non-biological methods (e.g. QSAR). 
2. First-order in vitro tests (e.g. general cytotoxicity tests). 
3. Second-order in vitro tests (e.g. target organ tests). 
4. Essential tests in animals. 
5. Tests in human volunteers. 
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At each stage, if the data produced is adequate to establish the toxicity of the 
substance for its intended use, then no further testing need be done. 
Alternatively, the data could be used to refine the subsequent testing stages. 
THE USE OF ACUTE TOXICITY TESTS IN DRUG DEVELOPMENT 
Acute toxicity testing is no longer synonymous with the LDso test - there are 
several versions of the LDso test itself, plus new methods of assessing acute 
toxicity in animals which require fewer animals than an LDso test and which 
do not simply look at death as an endpoint. Acute toxicity testing during drug 
development is carried out for several reasons. At the research stage, 
screening tests are required in order to make decisions concerning the future 
of new compounds. The evaluation stage requires more-certain data on which 
to base further decisions. Finally, the development stage necessitates 
considerable amounts of toxicity data to be generated, partly to ensure product 
safety and partly to satisfy certain regulations. Acute toxicity data is required, 
amongst other reasons, to classify drugs for labelling purposes (transport 
regulations) and to provide dose ranges for chronic toxicity studies. Clark et 
al., (1991) support the development of non-mammalian alternatives to animal 
acute toxicity testing, particularly as pre-screens and for mode of action 
studies. It is unlikely that one non-mammalian alternative test or battery 
would be used for all the reasons that the animal acute tests are performed. 
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Summary 
The cytotoxicities to 3T3-Ll cells of 150 coded chemicals, estimated by the FRAME kenacid blue 
method, are given as a basis for further studies on the relative in vitro toxicities of related and 
distinct sets of test chemicals, and as a basis for future attempts at the companson and 
correlation of estimates of toxicity obtained in vitro and in vivo. 
The expression of the results of in vitro cytotoxicity tests is discussed, as are vanous ways 
of comparing values obtained for different chemicals. It is suggested that there should be 
agreement on the inclusion of a standard set of reference chemicals In all cytotoxicity test 
validation trials. 
Key words.' cytotoxicity, kenacid blue dye-binding, 3T3-Ll cells. validatlOn. in vitro tests. 
alternatives to animals. 
Introduction 
The FRAME cytotoxicity test involves the measurement of total cellular protein by a dye-
binding method after a 72-hour period of continuous exposure to the test chemical. The results 
from a four-centre blind trial with 50 chemicals and human BCL-Dl cells were published in 
1986 (1). Other studies have involved comparison of the effects of 50 chemIcals on 3T3-Ll cells 
as assayed by the FRAME kenacid blue and Rockefeller neutral red uptake methods. and the 
use of 24-hour and 72-hour exposure periods (2.3), Many of the same chemicals have also been 
tested with V79 cells. using 4-hour and 72-hour exposure periods (41. 
The main aim of this paper is to present the results of estImatIon of the cytotoxicitIes of 150 
coded chemicals tested with murine 3T3-Ll fibroblast-like cells, as a basis for further studies. 
including in vitro/in vitro and in vitro/in vivo comparisons, and studies on partIcular types of 
chemicals, e.g. metals, detergents, cosmetics ingredients and pesticide formulatIons. 
In addition, the highest concentration tested in our previous blind trials was 1000\Jg/ml. We 
have now re-tested chemicals found not to be toxic at that concentration, up to concentrations 
at which cytotoxicity could be determined. 
Materials and Methods 
3T3-Ll cell culture, test chemical addition, and the ken acid blue (KB) assay method were 
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performed according to previously published procedures (1.2). with the exception that some of 
the tests were earned out in 96-well plates. rather than In 24-well plates. Control studies 
inchcated that the SIZe of the culture well did not affect the results obtaIned. 
Test chemicals were supplied coded as part of the FRAME Alternative Test Validation 
Scheme. Chemicals likely to be Insufficiently soluble in aqueous media were dissolved initiallv 
in ethanol, methanol or dimethyl sulphoxide. according to guidelines issued with them. T h ~ ~
final concentration of organic solvents was always 1%, at which concentration the rate of 
control cell growth was not affected. 
Cells were treated 24 hours after plating, and the KB assay was carried out a further 72 
hours later. After a range-finding test with a wide range of test chemical concentrations. 
definitive cytotoxicities were obtained by testing a narrower range of concentrations on three 
separate occasions, with three culture wells per concentration. 
Dose-response curves were calculated from the results obtained. then the results were 
summarised as lD20, lD50 and lD80 values, i.e. the concentrations of test chemicals ( ~ g / m l ) )
which reduced the final cellular protein content of test wells by 20%, 50% and 80%. respectively, 
in comparison with that of solvent control wells. 
Results and Discussion 
Summary of results obtained 
The results obtained for the 150 test chemicals are given in Table I, where they are listed and 
numbered in lD50 value order. They show that the chemicals tested had a wide range of in VItro 
cytotoxicities. with ID50 values ranging from <0.01 to 1 3 4 . 0 0 0 ~ g / m l . .
The lD50 value is considered to be the best indicator of in VJtro cytotoxicity. since it is taken 
from the middle ofthe dose-response curve. Nevertheless. as we have observed previously (1.2), 
the ID20 and ID80 values also give useful information about the shape of the dose-response 
curve. For example, indium nitrate Ino. 082, Table 1) gave a much less steep dose-response 
curve than gadolinium chloride (no. 089). Similarly, while bendiocarb Ino. 035) and 
pentachlorophenol (no. 036) gave very similar lD50 values, the dose-response curve for 
pentachlorophenol was much steeper. 
Expression of results 
When chemicals are tested as part of the FRAME Alternative Test Validation Scheme, the 
results are submitted before the identities of the chemicals are revealed. Only then does it 
become possible for their molecular weights to be taken into account. Although it must be 
remembered that in vivo toxicities tend to be expressed in units of mglkg body weight, 
comparison of in vitro cytotoxicities based on molar concentration would seem to be preferable, 
since the toxic effects of most chemicals would be expected to be related to the number of 
molecules, rather than to the weight of each molecule. The use of molarities also facilitates the 
comparison of different assay systems (5). 
The results obtained for the 150 test chemicals are listed and ranked in Table II in order of 
ID50 values (rnM), as calculated from molecular weights and the estimated ID50 values I ~ g / m l ) )
taken from the dose-response curves. 
The positions of the chemicals do not differ markedly in Table I and Table II. except. as 
would be expected, in the case of chemicals with relatively high or low molecular weights. For 
example, Tweens 40.60,20.85 and 80; numbers 067,073.075.093 and 099 in Table I. move up 
to positions 36, 46, 47.5,58 and 60 in Table II. Similarly, PEG 1900 and PEG 5000 move up f ~ o m m
numbers 149 and 150 in Table I to positions 128 and 122 in Table II. By contrast. sodIUm 
fluoride, lithium fluoride and potassium fluoride move down from numbers 046. 052 and 065 In 
Table I to positions 79, 95 and 91.5 in Table II. 
It should be noted that precise molecular weights cannot be given for polymers. such as the 
Tweens and the polyethylene glycols. 
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Table I: In vitro toxicities of 150 test chemicals. determined by the FRAME 72.bour 
KB method with 3T3·LI cells. listed and numbered in order of ID50 values 
No. Test Chemical Solvent ID20 ID50 ID80 
~ g / m l l ~ g / m l l IJg/ml 
001 5· Fluorouracil 0 <0.01 <0.01 <0.01 
002 6-Mercaptopunne monohydrate 0 <0.01 <0.01 <0.01 
003 Acrolein E <0.01 <0.01 <0.01 
004 Rotenone 0 <0.1 <0.1 <0.1 
005 Vincriat.me sulphate W 0.01 ± 0 <0.1 >100 
006 Cycloheximide M <0.1 <0.1 0.3 = 0.1 
007 Cadmium (II) chloride W 0.1 ± 0 0.1 ±O 0.2 = 0.1 
008 Tribut.yltin chloride E 0.1 ± 0.01 0.3 ± 0.01 0.4 = 0 
009 Silver <Il nitrate W 1±0 2±0 2=0 
010 Vanadium(V) oxide W 0.2 ± 0.1 2±0 3 = 1 
011 p-Chloromercuribenzoic acid 0 <0.1 3±1 8 :: 1 
012 Copper (I) chloride W 2±0 3±0 5=1 
013 Copper(1Il chloride W 2±1 3±1 4 = 1 
014 Mercury ,II) chloride E 2±1 4±1 6=0 
015 Chlorpromazine hydrochloride W 3±0 5±1 i = 1 
016 Benzalkonium chloride W 4±1 7±0 9=2 
017 Chloroquine sulphate W 4±0 7=0 >10 
018 Colchicine E 2±1 8±1 >10 
019 Hexachlorophene E 3±1 9±2 14 =:2 
020 Zinc <II) chloride W 6±1 9=0 12:: 1 
021 p-Aminophenol 0 4±2 10 ± 1 33 :: 12 
022 Selenium (IV) oxide W 5±1 10± 2 15 = 2 
023 Cobalt. <II) chloride W 3±1 11 ± 1 24 = 6 
024 Propanolol hydrochloride M 8±1 12±0 14 = 0 
025 - DiethJlstilboest.rol E 4±1 14 ±3 60:: 17 
026 Triton X-100 W 2±2 14 ± 3 50 = 12 
027 Thallium (I) sulphate W 7±3 15 ± 3 25 = 5 
028 Manganese (II) sulphate tetrahydrate W 11 ± 2 15 ± 1 25 = 3 
029 Zinc<ll) acetate W 12 ± 1 15 ± 1 18 = 1 
030 Diethyl maleate E 12 ± 0 17 ± 2 27 = 3 
031 Thallium <II acetate W 9±1 17 ± 2 30 = 2 
032 6-Aminonicotinamide 0 11 ± 1 20±6 27 = 2 
033 Iron (II) sulphate heptahydrate W I 2O±9 I 
034 Tellurium <IV) chloride 0 8±1 22± 2 31 = 2 
035 Bendiocarb 0 7=2 30= 5 14i = 3 
036 Pentachlorophenol E 22 ± 1 31 ± 1 38:: 1 
037 Nickel< II, sulphate heptahydrate W 20± 3 33± 3 53:: 3 
038 Phenylbutazone 0 29 ± 1 45 = 1 65:: 3 
039 Veraalide E 30 ± 1 45 ± 1 >50 
040 Butylat.ed hydroxyani80le E 30 ± 1 45 ± 1 >50 
041 Ioxynil 0 32 ± 4 47 ± 1 5i :: 1 
042 Fungizone W 8±2 48± 3 85 
043 Retinoic acid 0 40 ± 10 49 ± 10 5i = 9 
044 Dieldrin 0 26± 2 50± 3 123 = 25 
045 Tin (II) chloride W 21 ± 6 53 ± 10 124 :: j 1 
046 Sodium <Il fluoride W 35±6 53±4 73 = 4 
047 Rhodium <1m chloride trihydrate W 26 ± 3 55 ± 2 100 :: 1 
048 Tin <IV) chloride pentahydrate W 34 64±3 98 
049 2.4-Dinitrophenol 0 34 ± 10 72±9 
Bi = 10 
050 Sodium tetrdthionate dihydrate W 33 ± 4 74 ± 5 
128::: :!2 
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No. Test Chemical Solvent ID20 ID50 ID80 Ilg/ml Ilg/ml Ilg/ml 
051 Nickel (II) chloride hexahydrate W 43 = 3 77 = 13 98 ± 18 052 Lithium (I) fluoride W 51 ± 12 77±25 142:= 24 053 Paracetamol M 44±4 90± 10 136:= 18 054 Sodium dodecylsulphate W 66± 11 94± 12 162 = 17 055 Phenacetin D 84± 1 95± 1 >100 
056 Palladium <II) chloride W 62 ± 14 103±2 U5 057 Methylparaben E 64 = 4 105 ± 16 >300 058 Lead (II) nitrate W 53± 21 119 ± 45 345 = 19 059 Lead (IV) tetra-acetate D 82 ± 22 119±5 286 = 34 060 1.2.4-Trichlorobenzene E 89 ± 11 122 ± 14 >200 
061 Acrylamide W <100 123±8 182± 8 062 Iron (lin sulphate W 37 = 7 123 ± 24 309 = 69 063 Naphthalene D 44± 13 123± 1 189 = 9 064 Dociecylbenzene sulphonic acid, 
sodiumaait W 120±6 137 ± 1 150= 2 065 Potassium (I) fluoride W 70 = 16 150±6 260± 25 
066 Beryllium (II) sUlphate tetra hydrate W 66±9 157 ± 17 387 ± 48 067 Tween 40 E 53± 5 159 ± 49 295 = 50 068 2.4-Dichlorophenoxyacetic acid M 70± 15 162 ± 19 >500 069 6-Methylcoumarin E 130± 7 169 ± 16 403 = 140 070 [ i j e t h y l p h ~ a t e e E 93±22 198±8 281 ± 8 
071 Chloramphenicol M 96 =28 226 ± 41 397 ± 42 072 2.Chloroqmnoline E 145 ± 25 233 ± 17 331 ± 42 073 Tween 60 E 146 ± 31 244 ± 27 345 = 9 074 Dexamethasone D 74 252 = 43 >400 075 Tween 20 W 123 ± 5 262 ± 43 396 ± 42 
076 Yttrium (m) nitrate hexahydrate W 227 ± 20 262±7 286± 3 077 Phenytoin D 57 ±3 265±44 >1000 078 Acrylonitrile E 147 ± 28 266±40 290 ± 16 079 Thioacetamide E 167 ± 11 274±8 >500 080 Warfarin D 187 ± 39 285±26 398 ± 25 
081 l·Octanol E 236±6 298±4 360= 2 082 Indium (fin nitrate hydrate W 26±3 303 ± 57 546 = 97 083 3·Chloroaniline E 97 = 11 308± 68 460 ± 138 084 L-A.scorbic acid W 295 ± 60 323± 58 351 ± 55 085 Ammonium chloride D 168 ± 47 337 ± 63 >500 
086 Allyl alcohol W 191 ± 23 355± 52 521 = 34 087 Phorone E 188 ± 16 378 ± 27 600 = 68 088 Bromobenzene E 284 ± 23 389±29 486 ± 38 089 Gadolinium (III> 
chloride hexahydrate W 360 ± 3 389±6 419 ± 12 090 Iproniazid phosphate W 117 ± 20 393 ± 37 420 = 76 
091 Lanthanum (III) 
chloride heptahydrate W 373 441 ± 34 567 = 19 092 Acetylsalicylic acid E 153 = 28 465±86 821 ± 52 093 Tween 85 E 253 ± 149 507 ± 50 821 = 7 094 Trichloroacetic acid W 311 ±69 524 ± 109 658 = 126 095 2.4.6-Trinitrobenzene sulphonic 
772 ± 11 acid W 269± 42 536±46 
096 Phenobarbital M <500 543 ± 15 917 = 34 097 Lithium (I) chloride W 343 ± 67 M4±95 810 = 73 098 Carbon tetrachloride E 506 ±32 600± 28 665 ± 32 099 Tween SO E 135 = 25 619 ±69 836± 9 
100 laozepac D 292±9O &U±38 >1000 
.. __ .... a"'y 
No. Test Chemical Solvent 1020 1050 ID80 ~ g / m l l ~ g / m l l ~ g / m l l
101 1.2-Dibromoethane D 589 645 = 240 924 ~ ~ 250 102 Imidazole D 371 ::t 44 688 = 12 >750 103 Frusemlde D 628 = 70 756 = 52 873 = 45 104 Aluminium I III) 
chloride hexahydrate W 738 ± 120 830=60 1050 = 82 105 Acetonylacetone W 798::t 34 937 = 23 >1000 
106 Banum I III acetate W 566 = 280 982 = 62 2470 107 I-Heptanol E 887 = 26 1010 = 86 1150 = 74 108 Caffeine W 330 = 30 1110 = 57 3240 = 310 109 Aluminium <III) 
110 
nitrate nonahvdrate 
L-Cysteine h y d ~ o c h l o r i d e e W 953 ± 75 1190 = 37 1280 
monohydrate W 498 = 120 1190:: 160 1650 
111 Aniline E 1320 ± 170 1480 = 330 2540 = 190 112 Chromium (II}) 
chloride hexahydrate W 857 = 160 1500 = 24 2170 = 84 113 Thiophene E 1240 = 31 1880 = 130 >2000 114 Cyclophosphamide W 1320 = 150 1800 = 490 2470 = 100 115 Isoniazid W 1320 = 78 2170 = 330 39iO = 730 
116 Lithium III sulphate W 953 = 210 2460=600 6460 = 2000 117 Lithium III bromide W 1790 = 390 3290 = 130 7050 = 630 118 1-Pentanol W 2880 = 490 3540 = 550 4160 = 610 119 I-Hexanol W 2580 = 530 3600 = 540 4320 = 960 120 Calcium I III chloride dihydrate W 2230 3860 8900 
121 Sodium benzylpenicillin W 1730 3970 = 78 6280 = 48 122 Strontium III) chloride hexahydrate W 1940 = 290 4060 = 220 10.900::t 940 123 Streptomycin sulphate W 1450 4160 = 430 6990 = 240 124 Potassium II) chloride W 3060 = 300 4360=200 5560 = 75 125 Lithium <Il iodide W 2470 = 810 4890= 460 7710 = 1100 
126 I-Butanol W 3320 = 970 4780 = 490 6320 = 570 127 Magnesium (II) chloride hexahydrate W 3260 = 420 5600 = 750 7910 = 960 128 Sodium chloride W 1790 = 700 6230 = 720 8390 = 660 129 Pyr-role W 5740 = 230 6570 = 310 7430 = 380 130 Potassium iodide W 3280 = 860 7260= 440 8790 = 440 
131 Potassium III bromide W 5900 = 140 7780 = 390 9540 = 360 132 Potassium (I) sulphate W 6270 = 990 7860= 690 9230 = 330 133 Sodium III sulphate W 609O± 890 8930= 560 10.000 = 390 134 Sodium (I) bromide W 7250 = 450 9840± 910 11.300 = 1000 135 Kanamycin sulphate W 2960 = 970 11.000 = 1200 19.200 
136 I-Propanol W 7580 = 480 11.200 = 480 17.000 137 Sodium III iodide W 8730 = 1700 11.800 = 1500 16.400:: 1300 138 1.2-Dichloroethane W 8020 = 1600 13.600 = 2800 15.900 = 4000 139 2-Propanol W 7750 = 1000 14.200 = 1400 25.200 140 Dimethylsulphoxide W 11,800 = 2100 22.400 = 1700 38.300 = 5000 
141 Acetonitrile W 14.300 = 710 23.100 = 2200 31.400 = 4000 142 1.2·Propanediol W 19,100 = 1900 28.000 ± 2600 46.200 = 8900 143 Acetone W 26,900 = 7400 35.900 = 8500 43.700 = 6700 144 Ethanol W 23.200 = 1700 36.100= 870 38.700 = 1300 145 D-Fructoee W 15.500 = 2100 39,200 = 1200 55,900 = 340 
-:-
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No. Test Chemical Solvent ID20 IOSO IDSO 
~ g / m l l ~ g / m l l ~ g / m l l
146 Ethyl acetate W 24.600 ± 4900 43.300 ± 5800 60.000:: 7100 147 Methanol W 36.500 ± 9800 46.100 ± 10.00047.500 ± 5300 148 D-Glucose W 36.400 ± 7600 48.500 ± 3900 57.900 ± 5200 149 PEG 1900 W 21.000 ± 6300 77.100 ± 5500 115.000 ± 2200 150 PEG 5000 W 22.500 ± 5100 134.000 ± 6400 >160.000 
Values gIVen are the mean ± standard error of the mean for the concentratIOns of test chemICals that reduced t ~ ~
(lnal cellular p r o ~ 1 n n c o n ~ n t t of test cells by 20% (]D20). 50% (]D50) and 80% (]D80) in companson wIth solvent 
control wells. I = Indeterminate; the POints around the ID20 and ID80 points of the dose.response curve were too 
vanable for values to be recordi!d with conficknce. Solvent code: D = dImethyl sulp/aozlde; E = ethanol; M = 
methanol; W = water. Some values are taken from the p u b l i . s ~ d d (2.3) and unpubli.shed work of Roumary J 
Riddell. . 
Companson of in vitro cytotoxicities 
If the measurement of in vitro cytotoxicity is to be useful. then ways of comparing values 
obtained with one in vitro method. with other in vitro methods. and. ultimately. with in vivo test 
procedures. must be devised. This is not straightforward. since the values themselves have no 
absolute significance and the various methods which could be used for comparing them all have 
drawbacks. 
Rank order can be a useful basis for comparison of tests carried out by different methods 
within an experiment. but this is only valid when the same set of chemicals has been used. Also. 
ranking tends to imply that differences between positions in the ranking are eqUIvalent. 
However. this is not necessarily the case. In Table II. for example. rank positions 22-42 cover 
a much narrower range of molarities than do rank positions 1 l ~ 1 3 0 . .
Categorisation is the basis of classification of in vivo toxicities. such as acute lethal toxicity. 
long-term toxicity and irritancy. and EEC regulatory guidelines name the categories as "very 
potent", }>otent", "marginal" and "no significant effect" (6,7). The chemicals listed in Table II 
could similarly be placed in four categories, according to their 1050 values. e.g. ~ 0 . 0 5 . . 0.06-1.0. 
1.1-10.0 and ;;::10.1mM. However, this drastically reduces the significance of the values 
obtained in the in vitro cytotoxicity test. because it does not reflect the precise position of a 
chemical within a category which contains a wide range of values. Also. as in all categorisation 
schemes, values at the end of one category and at the beginning of the next category tend to be 
closer than to some others within the same category. For example, the value for gadolinium 
chloride (1.0mM, Table II) would be closer to that for phenytoin (1.1mm), in the next category, 
than that for zinc chloride (O.07mM), in the same category. This is also reflected in their rank 
order positions, being 74.5, 76.5 and 26.5, respectively. 
The use of standard reference chemicals could provide the best basis for comparison of 
results obtained by different methods. For example, the following ten chemicals selected from 
Table II would have a wide range of 1050 values and positions in the rank order: 
Chemical 1050 (mM) Rank 
cadmium chloride 0.001 7.5 
colchicine 0.02 16 
pentachlorophenol 0.12 36 
dinitrophenol 0.39 58 
sodium fluoride 1.3 79 
trichloroacetic acid 3.2 96.5 
ammonium chloride 6.3 107 
isoniazid 16 116.5 
pentanol 40 127 
dimethyl sulphoxide 287 144 
in vnlV cywunocJty ':'0 
Table II: In vitro toxicities of the ISO chemicals tested by the FRAME 72·hour KB 
method with 3T3·L1 cells. listed in order of IDSO values (mM). together with 
number of listing in order of IDSO value ( ~ g / m l ) )
Rank No. Test Chemical MW ID50 IDSO 
~ g / m l l mM 
2.5 001 5-Fluorouracil 130 <0.01 <0.0001 
2.5 002 6·Mercaptopurine monohydrate 170 <0.01 <0.0001 
2.5 004 Rotenone 394 <0.1 <0.0001 
2.5 005 Vincristine sulphate 923 <0.1 <0.0001 
5 003 Acrolein 56 <0.01 <0.0002 
6 006 Cycloheximide 281 <0.1 <0.0004 
7.5 007 Cadmium (II) chloride 183 0.1 0.001 
7.5 008 Tributyltin chloride 326 0.3 0.001 
10.5 011 p-Chloromercuribenzoic acid 357 3 0.01 
10.5 010 Vanadium (IV) oxide 182 2 0.01 
10.5 009 Silver (I) nitrate 170 2 0.01 
10.5 015 Chlorpromazine hydrochloride 355 5 0.01 
16 014 Mercury (II) chloride 272 4 0.02 
16 017 Chloroquine sulphate 418 7 0.02 
16 018 Colchicine 399 8 0.02 
16 016 Benzalkonium chloride 353ave 7 0.02 
16 013 Copper (II) chloride 134 3 0.02 
16 019 Hexachlorophene 407 9 0.02 
16 026 Triton X-100 647ave 14 0.02 
20.5_ 012 Copper (I) chloride 99 3 0.03 
20.5 027 Thallium (I) sulphate 505 15 0.03 
22 024 Propranolol hydrochloride 296 12 0.04 
23.5 025 Diethylstilboestrol 268 14 0.05 
23.5 042 Fungizone 924 48 0.05 
26.5 031 Thallium (I) acetate 263 17 0.07 
26.5 020 Zinc (II) chloride 136 9 0.07 
26.5 028 Manganese (II) sulphate 
tetrahydrate 223 15 0.07 
26.5 033 Iron (II) sulphate heptahydrate 278 20 0.07 
29.5 029 Zinc(II) acetate 184 15 0.08 
29.5 034 Tellurium (IV) chloride 269 22 0.08 
32 023 Cobalt (II) chloride 130 11 0.09 
32 022 Selenium (IV) oxide 111 10 0.09 
32 021 p-Aminophenol 109 10 0.09 
34 030 Diethyl maleate 172 17 0.10 
36 036 Pentachlorophenol 266 31 0.12 
36 037 Nickel (11) sulphate heptahydrate 281 33 0.12 
36 067 Tween 40 1284 159 0.12 
39 041 Ioxynil 371 47 0.13 
39 044 Dieldrin 381 50 0.13 
39 035 Bendiocarb 223 30 0.13 
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Rank No. Test Chemical MW ID50 ID50 
~ g / m l l mM 
42 032 6-Aminonicotinamide 137 20 0.15 
42 038 Phenylbutazone 308 45 0.15 
42 043 Retinoic acid 300 49 0.16 
44 039 Versalide 258 45 0.17 
45 048 Tin <IV) chloride pentahydrate 351 64 0.18 
46 073 Tween 60 =1300 244 0.19 
47.5 047 Rhodium <III) chloride trihydrate 263 55 0.21 
47.5 075 Tween 20 1228 262 0.21 
49 050 Sodium tetrathionate dihydrate 306 74 0.24 
50 040 Butylated hydroxy anisole 180 45 0.25 
51 059 Lead (IV) tetraacetate 443 119 0.27 
52 045 Tin (II) chloride 190 53 0.28 
53 062 Iron <IIIl sulphate 400 123 0.31 
54 051 Nickel <II) chloride hexahydrate 238 77 0.32 
55 054 Sodium dodecyl sulphate 288 94 0.33 
56 058 Lead (II) nitrate 331 119 0.36 
58 093 Tween 85 =1300 507 0.39 
58 049 2,4-Dinitrophenol 184 72 0.39 
58 064 Dodecylbenzene sulphonic acid, 
sodium salt 349 137 0.39 
60 099 Tween 80 1310 619 0.47 
61 055 Phenacetin 179 95 0.53 
62 056 Palladium (II) chloride 177 103 0.58 
63 053 Paracetamol 151 90 0.60 
64 074 Dexamethasone 393 252 0.64 
65 060 1,2,4-Trichlorobenzene 182 122 0.67 
66 076 Yttrium (III) nitrate hexahydrate 383 262 0.68 
67 057 Methylparaben 152 105 0.69 
68 071 Chloramphenicol 323 226 0.70 
69 068 2,4-Dichlorophenoxyacetic acid 221 162 0.73 
70.5 066 Beryllium (Ill sulphate 
tetrahydrate 177 157 0.89 
70.5 070 Diethyl phthalate 222 198 0.89 
72 080 Warfarin 308 285 0.92 
73 063 Naphthalene 128 123 0.96 
74.5 082 Indium (IIIl nitrate hydrate 301 303 1.0 
74.5 089 Gadolinium (IIIl chloride 
hexahydrate 372 389 1.0 
76.5 077 Phenytoin 252 265 1.1 
76.5 069 6-Methylcoumarin 160 169 1.1 
78 091 Lanthanum (In) chloride 
heptahydrate 371 441 1.2 
79 046 Sodium (I) fluoride 42 53 1.3 
80.5 090 Iproniazid phosphate 277 393 ·1.4 
In vitro evtotoxicitv 
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Rank No. Test Chemical MW ID50 ID50 
~ g / m l l ruM 
80.5 072 2-Chloroquinoline 164 233 1.4 82 061 Acrylamide 71 123 1.7 83.5 095 2,4,6-Trinitrobenzenesulphonic 
, 
acid 293 ~ ~536 1.8 83.5 084 L-Ascorbic acid 176 323 1.8 86 103 Frusemide 331 756 2.3 
86 081 1-0ctanol 130 298 2.3 86 096 Phenobarbital 232 543 2.3 88.5 100 Isoxepac 268 644 2.4 88.5 083 3-Chloroaniline 128 308 2.4 90 088 Bromobenzene 157 389 2.5 
91.5 092 Acetylsalicylic acid 180 465 2.6 91.5 065 Potassium (I) fluoride 58 150 2.6 93 087 Phorone 138 378 2.7 94 123 Streptomycin sulphate 1458 4160 2.9 95 052 Lithium (I) fluoride 26 77 3.0 
96.5 109 Aluminium <III) nitrate 
nonahydrate 375 1190 3.2 96.5 094 Trichloroacetic acid 163 524 3.2 98.5 101 1,2-Dibromoethane 188 645 3.4 98.5 104 Aluminium (III) chloride 
hexahydrate 242 830 3.4 100 079 Thioacetamide 75 274 3.6 
101 106 Barium (11) acetate 255 982 3.8 102 098 Carbon tetrachloride 154 600 3.9 103 078 Acrylonitrile 53 266 5.0 104 112 Chromium (III) chloride 
hexahydrate 266 1500 5.6 105 108 Caffeine 194 1110 5.7 
106 086 Allyl alcohol 58 355 6.1 107 085 Ammonium chloride 54 337 6.3 108 114 Cyclophosphamide 279 1800 6.5 109 110 L-Cysteine hydrochloride 
monohydrate 176 1190 6.8 110 105 Acetonyl acetone 114 937 8.2 
111 107 1-Heptanol 116 1010 8.7 112 102 Imidazole 68 688 10 113 121 Sodium benzylpenicillin 356 3970 11 
114 097 Lithium (I) chloride 42 554 13 
115 122 Strontium <II) chloride 
hexahydrate 267 4060 15 
116.5 115 Isoniazid 137 2170 16 
116.5 111 Aniline 93 1480 16 
118 135 Kanamycin sulphate 581 11,000 19 
119 113 Thiophene 84 1680 20 
120 116 Lithium (I) sulphate 110 2460 .22 
R.H. Clothier et ai. 
Rank No. Test Chemical MW IDSO ID50 
~ g / m l l mM 
121 120 Calcium (II) chloride dihydrate 147 3860 26 122 150 PEG 5000 ==5000 134.000 27 123 127 Magnesium (II) chloride 
hexahydrate 203 5600 28 124.5 125 Lithium (I) iodide 134 4690 35 124.5 119 1-Hexanol 102 3600 35 
126 117 Lithium (I) bromide 87 3290 38 127 118 1-Pentanol 88 3540 40 128 149 PEG 1900 ==1900 77.100 41 129 130 Potassium (I) iodide 166 7260 44 130 132 Potassium (I) sulphate 174 7860 45 
131 124 Potassium (I) chloride 75 4360 58 132 133 Sodium (I) sulphate 142 8930 63 133 126 I-Butanol 74 4780 64 134 131 Potassium (I) bromide 119 7780 65 135 137 Sodium (I) iodide 150 11.800 79 
136 134 Sodium (I) bromide 103 9840 96 137 129 Pyrrole 67 6570 98 138 128 Sodium (I) chloride 58 6230 107 139 138 1.2-Dichloroethane 99 13.600 138 140 136 I-Propanol 60 11.200 186 
141 145 D-Fructose 180 39.200 218 
142 139 2-Propanol 60 14.200 236 
143 148 D-Glucose 180 48.500 269 
144 140 Dimethyl sulphoxide 78 22.400 287 
145 142 1,2-Propanediol 76 26.000 342 
146 146 Ethyl acetate 88 43.300 491 
147 141 Acetonitrile 41 23.100 562 
148 143 Acetone 58 35,900 617 
149 144 Ethanol 46 36.100 783 
150 147 Methanol 32 46.100 1441 
ID50 ualue (mM) is calculated using the ID50 concentration (lLglmiJ. as measured. and the 
molecular weight (MW). 
Thus. silver nitrate would be classed as less toxic to 3T3-Ll cells than cadmium chloride. but 
more toxic than colchicine; chloramphenicol would be classed as less toxic than dinitrophenol. 
but more toxic than sodium fluoride; pyrrole would be classed as less toxic than pentanol. but 
more toxic than dimethyl sulphoxide; and ethanol would be classed as less toxic than dimethyl 
sulphoxide . 
. -..... "": .. '. --
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Difficult chemicals 
The FRAME set of test chemicals for use m validation studies was deliberately chosen to mclude 
not only chemicals of known and different degrees and mechanisms of toXICltV. but also 
chemicals likely to cause difficulties when applied to continuous cell lines in c u l t u r ~ . .
For. example. the in vivo t o ~ i c i t y y of ~ ~ number of chemicals is mediated through the active 
productIon of reactIve metabolItes. which often results in organ-selectIve toxiCItv t 81. The 
~ ~ e e s y ~ t e m s s involved are ~ o t t l i k e l ~ ~ to be s ~ c i e n t l y y active in most cell lines to Penrut the 
IdentificatIon of such metabolism-mediated toXlC1ty. This is reflected in the low cvtotoXlCltv to 
3T3-Ll cells of chemicals such as bromobenzene. carbon tetrachloride, ~ l l v l l alcohol. 
cyclosphosphamide and aniline. which are known to be metabolised to toxic reactIve 
metabolites in vivo. 
Some of the other chemicals in the set are particularly volatile at 37°C. including 
acetonitrile. dichloroethane. thiophene and acrylonitrile. so the values obtained mav not be a 
true reflection of the effects of their interactions with 3T3-Ll cells. Particular care ';"as taken 
with cultures treated with these chemicals, because ifhigh concentrations of the test substance 
were close to the control wells, contamination could possibly occur. The plating was arranged to 
minimise this possibility, and on occasion two or more sets of controls were used. 
Other chemicals, such as acetone and carbon tetrachloride, reacted visibly with the plastic 
at higher range-finder concentrations. However, such high doses were not found to be close to 
the lD50 doses. 
Some chemicals in the set are only sparingly soluble in any of the four solvents used. 
including lead tetraacetate, iron (lIl) sulphate, aluminium chloride, aluminium nitrate and 
barium acetate. Thus, the cytotoxic concentration given may not accurately reflect the actual 
concentration to which the cells were exposed. if precipitation occurs. 
Finally, some of the test chemIcals are already present in the culture medium in significant 
amounts, including sodium chloride, potassium chloride, calcium chloride and glucose. These 
amounts are not included in the calculatIOn of toxicity of the chemicals concerned. as we prefer 
to determine the toxicity of added chemical, just as LD50 determinations do not take mto 
account the natural presence of a chemical within the bodies of test animals. 
All of these factors would be expected to affect in vitro cytotoxicity, and they must be 
recognised when one is interpreting and determining the value of the information provided by 
tests such as the FRAME KB test. 
Conclusions 
Rigorous validation and evaluation will be e ~ s e n t i a l , , if .the . ~ o t e n t i a ~ ~ value of in v i ~ r o o tests in 
toxicology is to be realised and usefully exploIted (9), ThIS wIll necessItate the estabhshment of 
an extensive amount of in vitro toxicity data and critical comparison and assessment of the 
various methods which are in the course of development. 
As a result of our experience both in establishing the FRAME Alternative Test Validation 
Scheme and as participants in it, we suggest that comparison between different in vitro tests 
will only be possible if an agreed set of standard reference chemicals are tested in all of them. 
The choice of such a set should reflect types of chemicals. as well as mechanisms of tOXICIty and 
also the availability and reliability of full in vivo toxicity proftles. 
The ten chemicals we have listed could be included in such a set, but it should also mclude 
chemicals which have been shown to have different cytotoxicities in different cell lines. such as 
phenacetin, paracetamol and aniline (3,4). 
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In Vitro Cytotoxicity of 24 Chemicals to Mouse Teratocarcinoma Cells 
Karen Atkinson, Lesley Hulme, Richard H. Clothier and Michael Balls 
DepartmentofHumanMorphology,UniuersityofNottinghamMedicalSchool,Queen'sMedical 
Centre, Nottmgham NG7 2UH, UK 
Introduction 
In vitro cytotoxicity assays involving undifferentiated permanent cell lines are now in 
widespread use. However, since differentiation is such a pivotal event in the maintenance of 
many adult tissues in vivo, and is of particular importance during embryonic. fetal and 
postnatal growth and development, it was decided to investigate the effects of chemicals on 
cells capable of differentiation in vitro. F9 was chosen as a suitable cell line. since F9 cells 
are derived from a mouse testicular teratocarcinoma and can be stimulated to differentiate 
in culture on exposure to retinoic acid < 1). an event which can be monitored according to both 
morphological and biochemical criteria. F9 cells have also been used extensively as an in vitro 
model in studies on early events in embryogenesis (21. -
The chemicals chosen included some of those recommended for use in the validation of 
in vitro tests for teratogenicity (3 L In the initial phase of this study. the baSIC cytotoxiCIty of 
24 chemicals to undifferentiated F9 cells was assessed. and the results were compared WIth 
values obtamed by the standard FRAME kenacid blue method with 3T3-Ll undifferentiated 
mouse fibroblast-like cells (4l. 
Materials and Methods 
Reagents 
The test compounds were supplied coded by FRAME (Fund for the Replacement of Ammals 
in Medical Experiments), as part of the FRAME Alternative Test Validation Scheme (5l. 
Cells 
F9 cells <obtained from Dr Ann Daly, Department of Dermatology, The Royal Victoria 
Infirmary, Newcastle-upon-Tyne, UK), were cultured according to the method of Daly & 
Redfern (6). 
Prior to use for cell culture. all culture surfaces were pre-rinsed with a 0.1 r;; gelatin 
solution <Sigma Chemical Co .. Poole. Dorset. UK l. After aspiration of excess gelatin, tissue 
culture plasticware was left to dry overnight before cells were plated. UndifferentIated F9 
cells were routinely maintained in 80cm;! flasks (Costar. Northumbria BiolOgicals Ltd, 
Cramlington. Northumbria. UK) in a humidified 5t;( CO:! atmosphere at 37°C. The culture 
medium used was Dulbecco's modified Eagle's medium (DMEM: Gibco Ltd. Paisley. UK), 
supplemented with: lOlk fetal calf serum (Gibeo). 100lU/mL sodium benzylpenicillin (Glaxo 
Laboratories Ltd. Greenford. Middlesex. UK) and 100pg/mi streptomycin sulphate (Evans 
Medical Ltd. Liverpool. UK). Before plating. the F9 cells were washed twice with pre-warmed 
phosphate buffered saline <PBS). and dissociated with 1ml trypsin/EDT A. 
Basic cytotoxicity testing 4' . 
F9 cells were plated at a seeding density of 5 x 10 cells/well. In 2 ~ ~ wells of a gelatIn-coated 
24-well plate (Costar). and incubated overnight. The last wel.l contamed no .cells and was used 
as a reference blank. Test chemicals were dissolved in medIUm or In medIUm contaInmg an 
organic solvent (ethanol or dimethyl sulphoxide). as recommended by FRAME. Orgamc 
solvents were kept at 1 rN· v/v. a concentration which did not adversely affect the rate of growth 
of control cells. 24 hours after plating, medium was aspirated. from the wells and replaced 
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Wlth a range of doses of test chemIcal. Three wells were treated Wlth medium alone \ medIum 
control) or medIUm contaInmg F7c solvent (solvent control). The cells were left exposed to the 
test chemIcal for a 48-hour period. The cells were then washed tWlce Wlth pre-warmed PBS 
before beIng fixed. staIned and assayed for total cellular protein bv the FRAME kenacid blue 
method (51. Dunng the exposure period. the cells were regularly' examIned for any changes 
In morphology. 
Initially, a range-finding test was carned out USIng a wide range of test chemical 
concentrations. Definitive cytotoxicities were then obtaIned by testIng a narrower range of 
concentrations on at least three separate occaSIons, Wlth three culture wells per concentration. 
Dose-response curves were calculated from the results obtained. and ID2o, I D ~ o o and IDso values 
estimated. l.e. the concentratIons of test chemIcal ( ~ g / m l ) ) which reduced the final cellular 
protein content of test wells by 2 0 ~ , , SOCk and 80'l1., respectively, in comparison Wlth that of 
solvent control wells. 
Table I: In vitro cytotoxicities of 24 chemicals to F9 cells 
Chemical 
S-Fluorouracil 
Colchicine 
6-AmInonIcotinamide 
Dieth y lstil boestrol 
Dexamethasone 
6-Methylcoumarin 
CadmlUm (II) chloride 
Acetylsalicylic acid 
Phenytoin 
Retinoic acid 
Pentachlorophenol 
Thalidomide 
2.4-Dinitrophenol 
ISOnIazid 
Caffeine 
Chloramphenicol 
Sacchann 
Trichloroacetic acid 
Cyclophosphamide 
SodlUm benzylpenIcillin 
Sodium (1) chlonde 
Methanol 
Ethanol 
Dimethyl sulphoxide 
I D 2 0 ~ g / m l l
± S.E.M. 
0.005 ~ ~ 0.001 
0.009 ± 0.007 
0.03 ± 0.01 
0.04 ± 0.02 
0.2 ± 0.1 
0.3 -+ 0.1 
0.5 ± 0.02 
1 + 0.3 
0.5 ± 0.1 
3 ± 1 
14 ± 1 
5 ± 0.3 
28 ± 3 
30 ± 7 
62 ± 29 
57 ± 19 
130 ± 20 
390 ± 60 
1100 ± 150 
1300 ± 260 
2400 ± 350 
10000 ± 1500 
12000 ± 2000 
21100 ± 1700 
"ma:umum solubiltty In aqueous medium 
;, n = 1 
I D 5 0 ~ g / m l l
::: S.E.M. 
0.007 -+- 0.002 
0.02 ± 0.01 
0.3 :!: 0.1 
0.3 ± 0.2 
0.7 ... 0.2 
0.7 ± 0.1 
1 ± 0.4 
3 ± 0.6 
7 ± 3 
9 ± 1 
20 ± 3 
33 ± 9 
57 ± 6 
60 ± 13 
111 ± 46 
272 ± 26 
330 ± 70 
790 ± 80 
1750 ... 210 
2600 -+- 390 
3600 ± 540 
20900 ± 1400 
21000 ± 3400 
28500 ± 1100 
I D 8 0 ~ g / m l l
::: S.E.M. 
>0.5 
0.03 ::! 0.02 
11 ::: 2 
8 ± 2 
>100 
54 ... lOe 
2 ::: 0.1 
203 ::: 92 
>200 
15 ::: 1 
30 ::: 3 
>500· 
86 
136 ± 33 
333 ::: 42 
614 ::: 172 
78001> 
>20000 
2650 -+- 310 
5900 -+- 140' 
5300 ::: 610 
70300 ... 3400 
38800 ::: 5700 
39200 ± 300 
' T ~ e = I E , , ID and ID are the concentrations of test chemical (llg/ml ) which reduces the f i n a ~ ~
c e l l u l a ~ l ~ r o t ; i n n conte':t of test wells by 20%, 50% and 80% respectIVely In comparlSon Wlt 
that of .o;oluent control wells. 
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Results and Discussion 
The ID2o, 1Dso and 1Dso values obtained for F9 cells following exposure for 48 hours to 24 test 
cherrucals ranged from 0.005 to 7 0 , 3 0 0 ~ g / m l l (Table D. The toxicity profIles were not all linear 
or exponential, i.e. the 1Dso value was difficult to estimate. This was particularly true for 
phenytOm and thalidomide, where problems of solubility were encountered. 
When the chemicals were ranked in order of 1Dso (mM) values for F9 cells alongside the 
values obtained for 3T3-Ll cells after 72 hours (4), there appeared to be substantial differences 
between the cytotoxicities for 3T3-Ll cells and undifferentiated F9 cells for some of the 
chemicals tested, e.g. dexamethasone, 6-methylcoumarin, caffeine and thalidomide <Table Ill. 
As is the case with F9 and 3T3-Ll cells, it is not always possible to maintain different 
cell lines under the same conditions. The standard kenacid blue test uses an exposure penod 
of 72 hours, during which time control 3T3-Ll cells would be expected to remain in the 
exponential growth phase. However, F9 cells grow more rapidly, and reach the plateau phase 
before 72 hours. 
Table II: In vitro cytotoxicities of 24 chemicals to F9 and 3T3·Ll cells 
Chemical F9 3T3-Ll a 
ID50 (mM) ID50 (mM) 
Colchicine <0.0001 0.02 
5-Fluorouracil <0.0001 <0.0001 
Diethylstilboestrol 0.001 0.05 
Dexamethasone 0.002 0.64 
6-Aminonicotinamide 0.002 0.15 
6-Methylcoumarin 0.005 l.1 
Cadmium (II) chloride 0.006 0.001 
Pentachlorophenol 0.007 0.12 
Acetylsalicylic acid 0.02 2.6 
Phenytoin 0.03 l.1 
Retinoic acid 0.03 
0.16 
<l.9b Thalidomide 0.13 
2,4-Dinitrophenol 0.31 0.39 
Isoniazid 0.44 16 
Caffeine 0.57 5.7 
Chlorophenicol 0.84 0.70 
Saccharin 1.6 25 
Trichloroacetic acid 4.8 3.2 
Cyclophosphamide 6.3 6.5 
Sodium benzylpenicillin 7.3 11 
Sodium chloride 62 107 
Dimethylsulphoxide 365 287 
Ethanol 458 783 
Methanol 652 1141 
Ataken from Clothier et al. (1988), except for saccharin and thalidomide (preuLOusly 
unpublished) . 
"maximum solubility in aqueous medIUm l II La . t t 
The ID is the concentration of test chemical which reduced the {ina ce u r protein con en 
of test :ells by 50% in comparison with that of appropriate solvent control wells 
. 
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In the presence of 0.1 x 106M retinOlc acid. F9 cells can be mduced to differentiate. 
Undifferentiated F9 cells in culture are relatively small and rounded in appearance. anci are 
densely packed; however. after a 48-hour exposure to this concentratIOn of retinOlC aCld. the 
cells became larger and paler. and several developed long processes. Since such changes In 
cell appearance are thought to give an indication of cellular differentiation. F9 cells were 
observed at regular intervals during the determination of the baslc cytotoxicities of all the 
test compounds, in an effort to establish whether any of the chemicals were capable of inducing 
differentiation. With the exception of retinoic acid, microscopical observation Indlcated little 
change in the appearance of the cells. 
When linear regression analysis was performed on Log 1DsomM (F9) versus Log IDsomM 
(3T3-Ll) values, a correlation coefficient of 0.88 was obtained. Differences between the I D ~ o o
values of the two cell lines with the chemicals tested support the concluslon of Riddell et al. 
(7) that different cell lines may not always exhibit similar susceptibilities to the CytotOXlC 
effects of chemicals. 
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The in vitro cytotoxicities of 59 chemicals, expressed as 1050 values (i.e., concentra-
tions of test chemicals that reduced the final cellular protein content of test cultures 
by 50% in comparison with appropriate solvent control cultures) and obtained uSing 
murine 3T3-L 1 cells and the FRAME kenaCid blue method, have been compared With 
rat oral and mouse Intraperitoneal (ip) L050 values. A better In Vivo/in vitro correlation 
was obtained for the 59 chemicals with mouse Ip L050 values (r - .80) than With rat 
oral L050 values (r - .76), but the best in vivo/in vitro correlation was found when the 
most toxic of the rat and mouse values were used in the compaflSon (r - .81). 
INTRODUCTION 
Much attention has recently been focused on the potential value of 
in vitro tests for identifying chemicals likely to cause ocular and dermal 
irritation (e.g., Reinhardt et aI., 1985; Frazier et aI., 1987), but less consid-
eration is being given to their use in predicting other expressions of 
acute toxicity resulting from short-term exposure. 
The FRAME cytotoxicity test for assessing the relative acute in vitro 
toxicities of chemicals was developed through the collaboration of four 
tissue culture laboratories, with the support of a number of industrial 
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Requests for reprints should be sent to Or. R. H. Clothier. Department ot Human Morphotogy, 
University of Nottingham, Queen's Medical Centre, Nottingham NG7 2UH, Untted Kingdom. 
571 
MoIecu .... ToxicololY, 1:571-517, 1987 
rAft ........ © 1987 by Hemisphere Publishinl C o r p o r ~ t i o n n
572 R. H. CLOTHIER ET Al. 
companies (Balls and Horner, 1985; Knox et aI., 1986). The method in-
volves determination of the concentration of test chemical that inhibits 
ce,lI p r o l i f e r a t i ~ n , , ~ a l c u l a t e d d from measurements of total cellular pro-
tein by a dye-binding method after a 72-h exposure period. The results 
of a blind trial with 50 coded chemicals and human BCL-D1 fibroblast 
like cells i!'dicated that the test p ~ o . c ~ d u r e e gave results with a high 
degree of Interlaboratory reproducibility (Knox et aI., 1986). Riddell et 
al. (1986) compared the cytotoxicities of these 50 chemicals to BCL-D1 
and murine 3T3-L 1 fibroblastlike cells and found that there were sub-
stantial differences with eight test chemicals. Agreement between the 
results obtained with different cell lines, with some notable exceptions, 
was also found by Garle et al. (1987), who studied the effects of 27 of 
the FRAME chemicals on hamster V79 cells. 
A set of more than 150 blind trial chemicals has now been collected 
with the advice and assistance of the FRAME Research Advisory Com-
mittee on Cytotoxicology. The set of chemicals comprises chemicals 
with known and different degrees and mechanisms of toxicity, some of 
which are unstable, volatile, or insoluble in water, or are metabolically 
activated or detoxified in vivo. These chemicals form the basis of the 
FRAME Alternative Test Validation Scheme (Balls and Horner, 1985). 
In vivo/in vitro validation studies are complicated and difficult to 
organize, carry out, and evaluate (Balls and Clothier, 1989). One of the 
biggest problems is the informed but unbiased selection of appropriate 
in vivo toxicity data of sufficiently high quality, since data are available 
from yarious laboratories, obtained with a variety of species, strains, 
and treatment routes. The Central Toxicology Laboratory of Imperial 
Chemical Industries (lCI) pic is supporting FRAME through the provi-
sion of in vivo toxicity profiles for chemicals included in the FRAME 
validation set (Purchase et aI., 1986). Summaries of profiles for 50 of the 
FRAME blind trial chemicals have been published (Purchase et aI., 1987). 
An alternative and comprehensive source of information is the Registry 
of Toxic Effects of Chemical Substances (RTECS) of the U.S. National 
Institute for Occupational Safety and Health (Lewis and Tatken, 1980). 
Fry et al. (1988) have recently drawn a t t e ~ t i o ~ ~ to the wide , r ~ ~ g e e of 
routes and species used in assessing the In VIVO acut,e t o x l c l ~ l e s s of 
chemicals. They have recommended the use of mouse intraperitoneal 
(ip) or intravenous (iv) LD50 values in preference to rat oral LD50 values 
suggested by Balls and Horner (1985), mai!,ly on the grounds that the 
cells used in in vitro cytotoxicity tests are directly e x p o ~ e d d to t e s ~ ~ c h ~ m m
icals, as are cells receiving chemicals by the Ip or IV rO,ute In, VIVO, 
whereas only a fraction of an oral dose may become available In the 
systemic circulation. , ' ' 
We have recently published the ~ e s u l t s s o ~ ~ a blind tnal ,With 150 
coded chemicals and murine 3T3-L 1 flbroblasthke cells ( C l o t h ~ e r r ~ t t a,l., 
1988). In this paper, as a contribution to consideration of how In VIVO/In 
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vitr? .c?mparisons should be carried out, we have compared the in vitro 
toxIcities of some of these chemicals with published in vivo acute toxic-
ity data. 
IN VIVO/IN VITRO COMPARISONS 
In the ICI toxicology profiles, toxicity is classified and tabulated as 
very potent, potent, marginal, or without significant effects, broadly 
according to guidelines given for acute and long-term toxicity in Annex 
(VII)D to the Vlth Amendment of the EEC Directive on the Classification 
of Dangerous Substances (67/548/EEC). However, although comparison 
of in vitro numerical values and in vivo toxicity categories is possible, 
where numerical expressions of in vivo toxicity can reasonably be ob-
tained from the literature, the comparison of two sets of quantitative 
data is more straightforward. We have therefore calculated rat oral and 
mouse ip LD50 values from the data given in the ICI toxicology profiles 
(Purchase et aI., 1986), expressed in Table 1 as the mean of the range of 
values given (mg/kg) + the standard error of the mean. 
These rat and mouse L050 values were used to calculate the in vivo 
toxicities (mmol/kg) in Table 2. For chemicals for which no ICI profiles 
were available, values were taken from RTECS (Lewis and Tatken, 1980). 
Table 2 also contains the in vitro cytotoxicity results taken from Clothier 
et al. (1988), given as 1050 values, the 1050 value being the concentra-
tion of test chemical (mM) that reduces the final total cellular protein 
content of test wells to 50% of that of appropriate solvent control wells. 
Although rat oral LD50 values were available for 94 of the 1S0 
FRAME test chemicals, and mouse ip LD50 values were available for 86 
of them, both rat oral and mouse ip data were found for only S9 of the 
chemicals. These 59 chemicals are included in Table 2, and this was the 
only reason for their selection from the 150 in the full set. 
When linear regression analysis was used to compare the in vitro 
(log ID50) values and the rat and mouse in vivo (log LDSO) acu.te toxici-
ties, the following correlation coefficients (r values) were obtamed: 
Rat oral/in vitro 
Mouse ip/in vitro 
Most toxic (rat or mouse)/in vitro 
Least toxic (rat or mouse)/in vitro 
DISCUSSION 
r -
r -
r -
r -
.76 
.80 
.81 
.78 
It will not be possible to fully e.valu.ate t h ~ ~ ~ e l e v a n c e e .of in v i t ~ o o
cytotoxicity measurements to acute m VIV? tOXICity, or their p o t e n t l ~ 1 1
value in replacement alternative tests, until a large number of chemi-
cals have been tested in a variety of test systems. We have been able to 
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TABLE 1. Rat Oral and Mouse ip LD50 Values Calculated from the ICI Toxicology P r o f i l e s ~ ~
Chemical Rat oral LD50 Mouse Ip LD50 (mglkg) (mglkg) 
Acetonitrile 3730 ± 500 (12) 336 ± 77 (4) Acetonyl acetone 2150 (2) 1600 (1) A c e ~ l s a l i c Y l i c c acid 1780 ± 180 (13) 340 ± 32 (3) Acro ein 
Acrylamide 36 ± 8 (4) :- (1) 197 ± 15 (10) 170 (1) Amonitrile 109 ± 12 (9) 39 ± 8 (4) A (versalide) 316 (1) n.a. p-Aminophenol 519 ± 86 (3) n.a. Aminophylline 384 ± 43 (3) 244 ± 10 (4) Aniline 486 ± 74 (5) 492 (1) l-Ascorbic acid n.a. 1760 ± 590 (3) Bendiocarb 139 ± 26 (5) n.a. Benzalkonium chloride 405 ± 49 (9) 10 (1) Bromobenzene 2570 ± 410 (4) 1000 (1) B u ~ l a t e d d hydroxyanisole 3320 ± 420 (8) n.a. Ca eine 350 ± 89 (9) 268 ± 9 (3) Chloramphenicol 2500 (1) 1270 ~ ~ 20 (4) p-Chloromercuribenzoic acid n.a. 38 (2) Chloroquine 832 ± 114 (4) 73 (2) Chloropromazine 329 ± 116 (4) 114 ± 13 (3) Colchicine n.a. 3.9 ± 1.7 (4) Cyclohexi m ide 2.1 ± 0.2 (3) 138 (1) Cyclophosphamide 219 ± 73 (8) 461 ± 86 (6) 
2,4-Dichlorophenoxyacetic acid 1490 ± 400 (11) 263 (2) 
Diethylstilbestrol n.a. 67 ± 28 (1 +) 
Dimethyl sulfoxide 16,900 ± 3200 (9) 13,100 ± 1500 (8) 
2,4-Dinitrophenol 37 ± 4 (3) 26 (1) 
Ethanol 13,200 ± 1800 6000 ± 890 (5) 
D-Glucose 25,000 (1) n.a. 
loxynil 161 ± 31 (8) n.a. 
Iproniazid 312 ± 62 (3) 5% ± 49 (7) 
Isoniazid 2350 ± 400 (4) 138 ± 7 (3) 
Lithium chloride 764 ± 202 (3) n.a. 
Methanol 10,000 ± 800 (9) 8,400 ± 2310 (3) 
6-Mercarctopurine 382 (1) 251 ± 22 (7) 
6-Methy coumarin 1680 (1) n.a. 
Methylparaben n.a. 860 (2) 
Phenacetin 2570 ± 410 (10 1040 ± 200 (6) 
Phenobarbital 349 ± 77 (6) 231 ± 43 (4) 
Phenylbutazone 742 ± 92 (8) 259 ± 47 (3) 
Phenytoin 2140 ± 310 (3) 220 ± 30 (4) 
Potassium iodide n.a. 1120 ± 30 (1 +) 
Retinoic acid 2000 (1) 425 (2) 
Sodium chloride 4300 ± 620 (4) 3100 (1) 
Sodium dodecyl sulfate 1860 ± 400 (3) 250 (1) 
Thioacetamide n.a. 300 (1) 
Warfarin 74 ± 29 (11) n.a. 
"Values given represent the mean ± SEM of (n) individual rat oral or mouse ip LD50 values 
given in the full ICI toxicology profiles (Purchase et aI., 1986). Data from rats under 3 mo old and 
"average lethal dose" values were excluded from the calculation. The value for Am was kindly 
provided by Stephen Pennisi (see Purchase et aI., 1987). n.a., Not available; (1 +) - mean of an 
unspecified number of values. 
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TABLE 2. In V i ~ r o o Toxicities of 59 Chemicals. Tested by the FRAME 72-h KB Method with 3T3-L 1 
Cells. and In VIVO Toxicities Based on Rat Oral and Mouse ip LOSO Oata 
L050 (mmol/kg) 
Chemical 1050 (mM),i Rat oral Mouse Ip 
6-Mercaptopurine 
monohydrate 0.0001 2.5 1.7 
Rotenone 0.0001 0.34 0.01 
Acrolein 0.0002 0.64 0.13 
Cycloheximide 0.0004 0.01 0.49 
Cadmium(11) chloride 0.001 0.48 0.05 
Chlorpromazine hydrochloride 0.01 0.93 0.32 
Mercury(1I) chloride 0.02 0.004 0.02 
Chloroquine sulfate 0.02 2.6 0.23 
Benzalkonium chloride 0.02 1.1 0.03 
Copper(lI) chloride 0.02 1.0 0.06 
Zinc(lI) chloride 0.07 2.6 0.23 
I ron(ll) sulfate 
heptahydrate 0.07 2.1 0.42 
Zi nc(ll) acetate 0.08 14 0.31 
Cobalt(ll) chloride 0.09 0.62 0.38 
Phenylbutazone 0.15 2.4 0.84 
Retinoic acid 0.16 6.7 1.2 
lin(lI) chloride 0.28 3.7 0.35 
Nickel(ll) chloride 
hexahydrate 0.32 0.81 0.20 
Sodium dodecyl sulfate 0.33 6.5 0.87 
2,4-Dinitrophenol 0.39 0.20 0.14 
Phenacetin 0.53 14 5.8 
Palladium(lI) chloride 0.58 1.1 0.59 
Paracetamol 0.60 16 2.4 
Chloramphenicol 0.70 7.7 3.9 
2,4-Dichlorophenoxyacetic 
acid 0.73 6.7 1.2 
Naphthalene 0.96 14 1.2 
Phenytoin 1.1 8.5 0.87 
Lanthanum(111) chloride 
heptahydrate 1.2 17 0.49 
Sodium(l) fluoride 1.3 4.3 1.2 
Iproniazid 1.4 1.7 
3.3 
Acrylamide 1.7 2.8 
2.4 
Phenobarbital 2.3 1.5 
1.0 
Bromobenzene 2.5 16 
6.4 
Acetylsalicylic acid 2.6 9.9 
1.9 
1.2-Dibromoethane 3.4 0.57 
1.2 
Carbon tetrachloride 3.9 18 
30 
Acrylonitrile 5.0 2.1 
0.74 
~ h e e 1050 value is the concentration of test chemical (mM) that reduced the final cellular 
protein content of test wells by 50% in comparison with that of appropriate solvent control 
wells. 
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TABLE 2. In Vitro Toxicities of 59 Chemicals. Tested by the FRAME 72-h KB M h d Cells d I v· 1 ... et 0 with 3T3-L 1 
• an n IVO OXlcltles Based on Rat Oral and Mouse ip LD50 Data 
LD50 (mmol/kg) 
Chemical ID50 ( m M ) ~ ~ Rat oral Mouse Ip 
Chromium(lll) chloride 
hexahydrate 5.6 6.7 2.0 
Caffeine 5.7 1.8 1.4 
Allyl alcohol 6.1 1.1 0.72 
Ammonium chloride 6.3 31 9.0 
Cyclophosphamide 6.5 0.79 1.7 
Acetonyl acetone 8.2 19 14 
lithium(l) chloride 13 18 14 
Strontium(lI) chloride 
hexahydrate 15 14 5.7 
Isoniazid 16 17 1.0 
Aniline 16 5.2 5.3 
Calcium(1I) chloride 
dihydrate 26 9.0 2.5 
Magnesium(ll) chloride 
hexahydrate 28 40 1.0 
Sodium(l) iodide 79 29 5.8 
Sodium(\) chloride 107 74 53 
2-Propanol 236 97 16 
Dimethyl sulfoxide 287 217 168 
1,2-Propanediol 342 263 150 
Ethyl acetate 491 125 8.1 
Acetonitrile 562 91 8.2 
Acetone 617 168 22 
Ethanol 783 287 130 
Methanol 1441 313 263 
~ h e e ID50 value is the concentration of test chemical (mM) that reduced the final cellular 
protein content of test wells by 50% in comparison with that of appropriate solvent control 
wells. 
compare the in vivo and in vitro toxicities of 59 chemicals, including 
organic solvents, metal salts, and pharmaceuticals. Since no allowance 
was made for the chemicals deliberately included in the FRAME set 
because they would cause difficulties for in vitro cytotoxic test systems, 
the good correlations found between the in vitro 1050 values and either 
rat oral or mouse ip LOSO values were encouraging. The correlation 
with mouse ip values was better than that with rat oral values, which 
supports the suggestion of Fry et at. (1988). 
The best in vivo/in vitro correlations were obtained when the most 
toxic of the rat oral or mouse ip values or the mouse ip values alone 
were used in the comparison. Fry et at. (1988) suggested that LDSO val-
ues determined in the most sensitive species of those for which a rea-
sonable database exists should be used for in vivo/in vitro comparisons. 
COMPARISON OF IN VITRO/IN VIVO DATA 
They were referring to ip or iv LD50 values, but the use of ip, iv, or oral 
LD50 values at this stage of development of in vivolin vitro comparative 
studies might also be considered more reasonable. 
Another approach to in vitro test validation is to consider groups of 
related compounds, such as surfactants, metals, or alcohols. This de-
pends on having sufficient data for a meaningful comparison to be 
made. Our experience with metallic compounds (Hulme et aI., 1989), 
however, indicates that the in vivo/in vitro correlation coefficients ob-
tained with mouse ip are better than for the 59 unrelated chemicals 
considered in this paper. 
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The FRAME in vitro cytotoxicity assay and a physicochemical parameter for metal ions 
(i.e., "sohness," a,; were assessed for their ability to predict the in vivo acute toxicities 
of 52 metallic compounds. The in vitro assay was found to be more useful, since it 
measures the toxicity of the whole compound, as does the in vivo method. The soh-
ness parameter applies to the metal ion only, so it cannot be used to predict the 
toxicity of compounds containing relatively nontoxic metal ions and toxic anions 
(e.g., potassium fluoride). The in vitro toxicity values (expressed as 1050 values, i.e., 
concentrations of test chemicals that reduced the final cellular protein content of test 
cultures by 50% in comparison with appropriate solvent control cultures) correlated 
better with mouse ip L050 values than with rat oral LQ50 values. 
INTRODUCTION 
The exposure of living organisms to metallic compounds is increas-
ing, but the potential toxic hazard of most metals remains poorly un-
derstood (Friberg and Nordberg, 1986). At present, the vast majority of 
toxicity tests are conducted on laboratory animals. However, relatively 
This work was supported by the industrial sponsors of the FRAME Research Programme. 
Requests for reprints should be sent to Dr. R. H. Clothier, Department of Human Morphology, 
University of Nottingham, Queen's Medical Centre, Nottingham NG7 2UH, United Kingdom. 
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simple , a n ~ ~ rapid in vitro assays are now being developed that could act 
as preliminary screens and possibly replace the need for animal tests 
altogether (Balls and Horner, 1985). The use of quantitative structure-
activity relationship models (involving parameters such as metal "soft-
ness") is also increasingly a part of the initial phase of toxicity assess-
ment (Balls, 1986). 
T h ~ ~ FRAME test is a straightforward and reproduCible method for 
assessmg acute basal cytotoxicity (Knox et aI., 1986). The results of a 
blind trial with 150 chemicals and mouse 3T3-L 1 fibroblastlike cells 
have r e ~ ~ ~ t l y y been published (Clothier et aI., 1988). In this paper, the 
cytotoxIcities of 52 metallic compounds (expressed in terms of the 
I ~ 5 0 0 value, i.e., the concentration of test chemical required to reduce 
fmal total cellular protein to 50% of appropriate solvent control levels 
after a 72-h exposure period) are compared with published in vivo 
acute toxicities. 
Rat oral LD50 values are widely used as indices of acute toxicity. 
However, Fry et aL (1988) have recently suggested that data obtained 
following exposure by the intraperitoneal (ip) or intravenous (iv) route 
might be more appropriate for comparison with in vitro cytotoxicity test 
results. Both rat oral and mouse ip LD50 values were therefore used in 
ou r analysis. 
A physicochemical parameter, namely, the Iisoftness" of the metal 
ion, has been compared with in vivo and in vitro metal ion acute toxic-
ity (Williams et aL, 1982; Cox and Harrison, 1983; Tan et aL, 1984; Ba-
bich et aL, 1986). The IIsoftness" of a metal ion governs its metal-
ligand interactions, but the biological significance of this (in terms of 
metal-ligand binding as the toxic mechanism) is questionable. There is 
some controversy concerning the capacity of the softness parameter 
to predict the in vivo acute toxicities of certain groups of metals (Wil-
liams et aI., 1982; Kaiser, 1985). We therefore carried out in vitro/soft-
ness and in vivo/softness comparisons, in addition to the in vivo/in 
vitro comparisons. 
MATERIALS AN D METHODS 
3T3-L 1 cells were cultured, exposed for 72 h to the test chemicals, 
and then final cellular protein content was determined by the ,kenacid 
blue assay method, as previously described (Knox et aL, 1986; Riddell et 
aI., 1986). Pb(CH]COO) .. and CrCI3·6H 20 were obtained from Sigma 
Chemical Co. Ltd., Poole, Dorset, UK, and KCI, CaCI 2 • 2H 20, 
Ba(CH]COO)2, AICI]' 6H 20, SnCI .. · 5H 20, CuCI 2, Zn(CH3COO)u Mn-
50 '4H ° Ni50 ... 7H 20, Fe50 ... 7H20, Fe2(SOJ3, and BeS04 '4H 20 were o b t ~ i n e d d from BDH Ltd., Dagenham, Essex,. UK. The r e m a i ~ i ~ g g com-
pounds were obtained from Aldrich Chemical Co. Ltd., Gillingham, 
Kent, UK. The test compounds were dissolved directly into culture me-
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Pb(CH 3COO)4 and TeCI4, which were dissolved in dimethyl sulfoxide 
(DMSO). The DMSO was diluted to 1 % final concentration in the test 
solution according to a previously published protocol (Riddell et aI., 
1986). 
Metal salts present as components of the cell culture medium were 
1.8 mM calcium(ll) chloride, 0.3 x 10- 3 mM iron(lll) nitrate, 5.4 mM 
potassium(1) chloride, 0.81 mM magnesium(ll) sulfate, 110 mM sodium(l) 
chloride, 45 mM sodium(l) hydrogen carbonate, and 0.9 mM sodium(l) 
dihydrogen phosphate. 
Acute in vivo toxicity data (rat oral and mouse ip LD50 values) were 
taken from the ICI Toxicology Profiles (Clothier et al., 1989) or, if not 
available from this source, from the NIOSH Registry of Toxic Effects of 
Chemical Substances (Lewis and Tatken, 1980). 
The "softness" (up) of a metal is defined in terms of the coordinate 
bond energies (CBE) of the iodide (I) and fluoride (F) of the metal: 
CBE(F) - CBE(I) 
u -
p CBE(F) 
Softness values were taken from Williams et al. (1982), except those for 
L"+ N + K+ C + C 2+ F 2+ S 2+ AI)+ y3+ d L 3+ h" h k I, a, , u, a , e , n, , , an a, w IC were ta en 
from Pearson and Mawby (1967). 
Linear regression analysis was performed on in vivo versus in vitro 
values, in vivo versus softness values, and in vitro versus softness val-
ues, using log ID50, log LD50, and log up values. 
RESULTS 
The ID50 values (mM) for the 52 compounds tested are shown in 
Table 1, and range from 0.001 mM to more than 100 mM. Selected in 
vivo data (namely, rat oral and mouse ip LD50 values) are also given, 
where available, along with softness values. 
The results for different salts of the same metals (e.g., lithium, so-
dium, and potaSSium, Table 1) indicate that the toxicity of the anion of 
the metallic compound is also of great importance. Of the halides, fluo-
rides are clearly the most toxic in vitro. Sulfates also appear to be 
slightly more toxic than the chlorides, bromides, and i o d i ~ e " s : : Since 22 
chlorides were tested, direct comparison between the toxIcities of the 
metal ions is possible. " 
Comparison of in vitro and in vivo ~ o x i c i t i e s s g a ~ e e good c o ~ r e l a t l o n s s
(Table 2a) with in vitro results correlating better With mouse Ip values 
(r - .86) than with rat oral values (r - .73). The correlation coefficients 
were slightly higher for the chlorides than for all the m e t ~ 1 1 compounds 
(r - .90 and .75 for mouse ip and rat oral values, respectively). 
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TABLE 1. In Vitro Cytotoxicities of 52 Metallic Compounds to 3T3-L 1 Cells. with Rat Oral LD50. 
Mouse ip LDSO. and Softness ( a ~ ~ Values 
LDSob LDSob 
IDSoa rat oral mouse ip Softness' 
(mM) (mmol/kg) (mmollkg) ( a ~ ~
Cadmium(ll) chloride 0.001 0.48 0.05 0.081 
VanadiumM oxide 0.01 0.05 
Silver(l) nitrate 0.01 0.13 0.073 
Mercury(lI) chloride 0.02 0.004 0.02 0.064 
Copper(ll) chloride 0.02 1.0 0.06 0.104 
Copper(l) chloride 0.03 2.7 0.112 
Thallium(l) sulfate 0.03 0.215 
Thallium(l) acetate 0.07 0.14 0.215 
Zinc(ll) chloride 0.07 2.6 0.23 0.115 
Manganese(11) sulfate' 4H2O 0.07 2.4 0.124 
I ron(1I) sulfate' 7H2O 0.07 2.1 0.42 0.129 
Zinc(1I) acetate 0.08 14 0.31 0.115 
Teliurium(lV) chloride 0.08 
Cobalt(1I) chloride 0.09 0.62 0.38 0.130 
Selenium(lV) oxide 0.09 
Nickel(1I) sulfate' 7H2O 0.12 0.14 0.126 
Tin(lV) chloride' 5H2O 0.18 0.18 0.075 
Rhodium(lll) chloride'3H2O 0.21 0.055 
Sodium(l) tetrathionate' 2H2O 0.24 0.211 
Lead(lV) tetraacetate 0.27 
Tin(ll) chloride 0.28 3.7 0.35 0.148 
I ron(1I1) sulfate 0.31 0.097 
Nickel(lI) chloride' 6H2O 0.32 0.81 0.20 0.126 
Lead(ll) nitrate 0.36 0.131 
Palladium(ll) chloride 0.58 1.1 0.59 0.069 
Yttrium(lll) nitrate'6H2O 0.68 6.2 0.147 
Beryllium(ll) sulfate'4H2O 0.89 0.78 0.172 
Indium(1I1) nitrate' xH20 1.0 0.100 
Gadolinium(1I1) chloride'6H2O 1.0 1.4 0.157 
Lanthanum(lll) chloride' 7H2O 1.2 17 0.49 0.171 
Sodium(l) fluoride 1.3 4.3 1.2 0.211 
Potassium(l) fluoride 2.6 4.2 0.232 
Lithium(l) fluoride 3.0 0.247 
Aluminum(111) nitrate' 9H2O 3.2 0.7 0.136 
Aluminum(11I) chloride'6H2O 3.4 28 0.136 
Barium(lI) acetate 3.8 3.6 0.184 
Chromium(1I1) chloride' 6H2O 5.6 6.7 2.0 0.107 
~ h e e IDSO values were taken from Clothier et al. (1988). The ID50 is the concentration oi test 
chemical which reduces the final cellular protein content of test wells by 50% in comparison With 
that of appropriate solvent control wells. 
blDSO values were taken from the Registry of Toxic Effects of Chemical Substances (LewIs and 
Tatken, 1980), except those for lithium chloride. potassium iodide, and sodium chloride, whid 
were taken from ICI Toxicology Profiles (Clothier et al., 1989). 
cSoftness (af! values were taken from Williams et al. (1982), except for those for Li" . Na" . K" 
Cu +, Ca2+, Fe +, Sn2 +, AI3+, y 3 +, and La3+, which were taken from Pearson and Mawby (1967). 
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TABLE 1. In Vitro Cytotoxicities of 52 Metallic Compounds to 3T3-L1 Cells, with Rat Oral LD50, 
Mouse ip L050, and Softness (C7 p) Values (Continued) 
LOsot> L050b 
1050a rat oral mouse ip Softness' 
(mM) (mmol/kg) (mmollkg) (C7P> 
lithium(l) chloride 13 18 14 0.247 
Strontium(ll) chloride' 6H2O 15 14 5.7 0.1n 
lithium(l) sulfate 22 0.247 
Calcium(ll) chloride'2H2O 26 9.0 2.5 0.181 
Magnesium(lI) chloride' 6H2O 28 40 1.0 0.167 
lithium(l) iodide 35 0.247 
lithium(l) bromide 38 0.247 
Potassium(l) iodide 44 6.7 0.232 
Potassium(l) sulfate 45 0.232 
Potassium(l) chloride 58 7.4 0.232 
Sodium(l) sulfate 63 0.211 
Potassium(l) bromide 65 0.232 
5odium(l) iodide 79 29 5.8 0.211 
50dium(l) bromide 96 34 0.211 
Sodium(l) chloride 107 74 53 0.211 
ol-fhe 1050 values were taken from Clothier et aL (1988). The 1050 is the concentration of test 
chemical which reduces the final cellular protein content of test wells by 50% in comparISon with 
that of appropriate solvent control wells. 
bLDSO values were taken from the Registry of Toxic Effects of Chemical Substances (Lewis and 
Tatken, 1980), except those for lithium chloride, potassium iodide, and sodium chloride, which 
were taken-from ICI Toxicology Profiles (Clothier et aL, 1989). 
cSoftness (C7f.) values were taken from Williams et aL (1982), except for those for li + , Na + , K + • 
Cu+, Ca2 +, Fe +, 5n2 +, AI3+, y3+, and La3+, which were taken from Pearson and Mawby (1967). 
Softness values can only be used on a comparative scale among 
ions of the same valency (Williams et aI., 1982). The compounds tested 
were therefore divided into metal valency groupings before their in 
vitro and in vivo toxicities were compared with their up values. How-
ever, the numbers of compounds containing monovalent, trivalent, and 
tetravalent metals were inadequate for valid correlations to be made. 
Hence, correlation coefficients were calculated for all the divalent com-
pounds tested and for divalent chlorides only (Table 2b). 
For all divalent compounds, the softness parameter had a similar 
correlation with in vivo toxicities (r - .71 and r - .69) to that for the in 
vitro assay (r - .71). The softness/in vivo correlations improved when 
divalent chlorides only were used in the comparison (Table 2b). Never-
theless, the highest correlation coefficient (r - .89) was obtained when 
the in vitro 1050 values were compared with mouse ip L050 values. 
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TABLE 2. Comparison of In V"t d I V· .. 
M II
· C I ro an n IVO Acute TOXIcities and Softness Parameter Values tor 
eta IC ompounds 
(a) Correlation of In Vivo (log 1050) with In Vitro (log LD50) Toxicities 
Comparison Compounds tested 
Correlation 
coetiicient (f) n 
Rat oral/in vitro All compounds 0.73 ., .. -, 
Mouse ip/in vitro 
Chlorides only 0.75 17 
All compounds 0.86 28 
Chlorides only 0.90 18 
(b) Correlation In Vivo (log L050), Softness (log up)' and In Vitro (log 1050) Values 
Correlation 
Comparison Compounds tested coefficient (f) n 
Rat oral/up All divalents 0.69 15 
Divalent chlorides 0.81 11 
Mouse ip/up All divalents 0.71 15 
Divalent chlorides 0.76 11 
In vitro/up All divalents 0.71 18 
Divalent chlorides 0.73 11 
Rat oral/in vitro All divalents 0.61 15 
Divalent chlorides 0.70 11 
Mouse ip/in vitro All divalents o.n 15 
Divalent chlorides 0.89 11 
DISCUSSION 
Of the two alternatives assessed, the in vitro cytotoxicity assay was 
found to be the better predictor of in vivo toxicity for the metallic com-
pounds tested. 
The in vitro toxicity data gave a better correlation with mouse ip 
values than with rat oral values (Table 2a). Absorption of metallic com-
pounds from the gut is known to vary widely according to the metal 
and anion concerned, the solubility of the compound, and the state of 
the subject animal (Camner et aI., 1986; Nordberg et aI., 1986). Continu-
ous treatment of cells in culture with a compound possibly mimics 
better ip dosage, where there are fewer absorption barriers to tissue 
exposure (Fry et aI., 1988). 
In order to compare toxicities of the metal ions, one should select 
compounds with the same anion, bearing in mind the predominant 
anion in the culture medium is chloride. The contribution of the anion 
to the toxicity of a compound is unimportant when the more toxic 
compounds are tested [e.g., tin(ll) chloride, 1050 0.28 mM). However, 
when compounds of low toxicity [e.g., sodium(1) chloride, ID50 107 
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mM] are dissolved, a Significant increase in the total anion concentra-
tion in the culture medium occurs, giving the possibility of anion ef-
fects. 
Our in vivo/softness correlations (Table 2b) show how softness be-
ing a property of the metallic ion, becomes more useful in c o m p a r i ~ o n s s
~ e t w e e n n compoun?s .with the same anion. The softness parameter is 
~ ~ c a p ~ ? l e e . of p r e d l ~ l n g g th.e } o x i ~ i t i e s s of compounds consisting of 
tOXIC anions and nontoxIc cations [such as sodium(1) tetrathionate 
and potassium(l) fluoride]. In addition, in vivo/softness comparisons 
among compounds with the same anion are only meaningful where 
there are sufficient metal ions in the valency groupings. This limits 
comparisons involving metal ions with unusual valencies. A further lim-
itation of the softness alternative is the variability and availability of 
published up values for metals in all their valency states. Thus, there is 
no positive indication that up has any real value as a means of predicting 
metal toxicity, least of all metal compound toxicity. 
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THE POTENTIAL USEFULNESS OF A DIFFERENTIATING 
TERATOCARCINOMA CELL LINE IN IN VITRO 
TOXICITY TESTING 
L. M. HULME, K. A. ATKINSON, R. H. CLonnn· and M. BALLS 
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Abstract-A number of in vitro systems have been put forward as potential alternative methods for testing 
chenucals for teratogenic potential. The most promising of these systems, for example mammalian whole 
embryo culture and the micromass technique, are currently undergoing further interlaboratory validation. 
However, such tests involve the use of a considerable number of animals. It was therefore decided to 
investigate the possible use of a permanent cell line that possessed many of the properties of embryonic 
cells, that is a differentiating cell line. F9 (derived from a mouse teratocarcinoma), in the development 
of an in vitro teratogenicity test. In a preliminary study, six chemicals were tested for their modulating 
effects on differentiation in undifferentiated. differentiating and differentiated F9 cells. These effects were 
assessed morphologically and by measunng the production of laminin (a biochemial marker of F9 
differentiation). The use of the F9 cell line in in vitro teratogenicity testing shows promise, but further 
work is necessary before its potential can be fully evaluated. 
IntroductiOD 
Over the past decade a variety of in vitro systems have 
been suggested as possible alternatives for use in the 
prediction and evaluation of the teratogenic potential 
of chemicals (for reviews, see Brown and Freeman, 
1984; Neuben, 1989). Of these, mammalian whole 
embryo culture (Schmid, 1983) and the micro mass 
technique (Flint, 1987) appear to be among the most 
promising. Already established as prescreens, these 
methods are currently undergoing further interlab-
oratory validation to assess their potential as genuine 
replacement alternatives. However, both these 
methods require the sacrifice of a significant number 
of animals. and the whole embryo method is legally 
classified as an animal experiment in Britain. It was 
therefore decided to investigate the possible use of a 
permanent cell line that would grow and d i ~ e r e n t i a t e e
in culture in a manner related to that whIch occurs 
during embryonic development, th.us e l i r I 1 : i n ~ t i n g g the 
need for animals. Since cell dJfferentJatlon and 
growth are pivotal events d u r i ~ g g e m ~ r y o g e ~ e s i ~ . . th.eir 
modulation in vitro by a chemIcal nught be mdlcatJve 
of teratogenic potential of the latter. A literature 
survey revealed that a number of c::ell l i n ~ ~ . are 
commonly used as in vitro models of differentJatJon. 
For example, Mummery et aI. (1984) ~ ~ a neuro-
blastoma cell line in a test for teratogeruClty but the 
endpoint of differentiation was only assessed mor-
phologically; it is d e s i ~ b l e e to. use a quantJfiable 
endpoint wherever poSSible (Kimmel et al., ~ ~982). 
F9 cells. originally derived from a mouse. t e s . t J c u 1 ~ ~
teratocarcinoma. can be stimulated by retJnolc aCid 
(RA) to differentiate biochemically as well as mor-
eTo whom correspondence should be addressed. 
Abbrnilliioru: ELISA _ en.zyme-Unked immunosorbent as-
say; PBST _ phosphate buffered saline conWDlDI 
O.OS'I. v/v Tween 20; RA - reunOIC aad. 
phologically (Strickland and Mahdavi, 1978), hence 
allowing differentiation to be both observed and 
quantified. The biocbemical markers of the differen-
tiation include increased synthesis of laminin and 
plasminogen activator, increased infectivity by SV40 
virus and decreased alkaline phosphatase activity 
(Moore et al., 1986; Strickland and Mahdavi, 1978). 
The differentiated phenotype is thought to resemble 
that of parietal endoderm cells in the mouse embry-
onic ectoderm (Hogan et al., 1983; Strickland et al., 
1980), and the cells have been widely used as an 
in vitro model of early events in embryogenesis 
(Strickland, 1981). 
In a preliminary study, the general cytotoxicities 
and the effects on cellular morphology of six chemi-
cals were determined in undifferentiated, differentiat-
ing and differentiated F9 cells. The amount of 
laminin produced by differentiated cells exposed to 
chemicals was measured and compared with final 
total cellular protein levels. The potential use of F9 
cells in an in vitro test for teratogenicity is discussed. 
Materials and Methods 
Cells. F9 cells. a gift from Dr A. K. Daly of the 
University of Newcastle-upon-Tyne, UK. were cul-
tured according to the method of Daly and Redfern 
(1987). 
Reagents. Cell culture reagents. lamir,tin and .anti-
laminin antibody were obtained from Glbco, PaIsley, 
UK; anti-rabbit IgO alkaline phosphatase conjugate. 
all-trans retinoic acid. caffeine. cyclophospbamJde, 
Tween 20 and p-nitrophenol phosphate were from 
Sigma Chemical Co. Ltd, Poole. Dorset. UK; cad-
mium (II) chloride and S-ftuorouraClI were from 
Aldrich Chemical Co. Ltd, Gillingham, UK; and 
dimetbylsulpboxide was from SOH. P,,?le, Dorset. 
UK. Thalidomide was a gift from Rhone-Poulenc 
Ltd, D a ~ ~ UK. 
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Table I. /" VitrO tOXICIties of SIX cherruca1s to undifferentiated. differentlaung and differentiated F9 
cells 
1010 (mM)-
Undifferentiated Differentiating Differenttated 
Chcnncal cells cells cells 
S· Fluorouracil <0.0001 0.001 0.001 
Cadmium (II) chloride 0.006 om 0.01 
Thalidomide 0.13 >1.9t > 1.9t 
Caffeine 0.57 1.9 1.7 
Cyclophosphamide 6.3 2.8 4.9 
Dimetbylsulphoxide 365 328 322 
-The 1010 is the concentrauon of test chemical that reduced the final cellular protem content of test 
wells by SO-/_ in companson With that of appropnate solvent control wells. 
tMulmum solubility In aqueous medium. 
Cytotoxicity tests. 
(a) On undifferentiated cells. 5 x 10" cells/well were 
plated in 24-well tissue culture plates and incubated 
overnight. The medium was replaced with medium 
containing test chemical dissolved in solvent, with 
solvent alone (final concentration of solvent being 
maintained at I %) or with medium alone. After 
exposure to test chemicals for 48 hr, the cells were 
assayed for total cellular protein by the kenacid blue 
method (Knox et aI., 1986). 
(b) On differentiating cells. Cells were plated and 
treated as for differentiated cells, but test chemical 
and control media also contained 0.1 x 10-6 M-RA. 
After the 48-hr exposure, cells were solubilized in 
1 M-NaOH for 2 hr and the extracts were assayed for 
total cellular protein by the method of Bradford 
(1976). Standards were prepared from a protein 
standard solution (Sigma). -
(c) On differentiated cells. Differentiated cells were 
prepared by growing F9 cells for 5 or 6 days (includ-
ing one subculture) in the presence of 0.1 x 10-6 M-
RA. Chemical treatments and the Bradford assay 
were conducted as for differentiating cells. 
Each chemical concentration was tested in tripli-
cate on at least three separate occasions. The 1D5O 
values. that is concentrations that reduced the final 
total cellular protein content of test wells by 50% in 
comparison with the appropriate solvent control 
wells. were calculated from the dose-response curves. 
2 3 4 5 e 7 8 
concentr8tlon (mM. 10-3) 
Fig. I. The effects of S-ftuorouracil on laminin and protem 
levels from differentiated F9 cell cultures. (-e-) lammm 
in culture medium (-0-) cellular protein. 
Enzyme-linked immunosorbent assay (ELISA) for 
laminin. This method was modified from that of 
Williams et al. (1987). Medium samples were taken at 
the end of the 48-hr test period, and were stored at 
- 20°C until required. Samples were centrifuged to 
remove dead cells, diluted 1 in 5 in phosphate 
buffered saline (PBST; containing 0.05%, v/v. Tween 
20) and co-incubated overnight at 22°C with rabbit 
anti-Iaminin antibody. Co-incubations were then 
transferred to a laminin-coated ELISA microplate 
(50 ng laminin/well) for 30 min at room temperature. 
After washing with PBST. anti-rabbit IgG alkaline 
phosphatase conjugate was left on for 60 min. After 
further washing with PBST, the enzyme substrate. 
p-nitrophenol phosphate. was added in a pH 9.8 
buffer. The production of yellow p-nitrophenol was 
measured at 404 nm in a Kontron plate reader. A 
standard curve was constructed using purified mouse 
laminin in the co-incubation. 
Results 
Six chemicals were tested for cytOtoxlClty to 
undifferentiated, differentiating and differentiated F9 
cells. They were chosen because of their widely 
varying toxicities, modes of action and effects in vivo. 
The results (Table 1) indicate that the cells in the 
three culture situations were equally sensitive to 
cadmium (II) chloride, cyclophosphamide and 
10 
a ______ 
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concent r8t Ion 
50 eo 
(mM .• 10·3) 
Fig. 2. The effects of cadmium (II) chloride on laminm and 
protein levels from differentiated F9 cell cultures. (-e-) 
laminin in culture medium. (-0-) cellular protem. 
Ulnerenuaung teratocarctnoma cell line 591 
dimethylsulpboxide. and that the differentiating and 
differentiated cells were less sensitive to 5-ftuoro-
uractl. thalidomide and caffeine. 
Treatment medium samples from cytotoxicity tests 
with differentiating and differentiated F9 cells were 
assayed for tbe presence of laminin. Medium samples 
from differentiating cells did not show any detectable 
laminin (lower limit of detection is approximately 
5 ng/ml), while differentiated cells produced laminin 
in readily detectable amounts. 
Three categories of relationship between protein 
and laminin levels following exposure to the chemi-
cals were observed: (a) where the protein level fell 
more than tbe laminin level, with 5-ftuorouracil 
(Fig. 1) and caffeine (data not shown); (b) where the 
laminin level fell more than the protein level, with 
cadmium (II) cbloride (Fig. 2); (c) where the protein 
and laminin levels followed each other, with 
dimethylsulphoxide (Fig. 3), cyclophosphamide and 
thalidomide (data not sbown). 
Apart from RA, none of the chemicals tested 
induced morphological changes in normal F9 cells at 
the concentrations and over the time scales tested 
(except for the expected shrinkage of dying cells). 
Morphological changes induced by RA in the differ-
entiating and differentiated cell test were not affected 
by the chemicals tested. 
Discussion 
F9 cells possess several characteristics that make 
them a useful model of cellular differentiation in 
toxicity studies: (I) they differentiate morphologically 
and biochemically in response to RA and other 
chemicals (Moore et al., 1986; Nishimure et al., 1983). 
(2) They are easy to maintain in culture, and, being 
a continuous cell line, offer considerable advantages 
over primary cultures in terms of cost, technical 
expertise required and reproducibility. (3) The bio-
chemical marker of differentiation, that is laminin, is 
readily quantifiable by ELISA without needing to fix 
or disrupt the cells. 
These preliminary observations suggest that f u ~ ~
ther investigations in the potential use of F9 cells In 
1 0 0 - r - - - ~ _ _
I , 
100 
, 
200 300 400 
concentretton (mil) 
in vitro teratogenicity testing would be worthwhile. It 
appears tbat different chemicals can affect lamlnin 
production by differentIated F9 cells in several wavs. 
and tbat the differentiated functIon as well as ~ l l l
division can be the target for chemIcal actlon. 
There appears to be no simple explanatlon as to 
why differentiating and differentiated F9 cells are less 
sensitive to 5-ftuorouracil. thalidomide and caffeine 
than normal cells. Differentiated cells have a slower 
growth rate tban tbe undifferentiated cells. but this is 
not true for the differentiating cells, so altered growth 
rate cannot be the only reason why there is differen-
tial sensitivity. 
The biochemical marker of differentiation. that is 
the laminin level in the medium. was higher than 
expected from tbe protein level in 5-ftuorouracil 
(Fig. 1) and caffeine-treated culture wells. Micro-
scopical observation showed a slow build-up of tox-
icity over tbe 48 hr-period for both chemicals. hence 
laminin may have been released by cells before they 
were killed. Alternatively, 5-ftuorouracil may have 
affected cell division without affecting cell viability or 
its ability to produce laminin. CadmIUm (II) chloride 
caused the laminin level to drop below that expected 
from the protein level (Fig. 2). This points to 
cadmium interfering with the process of lamimn 
production either intracellularly or at surface sites. 
without affecting cell proliferation. 
In addition to the effect of chemicals on laminin 
production by differentiated cells, the possibility of 
chemicals inducing differentiation or inhibiting the 
action of retinoic acid over longer time scales needs 
to be examined. 
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